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Parkinson’s Disease (PD), Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy 
(MSA) are incurable neurodegenerative conditions.  A lack of palliative care provision has 
been demonstrated for people with PD.  Few studies have investigated the palliative care 
needs of people with PSP or MSA.  Place of death for those with PD differs from age 
matched controls, but the effect of place of death on the quality of end of life care has not 
been explored.  
The aims for this project were to explore: 
a) the palliative and end of life care needs for people with PD/PSP/MSA 
b) whether the quality of the end of life care experience varies by location  
 
Methods 
This is a mixed methods study involving closed internet forums, semi-structured interviews 
and survey data from national bereavement surveys.  
  
Results 
The rarity of PSP/MSA shaped experiences. There was a need for continuity of care which 
was often lacking in the NHS/social care.  
The factors that were important at time of death were that individual worth was recognised, 
time was given and good communication was attempted.  Hospices delivered the highest 
rated care, due to their holistic nature.  The chaotic nature of hospitals made personalised 
care provision difficult.  Care homes provided good emotional support.  Although home was 
the most preferred place of death, if additional support was not present it was difficult for 
informal carers to manage.  





There are ongoing studies investigating palliative care provision for people with neurological 
diseases, focussing on short term interventions.  Although this may work for those with PD it 
is likely to work less well for those with PSP/MSA.   
The difficulties people with PD/PSP/MSA encounter with communication affects the way 
they are treated within the NHS and means that earlier discussions about the future are 
required if wishes are to be understood.  
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Chapter 1 Introduction 
This chapter briefly outlines the background to the project, its main aims and the methods 
used to explore those aims.  At the end of the chapter is an outline of the thesis.  
1.1 Background and Aims 
PD, PSP and MSA are all incurable, progressive, neurodegenerative conditions.  As they 
progress they can affect mobility, speech, swallowing and cognition; with pain, falls and 
infections common.  PD is the second most common neurodegenerative disorder whereas 
PSP and MSA are rare.  Prognosis varies widely within the disease groups.  On average PSP 
and MSA survival times from the start of symptoms are thought to be 6-10 years; there is 
debate about whether PD shortens life expectancy at all.  Each condition causes a wide 
range of physical symptoms, including pain and fatigue, psychological symptoms of 
depression and anxiety, difficulties with social care due to decreasing mobility and 
potentially impact on spirituality as loss of independence (and for PD/PSP cognition) is so 
marked.     
Palliative care is the ‘active holistic care of patients with advanced progressive illness’ (1, 
p20) and aims to address physical, psychological, social and spiritual concerns. Its aim is to 
achieve the best quality of life possible for a person who has a life limiting disease and their 
family.  The provision of palliative care has no timescale attached and is applicable from the 
diagnosis of a life threatening condition (2).  End of life care varies in definition but in most 
UK policy it encompasses the care provided for people who are likely to die in the next 
twelve months, including those in the last few days of life (3). 
A surprisingly small number of articles exploring palliative care for people with PD exist, 
although they are increasing in frequency (4-11); only two explicitly explore the end of life 
(5, 12).  Aside from Saleem et al’s (11) study which looked at the experiences of people with 
PD, PSP and MSA there are only a couple of original articles that explore palliative care 
concerns in PSP and MSA alone and they are related to retrospective note reviews regarding 




single issues such as advance care planning in MSA (13) or triggers for hospice admissions in 
PSP (14) rather than experiences as a whole.   
For some time one of the factors felt necessary for achieving ‘a good death’ has been 
whether a person dies in their preferred place of care.  Although PD palliative care needs 
have been explored, achievement of a PPOD and whether the location of end of life care 
impacts on the quality of that care has not previously been explored for people with PD.  
This thesis therefore aims to investigate two relatively unexplored areas of palliative and 
end of life care research:  
1. The palliative and end of life care needs of people with PD, PSP and MSA 
2. Whether the quality of the end of life care experience varies by location for people 
with PD, PSP or MSA.  
1.2 The palliative and end of life care needs for people with PSP and MSA 
Previous studies have shown that people with PD have a palliative care need equivalent to 
those with cancer (7, 15) or motor neurone disease (MND) (12).  Although people with 
cancer and MND have had access to specialist palliative care (SPC) and hospice support 
since its inception in the 1960s, the same is not true of people with PD.  Despite PSP and 
MSA progressing more rapidly than PD and people with these conditions having lower 
quality of life scores than those with PD (6, 16, 17), there are very few studies exploring the 
palliative care needs and experiences of care for people with PSP or MSA (6, 18) and none of 
a qualitative nature.  
As palliative and end of life care, regarding people with PSP and MSA had been rarely 
explored, the decision was made to undertake this part of the study using qualitative 
methods, so that issues could be explored in greater depth.  It was likely that many of the 
issues that have previously been described in palliative care, such as a lack of information 
and co-ordinated support, would be present for those with PSP and MSA and would be 
similar to people with PD.  However, because the conditions are rarer and progress more 




quickly it was felt there may be additional palliative and end of life care concerns that were 
unique to people with these conditions and their carers.  
Chapter 5 of this thesis relates to this aim and shows the ways in which the experiences of 
people dying with PD differ from the experiences of people dying with PSP and MSA.   
1.3 Location of end of life care  
When this project began ensuring that people who were dying achieved their PPOD was still 
high on the political and sociological agenda.  Only one study had previously ascertained 
where the PPOD might be for people with PD, that of Goy and Carter in the USA (12); UK 
preferences were unknown.  There had for some time been a goal of achieving a home 
death for most people and yet in 2009 Snell et al (19) had shown that only 9% of people 
with PD died at home, compared to 17% of those dying with other conditions in an age 
matched population.  In 2013 Sleeman et al (20) showed similar findings when comparing 
PD (9.7% died at home) to MND (27.1%).  They also demonstrated that far fewer deaths 
occurred in hospices for people with PD (0.6% vs 11.2% MND).  In 2018 Public Health 
England produced a data analysis report regarding deaths associated with neurological 
diseases, which showed that people with PD die most frequently in institutional settings, 
(care homes and hospitals) rather than in their own private homes (21).  However, as many 
people with PD have moved into care homes during the course of their disease, people with 
PD die in their usual place of residence more often than people with other neurological 
diseases (57% vs 45% MND) (21) whether or not this impacts on their experience is 
unknown.    
Gradually there has been a decrease in emphasis on achieving the goal of PPOD, 
predominantly because when the views of people who are actually dying are explored, 
rather than that of the general population, place of death appears to be of less importance 
than policy had previously suggested (22).  
Currently the focus has moved to improving care regardless of the location and aiming to 
address the attributes that can improve the end of life care, wherever that care occurs (23).   




Although most people with PD die in hospitals or care homes there has not been any 
exploration into whether this impacted on their end of life care experience.  The National 
bereavement surveys indicated that care homes provided a higher level of symptom 
support than hospitals and home environments, with hospices seeming to score best (24); 
but it is not known whether this stands true for people with PD, PSP or MSA.  In addition, 
place of death has not been explored to ascertain the attributes that matter regarding staff 
and environment for people with PD, PSP or MSA.  This thesis aims to address these 
concerns and the results are presented in Chapter 6.  
In order to investigate whether location has an impact on the quality of end of life care for 
people with PD, PSP and MSA a mixed methods approach was taken.  This involved 
accessing data from the national bereavement surveys (VOICES 2012-15) and analysing the 
data that related to people who had died from PD (n=1007), PSP (n=44) and MSA (n=23).  In 
addition, qualitative interviews with bereaved carers of people who had died from PD, PSP 
or MSA provided additional depth and allowed a better understanding of experiences across 
the differing care locations.   
1.4 Methodology 
As a practising UK geriatrics trainee with an interest in PD, PSP, MSA and palliative care the 
underlying methodology of this mixed methods project was pragmatism.  The aim was to 
explore the experiences of bereaved carers in order to make recommendations for practice 
that might improve the palliative and end of life care experiences of people with these 
conditions and their relatives.  To achieve this aim, aspects of the interviews that were more 
closely related to encounters with healthcare professionals (HCPs) were the focus of the 
analysis and as such the aspects that related more closely to relationships with family, 
friends and communities are not explored in depth within this thesis.   
1.5 Carers 
The term carer is not a term that the relatives I interviewed would necessarily identify with, 
and Roger and Medved (25) found that as a term it is actively disliked by people with PD 




themselves as it presents their relationships with their main family support in too clinical a 
manner.  I did not use the term ‘carer’ when conducting the interviews and referred to 
people by name or relationship i.e. wife, mum etc however, the term ‘carer’ or ‘informal 
carer’ is used within this thesis for ease of group comparisons and because it is the term 
used within the VOICES survey analysis and throughout the literature.   
1.6 Outline of thesis 
Chapter 2: Literature review 
This chapter sets out the background to the project. The first part explains the pathology, 
clinical findings and epidemiology of PD, PSP and MSA, and explains that they have a high 
degree of symptom burden and that there is a potential need for specialist palliative care 
input from the start.  The second part discusses end of life care provision and the current 
policies in place to guide end of life care provision in the UK.  The third part discusses place 
of death and why it may affect the quality of the end of a person’s life; it also considers the 
historical background of dying and illustrates why place of death is thought to be so 
important.  
Chapter 3: Methodology and methods 
This chapter explains why pragmatism was the methodology of choice for this mixed 
methods project and then outlines the project design.  It discusses the methods used for 
recruitment, sampling and analysis. 
Chapter 4: Demographic results 
This chapter outlines the demographic details of the quantitative and qualitative samples.  
Chapter 5: Palliative care needs of people with PD, PSP and MSA 
This chapter considers the palliative care needs of people with PD, PSP and MSA, comparing 
PD to the two rarer diseases.  As this chapter explores needs from diagnosis onwards most 
of the factors relate to people living in their own homes.  It first outlines issues regarding 
information gathering and shows how these might impact on ACP.  It then highlights 




problems with navigating the system and getting adequate home support.  The third part 
discusses how a lack of knowledge about the diseases impacted on the care that was 
provided and the final part shows how crucial support from family, friends and the disease 
charities was to enable a person to stay at home for as long as possible.    
Chapter 6: Quality of service provision in the last three months of life, place of death and 
bereavement 
This chapter compares the quality of service provision in the last three months across four 
different places of death; hospitals, care homes, home and hospices.  It discusses staff 
attitudes towards the dying, the control of symptoms, awareness of dying and choices about 
PPOD and explains how these impact on the end of life experience.  The last section covers 
staff attitudes towards carers themselves and includes bereavement support.  As the end 
stages of the diseases occur in a similar way, and the qualitative data did not indicate a 
difference between the diseases with regard to specific locations (and the numbers for 
PSP/MSA were too small to provide meaningful statistical comparisons in regard to place of 
death) the diseases are combined in this chapter, so it is the comparison of the location of 
the services that is the focus, rather than a comparison of the diseases.  The quantitative 
and qualitative data are integrated to illustrate where there are differences across the 
locations of care and what those differences might mean.  
Chapter 7: Discussion of themes 
This chapter pulls together the two previous results chapters and explains how they fit into 
the overall themes of the project: the emotional and practical elements of preparation, 
support and identity, before then comparing them with existing literature. 
Chapter 8: Discussion regarding changes to service provision 
This chapter starts with a summary of the PD, PSP and MSA specific literature and how it 
compares to the findings of this project.  The main section suggests improvements for 
service provision in line with the pragmatic methodology that underpins this project.  The 
final part of this discussion chapter outlines the strengths and limitation of the project and 













Chapter 2 Literature Review 
2.1 Methods/search terms of the literature review 
Prior to commencing this research project, a literature search was performed in regard to 
the main research question: the palliative and end of life care needs for people with PD, PSP 
and MSA. This was undertaken using Medline and Scopus.  
Within Medline the keywords of ‘Parkinson’s disease or PD’, ‘Multiple system atrophy or 
MSA’ and ‘Progressive supranuclear palsy or PSP’ were combined with a search with the 
keywords ‘palliative care OR terminal care OR end of life’.  Within Scopus ‘Parkinson’s 
disease’, ‘Progressive Supranuclear Palsy, and ‘Multiple system atrophy’ were searched for 
as article titles, abstracts or keywords and the terms ‘palliative care or end of life’ were 
searched for within the results. The initial searches were performed in September 2015 with 
the results illustrated in Figure 1. 
Journal articles, review articles, conference abstracts and letters regarding original research 
were included in the searches.  Review articles were predominantly used to hand search for 
additional relevant literature.  Articles that were opinions/advisory, related solely to 
medication or the development of survey tools and outlines for future projects were 
excluded.  Articles that focussed predominantly on carer burden or the impact on HCPs, 
rather than on the experiences of those with the diseases were also excluded.  Within the 
initial search were several conference abstracts that included data that was then published 
as a journal article at a later date and it is the later journal articles that are included in this 

























Throughout the project regular literature searches were performed using the same terms on 
both Medline and Scopus, with the final searches occurring in Summer 2019.  Grey literature 
in the form of theses, audits and websites relating to the diseases was also searched to 
ensure developing areas of research were not missed.   As the methodology of the project 
was pragmatism, meaning there was a need to relate the findings to current policy, a large 
amount of grey literature was also searched through and read in regard to UK policy.  This 
was searched for through NHS England’s website, the gov.uk website and using search 
engines to search for ‘end of life care policy UK’ and ‘palliative care policy UK’.  Further 
reports/grey literature were also reviewed after checking the reference lists of policy 
reports and the ambitions for palliative care framework. 
Medline: PD AND 
palliative care/terminal 
care/end of life = 87 
results 
Scopus: PD: Search within 
results for ‘Palliative care 
or end of life care’ = 411 
 
Medline: 51 abstracts 
read  





read in full 
 
10 original articles 
included: Tuck et al, 
Sleeman et al, Saleem et 
al, Higginson et al, 
McLaughlin et al, Hasson 
et al, Giles & Miyasaki, 
Goy et al, Lee et al, 
Hudson et al, Snell et al 
  
Medline: PSP AND 
palliative care/terminal 
care/end of life = 10 
results 
 
Scopus: PSP: Search within 
results for ‘Palliative care 
or end of life care’ = 16 
Medline: MSA AND 
palliative care/terminal 
care/end of life = 7 results 
Scopus: MSA: Search 
within results for 
‘Palliative care or end of 
life care’ = 31 
Medline: 10 abstracts 
read  
Scopus:  5 abstracts 
read 
3 articles read in full 
 
 
Medline:  abstracts 
read  
Scopus: 4 abstracts 
read 
2 articles read in full 
 
 
3 original articles 
included: Saleem et al, 




2 original articles included: 




Figure 1 Initial literature search 




Once data had been collected, analysed, and the developing themes were clearer, further 
literature searches were performed in regard to issues such as identity, loss of self, the wish 
to die/ hasten death, advanced care planning, preparation and bereavement.  If the data 
were scarce in regard to these topics within the movement disorder literature, then a search 
for these factors and motor neurone disease (mnd/als1) was also used.  Mnd has long been 
considered a palliative disease and as such a greater amount of palliative/end of life care 
literature exists concerning the experiences of people with mnd.  
During all searches any relevant literature was added to an excel workbook that was used as 
a framework to ascertain the main results and themes of each piece of literature. This 
workbook was used to update the original literature review in order to provide a 
chronological and conceptual background to this research project.  
A narrative literature review was used so that biomedical studies regarding PD/PSP/MSA 
could be readily combined with social theory about dying and current policy. The fact that a 
large proportion of the project was qualitative meant it was important to explore 
sociological concepts within the literature review/discussion chapters and the pragmatic 
methodology of the project meant that suggested improvements in care had to be relevant 
to current UK policy.   
2.2 Background 
PD, PSP and MSA are all progressive neurodegenerative conditions for which there is no 
known cure.  They overlap in terms of symptoms, with all showing variable signs of 
Parkinsonism – comprising slowing down (aka bradykinesia), rigidity, postural instability and 
tremor (26), but they have differing pathophysiology, additional features and prognoses.  
They are also known as ‘movement disorders’ and people with the conditions are reviewed 
 
1 ALS – amyotrophic lateral sclerosis in the term use for mnd in the USA. It is a rapidly 
progressing, rare, neurodegenerative disease with no cure and an average prognosis of 2-4 
years from symptom onset.  




regularly in ‘movement disorder clinics’ which may be run by neurologists, geriatricians, or 
both, with input from specialist nurses.     
2.3 Epidemiology 
PD is the most common of the three disorders, with a prevalence of around 130/100000 in 
the UK (27), whereas MSA and PSP have prevalences of around 2-5/100000 and 4-5/100000 
respectively (28-30).  The incidence of all three increases with advancing age (31, 32) and 
normally occurs above the age of 50.  
2.4 Pathophysiology and clinical features 
All three diseases are caused by a loss of neurones.  Although the exact aetiology of the 
neuronal loss is unknown it is felt to be due to various different mechanisms, including 
oxidative stress and the accumulation of additional proteins in the brain (tau for PSP and α-
synuclein for PD and MSA)(33-35).  It is this protein accumulation that is used to make a 
definitive diagnosis at post mortem (26, 36, 37).  As the neurones die, dopamine levels are 
reduced.  Dopamine is the main neurotransmitter in the basal ganglia area of the brain.  The 
basal ganglia are responsible for fine motor control and planning movement, which explains 
the motor features of Parkinsonism detailed above.  A DaTscan, which shows the level of 
dopamine transporters (DaT) present in the brain, can be a useful tool to aid clinical 
diagnosis, as in all three diseases the scan will be positive (i.e. show reduced dopamine 
transporters, reflecting the loss of the neurones the transporters are on).  In PSP, the area 
superior to the nuclei is also affected, leading to a vertical gaze palsy; the disease is also 
associated with an increased incidence of early falls (36).  In MSA, as the name implies, 
multiple areas of the brain are affected, including the cerebellar pathways (responsible for 
co-ordination) and the autonomic pathways, deficiencies in which can lead to urinary 
incontinence and an orthostatic decrease in blood pressure (37).  




2.5 Staging of PD, PSP and MSA 
All three diseases are progressive and over time lead to increasing disability.  One of the 
common tools used to denote the severity of PD is the Hoehn and Yahr rating scale (as 
shown in Table 1).  The scale is often used in research to denote the equivalent stage of 
MSA and PSP as well. 
 
 
The Hoehn and Yahr scale is used in research, as well as in clinical practise, alongside the 
Unified Parkinson’s Disease Rating Scale (UPDRS).  This scale was developed in the 1980s 
and originally consisted of four parts covering mood, motor disability, motor impairment 
and the motor/non-motor complications of treatment (39).  A criticism of these scales was 
that they concentrated predominantly on the motor features of the disease.  There are 
many non-motor symptoms that commonly affect people diagnosed with PD including sleep 
disturbances, fatigue, gastrointestinal problems, psychiatric problems (anxiety and 
depression), pain and cognitive impairment (40).  As these symptoms are so common, and 
often lead to more morbidity than the motor symptoms, especially at an earlier stage, the 
UPDRS was modified in 2008 by the movement disorder society to include more of the non-
motor symptoms (41).  Similar rating scales have been developed for PSP and MSA, the 
PSPRS (42) and the UMSARS (43) respectively.  However, as with the original UPDRS they 
predominantly focus on diagnostic motor features rather than non-motor issues.  The same 
non-motor problems are known to occur in MSA and PSP, perhaps to an even greater extent 
Stage Features 
1 Unilateral involvement only usually with minimal or no functional disability 
2 Bilateral or midline involvement without impairment of balance 
3 Bilateral disease: mild to moderate disability with impaired postural reflexes; 
physically independent 
4 Severely disabling disease; still able to walk or stand unassisted 
5 Confinement to a bed or wheelchair unless aided 
Table 1 The Hoehn and Yahr Rating scale, reproduced from Goetz et al (38 p1021)  




and severity than in PD, as these conditions progress more quickly than PD (37), with less 
effective treatment available.  
In 1998 MacMahon and Thomas (44) described four clinical stages of PD starting with 
diagnosis, where information is shared; a maintenance phase where drugs control 
symptoms; a more complex phase where drugs work less effectively and increasingly 
complicated drug regimens or surgical options are considered; and lastly a palliative phase 
of the disease.   
2.6 Treatment 
In the 1960s levodopa (a synthetic dopamine precursor) was developed.  It is absorbed from 
the gut in combination with an aromatic amino acid decarboxylase inhibitor2, which 
prevents peripheral breakdown of the drug.  Once it crosses the blood brain barrier it is 
converted into dopamine by the brain and it has proven to be a very effective treatment for 
PD in terms of reducing motor symptoms.  There have been other treatments developed, 
which act by stimulating post-synaptic dopamine receptors (dopamine agonists) or by 
preventing the breakdown of dopamine, either centrally (MAO-B inhibitors) or peripherally 
(COMT inhibitors), and all help motor symptoms to some degree.  None of these drugs has 
had any significant effect on disease progression however and they do not aid non-motor 
symptoms.  The same drugs are often tried to help motor symptoms in MSA (37) and PSP 
(35) but they do not work as well, or for as long, as in PD and for some people they offer no 
benefit at all.   
2.7 Prognosis 
Survival times for PSP are thought to be between 6-12 years (45) from start of symptoms 
and MSA has been shown to have a median survival of 9.8 years (46).  There is ongoing 
debate about whether PD shortens survival at all; patient information sites and leading 
 
2 carbidopa in the case of ‘sinemet’ or benserazide in the case of ‘madopar’ 




charities deny a shortened life expectancy, though two meta-analyses suggest a mortality 
ratio of between 1.5-2.2 (47, 48).  More recently, a 2017 study regarding synucleinopathies 
(PD, MSA) in the USA showed that people with PD were 1.75 times more likely to die than 
age matched controls, and this increased to 3.86 if dementia was present (for MSA the 
hazard ratio was 10.5) (49).  PD, PSP and MSA show a lot of variability amongst diagnosed 
individuals with regard to symptoms and prognosis and this is perhaps why some public 
patient sites claim that the disorders are not life-threatening (50, 51).  In part, for PD at 
least, this seems to come down to semantics.  NHS Choices (50), Parkinson’s UK (52) and the 
Michael J Fox research foundation (53) all claim that PD does not directly cause death but as 
symptoms worsen the body is more susceptible to life-threatening incidents or infections; 
so without the weakened state of advanced PD a person would likely live longer.  
 Cause of death (COD) 
Several studies have analysed death certificate data to determine what people with PD died 
from and all have shown that pneumonia is a far more common COD amongst PD patients 
than the general population, with the prevalence of ischaemic heart disease, 
cerebrovascular disease and malignancy the same, or often less, than an age-matched 
population (54-57).  As pneumonia is more common with reduced mobility and impaired 
swallowing, both common problems with advanced PD, the PD is very likely to have 
contributed to these deaths.  Nath et al (58) showed the same was true for PSP, with 
pneumonia by far the commonest terminal event prior to death.  Much discussion regarding 
COD centres around how the death certificate is written and where the neurological 
disorder is placed on the death certificate, if at all (Chapter 3.8.3 and Appendix C explain this 
in greater detail).  Nath et al (58) discuss that PSP is often not recorded properly and so it is 
hard to obtain death certificates for this population and Pennington et al in North East 
England and Hobson et al in Wales both showed that only 63% of their known PD patients 
had PD mentioned anywhere on the death certificate (55, 57).   
There are four studies looking specifically at COD in MSA (59-62) and three showed sudden 
death is relatively common (59, 61, 62) ranging from 14.5% (62) to 38.1% (61).  Other than 




sudden death, the patients with MSA tended to have died from pneumonia, urine infection 
or aspiration, so normally with direct complications from the disease.  One study compared 
MSA to PD and though the numbers were small (n=21 for each) all those with MSA died 
from potential complications, whereas people with PD also died from cancer, stroke or 
myocardial infarction (61).  It would seem that MSA and PSP contribute to death more 
directly than PD, where a large number of patients die from other problems common with 
ageing, possibly before they have reached an advanced stage of PD.  A recent study by 
Moscovich et al would support this claim as those dying in an earlier stage of PD had similar 
causes of death to an age matched population, whereas those with advanced stage PD died 
of similar causes to those with PSP/MSA, mostly from sepsis or pneumonia (63).   
2.8 Palliative Care need 
As all three conditions are incurable they could be considered palliative, in line with the 
original 1990 definition of palliative care from the World Health Organisation, where 
palliative care was seen to be “The active total care of patients whose disease is no longer 
responsive to curative treatment”(64 p11).    
However since their definition of palliative care changed in 2010 to “an approach that 
improves the quality of life of patients and their families facing the problem associated with 
life-threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual” (65) deciding whether or not the diseases are life-
threatening has potentially become a more important issue.   
Hudson et al (7) discussed that the uncertainty about whether PD should be considered a 
life-threatening disease places PD at odds with other palliative care populations.  They 
undertook a qualitative descriptive study in Australia, where they interviewed 8 patients, 21 
relatives and 6 health professionals to explore issues surrounding support and practicalities 
to answer the question ‘Would people with PD benefit from palliative care?’ Their robust 
thematic analysis identified 5 themes: the emotional impact of diagnosis, staying connected, 




enduring financial hardship, managing physical challenges and finding help for advanced 
stages. They explained that many of their findings, such as the grief response to a diagnosis 
of PD, feelings of isolation due to communication problems and challenges meeting the 
numerous physical changes PD brings, such as immobility, were very similar to those in a 
cancer population, the usual beneficiaries of specialist palliative care (SPC). They also 
discussed the need patients and relatives felt for more information about PD from specialist 
teams and that PD should be managed with multidisciplinary expertise from staff 
adequately trained in PD, with large levels of support being required as patients advanced.  
Giles and Miyasaki (4) reported similar findings with regard to the need for more 
information, coupled with a need for guidance about where to get it. Their small scale 
exploratory phenomenological work probed the lived experiences of the Canadian 
healthcare system for three people in the palliative stage of PD and their family members 
(n=4).  They also discuss the theme of ‘wanting and not wanting’, where relatives said they 
wanted more information but were ambivalent as to how much, especially regarding 
deterioration.  Given that this ambivalence existed even with advanced patients (Hoehn and 
Yahr 2.5-5) (4) this seems to support the point made by Hudson et al (7) that it is difficult to 
know when to offer a palliative approach to patients with PD as their long and variable 
disease trajectory may mean they do not consider themselves to have a life-threatening 
disease, even though they have similar needs to other patients using SPC services.  
Much of Giles and Miyasaki’s paper (4) was concerned with problems regarding home-care 
services in Canada; the participants were recruited from a tertiary hospital lacking a 
multidisciplinary team (MDT).  This makes their findings less generalizable to the UK where 
an MDT approach is more commonplace.  Hudson et al’s (7) participants were self-selecting 
and so it is unfortunately not clear how certain their PD diagnosis was.  In addition, the 
authors did not use a staging system specific to PD but separated participants into early 
stage (where they were essentially independent in everything) to middle/late stage 
(including any degree of help) (7); this makes it hard to understand how advanced the 
patients might be.  The small number of participants in both studies could also affect 
generalisability but nevertheless they explored the issues that matter to patients and their 




carers and showed why instigating palliative care might be a problem.  Hudson et al’s 
concluding point is that using prognosis for a SPC referral in neurodegenerative conditions is 
fraught with difficulties (7).  Indeed, since their paper was published further studies (6, 11, 
15) have discussed that due to their symptom burden people with PD should have SPC input 
from an early stage; not just at the point they appear to be deteriorating or approaching the 
end of life.    
 A review article by Wiblin et al, summarising the evidence for palliative care in 
neurodegenerative disease, suggests the same is true for those with PSP and MSA (18).  
Only two published articles regarding palliative care need have included people with PSP 
and MSA (6, 11); these articles concentrated predominantly on the symptom load of a single 
London cohort followed up in a longitudinal study.   
 Symptom load 
Lee et al (15) undertook a descriptive cross sectional survey of 123 patients known to have 
PD, with Hoehn and Yahr scores ranging from 1-5 (median 3), living in Northern England. 
They carried out face to face interviews to complete a Palliative Care Assessment Tool 
(PACA) for each participant.  The PACA allows patients to identify their symptoms and 
subjectively attest to their severity (in terms of how greatly they impact on their day) and it 
had previously been validated for cancer diagnoses and non-malignant conditions.  Lee et al 
found that participants had an average of 14.3 symptoms.  The most frequent were 
slowness of movement and pain, which were present in more than 85% of participants and 
dominated the day for 17% and 20% respectively.  Immobility was present in 50% and 
dominated the day in 29% and drowsiness, anxiety and insomnia were also common. Of the 
161 patients initially identified, those who did not take part were older, had more advanced 
disease, more cognitive impairment and were more likely to be living in nursing homes. 
Given that the authors found an increase in the frequency and severity of symptoms as the 
disease progresses, the study may have underestimated the degree of symptom load for PD 
patients.  Despite this, symptoms such as pain, immobility and constipation were present in 
comparable frequency and severity to cancer patients and so the authors argued that when 




symptom load is high, regardless of Hoehn and Yahr stage, a palliative care referral may be 
warranted. 
Higginson et al (6) also showed that the cohort of patients they followed over a year had a 
symptom load similar to, or more severe, than that of cancer patients.  They conducted a 
longitudinal community study involving 82 patients in the south east of England (48 with PD, 
18 with MSA and 18 with PSP); all participants were equivalent to Hoehn and Yahr stage 3-5, 
had mental capacity with minimal cognitive impairment, if any, and lived at home when 
recruited.  The authors conducted face to face interviews using a multitude of well validated 
questionnaires, many used previously or adapted to PD, to determine disability, symptom 
load, quality of life and depression levels.  Two thirds of the participants had at least severe 
disability, though this was more common for the PSP and MSA groups.  All three conditions 
had poor average quality of life scores and showed evidence of considerable psychological 
distress at baseline assessment.  By the end of the year almost 50% of those with MSA and 
PSP had died, compared to 6% with PD.  Problems with swallowing and communication 
were more prevalent for PSP (60%;80%) and MSA (76.5%;76.5%) than PD (40%;58%) and 
those with MSA had far more difficulty controlling urine.  Over the year the subjects stayed 
the same or deteriorated; the Hoehn and Yahr stage did not predict which participants 
would develop more symptoms over the year, but the higher the initial symptom burden at 
baseline, the more likely additional symptoms were to develop.  The authors postulated that 
given the long-term nature of symptoms a solution may be to initiate a referral to SPC for 
potential short-term intervention, which might assess and help manage pertinent 
symptoms, but could also allow those with multiple problems and deteriorating courses to 
remain under review.  This short-term symptom review option may sit better with patients 
not wanting to consider themselves terminal.       
The same cohort’s palliative care needs and initial baseline symptoms, including their 
severity, were also presented by Saleem et al (11) as a cross-sectional study.  Like Lee et al 
(15) the most burdensome symptoms found were lack of mobility (present in 50%) and pain 
(39%) (11) with other severe symptoms being difficulty using arms, difficulty 




communicating, fatigue, drooling, constipation, insomnia and falls.  The most frequent 
symptoms were immobility, pain, fatigue and daytime sleepiness which were all present in 
more than 80% of Saleem et al’s participants (11).  Patient and family anxiety was common 
and 65% of participants had been depressed to some extent in the previous 2 weeks.  
Saleem et al also discussed provision of information and practical support; 62% felt they had 
been given full information about their disease, though 38% would have liked more and 59% 
had their practical problems addressed (11).  Like Lee et al (15), Saleem et al showed that 
the higher the Hoehn and Yahr stage, the higher the symptom burden and they also showed 
that the prevalence of symptoms was equal to an advanced cancer population (11).  They 
explained that the guidance for long term neurological conditions talked about triggers for 
palliative care support but even though their patients met many of these triggers the 
majority had not been referred to SPC.  
These three papers have several strengths.  There are reasonable numbers of patients 
included, enough to make statistical conclusions sound, and the tools used to investigate 
symptoms and quality of life have been well validated previously.  As symptoms are likely to 
be linked to the disease, for which the same criteria are used worldwide, the findings 
regarding symptom load are likely transferable to other countries as well.  The main 
weakness of these studies is that they do not include anyone with a significant degree of 
cognitive impairment, despite the fact that in advanced PD around 40% have developed 
dementia (40).  This is likely due to the logistics of the studies, as those with cognitive 
impairment may well not recall symptoms, but it means there is a potentially large group of 
patients whose symptom burden we are less sure about and cognition, especially with 
regard to family relationships and whether participants are independent or not, is likely to 
play a large role in quality of life.  They also concentrated on people living in their own 
homes, whereas those with more advanced disease and closer to the end of life, indeed the 
people who may be at most need from palliative care support, are more likely to be in 
residential or nursing care.   




Initiating palliative care as a response to symptoms rather than prognosis fits with the ‘early 
identification and impeccable assessment of needs’ statement in the WHO definition of 
palliative care (65) and NICE guidance for PD (3) currently reflects this, with the suggestion 
that referral to SPC should be according to need, regardless of disease stage.   
A more recent study exploring the implications for SPC in Germany by Strupp et al (66) 
aimed to explore factors which led to people with Parkinsonism feeling subjectively more 
severely affected by their disease.  A survey was developed including open questions about 
why a person felt severely affected by their disease and the 814 complete responses were 
analysed against the more objective closed questions regarding disease severity and 
demographics.  In this study, although pain was a factor for 8.1%, unmet social needs such 
as help with everyday tasks, finances, information access and social integration were 
mentioned more often (in 28.1%, 11.6%, 9.9% and 9.9% respectively) as severely affecting a 
person; immobility was mentioned most (34.9%).  This indicates other factors, aside from 
symptom load that might be improved through a more palliative approach.  As a caution this 
study included all forms of Parkinsonism, including those without a known cause, and this 
likely affects the generalisability of the findings to a definite PD population.   
There is less guidance for PSP and MSA, but timely referral to SPC services is suggested in 
the guidance to professionals on the charity websites (67, 68).  In addition, in 2016 the 
European Association of Palliative Care and the European Academy of Neurology issued a 
consensus review suggesting that palliative care is included in guidelines regarding the care 
of all people with progressive neurological disease, in the same way it already exists for 
those with MND/ALS (69).   
 Would people with PD, PSP and MSA be receptive to specialist palliative care input? 
Studies, such as those related above, indicate that people with PD might benefit from SPC 
input.  Yet Fox et al, in a 2016 Irish study, found that HCPs were sometimes reticent to refer 
to SPC due to a perception that it could be emotionally harmful to patients (70).   




Fox et al later undertook a qualitative study with people who had PD (and to a lesser extent 
their carers) to establish what they perceived their care needs to be (9).  They also 
ascertained their views about SPC input.  Boersma et al carried out a similar study in Canada 
(10).  Both studies indicated a high degree of emotional burden from having PD and the 
effects it had on self-concept and social interaction (9, 10).  Decreasing mobility, 
independence and cognition contributed to changing roles within families and a reduced 
sense of identity (9, 10).  Both studies reported the difficulties with being uncertain about 
how the condition would progress and a mixed view on how much knowledge and 
discussion about the future was wanted (9, 10).  Significant gaps in care were identified in 
both studies, especially regarding emotional and spiritual support for coping with the impact 
of PD (9, 10).  This was thought to occur because medication management and physical 
symptoms were the focus of physician reviews.  A general lack of co-ordinated care from the 
multidisciplinary team was related and people with PD (and their carers) often felt 
unsupported.  Fox et al highlighted a lack of support was particularly true for people with PD 
who did not have informal carers (9).  In regard to SPC/hospice both studies showed the 
perception was that this was for people with cancer and many of those interviewed were 
not aware it was available for people with PD (9, 10).  Despite some initial misgivings about 
the term ‘palliative’ once the role of SPC was explained most people with PD, and their 
carers, were receptive to its input, even early in the disease process (9, 10).    
A strength of Boersma et al’s study (10) was that they purposefully sampled for cognitive 
impairment, thus gaining the views of a previously unexplored group.  This may well be why 
identity loss was a more prominent theme in their study than in others.  In addition, the 
authors undertook several steps to ensure the validity of their work including triangulation 
by using interviews and focus groups, and member checking.  A strength of Fox et al’s study 
(9) was that a third of the participants with PD had no informal carer; allowing the views of 
people living alone with PD to be explored.  In addition, the lead author kept a reflexivity 
diary to minimise bias towards the interpretation of the results. Unfortunately, the 
description of analysis techniques was limited in both studies, which may reflect negatively 
on their quality (71).  




Boersma et al (10) and Fox et al’s (9) findings add weight to Hudson et al’s (7) argument that 
people with PD would benefit from SPC from an emotional and social point of view, as well 
as from a symptom load point of view.  They also indicate that most people with PD and 
their carers would be open to SPC input if the ways it could help were clearly explained from 
an early stage.  In these studies (9, 10), those with more advanced disease were keener to 
have SPC input, but desire for help was variable at all stages of disease and very individual.  
There remains a question about the best way to deliver SPC services to people with PD, with 
more traditional style services/day hospices, joint working between neurological and SPC 
services, and short-term intervention all having been/being trialled.  
There are no published papers exploring the views of people with PSP/MSA, or their carers, 
regarding SPC provision.  Wiblin, in her thesis regarding palliative care need in MSA and PSP 
found that almost half of the people she interviewed had received SPC input and though a 
third of them could not define what palliative care was, they recognised its value in their 
care (72).  She also found that nearly half of her participants felt SPC equated to the end of 
life (72), which may dissuade some people from accepting its input, thus identifying the 
same potential barrier that Boersma et al (10) had found for people with PD.  Wiblin’s (72) 
conclusion was that people with PSP/MSA and their carers would benefit from an 
individually tailored palliative care approach throughout the course of their disease and 
would be receptive to SPC input .  
 Models of palliative care provision 
Given that individuality is key, is there a preferred model of palliative care provision for 
people with PD, PSP and MSA?  Boersma et al (10)and Fox et al (9) both argue that a holistic 
palliative care approach is needed but that this does not necessarily equate to SPC for all, 
i.e. emotionally and spiritually supportive coordinated care could potentially be delivered 
within existing services.  Wiblin et al (18) in their review regarding palliative care in 
neurological diseases showed where the roles of neurological services and SPC might 
overlap and the situations in which SPC may be needed (see Figure 2) 





Figure 2 The overlapping roles of clinicians providing general palliative care and those providing specialist palliative care. 
From Wiblin et al (18 p8) 
In terms of SPC there are few studies that exist in terms of evaluating the benefit to people 
with PD, PSP or MSA.  
Those that exist or are in progress look at:  
• traditional hospice services: where people attend hospice day centres regularly  
• integrated services: where movement disorder services and SPC work side by side 
throughout the disease course  
• short term palliative care input: shorts bursts of input at specific trigger points 
Badger et al (73) in the UK undertook a qualitative study (using semi structured interviews 
and an IPA3 approach) with 3 patients with advanced PD and 5 carers to explore the effect 
of SPC on coping with PD.  All were recruited from an integrated SPC movement disorder 
service.  The participants reported the same main stressors that Boersma et al (10) and Fox 
et al (9) had found, specifically those of uncertainty and impact on the self.  Badger et al (73) 
found that SPC helped manage uncertainty for people with PD and allowed carers to reduce 
 
3 Interpretative phenomenological analysis – a qualitative approach that focuses on each 
individual participant’s interpretation of their lived experience 




their levels of worry and vigilance.  SPC also addressed discussing the end of life and 
practical adaptations in a way non-SPC had not.  In terms of self-impact SPC helped people 
to engage in coping efforts to manage the change in their self-concept and made them feel 
worthy of care.  SPC also helped carers reduce their caring role briefly.  A major limitation of 
the study was that it only included people who were involved with, and continuing to have, 
SPC and so it would be less likely to report any negative effects.  There was also no 
information gathered about non-participants.  
Veronese et al (74), in Turin, undertook a phase 2 pilot RCT comparing fast track referral to 
SPC to a standard track SPC referral (a wait of 16 weeks) for people with advanced 
neurological diseases (PD = 16).  The main outcomes were to compare quality of life (QOL) 
indicators and carer burden.  Those in the fast track group showed significant improvements 
in QOL, pain, sleep, breathlessness, bowel symptoms and social isolation.  There were no 
significant reductions in carer isolation or burden, which the authors postulated might be 
because of the long-term nature of caring for people with neurodegenerative diseases. 
There was also a trend towards coping less well with the disease which was felt to be due to 
the advanced nature of the diseases and the conversations about dying that were taking 
place.  After the intervention ended participants could continue receiving SPC for as long as 
they wished to do so, but unfortunately the numbers of people that chose to do this were 
not reported.  
‘OPTCARE neuro’ is an ongoing RCT taking place at seven sites in the UK and is evaluating 
short-term integrated SPC provision for people with long term neurological conditions, 
including those with PD, PSP and MSA (75, 76).  The results of the trial are not yet published 
but the collaborators undertook a scoping exercise to ascertain the views of neurologists 
and SPC physicians in regard to existing services and barriers to the proposed intervention 
(75).  There were mixed views about the quality of interaction between existing services and 
the barriers identified related to perception about palliative care from patients and 
resources if SPC was available to all.  Interestingly a key barrier identified was that people 
with neurological conditions may require longer term SPC input and the palliative care 




physicians alluded to the difficulty that might be encountered in discharging people who 
had gained benefit.   
 Summary of palliative care need 
Several studies have indicated that SPC would be appropriate for people with PD, PSP and 
MSA to help with a high level of symptom burden (6, 11, 15).  Exploration of palliative care 
need for people with PD also identified a range of emotional and social issues, including the 
loss of self and a lack of co-ordinated care (7, 9, 10, 73).  SPC has been shown to be 
welcomed and beneficial to people with PD (73, 74) though timing of referrals and the most 
appropriate way to deliver the service has not yet been ascertained.   
2.9 End of life 
‘End of life’ has widely different definitions across studies, within the healthcare profession 
and amongst people with life threatening diseases.  To try and provide clarity the ‘Ambitions 
for palliative care and end of life care’ document defines a person as being at the end of life 
when they are likely to die within the next twelve months (77) (section 2.12 explains this 
document in greater detail).  There are only two studies that specifically sought to explore 
PD and the end of life, Goy et al’s (12) USA study, where end of life was defined as the last 
month and Hasson et al’s (5) Northern Ireland study, where end of life was not defined by 
time.  
In 2008 Goy et al  (12) explored the degree of suffering and needs at the end of life for 
people with PD related diseases (PDRD) compared to a sample of people with Amyotrophic 
Lateral Sclerosis4 (ALS).  ALS is recognised to be a cause of significant suffering at the end of 
life, with a high level of supportive need, and the authors hypothesized that PDRD needs 
and suffering might be similar and in need of just as much health care provision.  The 
authors conducted surveys with 54 bereaved carers of patients with PDRD (50 PD, 3 PSP and 
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1 MSA) and 50 bereaved carers of patients with ALS.  Fifty-two of the PDRD patients were 
felt to have died from Parkinsonism or its related complications.  The authors’ questions 
were based on previous survey instruments and expert opinion/experience and were 
concerned with the last month of life.  In terms of symptoms, difficulties with eating and 
communicating were frequent and severe for both conditions.  Forty-two percent of the 
parkinsonian patients had been in severe pain most of the time, with 27% receiving no pain 
medication for this.  Confusion and depressed mood were also found to be frequent and 
severe in PD and more common than in ALS.  Ninety percent of PDRD patients had a living 
will, 88% had a healthcare proxy and 81% of PDRD caregivers could state their loved one’s 
treatment goal. Despite this however, only 73% felt their loved ones’ wishes were closely 
followed (compared to 85% of those with ALS).  Comfort was the goal for most yet 27% had 
feeding tubes and 27% had breathing support.  56% of PDRD patients had received some 
hospice care, 70% knew death was imminent and 75% were accepting of death, with 85% at 
peace when they died.  The authors also looked at place of death and reported that 13% of 
PDRD patients died in hospital, 25% in their own home, 12% in another home and 40% died 
in long term care.  Only 42% died where they had desired.  ALS patients were more likely to 
die at home (56%) and 76% died where they desired.  The authors discussed that severity of 
suffering was identical between those people with PDRD and ALS but the PDRD patients had 
less hospice involvement (55% vs 66%).  They acknowledged that the number of PDRD 
patients with hospice involvement in their study was far greater than the national average 
of 13% but they did not provide an explanation for this finding.  They also pointed out that 
even though PDRD are less often considered to be life threatening, the carers and patients 
must have recognised the terminal trajectory of the diseases as they had made plans, were 
aiming for comfort and had hospice care involved.  
The only other research looking specifically at the end of life period regarding PD was 
reported by Hasson et al in 2010 (5).  This was a qualitative study, using semi-structured 
interviews to explore 15 former carers’ lived experience of palliative stage PD in Northern 
Ireland.  Two themes, ‘carer’s role’ and ‘burden and bereavement’, highlighted the 
difficulties of being a carer before and after the death of a relative.  They explained the 




feeling of social isolation and strain caring puts upon carers and the loss of role experienced 
once the relative with PD has died, made harder by poor bereavement support.  The strain, 
coupled with a lack of SPC service provision, or knowledge that a person with PD would be 
eligible for this, meant that it was not always possible to keep people with PD at home in 
the end, despite the wishes of their carers.  Carers also felt that specialists were difficult to 
access and concentrated too much on medication and not enough on the holistic aspects of 
the disease or practical social support.  Many carers were unprepared for their relative’s 
deaths, finding the eventual decline to be sudden, and all felt they should have been better 
informed about the advancement of the disease/imminent death.    
Hasson et al’s study (5) seems to contrast with Goy et al’s (12) findings in terms of patients 
and relatives being ready for death.  All carers in Hasson et al’s study claimed the need to be 
better informed about disease advancement and many were unaware death was imminent, 
whereas in Goy et al’s study 70% knew death was approaching and many had planned for 
the end, suggesting they knew the disease had advanced.  This may be to do with the way 
the participants were recruited.  Goy et al partly recruited through a movement disorder 
clinic, whereas Hasson et al recruited through posters in GP surgeries, libraries and PD 
support groups.  It is likely that those in Goy et al’s study therefore had better access to a PD 
team and support than people recruited from the community might have done. The 
differences probably also reflect the countries where the research was carried out, with 
levels of intervention and ACP known to be higher in the USA (78).   
Both studies (5, 12) used the views of bereaved carers to explore the end of life experience. 
There has been discussion about how valid a bereaved carer’s view might be, and whether 
views change over time as bereavement progresses (79), which would be particularly 
relevant in Goy et al’s case as some carers were bereaved 53months prior to interview.  A 
comprehensive review by McPherson et al (80) found that views of patients and carers 
correlated well for service evaluation, factual information given and overt features such as 
the ability to carry out tasks; but less well for pain and feelings, with carers over-estimating 
the level of pain and depression, which again has relevance for some of Goy et al’s findings.  




The review also makes the point, however, that often proxies, in the shape of bereaved 
carers, are the only way to get even close to reliable information about the end of life 
experience for people with uncertain disease trajectories; as identifying patients in this 
group who are terminal, is very difficult.  The cognitive impairment that is experienced in 
advanced PD and PSP, along with communication difficulties in the advanced stages of all 
three diseases also means gaining views from patients about their experience at the end of 
life would be very difficult.  More recently Sebring et al (81) conducted a cross sectional 
study of people with PD and their carers to compare their ratings of symptoms, emotional 
burden and social support.  They showed moderate to good agreement for many factors but 
found that agreement was poor for body pain, stigma, social support and anticipatory grief. 
Sebring’s study did not assess opinions regarding service evaluation.  When disagreement 
occurred, carers tended to report pain, depression and stigma as being more severe than 
the people they cared for with PD did.  The authors pointed out that often people with PD 
underplay mood symptoms compared to formal psychiatric assessment, but nevertheless 
cautioned against the use of proxy reporting for more subjective symptoms, especially in 
advanced disease.  
However, palliative care from its inception aimed to care not just for the person with a 
terminal disease but also their family, as a unit, and as such family views regarding service 
provision are not necessarily less valid than the views of the dying themselves.  In addition, 
one of the roles of palliative and end of life care is to ensure adequate bereavement support 
exists for family members.   
Certainly, carers are an important voice in shaping end of life care provision for patients and 
many of the reviews that have recently occurred within end of life care in the UK were born 
out of bereaved carers’ experiences.   
2.10 Recent history of UK End of Life care guidance 
The end of life care strategy (82), a joint effort between the government and the national 
council for palliative care, was published in 2008 with the aim of improving access to high 




quality end of life care for all, regardless of diagnosis or disability.  Its aim was to increase 
the profile of end of life care and to improve the experience, as it stated many people do 
not die as they would wish.  It highlighted changes in attitudes towards death and dying, 
explaining that people are less comfortable with death and dying than they were in the past. 
It also set out guidance for good quality care, such as improved communication about the 
fact a person was dying, good co-ordination of services, high quality care regardless of place 
of death and effective management of symptoms whilst treating the dying person with 
dignity and respect.  It also highlighted the need for monitoring services through surveys of 
bereaved relatives, national audit and complaints processes.  
At the time this strategy was published the Liverpool Care Pathway was widely regarded as 
the gold standard tool in end of life care (83).  It was essentially a checklist, to be used by 
HCPs, to ensure that they had informed the patient and/or their relatives that they were 
dying, that staff were regularly checking a patient for symptoms such as pain, 
breathlessness and nausea and that they had considered the patient’s spiritual needs. 
However, in 2013, a media furore occurred where examples of poor care associated with 
the Liverpool Care Pathway made headlines and this led to a review chaired by Baroness 
Neuberger (83) entitled ‘More Care, Less Pathway’; thus showing the power of bereaved 
relatives’ voices.  This review highlighted the fact that around 50% of people died in hospital 
and though many received good care through the pathway, there were cases where 
patients were not treated with the respect they deserved.  Where care was poor, the 
pathway was used as a tick box exercise accompanied by poor communication with patients 
and relatives, and this led to the recommendation that the pathway should be phased out. 
The review recommended the development of guidelines reflecting the principles of 
palliative care and technical guidance specific to certain disease groups.  It also 
recommended a system wide approach to improving care, suggesting the government make 
end of life care a larger priority, that end of life care is incorporated into hospital inspections 
and that more research is conducted into the experience of dying from the view point of 
patients, relatives and carers.   




2.11 Place of Death (POD) 
The government’s commitment to gathering views from bereaved carers, through the use of 
the VOICES questionnaire, was outlined year on year in the NHS Outcomes frameworks. 
VOICES (Views of Informal Carers Evaluation of Services postal questionnaire) was 
developed in 1995 by Professor Addington-Hall (84) and redesigned in 2011 to enable it to 
be used as a National survey (85).  It asked bereaved carers to comment on the experience 
of care/services in the last three months of life and looked at POD, i.e. home, hospital, care 
home or hospice.   
The survey was initially commissioned to be delivered annually by the Department of Health 
in 2011 and between 2013 and 2015 it was commissioned by NHS England.  The 
questionnaire was administered by the Office of National statistics (ONS) to a sample of 
nearly 50000 people annually (86, 87) whose relatives had died in the previous 4-11 months, 
with response rates of roughly 45% each year (86, 87).  Since the National survey began the 
results have shown little change year on year; telling us more people die in hospital than 
choose to, overall quality of care is felt to be poorest in hospital and best in a hospice, and 
pain is controlled least well at home.  The surveys have shown differences in quality of care 
according to COD, with the overall quality of experience felt to be better for people dying 
from cancer compared to other diseases (86, 87).  Deaths from cancer, cardiovascular 
causes and dementia have been looked at individually from the national data, but this has 
not occurred for other disease groups.  
There are studies regarding place of death for PD, but there are no studies regarding place 
of death for MSA or PSP.  Snell et al (19) compared patients who had died from PD to a 
control population over an eight year period and found that more people with PD died in a 
care home (36% vs 21%), less died at home (9% vs 17%) and the results for hospital deaths 
were similar (55% vs 59%).  Sleeman et al (20) compared patients with PD to those dying 
from MND and multiple sclerosis, and found that people with PD were more likely to die in a 
care home and less likely to die at home or in a hospice.  Cardiovascular disease or cancer 
increased the chances of a death at home, whereas pneumonia increased the chance of 




hospital death (20). Hobson et al in their community based cohort study found that people 
with PD were less likely to die in hospital than age matched controls (57). 
Although these studies show us where people with PD die, there is currently no data to tell 
us whether place impacts on the quality of end of life care they receive.  In addition, there 
are no studies that explore where people with PD, PSP or MSA might choose as their 
preferred place of death (PPOD), nor data to tell us whether this would be a priority for 
them at the end of life.  
 Preferred place of death (PPOD) 
There has for some time been a suggestion that dying at home is preferable, driven in part 
by an ideological stance regarding dying in traditional societies (88-90).  Aries, a French 
historian, compared the ‘tame death’ of the past, where people died at home surrounded 
by friends, religious customs and managed their death the way they saw fit to the ‘wild 
death’ that occurred within institutions, where responsibility and choice in dying was 
removed from the command of the dying person (88, 91).  Elias similarly alluded to the 
loneliness of the dying, especially within institutions, though he felt that Aries somewhat 
romanticised traditional deaths, which were likely to occur in pain without the symptom 
relief of modern medicine (92).  During the 1960s concern was growing in the USA at the 
increasing medicalisation of dying (93), with more people dying in hospital with reduced 
autonomy (94, 95) and similar concerns led Cicely Saunders to found the hospice movement 
in the UK, beginning the launch of palliative care as a speciality (91).  A part of the aim to de-
medicalise dying was to try and bring death out of hospitals and back into communities and 
homes.  This was championed as being an issue of importance by sociologists and policy 
makers and dying at home became somewhat synonymous with good end of life care and 
achieving a good death (96).  In policy, the end of life care strategy suggested that a good 
death was one that took place in familiar surroundings (82) and the National End of Life 
Care Intelligence Network in their ‘what we know now’ 2014 report stated that “Meeting 
people’s preferences for place of care and place of death is an important measure of the quality 
of end of life care” (97).  




The VOICES data suggests that most people, if they have a preference, want to die at home 
(24, 98, 99) and other surveys have shown hospital to be the least PPOD (100).  However, 
the majority of people within in the VOICES surveys had not expressed any preference and 
much of the work on PPOD, certainly the larger scale surveys, have taken place with healthy 
younger individuals rather than people with life limiting diseases.  Indeed in one of the 
largest UK surveys, by Gomes et al, only 13% of participants had been diagnosed with a 
serious illness in the preceding 5 years and as people aged their preference for dying at 
home decreased (100).  Gomes et al later undertook a systemic review of worldwide studies 
exploring preferences for place of death (101).  This found moderate strength evidence that 
people preferred dying at home.  However, the evidence for older people was less strong 
with qualitative data suggesting that even if a home death was ideally desired, 
circumstances precluded this being a realistic choice.  People dying from cancer were more 
likely to prefer a home death than those with non-malignant conditions and views were 
subject to change over time in around 20% of patients, with a declining preference for home 
as diseases progressed.  The review concluded that because most people choose home, 
more should be done to allow people to achieve their aim, but as a substantial minority 
change their mind, or think differently, flexibility should exist within the system (101).   
Conversely, other authors have pointed out that policy decries a home death as 
synonymous with a good death and that this puts a huge amount of pressure on those who 
are dying, and their families, to ensure a home death is achieved, with a tremendous 
amount of guilt felt by those left behind if it is not (22, 90).  In addition, pushing a home 
agenda fails to recognise that family members becoming carers can impact on the identity 
of relationships and formal care workers and equipment entering homes can change the 
meaning of ‘home’ (22, 90).    
Sue Ryder, a UK charity providing palliative, neurological and bereavement support also 
produced a report in 2013 which was critical of the political focus on dying at home. Their 
report ‘a time and a place’ (102) criticised the use of dying at home as a proxy for quality 
end of life care and explained that few studies explored the reasons behind a preference for 




home.  They understood the desire for home death to be at the forefront of policy because 
of the alignment between assumed public preference and the financial savings that dying at 
home, rather than in institutions, provides to the treasury.  However, they suggested that 
just accepting home is best prevented gathering knowledge of the factors that matter to 
people at the end of their lives and hindered the improvement of care across all locations of 
death. They championed more personalisation in end of life care rather than a focus on 
place.   
No-one has explored the wishes of people with PD, PSP or MSA previously.  As people with 
these conditions are older, dying at home may not be the priority.  In addition, the high 
degree of symptom burden, including impaired cognition, may well make dying at home a 
less realistically achievable choice.  
2.12 Advanced care planning (ACP) 
One way for people with degenerative diseases to make their views about preferred place 
of care known to HCPs is through ACP (103).  ACP allows a person to write down their 
wishes for the future and in the case of an advanced decision to refuse treatment (ADRT) 
they allow a person to refuse certain life prolonging treatment in a way that should be 
legally upheld.  ACP is strongly advised for people with progressive neurological conditions 
(104) as a way of maintaining autonomy if cognition or communication declines.  Despite 
their uses, and the fact that 60-90% of the general public is supportive of ACP, only 8% of 
the population in England and Wales is thought to have completed written plans (103).  
In 2015 Pollock and Wilson undertook a qualitative study in the UK investigating 
communication between HCPs and patients with life limiting diseases (105).  This revealed 
that less than half of the patients thought to be in the last month of life had made any plans. 
HCPs found it difficult to discuss ACP in terms of when to raise the issue and many patients 
did not welcome the idea of discussion either.  This meant that discussions were often 
reactive, in response to significant deterioration, and that ACP was primarily concerned with 
PPOD and resuscitation.  The authors commented very few plans were instigated to 




maintain autonomy for people who might later have diminished cognition and so 
opportunities were lost; they also felt more research into the experience of the frail elderly 
should be undertaken regarding communication and decision making.  
Also in 2015 Tuck et al (8) surveyed 267 PD patients in Oregon, across all disease stages, to 
ascertain their preferences for the timing of discussion about prognosis, ACP and end of life 
options.  They found 50% of the patients wanted early discussion about ACP and around 
12.5% wanted to discuss end of life options at diagnosis, though most preferred to wait until 
the disease worsened.  50% felt they could raise the issue of prognosis and 50% felt this 
should be the neurologist’s duty.  Age and time since diagnosis did not affect when 
participants felt discussion was warranted or who they felt should raise the issue.  A small 
proportion never wanted to discuss ACP (5.7%) or end of life plans (2%) and some only 
wanted discussion if they raised the issue themselves (12.6% for ACP and 20% for end of life 
planning).  Of the PD patients taking part 51.3% already had advanced care plans, 42.7% had 
ADRTs and 39% had a power of attorney (ie they had assigned someone to represent their 
views should they lose their own mental capacity).  Overall views were mixed and were not 
predictable by disease burden and so the authors suggested the only way to know if a 
person wanted to discuss the issue further was to sensitively ask.  We do not know how 
many patients in the UK with PD, PSP or MSA have made advanced plans but it is likely to be 
smaller than the percentages suggested by Tuck as ACP is more common in the USA (78, 
105). 
We do not actually know whether undertaking ACP improves the end of life experience for 
people with PD, PSP or MSA.  Some research has been done to explore whether plans 
improve the end of life experience for people with MND (106, 107) and this showed that 
they led to peace of mind for the patient and caregiver, and prompted more discussion so 
that awareness of the person’s wishes could build.  Participants also felt they helped to 
increase HCP’s awareness of a patient’s wishes.  However, they also felt a lack of HCP’s 
knowledge about the legality sometimes hampered their use and when plans were not 
followed this led to a lot of frustration and heartache (106).      




2.13 Current UK palliative and end of life guidance: 
Following the aforementioned Neuberger report ‘More care, less pathway’ (83) a large 
amount of work has been undertaken by the National Council for Palliative Care, along with 
multiple charities supporting people with life limiting disease and those caring for them, and 
new guidance has been published.  
Initially, as a direct response to the Neuberger report, the National Council of Palliative Care 
and their collaborators published, as the Leadership Alliance for the Care of Dying People, 
‘One chance to get it right’ (108) which essentially replaced the principles of the LCP and laid 
out the five priorities of care that should be fulfilled for a person who was imminently dying 
(see Figure 3) 
 
Figure 3 The five priorities of care for a person who is imminently dying, taken from 'One chance to get it right' (108, p7) 
These priorities focus on clear communication, including informing people that they are 
imminently likely to die.  This is in line with the awareness that many people would consider 
a necessary component of good end of life care.  Much like ‘place of death’ awareness of 
dying has long been felt necessary to allow a ‘good death’ (91, 94, 95, 109).  The fervour for 
making sure everyone is made aware has perhaps decreased somewhat (110) in line with a 
better understanding that people alternate between denial and acceptance to cope with 
their prognosis (111).  




The emphasis on comparing locations has lessened in the most recent palliative and end of 
life care guidance in favour of identifying aspects of good care that should be in place across 
locations.  ‘One Chance to Get it Right’ states that these priorities should be followed 
wherever a person might be dying, be it at home, in a hospital, care home or hospice (108).  
Similarly the NHS framework for end of life care in 2018 stated that transforming the 
experience of end of life care in the community and hospitals was one of its overarching 
workstreams (23).   
Following the release of ‘One Chance to Get it Right’ the ‘Ambitions for Palliative and End of 
Life Care’ document was published (77). This sets out six ambitions (see Figure 4) 
responsible for delivering care to people with incurable conditions and has been 
incorporated into national UK guidance.  These ambitions cover the time from diagnosis of 
an incurable disease through to after death bereavement support for carers.  This document 
will be explored in more depth in Chapter 8, as recommendations for practice borne out of 
this study are reported in line with these ambitions.  





Figure 4 The six ambitions for palliative and end of life care, taken from 'Ambitions for Palliative and End of Life Care' (77 
p11) 





The available literature shows that people with PD have a high symptom load which is 
comparable with other populations frequently receiving SPC.  The literature also shows that 
the emotional and spiritual needs of people with PD are high but not always adequately 
addressed by existing PD services, where medication and physical symptoms are often the 
predominant focus.  There has been shown to be a lack of information and co-ordinated 
health service provision for people with PD and an uncertainty about when to discuss future 
plans, despite recommendations this should be done early.  All these points indicate a 
potential role for SPC and people with PD are largely receptive to palliative care input.  
There has been very little qualitative work exploring the lived experience of people with 
PSP/MSA or their carers, especially in regard to their palliative and end of life care needs, 
despite the literature showing their symptom load is higher and quality of life scores lower 
than people with PD. 
We do not know where people with PSP and MSA die and although we know more people 
with PD die in care homes than at home, we do not know whether this affects their end of 
life experience.  Although ACP is advocated strongly for these conditions, we have no idea 
whether future plans improve the experience for people who make them.  Even though 
dying where one would choose is recognised as a marker of good end of life care we do not 
know whether people with these conditions express a preference and where that preferred 
place would be if they do.  Current guidance suggests more work should be done to explore 
the experiences of patients and their relatives at the end of life, including bereavement 
support, especially for those with complex conditions leading to increased frailty.  Despite 
this only Hasson et al touched-on bereavement for carers of people with PD and their lack of 
preparation for the end; bereavement for carers of those with PD, PSP or MSA has not been 
explored elsewhere.   
This study aims to address some of these gaps; Table 2 outlines the gaps in the literature 
and explains where they are addressed within this thesis 




GAP Where addressed 
Where are people dying from PSP/MSA 
most likely to die? 
Chapter 4 outlines this finding 
What are the palliative and end of life 
needs of people with PSP, MSA and their 
carers? 
What are the bereavement needs of carers 
of people with PD, PSP and MSA and are 
they adequately supported? 
Chapter 5 addresses this and compares the 
findings to those dying from PD 
 
Chapters 5 and 6 address bereavement  
Do people with PD, PSP and MSA have a 
PPOD? 
Chapters 5 and 6 both address this gap 
Does place of death affect experience and 
if so, how? 
Chapter 6 addresses this gap 
Table 2 Gaps in the literature and the locations within this thesis that addresses these gaps 
 




Chapter 3 Methods 
This chapter outlines the methods that were used to answer the aims and objectives of the 
study.  It begins with the methodology behind the project, discussing prior debates regarding 
the mixing of methods and the perspective of pragmatism.  The latter part presents a 
rationale for the project design and a flowchart to illustrate the components of the project. 
It then addresses the methods used for sampling and recruitment, data collection, analysis 
and integration.  
3.1 Methodology 
 The worldviews of positivism and interpretivism 
Positivism and interpretivism are opposing worldviews.  They are based on differing 
ontologies (views about reality) and epistemologies (views about knowledge).  
Traditional positivism is based on ontological realism (there is one true reality waiting to be 
discovered) and epistemological views that knowledge is only gained by discovering the 
truth about that single reality (112, 113).  Crotty (114 p8) stated this is an objectivist 
epistemology where a thing has meaning in itself as an object, irrespective of whether a 
human has interacted with it or is conscious of its existence.  This reflects research into the 
natural sciences where we are looking to explain something according to the laws of nature, 
but for centuries it had also been the preferred method of social science inquiry into human 
behaviour (115).  Over time, the difficulties with verifying one absolute truth led to some 
scholars discrediting such a fixed view (114) and most social scientists on this side of the 
reality/knowledge spectrum now practice a post-positivist view which accepts there is 
always possible doubt about the truth of a belief (116).  In practice this translates so that 
findings are presented with a probability of them being true (112).  From a positivist 
viewpoint, a research study should not be subject to bias, which might distort true meaning, 
and so steps are taken to reduce a researcher’s interference (116, 117).  Clear parameters 
are defined and set before the research takes place.  Positivism is traditionally associated 




with quantitative types of data (118); a hypothesis can be proposed and tested in an 
analytical manner, through the use of statistics, to provide a probability that something 
holds true.  The hypothesis behind the VOICES survey was that the place a person spent the 
end of their life would affect its quality.    
Conversely, rather than believing there is one true reality to be discovered, ontologically 
interpretivists believe there are multiple realities (or perspectives) which vary between 
individuals or societies (112).  Interpretivists follow a constructionist epistemology (114), 
something only has meaning because we interact with it and give it a meaning with the 
mind.  Interpretive research will be interested in finding out what things mean from an 
individual or societal perspective (118) and is more often associated with qualitative types of 
data because researchers are trying to understand the views of participants in their own 
words and in-depth (118).  Due to this, parameters cannot be pre-assigned.   Figure 5 details 
the ways in which subjects relating to this project might be seen according to the two 
epistemologies. 
Research subject Objectivist  Constructionist 
End of life The end of life is the 
twelve months 
preceding a person’s 
death.  
Some might believe the end of life starts as 
soon as an incurable disease is diagnosed. For 
some the end of life is the last few hours. For 
some the end of life is a chance to 
apologise/make right wrongs. For some the 
end of life can be a relief from suffering.   
Death Biological: the heart 
stops, breathing 
stops, the brain 
ceases to function 
Possibly biological but could be social. A 
person may believe they lost their relative 
long before they biologically died due to a 
change in personality or cognition.  
Conversely, they may not feel they have died 
because their memory of them persists. 
Figure 5 The ways in which the differing epistemologies might consider elements of this research project 
 Paradigms  
Positivism and interpretivism have been referred to as opposing paradigms.  Researchers 
interested in qualitative methods sought to bring about change as social science research, 




aside from anthropology, had largely been dominated by a scientific method of inquiry, 
relying largely on quantitative methods and data (119).  They championed the idea that 
quantitative research was tied to a realist (objectivist) epistemological paradigm and 
qualitative to a constructionist one (119).  From this point, for many, interpretivism (also 
known as naturalistic inquiry or constructivism) became synonymous with qualitative 
research/methods/data and positivism with quantitative (120, 121).  This further led to ’the 
paradigm wars’ with arguments over which form of research presented more correct 
conclusions.  It led to purists from either side being left unable to acknowledge the research 
outputs from the other, even though they may be looking at the same field of study, and led 
to degree programmes which taught only one form of research (112).  However, some 
researchers were finding that it was practically useful to mix quantitative and qualitative 
data within a single research study to provide a more comprehensive view.  In 1988 Howe 
(120) argued in his seminal paper that methods for undertaking research were not tied to 
one worldview or the other, that the differing approaches in ‘qualitative research and 
quantitative research’ were not all that different at any level (i.e. data, analysis etc) and that 
interpretivism and positivism do not exhaust all possibilities for world views.  Howe argued 
the case for taking a pragmatic approach to research and suggested that it was feasible and 
probably advisable to mix qualitative and quantitative components to answer a research 
question (120).  Since then there has been a growing drive for combining qualitative and 
quantitative methods and agreement has largely been reached that such research is to be 
termed ‘mixed methods’ (122).  The paradigm wars and arguments about compatibility have 
largely died down, but there remains discussion about the extent to which philosophical 
concerns should guide research inquiry, especially within the mixed methods community 
(122).   
 My theoretical stance/perspective 
When starting this project, as a practising UK doctor, I was unaware that there could be any 
negative reaction to the idea of mixing qualitative and quantitative data.   My overarching 
aim was to complete a piece of research that would explore end of life care delivery for 




people with PD, MSA and PSP and allow suggestions for improvements to be made if any 
deficiencies were found.  As Gorard (113) suggests, research objectives being the driving 
force for a project is likely to be the case for most novice researchers, especially if they have 
not come from a social science background.  He suggests that research questions are more 
practically important than philosophical concerns, something which other methodologist 
based researchers agree with(122), and certainly my project design was driven more by 
research questions that may lead to useful improvements in care than philosophy.  However, 
I understand the view that research can never be entirely devoid of philosophy because the 
researcher inevitably brings their experience with them when designing their project.  This 
being the case, in order to be transparent I would suggest that my views are similar to 
Johnson and Onwuegbuzie (117): I agree that there are objective, subjective and 
intersubjective perspectives and so my stance equates to ontological plurism.  If I 
extrapolate this into the relevance of my initial views about this research project I believe 
that for people with PD, PSP and MSA the underlying pathophysiology is occurring, leading 
to a reduction in dopamine levels which then causes signs/symptoms, and this will happen 
whether the person has a diagnosis or not (objectively they have the disease).  However, 
how important it is for a person to get a diagnosis and how they live their life with the 
disease label varies from person to person (subjective) and will in part be influenced by 
societal views (intersubjective), for example, views on disability.  The same will likely be true 
of their views on wanting to know about their prognosis, which may have relevance in terms 
of planning for the end of life and impact on place of death.  
 Pragmatism 
My views best align with a pragmatic approach in which, Morgan states, ‘there is no problem 
with asserting both that there is a single “real world” and that all individuals have their own 
unique interpretations of that world’ (119, p72).  Pragmatists would argue that the outcome 
of the study is more important than philosophical concerns (117, 121) and some would 
assert that discussions about the nature of reality are only important if they would make a 
difference to the problem at hand (119).  One could argue that being more concerned with 




research questions and outputs than philosophy aligns to an a-paradigmatic stance towards 
research (123) rather than a pragmatic one, but my desire for the research outputs to make 
a positive difference to the care of people with PD, PSP and MSA approaching the end of 
their lives fits with the value-orientated approach of pragmatism (117, 120).  I am also 
cognisant that what is relevant at the time that I undertake this study may change in the 
future, for example, a cure may be discovered and pragmatism embraces the idea that a 
theory is only true whilst it works; there may be a time in the future where something we 
think we know is proven false (121).  
3.2 Project design 
 Mixed methods 
Through taking a pragmatic approach, the initial research questions as described below were 
most appropriately addressed using a mixed method approach   
• What are the palliative and end of life needs for people with PSP and MSA? (QUAL) 
• Where do people with PD, PSP and MSA die? (QUAN and QUAL)  
• Where did they want to die and why? (QUAN and QUAL) 
• Is place of death important? (QUAL) 
• Does place of death affect quality of death? (QUAN and QUAL) 
• What impacted most on the end of life experience? (QUAL) 
It was felt that using both qualitative and quantitative data would allow a more 
comprehensive and generalizable overview of factors affecting end of life care because they 
could answer questions which were both different and overlapping, with the purpose for 
mixing therefore being one of complementarity (124).  The VOICES (Views of Informal Carers 
Evaluation of Services) survey is well validated (85), considers the needs of carers as well as 
those of the dying person and has been used multiple times to compare places of death for 
various causes of death.  It was therefore chosen as the survey tool for this project to 
provide the quantitative data.  Semi structured interviews were chosen to provide 




qualitative data, as we postulated that other factors might overshadow place of death in 
terms of importance at the end of life and a survey alone would not allow exploration of 
issues in depth.  Even if place of death was the factor of principle concern the survey might 
have told us that people were perceived to be treated with more respect and dignity in a 
hospice than a hospital, as with other causes of death (24), but not why there was a 
difference, nor what respondents viewed as the meaning of respect and dignity.  It was the 
depth of exploration into what made one place seemingly ‘better’ than another that was of 
interest, because without knowing this it would be difficult to suggest effective change to 
improve/individualise the quality of care.   
 Study participants 
Bereaved carers were recruited to be the participants in this study as the uncertain 
trajectories of PD, PSP and MSA means it is hard to know when the end of life is 
approaching.  In addition, decreases in communication and cognition are common as the 
diseases progress and fatigue becomes an increasing problem, especially at the very end of 
life, meaning that interviews near the end of life would be challenging and potentially 
inappropriate.   The validity of using caregivers’ viewpoints to explore the end of life has 
been discussed by McPherson et al (79) who showed that proxy views were well matched 
with regard to service evaluation.  Therefore, using caregivers viewpoints was felt to be 
appropriate as the main aim of the project was about whether interaction with the health 
and social care system affected the end of life experience, and if so, in what way.  




3.3 The original project plan 
The initial plan was to undertake an identical5, sequential6, QUAN→QUAL7 mixed methods 
study.  The plan was to send questionnaires to bereaved carers of those with PD, PSP and 
MSA, who were known to the Northumbria Healthcare NHS foundation trust’s PD service; 
alongside the questionnaire would be an opt-in option for those carers who were willing to 
be interviewed.  Purposeful sampling would then be used to determine the interview 
sample, so that of the carers who had opted in, ideally each ‘place of death’ (hospital, home, 
care home and hospice) was represented.  
After designing the project and populating an IRAS form I realised I needed to apply to our 
local Caldicott guardian (the healthcare trust’s Information Governance officer) in order to 
gain access to our former patients’ records and thus their next of kin details.  Unfortunately, 
the trust’s Caldicott guardian forbade the use of the next of kin details in deceased patients’ 
notes to contact potential participants.  The issue for the Caldicott guardian was one of data 
protection as he felt that using the next-of-kin details in the deceased patients’ notes to 
contact their relatives, for research purposes, would contravene the Data Protection Act 
(DPA).  Principle 2 ‘processing personal data for specified purposes’ was the area of concern; 
the carer’s personal details in patient’s notes were there for the purpose of contacting them 
regarding issues to do with patients, at no point had the carers been asked whether their 
next of kin details could be used to contact them about research projects.  However, other 
researchers seemed to have carried out similar projects without encountering this issue and 
NHS England has a toolkit for using VOICES locally which advises researchers to use the next-
of-kin details in patient’ notes to contact potential participants (125).  I spoke to one of the 
authors, from a similar study, to ask how they had managed to circumnavigate this issue and 
was told that their Caldicott Guardian had allowed them to proceed because they felt that 
 
5 The same participants take part in the Quan and Qual strands  
6 Information gathered from one strand is used to inform the other strand, which follows 
afterwards 
7 Both strands are of equal importance and the qualitative would follow the quantitative  




end of life research was important.  Explanation for these differing opinions was found in the 
guidance from the Information Commissioner’s Office (ICO) on the DPA.  Within the ICO’s 
guidance was a paragraph that stated ‘data can be used for previously unspecified purposes 
if the use is thought to be fair’ (126, p35).  The guidance further explained that it would be 
unfair to use the data if ‘it would be outside what the individual concerned would 
reasonably expect, or would have an unjustified adverse effect on them’ (126, p35); 
therefore it was up to the individual guardians to decide whether contacting relatives was 
fair or not.  Our Caldicott guardian was unmoved on the matter and so I was not able to 
retrospectively recruit bereaved carers.  Therefore, a revised design that allowed for local 
recruitment within the confines of the DPA was devised and combined with a strategy for 
national recruitment.  
3.4 The revised project plan and ethics approval 
After adjusting the recruitment strategy the design of the project changed to be a parallel8, 
concurrent9, QUAL+QUAN10 mixed methods study, illustrated in Figure 6.    
The project was registered with the Newcastle and Northumbria 1 research ethics 
committee (ref: 15/NE/0066).  It was granted an initial approval for the qualitative side of 
the project in March 2015 and a significant amendment was granted in September 2016 to 
allow access to the VOICES datasets and for national recruitment.   
 
8 Participants are all bereaved carers but different carers are recruited for each strand 
9 Data collection and analysis of the two strands takes place at the same time 
10 Both strands are of equal importance with regard to answering the goals of the study  





Figure 6 A flowchart illustrating the project design 




3.5 Ethical considerations 
 Increased grief in bereaved carers 
The principal ethical consideration was that carers had to revisit the end of their loved one’s 
life, which could have caused an increase in their grief.  It was made clear throughout the 
invitation letter, patient invitation leaflets and telephone introduction that there was no 
obligation to take part and that a participant could withdraw at any time.  This was 
reiterated during the interviews if carers seemed distressed by the issues they were relating. 
I undertook bereavement training with Cruse bereavement care prior to any interviews 
taking place and had arranged that the local chaplaincy service was happy to be contacted 
for local participants to provide support; as Cruse did not have a service in the north east at 
the time of the study taking place.  Prior to commencing the project I worked full time as an 
elderly care registrar and I was accustomed to discussing sensitive issues, such as death and 
dying, with patients and their relatives.  The potential for increased grief was more difficult 
to manage on the forums but clear signposting for the charity helplines and Cruse was 
provided and carers had an e-mail address to contact me on as well.  
 Internet forums 
Rather than taking comments from existing charity forums, closed forums were set up 
through the university and advertised on the charity websites.  Closed forums/message 
boards are only accessible to those who have registered with the site (127).  This meant that 
participants were made aware that their comments might be published and had to consent 
to take part, knowing their comments were for research purposes.  Although some of the 
comments on the existing charity forums could be accessed via an online search, without 
requiring a log in, using such comments seemed ethically wrong as the people posting 
probably felt they were doing so on a private message board (127).  To protect anonymity 
carer’s pseudonyms have been changed within this thesis and will remain changed in any 




further publications.  The forums were also closed and deleted after 6 months, which 
participants were informed about at the start (See Appendix A iv).     
 Informed consent 
Informed consent was gained from all participants.  For interview participants this was 
recorded on paper and for forum participants carers clicked to evidence understanding of 
terms and conditions (see Appendix A iii and v). 
 
3.6 Qualitative Data Collection 
 Local recruitment 
The Parkinson’s team were planning to send current patients a newsletter, summarising 
their completed research projects, and so I added a separate letter asking carers to send 
back their contact details if they were willing to be approached by the team about future 
research projects.  Positive responses to the letter generated a database of carers who had 
given their personal details to us for the specified purpose of being contacted about 
research (n=240).  Over time, as patients died, I checked the list to see whether their 
bereaved carers had given permission to be contacted about research.  If they had, after a 
bereavement period of at least three months, an invitation letter and information pack with 
details about the project was sent out (see Appendix A i and ii).  Included with the 
information was a reply slip that carers could return to indicate that they were interested in 
taking part.  If interested the reply slip prompted them to return the consent form in a pre-
paid envelope and provide an up to date phone number so that they could be contacted.  I 
then called the carers who had expressed an interest to verbally explain the project, check 
understanding of the process and arrange an interview date and location.  Because hospital 
records for the people who had died could be checked, a degree of purposeful sampling was 
undertaken; the carers of people who had been more advanced in their disease were 
preferentially sampled, as were those who appeared to have died from their PD rather than 




something else.  An attempt was made to purposefully sample for place of death but this 
was difficult to ascertain from hospital records. 
 National recruitment: Forums 
Given the delay faced with local recruitment, other recruitment strategies were 
contemplated including the use of forums/blogs.  I looked on the existing forums on PD, PSP 
and MSA specific websites by searching for streams concerning ‘death’, ‘dying’ and ‘end of 
life’, and I searched the internet using the same terms combined with the names of the 
three conditions. 
 Whilst there were a couple of forum threads where bereaved carers had shared their 
experiences forums were ‘closed’, due to the fact that they needed an e-mail address and 
password to participate in the forum.  The charities that represented all three diseases in the 
UK did not feel informed consent for research could be arranged through their existing 
forums but they agreed that if I set up my own forums they would provide a link and 
advertise through their websites.  
Newcastle University’s IT department set up three separate forums on the university servers, 
one for each disease.  A truncated participant information sheet was provided as an 
introductory section on the forum site (Appendix A iv); this explained about the project and 
that the plan was for the forums to stay open for about six months and then be closed down. 
Below this came the points of consent, and a statement explaining that by joining the forum 
participants agreed with these terms (Appendix A v).  Once the forums were made live, I 
joined them as the administrator which ensured I could adjust the settings of the forum and 
be the main contact point for participants.  All three had a thread started entitled ‘welcome’ 
and a disease specific opening statement was posted as shown in Figure 7.   





Figure 7 The initial post on the PD forum thread 
Once participants joined they could start their own threads if they chose.  As soon as the 
forums were working I contacted the charities again to ask them to advertise the sites – the 
approach taken by each organisation varied and the response was limited (see Figure 8). 
Overall the forums acted more like online interviews than an actual forum as the 
participants were directing comments to me, rather than interacting with each other.  Some 
people contacted me and said they would rather talk about their experiences one-to-one 
than on the forum and so I gave them the option of e-mails or a telephone interview.  
Because the carers had opted-in to the project we felt that ethically it was reasonable to 
offer telephone interviews if that was more in line with their wishes.  Some people started 
on the forums and then privately messaged me and so I continued to send them questions 
over e-mail.  One carer sent a document they had written about their previous experience.  I 
wanted to remain flexible and to do whatever worked best for the carers.    
 
Thank you for joining this forum. 
 
My name is Claire and I am a doctor/researcher working with 
Northumbria Healthcare NHS Foundation Trust and Newcastle University. 
I am interested in Parkinson's disease and end of life care and am trying 
to find ways of improving the end of life experience for people with PD. 
 
I am particularly keen to know whether the place a person dies, e.g. at 
home or in hospital, makes a difference to their experience, or whether 
other factors are more important. I'd be really interested to hear your 
views as a person who has lived through the experience and any 
comment you have to make would be really valuable  
 









Initially advertised on 
the research section 
of their existing 
forums. Later they 





Posted a link to the 
forum on their own 
forum but without 
any guidance or 
introduction 
Posted a link to the 




5 People joined at 
differing times over a 
couple of months and 
stayed to answer 
multiple questions 
15 people joined but 
only a couple 
commented.  Both 
answered several 
questions 
14 People joined, 7 
commented 
immediately but 
most then left. As 
the advert dropped 





0 1 (lady whose 
husband was still alive 
with CBD) 
3 (1 healthcare 
professional, 1 
person currently 
living with MSA and 
1 daughter of 








1 0 1 (+ 1 sent a written 
narrative) 
Figure 8 A table illustrating the advertising methods of the charities and the resulting recruitment 
 National recruitment: Interviews 
The MSA Trust agreed to send out information about the project to bereaved carers on an 
existing database, initially in the North East, then nationally.  The PSP association also agreed 
to contact bereaved carers about the study and sent out the information packs asking carers 
who wished to take part to contact me; one carer who had agreed to take part ran a support 




group and she contacted other bereaved carers about the project as well, so a small amount 
of snowballing took place.  Parkinson’s UK had contacted me about my project because they 
had appointed a lead for end of life care.  She wanted to know about this project and any 
potential difficulties in recruiting through Parkinson’s UK and after our discussion she agreed 
to talk to her colleagues about recruiting more carers; two additional carers were then 
recruited to interview.  Once carers had expressed an interest I contacted them by phone to 
explain the project verbally, check their understanding and to arrange an interview date, and 
sent them the consent form to sign (by hand or electronically).  
Figure 9 and Figure 10 show the timeline through the project and indicate the points at 
which carers were recruited. 





Figure 9 Timeline through the first part of the project 
  





Figure 10 Timeline through the second part of the project 
 
  




 Eligibility criteria for the qualitative sample  
Any person who had cared for someone who had died from PD, PSP and MSA was eligible to 
take part.  There was no way of verifying the diagnoses before recruitment except for the 
carers who were recruited locally, as hospital records could be checked.  A minimum time of 
three months after a relative’s death was set for sending invitations by post, as this was felt 
to be in line with studies that had used similar recruitment methods (106, 128).  No 
minimum time interval was set for people recruited through the forums as we judged that 
because the carers were opting-in to a public invitation they would only take part if they felt 
ready.  This view was supported by a study published in 2015, which suggested that allowing 
bereaved carers to make their own choice with regard to the timing of participation was 
beneficial to them and the researcher (129).  There was no maximum time of bereavement 
set because there does not appear to be a consensus over how long is too long in terms of 
validity, despite suggestions of recall bias over time (79, 130).  Some similar studies had 
opted for a maximum bereavement period of two years (5), but some had accounts from 
carers who had been bereaved 5-7 years previously (107, 131).  Logistically numbers, 
especially for carers of those with PSP or MSA, would have been very limited by 
implementing a maximum so we chose not to restrict the sampling by length of 
bereavement.  
Regarding the forums several people joined that were not bereaved carers.  Though their 
views provided additional insight they were not included in the subsequent analysis.  Two 
carers on the MSA forum were based in Australia; their forum entries were included in the 
analysis as the healthcare systems are not dissimilar and their views still gave insight into the 
issues that people with MSA and their carers face at the end of their lives.  
 




 Interview Process   
Regardless of the way that carers were informed about the project, all were sent a copy of 
the disease specific participant information sheets and a consent form.  Once a completed 
consent form had been returned, I called the carer to arrange a time and date for the 
subsequent interview.  This call allowed me to check understanding about the project, 
ensuring that informed consent had been given, and allowed the carer to ask further 
questions prior to the interview.  At the start of each interview I asked the carer again if 
they had any questions about the procedure or project and reiterated that they could stop 
the interview at any point.  Although an hour per interview had been proposed, there was 
no time limit set.  Interviews were either carried out face to face or over the phone.  All face 
to face interviews took place in the carers’ own homes.  They were recorded with a 
Dictaphone and once the interview had ended this was taken back to North Tyneside 
hospital.  All telephone interviews took place using a speaker phone, in a private room, in 
the North Tyneside education centre and were recorded using a Dictaphone.  Each interview 
was immediately downloaded onto my secure personal drive within the hospital network at 
Northumbria Healthcare NHS Foundation Trust and the original recording was erased from 
the Dictaphone.  During the transcription process names of people and places were 
replaced with an asterisk.  Pseudonyms were then developed for each carer and their 
relative and are used throughout the results sections of this thesis.  
 Interview data collection – topic guide 
Interviews were semi-structured using a short topic guide (Figure 11) as an aide memoire, 
rather than a list of questions.  First carers were asked to tell me a little about their life with 
their relative, and the disease, and then I asked them to focus on the last few months of life. 
Further questions were driven directly from the carers previous responses.  I felt the 
interviews flowed better this way, allowing me to build rapport with the participants.  It also 
allowed carers to focus on what actually mattered to them, which was especially important 
for the carers of people with PSP/MSA as end of life care with this group had not been 




previously explored.  Interim analysis on the forum samples and initial interviews allowed 
me to add additional areas of questioning for subsequent interviews. 
 
Figure 11 Topic guide for interviews (italics denote questions that were added later) 
 Sample size/data saturation 
20-30 carers was the number we were initially planning for the qualitative arm of the study. 
This number was chosen because reviews have suggested that the number of interviews 
conducted should be between 5-25 for studies of experience (phenomenology) and should 
be at least 15 for qualitative research (132).  In addition, 20-30 had been suggested as fitting 
the requirements of thematic analysis at doctorate level, which was the method we had 
chosen for analysis (133).  We felt that 10 carers in each disease group would give us the 
ability to compare the diseases and that an overall sample of 30 people would allow an 
adequate comparison of places of death, especially when combined with the VOICES data.  
However, there was some in-built flexibility in terms of numbers, as it was not clear at the 
outset (due to a dearth of qualitative research evidence on end of life among these groups), 
the numbers required to reach data saturation (134).  Recruitment of participants ceased at 
36 – the point at which no new themes were emerging following additional data collection. 
TOPIC AREAS: 
• Place 
o Where did your relative want to die? 
o Did the location affect their experience? 
o What were the staff like? 
o Was anything lacking in the services 
delivered? Was anything especially good? 
• Planning/communication 
o Who made the decisions? 
o Prior plans/discussions  
o Did being able to communicate affect 
their experience 
• What was on their death certificate? 









3.7 Quantitative data collection 
 Background of the VOICES survey 
The VOICES survey was developed in 1995 by Professor Addington-Hall and originally 
consisted of 144 questions targeted around health and social care provision in the last three 
months of life (84); it was redesigned into a shorter format in 2011 (VOICES-SF) consisting of 
58 questions (85).  The first half of the survey relates to the last three months of life and 
asks questions about service provision in the home, care home, hospital and hospice.  The 
latter half of the survey is concerned with the level of care in the last two days of life, 
regarding symptom control, personal care needs and communication, and ‘circumstances 
surrounding the death’ which relates to decision making, knowledge of dying, plans and 
bereavement.  
Between 2011 and 2015 the VOICES-SF was the tool used in the National survey of bereaved 
relatives, commissioned first by NHS England and then the Department of Health, and 
administered by the ONS.  In 2014, in light of the findings in the Neuberger report ‘more 
care, less pathway’(83), the survey was altered so that the wording and responses of some 
questions changed (98); two additional questions were added about food and drink in the 
last two days of life as well as a further three part question about communication with 
relatives (Appendix B has a copy of the 2014 survey, the additional questions have been 
starred).  A question regarding where the dying person had spent the last two days of their 
life was removed. 
 Sampling methods for the National Bereavement survey  
The ONS used stratified random sampling, stratified by COD, place of death and 
geographical spread, to post out surveys to around 49000 bereaved carers each year (98).  
The 2011 sample related to deaths between November and June, whereas subsequent 
surveys related to deaths that had occurred between Jan and April.  The carers had been 
bereaved 4-11 months prior to the survey being sent out.  All causes of death were eligible 
to be sampled except those caused by accident, suicide or homicide.  Place of death had to 




be either a home, hospital, care home or hospice.  The response rate was around 45% each 
year leaving a total response of around 110,000 carers across the five years.  
 Accessing the ONS VOICES datasets 
In June 2016 the ONS made all five years of the VOICES datasets available for public use 
through the UK Data Service.  However, to protect anonymity the finer detail variables were 
combined; this meant that COD was limited to a label of cancer, cardiovascular disease or 
other, with the data for the carers of those with PD, PSP and MSA within the ‘other’ 
category.  In order to access the ICD-10 codes for causes of death, enabling PD, PSP and 
MSA to be selected for, the special licence datasets had to be used.  To gain access to these 
datasets I had to be registered with the ONS as an approved researcher and had to have 
completed a SURE (Safe Users of Research data Environments) course.  I was only eligible for 
provisional approved researcher status and the conditions of the approval were that I had to 
access the data under the supervision of a fully approved researcher, Professor Richard 
Walker.    
Following project approval from the UK Data Service and the ONS; we therefore had a 
window of access (under special license) to the VOICES surveys between 20th February 2017 
and 31st August 2017, after which all of the datasets were destroyed in line with the request 
from the UK Data Service/ONS, as access was changing to secure lab only.   
3.8 Analysis 
 Qualitative   
The interviews and forum extracts were analysed according to the principles of Thematic 
analysis outlined by Braun and Clarke (135).  Thematic analysis was chosen because it does 
not need to conform to a set of philosophical principles, unlike grounded theory or 
interpretive phenomological analysis, and so fits within the methodology of pragmatism and 
mixed methods research.   




Braun and Clarke advocated a six–phased approach to analysis (135): the first step relates to 
familiarising yourself with the data, the second relates to coding the data, the third, fourth 
and fifth relate to generating, reviewing and defining themes and lastly the sixth relates to 
writing the report.  
Familiarising myself with the data 
All but two of the interviews were transcribed by me; the two interviews that were 
transcribed by a medical secretary were checked for accuracy against the recordings.  As 
well as providing the opportunity to familiarise myself with the data, transcribing the 
interviews allowed a degree of preliminary analysis to be done which enabled me to explore 
points of interest in subsequent interviews.  Once the interviews were transcribed, these 
were read and key concepts and points noted. 
Generating initial codes 
Coding was initially conducted by hand, then using Nvivo software to aid data management. 
Transcripts were examined line by line and sections of text were assigned a label(s)/code.  
Initially this was done separately for each disease group.  Individual data extracts could be 
assigned more than one code (see Figure 12 for an example).  I took an inductive approach 
toward analysis, so that the codes that were generated came directly from the data, rather 
than from a pre-determined list based on prior research.  As the analysis progressed it was 
apparent that some codes needed splitting and others needed condensing, at this point I 
used Nvivo to aid in their management.  Each disease became a project within NVivo with its 
own data set. 
 














Generating, reviewing and defining themes 
I collated the codes into themes by using hand written spider diagrams and by generating 
sets and higher-level nodes11 on Nvivo.  Some codes became collated into a main theme, for 
example support during disease, support at time of death and support after dying all 
became ‘Support’; some codes became subthemes, for example, staff attitudes.  In defining 
the themes some codes were split, reassigned or abandoned.  
Through reviewing the data sets separately it was apparent that almost all of the codes 
overlapped between MSA and PSP; I could also see that the overarching themes matched 
across all three disease groups.  Therefore, I generated a word document for each theme 
and populated them with data extracts arranged by subtheme; this allowed me to review 
the themes and check that they were reflective of the data.  I had colour-coded each extract 
by disease group and this allowed me to compare the diseases within the themes.  I then 
read through the interviews again to ensure that the themes fitted the most pertinent 
issues related by the carers.  
 
11 terminology for a code in Nvivo 
“as I was out of the room whilst they told my mum, I was unaware of the severity 
of it all. Upon my return, mum pointed out “Bury me”. Devastation, total 
devastation” MSAf2 
Coded as  
• communication person with MSA to carer  
• how was bad news broken 
• decision making – patient 
• future plans what 
• did person know dying 
• did carer know dying  
• impact of dying on carer 
Figure 12: Example of how extracts were coded 





IBM SPSS Statistics (Versions 21-24) was used to analyse the VOICES datasets.  
Within the UK data service there was one corresponding SPSS dataset for each surveyed 
year, and three datasets which combined the surveys of 2011-12, 2012-13 and 2014-15. 
Each dataset had been generated containing the answers to the VOICES survey and the ONS 
death certificate data (including age, sex, causes of death, place of death, deprivation level 
and NHS area) for all decedents whose relatives had been invited to take part, whether they 
had responded or not.  Data cleaning highlighted a coding anomaly12 in the 2011 dataset, 
therefore the 2011 set was excluded from analysis.  The ONS data and most of the survey 
questions were identical across the four years and so the 2012-13 and 2014-15 datasets 
were combined.  The question stem and responses regarding support for symptoms and 
care needs had altered between 2012-13 and 2014-15 and as they were not directly 
comparable only the 2014-15 data was used for comparisons of locations.  A question 
regarding where the dying person had spent their last two days was only present in the 
2012-13 surveys and questions regarding communication with carers were only present in 
2014-15.   
 Cause of death (COD) 
The data sets were searched for the ICD-10 codes that corresponded to PD (G20), PSP 
(G231) and MSA (G903) and where these diseases were recorded as the primary/underlying 
COD by ONS, the label of ‘other’ in the COD variable, which corresponded to a ‘3’, was 
replaced with a ‘4’ for PD, ‘5’ for PSP or a ‘6’ for MSA.  An additional variable was generated 
to account for people who had these diseases but were not thought to have died from 
 
12 The column for 1st COD was completely blank and carers response to place of death 
showed an oddly high response for dying in A+E and an oddly low response for dying in a 
care home, especially when compared to subsequent years  




them13, making the diseases contributary but not underlying COD (discussed in greater 
depth in Chapter 4).  This enabled an estimation of the proportion of people felt to have 
died because of the diseases.  As the people who had PD/PSP/MSA recorded as a 
contributory COD were potentially in an earlier stage of the disease and died from other 
causes the decision was made to focus only on the groups whose underlying COD was 
PD/PSP/MSA.  This also meant that a comparison could be made between people dying due 
to PD/PSP/MSA and those dying due to cancer, cardiovascular disease or ‘other’ causes. 
Appendix C illustrates how completion of a death certificate would account for an 
underlying or contributory COD being recorded. 
 Place of death (POD) 
POD is represented in the ONS data (ascertained by information recorded by doctors on the 
death certificate itself) and as a question for carers in the survey data (Q40 of VOICES 
survey, see Appendix B).  For the purposes of analysis, when survey questions were 
compared according to POD it is the place recorded by the ONS which was used, rather than 
the POD carers had selected in the survey.  This decision was made because it aligns with 
the way that the ONS themselves analysed the data(98).  This could impact on the analysis 
of survey responses as it is possible that ONS recorded POD as hospital but carers were 
answering about home.  However, when death certificate and carers’ POD were compared 
they matched 96% for hospital, 97% for care homes/home and for 95% hospices for those 
with PD and 100% in all locations for PSP/MSA.  In the 2012 survey carers were asked about 
where their relatives spent their last two days and again there was some discrepancy.  For 
example, ONS had recorded POD as hospital but the carer had said that their relative spent 
all of the last two days at home, in these cases it is likely the carers view relates to home but 
would be recorded as relating to hospital.  This question was removed from later surveys 
and so could not be used to exclude the data of people who had a mismatch.  In 2012-13 
 
13 PD, PSP or MSA were on the death certificate but were not recorded by the ONS as the 
primary COD  




11% of people recorded as dying in hospital were said to have spent all of the previous 2 
days elsewhere by their carers.  The same was true in 3% of care home deaths, 6% of home 
deaths and 0% of hospice deaths.   
 Comparisons 
Statistical analysis 
Every variable (see Appendices B and D for more information) was compared according to 
the primary COD and POD with frequency tables and cross-tabulations recorded.  
Comparisons to other conditions were age-matched.  Some of the survey responses were 
nominal, ‘yes’, ‘no’, ‘don’t know’, some were represented as Likert scales with either 
‘outstanding, excellent, good, fair and poor’ as the responses or ‘strongly agree, agree, 
neither agree/disagree, disagree and strongly disagree’ (see VOICES survey in Appendix B).  
As it cannot be assumed that the difference between outstanding and excellent, is 
necessarily the same as the difference between fair and poor, the Likert scales were treated 
as ordinal data.  Clinically relevant distinctions were then used to collapse the categories 
into nominal variables to allow comparisons to be made; for example, it was felt that good 
care meant a person was always treated with respect and dignity and so the categories 
became ‘always’ or ‘not always’ treated with respect.  Likewise, categories were collapsed 
into those who agreed or disagreed with statements, or those who received excellent or less 
than excellent care.  This approach has been used in previous studies using the VOICES 
survey (136).  How the variables were collapsed and compared depended on the individual 
questions.  Mostly, because excellence in healthcare should be the aspiration, the top one 
or two labels were compared to the rest.  So outstanding and excellent versus good, fair and 
poor; strongly agree/agree versus neither agree nor disagree, disagree and strongly 
disagree, and always versus less than always.  Not applicable and don’t know were selected 
out of comparisons as it skewed the percentages and affected the statistical calculations.  
When the fact that people had answered not applicable was felt to be an interesting and 
positive finding this was explored separately, for example, when ‘not applicable’ was 




answered regarding food and drink at the end of life.  Appendix D includes tables of the 
variables and indicates the way they were collapsed for comparison.  Categorical statistical 
analysis was performed using binary logistic regression to create odds ratios with 95% 
confidence intervals.  This method was chosen instead of chi squared testing as it allowed 
ranking of the differing locations and illustrated more clearly where the statistically 
significant differences lay; rather than showing a more global difference across the group.  
3.9 Meta inferences 
Because the survey and interviews were looking at slightly different aspects of the 
experience, they were predominantly integrated after the analysis had been completed.  
The exception was that once the qualitative analysis had been completed, the data extracts 
in the support theme were re-examined according to place of death.  This enabled a clearer 
comparison of places of death to be made and allowed patterns in the strands to be 
explored.  A process of abduction (117) then took place where questions were asked back 
and forth across the two strands with regard to place of death and similarities and 
differences were brought together and directly compared and explored, in line with the 
complementarity purpose of the study, to explain the experience in greater detail.    
Although many of the points raised in the qualitative strand did overlap with questions in 
the VOICES survey it was apparent that it had been useful to undertake the analyses 
separately as some of the main points of importance raised in the qualitative strand were 
not touched upon in the VOICES survey.   
3.10  Summary 
This chapter has outlined a background to mixed methods research and explained why the 
approach taken was one of pragmatism.  It has explained the project design, recruitment 
into the quantitative and qualitative strands, their analysis and integration.




Chapter 4 Demographics 
This chapter sets out the demographic details of the people who died (referred to as 
decedents by ONS), and their carers, for the quantitative data set (the VOICES samples) and 
the qualitative data set (interview/forum sample).  It also presents some descriptive findings 
regarding place of death for the quantitative sample. 
4.1 The quantitative data set 
This section first talks through the difference between contributory and underlying causes 
of death, comparing the demographics of people thought to die because of PD/PSP/MSA 
(underlying cause) with those who had PD/PSP/MSA but whose deaths were felt to occur 
due to a different condition (contributory cause)14.  The next section focusses on the 
response rates of carers whose relatives were recorded as dying with an underlying cause of 
PD/PSP/MSA and the factors which affected the responses.  The final part of the 
quantitative section presents the demographic details for the data that was used in the 
overall analysis when comparing places of death; including age, gender, social deprivation 
and POD and looks at factors which affected the overall rating of care.  
Figure 13 demonstrates pictorially how the final numbers included in the quantitative 
analysis were reached.
 
14 The ONS records up to 15 causes of death as mentioned on the death certificates.  Please 
refer to appendix C for an explanation of the way that a death is recorded as contributory or 
underlying 




Figure 13 : Flowchart detailing how final numbers included in quantitative analysis (shown in bold type) were reached 




 Contributory and underlying causes of death 
The information contained in the VOICES datasets included the demographic data of 
decedents for every survey that was posted to carers, whether they responded or not; 
based on the information provided to the ONS at the time the death was registered.   
There were 3990 decedents with PD, 107 decedents with PSP and 63 decedents with MSA 
mentioned somewhere on their death certificate.  Of these decedents the underlying COD 
was felt to be PD in 2029 (51%), PSP in 93 (87%) and MSA 51 (81%).  Appendix E includes 
tables comparing those who died with PD/PSP/MSA as contributory or underlying causes.  
Those decedents mentioned with PD as a contributory COD (n=1960) were more likely to be 
male (63% vs 60%) and to have died in a hospital (52% vs 34%)  than those dying from PD as 
an underlying cause and less likely to have dementia (17% vs 37%) or to have died in a care 
home (34% vs 52%). 
It is difficult to compare the contributory and underlying COD groups for those with 
PSP/MSA mentioned on their death certificates as the numbers for the contributory groups 
are so small (PSP n=14, MSA n=12).  However, the same trends were seen for those with PSP 
and MSA in terms of place of death; decedents where the PSP/MSA were felt to be 
contributory were proportionally more likely to have died in hospital than for the decedents 
where the PSP/MSA was the underlying COD (PSP 71% vs 28%; MSA 67% vs 41%).  
Interestingly, where PD/PSP/MSA were felt to be contributory causes, 19% of those with PD 
and 50% of those with PSP/MSA were recorded having pneumonia as their underlying COD; 
given that pneumonia is more common in these diseases this finding does call into question 
the accuracy of the way that death certificates are recorded. 




 Underlying COD PD/PSP/MSA 
Those dying from MSA died younger than those with PSP/PD (49% in 50-74 age group MSA, 
vs 37% PSP and 11% PD).  There were more men that died from PD (60%) and MSA (59%) 
than women, which was not true for those dying from PSP (male 49%).  People dying from 
these diseases appear to be less likely to have been recorded as living in areas with the most 
deprivation (31% PD/PSP and 22% MSA of deaths were recorded in most deprived 40%), 
which may well reflect the fact that these conditions occur in more advanced age as social 
derivation is linked to reduced life expectancy.  Dementia was mentioned on the death 
certificate for 37% of those dying from PD, 11% of PSP and 6% of MSA.  Figure 14 shows the 
POD according to the underlying COD.  It shows that people who died from PD appear more 
likely to die in a care home than those with PSP/MSA.  People with PSP appear more likely 
to die at home than those with PD or MSA.  Those with MSA appear more likely to have died 
in hospital or hospices than those with PD or PSP.







Figure 14 POD recorded by ONS when the underlying COD was PD, PSP or MSA [n], England 2012-15 (n, %) 




 Response rates 
Table 3 shows the response rates from carers of those whose underlying COD was felt to be 
due to PD/PSP or MSA.  
Condition Number of questionnaires 
sent 
Response rates n (%) 
PD 2029 1007 (50) 
PSP 93 44 (47) 
MSA 51 23 (45) 
Table 3 Response rates from carers where the underlying COD was PD, PSP or MSA 
Response rates were affected by POD, age and deprivation index.  PD carers were 
significantly less likely to respond if the POD was listed as hospital compared to care home 
[OR 0.81 (0.67 to 0.99) p=0.036] or at home [OR 0.66 (0.49 to 0.87) p=0.004]; the 
comparison with hospices was not statistically significant [OR 0.62 (0.31 to 1.24) p=0.18].  
PD carers were significantly less likely to respond if the decedent was in the most socially 
deprived 20% when compared to those in the middle [OR 0.60; CI 0.44 to 0.83: p=0.002], 2nd 
least deprived [OR 0.68; CI 0.50 to 0.92: p=0.012] or least deprived 20% [OR 0.67; CI 0.49 to 
0.90: p=0.009].  Response rates for PD carers were not affected by the age, gender or 
dementia status of the decedent.  
Carers for those with PSP/MSA were more likely to respond if decedent was older than 75 
and PSP carers were more likely to respond if they were in the least deprived social group; 
response rates were not affected by gender, dementia status or POD.  
 Sample used for comparative analysis  
Table 4 shows the demographic details for decedents whose underlying COD was PD/PSP or 
MSA, where the carers had responded to the survey.  Table 5 shows the demographic 
details for the carers who responded to the survey.     






Underlying COD n (%)  
PD [1007] PSP [44] MSA [23] Total PDRD [1074] 
Age     
50-74 100 (10) 10 (23) 7 (30) 117 (11) 
75-84 491 (49) 23 (52) 14 (61) 528 (49) 
85+ 416 (41) 11 (25) 2 (9) 429 (40) 
Gender     
Male 596 (59) 18 (41) 14 (61) 628 (58) 
Female 411 (41) 26 (59) 9 (39) 446 (42) 
Deprivation index     
Most deprived 20% 105 (10) 4 (9) 3 (13) 112 (10) 
2nd most deprived 20% 169 (17) 5 (11) 1 (4) 175 (16) 
Middle 20% 237 (24) 14 (32) 7 (30) 258 (24) 
2nd least deprived 20% 248 (25) 10 (23) 6 (26) 264 (25) 
Least deprived 20% 248 (25) 11 (25) 6 (26) 265 (25) 
Dementia     
Yes 377 (36) 3 (7) 1 (4) 381 (3) 
No 630 (63) 41 (93) 22 (96) 693 (65) 
Place of death     
Hospital 312 (31) 11 (25) 10 (44) 333 (31) 
Care home 528 (52) 18 (41) 9 (39) 555 (52) 
Home 147 (15) 12 (27) 4 (17) 165 (15) 
Hospice 20 (2) 3 (7) 0 23 (2) 
Ethnicity15     
White 936 (93) 43 (98) 21 (91) 1000 (93) 
Religion16     
Christian 844 (84) 37 (84) 18 (78) 899 (84) 
No religion/other 143 (14) 7 (16) 4 (18) 154 (14) 
Table 4 Decedent Demographics 
 
15 This is answered by carers in the VOICES survey and because some carers did not answer 
the questions the % figures as a proportion of those who answered are slightly higher than 
those shown  




Demographics of carer Underlying COD n (%)  
PD [1007] PSP [44] MSA [23] PDRD 
[1074] 
Relationship to decedent     
Spouse 333 (34) 21 (48) 14 (61) 368 (34) 
Child 544 (55) 19 (43) 8 (35) 571 (53) 
Other 116 (12) 4 (9) 1 (4) 121 (11) 
Age     
18-49 102 (10) 4 (9) 6 (27) 112 (10) 
50-59 300 (30) 11 (25) 3 (14) 314 (29) 
60-69 279 (28) 13 (30) 4 (18) 296 (28) 
70-79 198 (20) 10 (23) 6 (27) 214 (20) 
80+ 116 (12) 6 (14) 3 (14) 125 (12) 
Gender     
Male 331 (33) 23 (52) 8 (35) 362 (34) 
Female 628 (62) 20 (45) 15 (65) 663 (62) 
Ethnicity     
White 959 (95) 44 (100) 21 (91) 1024 (95) 
Table 5 Carer Demographics 
 Overall rating for care in the last three months 
The overall rating for quality of care in the last three months was affected by COD, as shown 
in Figure 15 . 
 




















Overall rating of care in the last 3 months, by cause 
of death, England 2012-15




Carers whose relatives died of PD were significantly more likely to feel the quality of care 
was positive (outstanding/excellent/good) than the carers of people dying of PSP [OR 2.48; 
CI 1.19 to 5.18: p=0.0015]; there was no statistically significant difference between those 
who died of PD and those who died of MSA [OR 1.33; CI 0.39 to 4.58: p=0.65].  A greater 
proportion of the carers of those who died from PSP and MSA felt that their care had been 
outstanding or excellent, compared to those who died from PD, but the differences were 
not statistically significant.  
Other demographics that may have affected the overall rating of care were compared with 
the diseases combined, because the numbers for PSP/MSA were too small to allow any 
statistical inferences to be made.  Appendix F contains the proportions for the individual 
causes of death and shows that for most variables the patterns of PSP/MSA followed that of 
PD.  Appendix G details the odds ratios, confidence intervals and p values for the findings 
detailed below.   
Overall quality of care was not affected by the age, gender, deprivation index or religion of 
the decedent, nor by the presence or absence of dementia being mentioned on the death 
certificate.  Carers who were spouses were significantly more likely to answer that care had 
been positive than carers who were the decedents’ children.  The older a carer was, the 
more likely they were to feel that care was positive; with carers over the age of 60 
significantly more likely to rate care positively than those aged between 18-49.  Male carers 
were more likely to rate care positively than their female counterparts.  
In terms of POD, there was a statistically significant difference across the group. Carers 
whose relatives died in hospital were significantly less likely to rate care positively than 
carers whose relatives died in care homes [OR 0.60; CI 0.43 to 0.85: p=0.003]; there was not 
a statistically significant difference when comparing hospital deaths to home or hospice 
deaths, despite the apparent fact the hospices and home deaths appeared to be rated even 





Figure 16 Overall rating of care in the last three months by POD, England 2012-15 
However, regarding POD these results should be interpreted with caution because clinically 
and practically comparing the overall score of the whole of the last three months to the POD 
makes little sense.  As an example, of those who died in a hospice 78% had spent some of 
their last three months in hospital and 35% of them had spent time at home, so their carer’s 
overall rating of care for the last three months would likely refer to a multitude of places of 
care and make a comparison based on POD alone difficult.  This factor likely explains why in 
the subsequent results chapter hospice appears to be rated much higher, in terms of 
excellent care, than this overall rating scale would suggest it performs.  When comparing 
those who answered they had spent all of the last three months in a care home the overall 
rating went up and for those who had spent all of their time in a hospital the overall rating 
went down (see Appendix G xi).  Chapter 6 compares the different places of death in closer 





























Overall rating of care in the last three months by 
place of death, England 2012-15




4.3 The Qualitative sample 
This section presents the details of the qualitative sample.  Because the recruitment was 
undertaken as a convenience sample, aside from those who died locally it was difficult to 
ensure all places of death were sampled, but there was interview data across all locations 
for each of the disease groups.  Although no-one with PSP died in a hospice (as Table 6 
shows), two carers related that their loved ones had spent a couple of months within 
hospices in the last months of life.   
Compared to the VOICES sample, the carers in the interview/forum group were more likely 
to be spouses and they had, for the most part, been bereaved for a longer period. 
Interviews were undertaken by telephone in most cases (n=18); the rest were undertaken 
face to face at the carer’s home (n=6).  
Demographics of decedent Underlying COD n (%) 
PD [n=13] PSP [n=9] MSA [n=14] 
Age    
50-74 2 (15) 3 (33) 11 (79) 
75-84 9 (69) 4 (44) 3 (21) 
85+ 2 (15) 2 (22) 0 
Gender    
Male 10 (77) 5 (56) 5 (36) 
Female 3 (33) 4 (44) 9 (74) 
Place of death    
Hospital 7 (54) 5 (56) 7 (50) 
Care home 3 (23) 3 (33) 1 (7) 
Home 2 (15) 1 (11) 4 (29) 
Hospice 1 (8) 0 2 (14) 
Demographics of carer  
   
Relationship to decedent    
Spouse 10 (77) 6 (67) 11 (79) 
Child 3 (23) 3 (33) 3 (21) 
Gender    
Male 2 (15) 2 (22) 6 (43) 
Female 11 (85) 7 (77) 8 (57) 
Average bereavement 
(range) 
18 months  
(1 to 78) 
34 months  
(3 to 84) 
40 months  
(1 to 96) 
Number of interviews 8 7 9 
Number of forum entries 5 2 5 













The word counts of the interviews and forum samples are provided to give an indication 
about the amount of data in the forum entries.  Although the forums contained less 
















Jennifer  Doris PD Daughter 3 years - 6053 Care Home 
Sandra Edmond PD Wife 6.5 years - 3306 Home 
Moira Samuel PD Wife 1 month - 960 Hospital 
Pippa Cedric PD Daughter 15 months - 2039 Hospital 
Martha Fred PD Wife 5 months - 810 Home 
Brenda Eddie PD Wife < 1 month 117 mins 21662 Hospital  
William Pearl PD Husband 7 months 64 mins 6650 Hospital 
Barbara Derek PD Wife 9 months 78 mins 11091 Care Home 
Angela Graham PD Wife 2 years 100 mins 11925 Care Home 
Pam Andrew PD Wife 2 years 77 mins 9756 Hospice 
Susan Paul PD Wife 16 months 78 mins 10543 Hospital 
Simon Gladys PD Son 14 months 65 mins 9488 Hospital 
Betty Donald PD Wife 7 months 59 mins 7896 Hospital  
        
April Janice PSP Daughter 6 months - 3906 Hospital 
Samantha Ronald PSP Daughter 3 years - 1498 Hospital 
Peter Yvonne PSP Husband 14 months 82 mins 11362 Care Home 
Constance Thomas PSP Wife 9 months 141 mins 16887 Care home 
Stephanie Nigel PSP Wife 6 years 87 mins 11361 Hospital 
Kate Marion PSP Daughter 7 years 75 mins 12509 Hospital 
Margaret Chris PSP Wife 3 months 130 mins 20650 Home 
Hope Dennis PSP Wife 6 years 102 mins 11652 Hospital  
Colin Grace PSP Husband 1 year 65 mins 9029 Care Home 
        
Charlene Evelyn MSA Daughter < 1month - 502 Hospital 
James Rachel MSA Husband 3 years - 1086 Home 
Nicole Jake MSA Wife 8 years - 663 Home 
Abigail Stella MSA Daughter 4 months - 2022 Care home 
Cecil Elizabeth MSA Husband 3 months - 7015 Home 
Julie David MSA Daughter 8 years 84 mins 12054 Hospital  
Helen Tony MSA Wife 7 years 110 mins 21346 Hospital 
Vincent Beatrice MSA Husband 3 years 123 mins 20052 Hospital 
Paul Emmy MSA Husband 1 year 76 mins 10265 Hospice 
Elaine Stephen MSA Wife 2 years 134 mins 25388 Hospice 
Aileen John MSA Wife 4 years 85 mins 12230 Hospital  
Charles Anna MSA Husband 3 years 67 mins 6931 Hospital 
Philip  Thelma MSA Husband 6 years 180 mins 21786 Hospital 
Sebastian Jade MSA Husband 15 months 90 mins 10685 Home 




relevant to the research questions, especially regarding the experiences encountered in the 
differing places of death.  Appendix H contains mini case studies for each carer’s narrative to 
provide the background for subsequent quotes.   
4.4 Summary 
This chapter has presented the demographic details of the quantitative and qualitative 
samples.  It also explained demographic factors which affected response rates and the 





Chapter 5 The palliative and end of life needs of people with PD, PSP, MSA and 
their carers 
This chapter presents the main components of the qualitative interviews and forums and 
allows for a comparison between the views of those caring for people with PD and those 
caring for people with PSP or MSA.  
The principle themes from the qualitative interviews were those of preparation, support 
and identity (see Figure 17).  In this chapter these themes equate to a discussion about the 
future and ACP (Preparation); co-ordinated care (Support) and knowledge about the 
diseases/community spirit reflecting collective and relational aspects of identity (Identity). 
 
Figure 17 The principle themes of the project and an indication of the ways they are discussed in this chapter 
 
5.1 PREPARATION: Prognosis, Information Gathering and ACP 
As stated in the introduction and literature review, current guidance suggests that people 
should be aware of their prognosis and receive timely information to enable them to plan.  
This section discusses communication about the future between people with PD/PSP/MSA 
and their relatives and HCPs.  It then discusses how these discussions, or lack of them, can 



















Figure 18 The components of future planning 
 
 Prognosis 
In most cases there was a delay in diagnosis for those with PSP/MSA.  Most had to pay 
privately to see a neurologist and several had been diagnosed with something different 
beforehand (often PD).  Those with PSP/MSA had found this delay frustrating.  Some had 
researched their likely diagnosis themselves and knew time was limited.  Others knew 
something was wrong and wanted to get to the bottom of it, though in retrospect a couple 
of carers were glad there had been a delay. 
“you get angry that you’re not getting anywhere but then you look back and 
you think well we had three years when we didn’t know what was going to 
happen, so actually that was quite nice” Helen (MSA)17 
Once given a diagnosis, the majority of those with PSP/MSA were told that there was no 
available treatment to slow the progression of the disease and that they had a life-limiting 
prognosis.  
“when I first found out about MSA I knew that I was watching my wife die 
from the very beginning day by day, week by week, month by month, year 
by year and I knew she was dying, it wasn’t a case of if.  I knew there was an 
around about seven years prognosis” Paul (MSA) 
 
17 Each quote is followed by the carer’s alias and the curved brackets indicate the COD of 




In contrast prognosis for those with PD was seemingly raised rarely by movement disorder 
teams.  This may be due to the heterogeneity of PD, which does make predicting an 
individual’s prognosis difficult.  Indeed those in the interview group with PD lived for 5-25 
years after their diagnosis; a much larger range of time than those with PSP/MSA (1-5 
years).  Once the disease had progressed, years later, a couple of those with PD had been 
told they were in the end stages, but they were in the minority.  Most carers felt that clinic 
appointments centred around medication, whether it was helping or not, whereas they 
would’ve welcomed more frank discussions about what could happen with PD. 
 “I think that more information about PD and the various stages of the 
disease being communicated to the main carer in advance can only be 
helpful.  It will help to come to terms with the situation and also to plan for 
it...  I also think that a conversation about the fact your loved one is dying 
would also have been very helpful and in particular advance of what you can 
expect the various stages and interventions to be” Sandra (PD) 
Timing in regard to when conversations about the future should happen was discussed.    
“CM: anything else you we could do better at the end of life for Parkinsons’s 
disease? 
Betty: I think really just keeping people informed of how bad it can get and 
what it can do to people 
CM: when do you think is the right time to tell people that sort of thing? 
Betty: at the beginning of the deterioration 
CM: so as things start to go downhill 
Betty: yeah coz you sometimes think gosh what’s happening and then you 
think maybe this is the way it’s supposed to be” Betty (PD) 
Marking the point of decline where it would be relevant to bring up discussions about the 
future might be difficult, but Pippa’s view was that there should be more honesty at an 
earlier stage to better prepare people for what lay ahead  
“I feel it is about being honest about the future so people can truly plan their 
future and live for now rather than hoping that something miraculous will 
happen and their mobility will improve and their Parkinson’s will be 
cured…there needs to be more honesty amongst professionals about what a 
Parkinson’s diagnosis means. When my father was diagnosed they said you 
won't die from Parkinson’s but you will die with it. There is no doubt that 




Pippa had witnessed her father and others put off decisions whilst waiting to get better with 
their medication.  She felt it should be clearer no cure was coming.  In the death certificate 
data supplied by ONS, 51% of those with PD were felt to have died as a direct consequence 
of their PD and yet even carers who had been told their relatives had end stage PD felt that 
it was not a COD.   
“Mum knew she did not want to be resuscitated or have her life extended if 
she had an accident or went into heart failure or other such conditions. She 
knew Parkinson's was not terminal”  Jennifer (PD) 
 Information about disease progression 
Because those with PD and their carers felt that PD was not a COD and because clinics 
largely focussed on medication, rather than discussions about decline, there was no 
suggestion for most that discussion should be had about the future.  Pippa felt that by the 
end of her dad’s life the PD team had given up on her dad, “as if they didn’t really want to 
discuss the end of life”, and even when people had good access to PD teams and nurses for 
support regarding symptoms, discussions about how near the end might be and what might 
happen did not appear to have been had. 
“The first indication I had that my husband was seriously ill was the 
telephone conversation I had with the Parkinson's Nurse when I rang to tell 
her he was in hospital again with bronchopneumonia.  This was about 2 
months before he died and up until then no-one had even hinted how very ill 
he was.  It was then I realised that maybe he did not have much longer to 
live” Sandra (PD) 
It could be assumed that those with PSP/MSA had more opportunity to discuss the future as 
they were told their conditions were life limiting.  However, once they had been told their 
prognosis there was little further explanation as to what the future might bring, or how the 
end might come; some were told there was nothing the neurologist could offer them and 
one respondent was even told not to come back. 
“the neurologist basically said ‘you don’t really need to come back and see 
me there’s nothing much I can do for you, make sure you’re in touch with 
our Parkinson’s nurse at the hospital they’ll probably be the best person for 
you’ which um charming; didn’t get any information about what that was, 
what it meant, what it might mean for the future or anything, yeah lovely, 




Even though other neurologists were reported to be empathetic and engaged, none had 
given help with planning for the future, or really discussed it.  Those with PSP/MSA were 
either signposted towards the charities to gain more information or searched the Internet 
for more information themselves, or their carers did 
“I got a lot of information off the internet as one does these days, 
sometimes of course that’s not necessarily for the good but, you know, when 
you have a need to glean information” Constance (PSP) 
The amount of information they sought was very much dependent on their reaction to the 
news and the way they chose to cope with the diagnosis.  Individuals seemed to react with a 
‘fight or flight’ response, that is they either chose to search for information so that they 
could be prepared for what was coming, 
“I know he looked it up on the internet and I know he’d got this ‘my PSP files’ 
he started this file and I found that out after, so he was aware what a 
devastating diagnosis it was” Stephanie (PSP) 
or they preferred not to look any further  
“Gail instructed me not to study the internet, which was a waste of time of 
course because my two daughters immediately did and told me what it said 
but Gail wasn’t up to speed in many senses, she didn’t want to know and 
that generated its own problems” Colin (PSP) 
This response was true not only for the person with the disease but also for their carers; 
some carers wanted to know everything   
“I’m the sort that I wanted to find out as much as I could, I wanted to know 
what we were up against” Elaine (MSA) 
whereas other carers preferred not to read about what might happen 
“I looked it up on the internet, I read a little bit of it and I thought I don’t 
want to know anymore I’m just going to take each day as it comes” Helen 
(MSA) 
The practical (whether they had access to information) and emotional (whether they 
wanted to access information) ability to find out more about the diseases and their 
progression had a direct effect on whether plans were discussed.  Those with PD were 




frequently; their interpretation of their situation, with regard to planning, was therefore 
more often related to ageing and their ability to think about their own mortality in general, 
rather than related to their disease.  In contrast those with PSP/MSA were more often 
confronted with the life limiting nature of their diseases and therefore their emotional 
ability to search for information and plan was more closely related to their disease.   
The discussions people with the diseases had with their families and HCPs, the types of 
plans made, and the reasons for making them will be discussed in the sections below. They 
make up the ‘who’, the ‘what’ and the ‘why’ of ACP and we will look at each in turn. 
 
 
 ACP (WHO) – within the family 
The ability to think about what the future might bring and whether people could discuss the 
future had the most impact on plans being made.  There was little difference between 
people with PD, PSP or MSA in this regard.  If there was disinclination to discuss the future 
then conversations about the end of life weren’t had at all or they were mentioned only 
when a prompt appeared, for example, a TV programme about funerals.  If there was a 
reluctance to think about the end of life from a carer’s point of view this could shut down 
discussion and limited the making of plans.  
ACP 
WHO: Discussions about the future with 
family/HCP 
WHAT: What future decisions were made? 
WHY: Reasons for undertaking, or not 
undertaking, ACP 
 




“Helen: the way I looked after Tony was as if he was going to get better and 
that’s how Tony thought, he was going to get better  
CM: yeh he was fighting it each day  
Helen: yes he did he fought it every day um he never gave in to it so I think 
for me to say well you know you’re going to lose this battle what are we 
going to do would’ve floored him again and so, you know, I didn’t” Helen 
(MSA) 
Less often a person had made plans for the end of their life but did not want to discuss this 
with their carer.   
“she was concerned for me and I think that’s why when it came to issues of 
death and her condition that it was like getting blood out of a stone trying 
to raise the subject, so I left it alone” Paul (MSA) 
As these quotes show, avoidance of the topic could be generated from either those with the 
diseases or their carers and often the reason people gave for being reluctant to discuss the 
future was a desire to protect the other person.   There was perhaps also an element of self-
preservation, as raising the subject was acknowledged to be difficult.  
“it’s a heck of a lot easier to avoid the question <where would you like to 
die?> isn’t it and so would I actually have had that discussion or not, I don’t 
know, it’s difficult” Simon (PD)  
If both parties were willing to discuss the future and what it might bring then plans, or ideas 
about what people would want, had more chance of being discussed and written down.  
“we talked about death all the way through from day one you know and 
where he wanted to die. I wanted to know what he wanted to happen and 
he had a DNR put on his file from the very start and he wouldn’t’ve had a 
feeding tube - he said ‘when I get to that point that’s it, I want to be gone” 
Elaine (MSA) 
However, even when both parties were willing to discuss the end this didn’t always translate 
into concrete plans; many people just didn’t feel they were at the stage where plans needed 
to be recorded or issues such as POD needed to be discussed, as death wasn’t imminent.  
“P: well it’s like everything else, you look at it and think well there’s no 
problem, we haven’t got a problem at the moment, we were muddling along 





April felt it was this delusion regarding time that stopped discussions being had rather than 
the emotional difficulty that other carers had implied.  
“My feeling is that people don't talk about dying because we all delude 
ourselves that we have plenty of time. Even when my mother was in the 
final stages of a degenerative disease, I did not grasp that death was so 
close. I think this delusion stops people talking, rather than fear of broaching 
a sensitive subject” April (PSP) 
This quote suggests that guidance about what the end of life with these conditions might 
look like would be useful.  It may help people dying, or at least their carers, to know the end 
is approaching and to discuss the end and what those dying may want.  There were triggers 
that indicated that the end of life was approaching in the narratives that some carers 
related but these did not appear to have been communicated.   
Whether discussions about the future were delayed by a delusion of time, denial regarding 
prognosis or the sensitivity of the issues, the danger of delay was that by the time thoughts 
about recording plans came it was too late, the ability for the person with the disease to 
communicate (PSP/MSA), or make decisions (PD), was gone.  
“Because she lost her ability to communicate quite quickly and we were slow 
on the uptake of talking about things before, we didn’t really know what 
sort of care she wanted later on in life” Kate (PSP) 
Therefore, because of disease burden, there is a particularly pertinent timeliness element to 
making advanced plans for those with these neurodegenerative conditions.  This is further 
evidenced by looking at the question in the VOICES survey that relates to decision making.  
Those with PSP, MSA and PD appear less able to be involved in decisions about their care in 





COD [number answering question] He/she was not able to be 
involved in decisions regarding 
care in the last 3 months [n (%)] 
Cancer [24716] 1807 (7) 
Cardiovascular diseases [21671] 3452 (16) 
Other [35690] 7865(22) 
PD [989] 301 (30) 
PSP [44] 23 (52) 
MSA [22] 5 (23) 
Table 8 Ability of the decedent to be involved in decisions about their care in the last 3 months of life, by underlying COD, 
England 2012-15 
In addition, carers who’s loved ones had completed ACP felt it was easier to discuss the end 
of life when you weren’t confronted with the end approaching imminently and so earlier 
discussion was suggested as being beneficial from this point of view also.  
“Talking about it when it is less critical early on in diagnosis was what my 
Mum had wanted to do - then it was put aside”  
Jennifer (PD) 
 
 ACP (WHO) – Healthcare involvement 
Discussion, and certainly recording of plans, was more likely when a person external to the 
family was involved.  There were mixed feelings about GPs facilitating ACP.  Some had found 
their GPs very helpful for talking through plans. 
“The Compassion in Dying charity suggested that you involve your GP in 
writing the Decision <ADRT>.  Mum had an appointment with him to talk it 
over and he made some suggestions and ensured she understood what she 
had written and the medical implications”  
Jennifer (PD) 
Others felt they did not have enough time or raised issues such as DNAR insensitively.   
“we had no idea this lady <GP> was coming, she knocks on the door, she 
comes in with these pieces of paper and she said, ‘you fill these in and then 
we will talk on the phone or I’ll see you, no, no we’ll talk on the phone’.  So 
we don’t know what they are and after we start looking at them it looks like 
it’s some sort of advance care plan, well I know it is now and they wanted to 
discuss DNR and all sorts of things that Yvonne just did not want to discuss 




Despite Peter explaining that his wife had not wanted to discuss resuscitation, once she was 
attending the hospice day centre she was able to discuss the future and make decisions 
about what she wanted  
“So what actually happened, we joined the hospice <as a> day patient, a 
wonderful nurse <name>, we spent 4 sessions with her, we’d take tea and 
she works her way through advanced care planning and Yvonne agrees a 
DNR order” Peter (PSP) 
Hospices and SPC services were often the facilitators of recorded plans as they were 
particularly skilled at navigating difficult discussions.  The time, empathy and continuity they 
showed enabled plans to be discussed even with those who seemed initially reluctant to talk 
about the future.  Some care homes had ACP built in to their admissions process, covering 
not just the practical elements of future care, such as DNARs or PEG tubes, but also 
emotional elements such as hand holding and music.  When discussions had been had with 
these services plans were more likely to be recorded at an earlier stage and families were 
less likely to have delayed decision making.  It may well be that specialist nurses help with 
future planning in some areas but this was not the case with the carers interviewed.  Nor 
was there any guidance in the making of plans from movement disorder clinics, aside from 
suggestions to claim benefits because ‘the illness is not cost free’ (Stephanie PSP) and to ‘do 
everything you want to do now’ which hinted at the speed of progression for PSP/MSA.  
 ACP (WHAT) 
As suggested above, the ability to gather information about the diseases and to discuss 
what their prognosis meant for the future affected what plans, if any, were made.  For those 
with PD, because often prognosis was not raised, plans were made regarding a general 
ability to think about death in the distant future and were often not to do with PD but 




“We had got it <LPA18 and PPOD> all sorted out well in advance when we 
made our wills ten years ago. There was no pressure to do it then, it just 
seemed a good thing to do along with the wills” Martha (PD) 
Whereas those with PSP/MSA had been told their prognosis and so their plans were made 
regarding their ability to think about a time limited life and they were often more disease 
specific. 
  “do you know the next main watershed Claire was going to be whether she 
was going, when her swallow deteriorated enough, that she had to be PEG 
fed, Thelma didn’t want to be, we discussed that with the speech and 
language lady” Philip (MSA) 
DNAR was the commonest advanced decision across the three groups.  Three people had 
ADRTs and several had LPAs, but by no means the majority.  There had been some 
discussion about PPOD but rather than stating a preferred place more often people had 
discussed that they did not want to die in hospital or go into a care home. 
“we promised her she wouldn’t ever be alone, or live in a home, or die in 
hospital” Charlene (MSA) 
Those with PSP/MSA were more likely to have discussed a PPOD than those with PD.  Those 
with PSP/MSA had discussed PEG feeding more often than those with PD.  This reflected the 
fact that PSP/MSA progress faster and swallowing issues occur earlier.  Therefore, those 
with PSP/MSA had often been seen by speech and language therapists at an earlier stage 
and discussions about PEG feeding had been introduced by them.  Brain donation was the 
one advanced decision that did appear to have been discussed in movement disorder clinics, 
it was discussed regarding future research for a cure.  This was raised more frequently for 
those with PSP/MSA and many of those with MSA had agreed to donate their brains to 
research, seemingly because the MSA trust had sent out information about it. 
 
18 Lasting Power of Attorney – these documents allow a named person to make decisions on 
behalf of an individual should that individual lose the capacity to make decisions for 




 Reasons for ACP (WHY) – being in control 
There was no difference across the diseases regarding the reasons that people undertook 
ACP.  One of the principle reasons for undertaking ACP was to allow those with the diseases 
to maintain their autonomy; ensuring that decisions that were made about their care 
aligned with their wishes.  
“When she wrote the Advance Decision and End of Life Plan it gave Mum the 
feeling of being in control - she said Parkinson’s had taken so much control 
from her that the plans meant she could feel that she would be in control of 
the end of her life - through my voice and her written words” Jennifer (PD)  
Being in control of future decisions was the reason given in all three cases where an ADRT 
had been made; this and a LPA for health and welfare being the only legal way for a family 
to refuse treatment and ensure that their loved one’s wishes are enforced.  As discussed 
previously this is particularly pertinent in these conditions as the ability to communicate 
often becomes reduced/absent towards the end of life and advocacy becomes increasingly 
important.  Carers found that knowing their relative’s wishes helped them be sure that they 
were doing what their loved one would have wanted. 
“If you have those confronting conversations with your loved one before the 
illness becomes really challenging then it makes things somewhat easier 
when the time comes. Ultimately for us it was about really listening to mum 
and hearing what it was that she needed, physically, emotionally, 
psychologically and spiritually” Abigail (MSA) 
This also allowed them to be advocates and ensure their loved one’s wishes were carried 
out. 
“I think we were open about it and we talked about it.  I think that was 
definitely a benefit and I knew exactly what he wanted, and you know I 
made sure he got it” Elaine (MSA) 
However, unless a person’s wishes were written down on a legal document such as an ADRT 
they were not always followed.  Doctors’ views did not always align with carers’ and, unless 
a LPA was in place, carers’ wishes could be overruled.  
“I remember getting taken into this room and dad was crying and I was 
crying saying ‘look there’s just no point in her having it <a PEG tube>, if it 
gave her quality of life then fair enough’ but they said ‘no because she’s not 




legally’ and dad was like ‘well I’m going to put a pillow over her head, don’t 
give it to her’ and it was one of these situations where it was really 
stressful… that’s the sticking point in mums care it’s the only thing that I felt 
completely out of control over” Kate (PSP)  
In the case of this family and others who had not discussed the end of life, or made specific 
plans, there was some sense of regret that situations like this might have been avoided if 
they had been more prepared.   
“One of my regrets is that I avoided discussing end of life care.  He didn’t 
want a PEG but perhaps two cycles of antibiotics and five weeks in hospital, 
all to no avail, could have been avoided” Stephanie (PSP) 
 Reasons for ACP (WHY) – being ready to die 
Carers appeared to have more difficulties with being prepared for the end to come than 
their loved ones; almost all of those dying from the diseases, with only one or two 
exceptions, were ready for their lives to end.  
“He had previously told his carer he did not want to live anymore and his 
quality of life was poor” Sandra (PD) 
Therefore, although some plans were used to state a PPOD, or to improve the quality of the 
end of life through personal touches, one of the main reasons people wanted to make 
decisions, such as to refuse a PEG or complete a DNAR was because they did not want their 
life sustained when it had reduced quality.  
“he didn’t want a PEG put in to help with eating, as he had been advised, as 
he felt if he couldn’t eat or drink without it then there was no reason to be 
alive” Nicole (MSA) 
One of the reasons those with the diseases chose to donate their brains to research was to 
counteract how much the disease had taken away.  
“at that time he could still communicate to a certain extent, he said ‘well 
that’s about the only thing I can do that’ll be left of me that can do some 
good, that’s the only thing that I feel I could do some good with at the end 
of all this” Aileen (MSA) 
Although these quotes may suggest that hopelessness and loss of self were the main 
reasons that people were ready to die, there were not always negative thoughts associated 




“she had made the decision not to be resuscitated?  
P: oh, yeh she did because she was quite a religious person and she never 
spoke to me um oh maybe up to a year before she died she did tell other 
people that God was waiting for her” Paul (MSA) 
And in the thought that they were protecting their carer. 
Sebastian: “she would ask our pastor occasionally and perhaps the week 
before ‘is it alright to ask Jesus to take me now?’ <laughs>  
CM: but she wasn’t saying that in terms of, because it doesn’t sound like she 
was depressed 
Sebastian: she’d had enough of it really yeh, no she wasn’t depressed 
CM: no, she’d just had enough of having it 
Sebastian: yeh and I think she was also, according to my sister, a little 
concerned for me… she didn’t want me to have to put up with it that much 
longer either because she could see that it was quite an undertaking doing 
what we were doing” Sebastian (MSA) 
They were ready to go and therefore did not see the point in being resuscitated or having a 
PEG and made plans to refuse both accordingly. 
 Reasons for ACP (WHY) - wishing to hasten death? 
A small proportion of people with MSA/PSP had mentioned euthanasia to their relatives or 
HCPs; there were no active mentions of euthanasia for those with PD, though a few had 
refused their medications in a tacit suggestion that they had had enough and wanted to die 
sooner.  Rachel (MSA) and Dennis (PSP) had actively requested help to end their lives.  
Other people with PSP/MSA, like John, had planned to end their lives if things got worse.  
“he said that he would stockpile pills or something, he would do something, 
before things got too bad” Aileen (MSA) 
A couple of other people with PSP/MSA had mentioned the idea of ‘Switzerland’ in response 
to articles or television documentaries.  Philip’s wife, Thelma (MSA), had said that she 
wouldn’t go to Switzerland but if her doctor offered her an injection the next day ‘she would 
take it’.  Interestingly though, he pointed out that her views appeared to change as the 
disease progressed and she never mentioned it again. 
“the funny thing was that it was spoke about fairly early in the proceedings 
and after a while, probably still with three or four years to go, it was never 




ever talked about wanting to have an injection or whatever again” Philip 
(MSA) 
As it happened Philip felt that Thelma had been given an assisted death using increasing 
sedation.  
“CM: the implication you took from that, or the implication was, that they 
were sort of helping her to die? 
Philip: yes 
CM: ok that’s what I 
Philip: well I don’t know what else you’d infer that you know when the first 
one is sort of easing her passage and she’s still there and they look surprised 
and then they come back and they’re adamant that this will be quick that its 
more of whatever it was maybe in a massive dose or whatever and it’s to 
save her just lying in that state for any longer and it did happen quite quickly 
after that… That isn’t something that I’m bitter about” Philip (MSA) 
Yet what he was more upset about was that they had been told she was getting better and 
so her transfer to the hospice, her PPOD, was cancelled.  Several other carers felt that their 
relatives had died under strong sedation.  Although they did not necessarily feel it had 
hastened their death, they felt that if sedation helped their relatives be more comfortable, 
they did not have a problem with the fact they may have died sooner because of it.  One 
carer, Julie, had joined ‘Dignitas’ herself having witnessed what her dad had been through 
with MSA.  
Despite many people with the diseases being emotionally ready to die, most had not 
requested their lives be ended prematurely.  There were those who had discussed the issue 
with their spouses and were against the principle of euthanasia, despite being clear they did 
not want to live any longer. 
“Colin: Grace was absolutely determined she didn’t want treatment, she 
wanted out broadly and that was that 
CM: When you were saying she didn’t want any more things had she ever 
brought up the idea of having her life ended early or anything like that? 
Colin: no, no, that’s an interesting question and it’s a question I’ve asked 
myself, for myself.  She and I had discussed over the years the Swiss thing 
and all the rest of it, possibilities, but I think, no she didn’t want, she had 
never ever made any reference to that.  She could have made some 
reference on an Ipad or something that would have sent me into a dither 
and a tizzy and all the rest of it but she didn’t want it and she was not in 




very concerned that people should be able, she didn’t want people taking a 
decision for somebody to die, the risk of other people making a decision for 
the wrong reasons, so she was very much seeing it out” Colin (PSP) 
When euthanasia had been mentioned, though it was not acted upon, it was sometimes 
considered when deciding upon medical intervention at the end of life 
“Rachel had discussed with me many times the option of euthanasia, in the 
last stages she would have taken that option, indeed asking me to help her, 
which was something I could not directly do, but I was mindful of this when 
discussing the continued battle against infection with the doctor, and in 
retrospect, I believe it was the major consideration on our minds when 
making the decision to discontinue the heavy antibiotic regime she was on 
at the time. This decision ultimately led to her passing” James (MSA) 
Interestingly though, a lack of intervention being attempted was one of the principle 
concerns of a hospice consultant who disagreed with Chris (PSP) about the wording of his 
ADRT, seemingly not understanding, from the point of view of Margaret, that her husband 
had already had enough.  
“he wanted to make his own decision about the refusal of treatment, the 
ADRT form, well we had quite a few tussles with <the hospice consultant> 
because he said ‘well what if he gets something like pneumonia, pneumonia 
is treatable, if he’s in hospital we can treat that’.  But Chris’ attitude was for 
what, you know, that’s the body’s way of saying enough is enough… yes it’s 
treatable but for what, you know, what gain was it going to be for him other 
than prolong his life, which was becoming more and more unbearable” 
Margaret (PSP) 
The concern of the hospice consultant, regarding giving up too soon, was one of the reasons 
given for an avoidance of recording plans by a couple of carers.  
“I discussed with the GP about circumstances where I might have felt that 
resuscitation wasn’t right but you kind of worry about signing one of those 
forms where, I don’t know, kind of mum had to go into hospital for another 
reason but say she developed an infection or something whether they’d feel 
well is it worth the treatment because a DNR’s in place” Simon (PD) 
And Stephanie explained that her husband had not wanted to donate his brain for research 
due to the same concern. 
“I suppose in a way he’s got the feeling that things will be stopped before 




be taken before completely necessary and therefore your chances of living 
will be impaired you know” Stephanie (PSP) 
And so a feeling that HCPs might not put in as much effort if they saw plans had been made 
was a reason for not wanting to record them, along with the difficulties in having the 
discussions to make plans in the first place.   
 Preparation summary 
This section has presented the elements of preparation that people with these diseases 
make.  There is some difference between PD and PSP/MSA as people with PD are rarely told 
that it could be life limiting, even when entering the palliative stages.  However, even 
though people with PSP/MSA are aware the diagnosis will shorten their life expectancy the 
way that they prepare for the future is very individual.  This is based in part on the 
information they are given and the opportunities they have for discussion with their family 
and/or HCP and in part on their own emotional ability to think about the future.   Honest 
conversations at a reasonably early stage were a key component of allowing individual 
wishes to be maintained in the face of a decreasing autonomy through a lack of mobility, 
communication and cognition.  Although a proportion of planning was down to the 
emotional preparedness of those with the diseases (and their carers) more guidance would 
have been welcomed from movement disorder teams so that they were aware of the type 
of decisions they might need to make and had more idea about the way the end might 
come.  Whilst hospices were great at facilitating plans they are not always easily accessed 
(as the next few sections will show) and arguably it should not fall to them to have 
discussions about the future, when movement disorder teams may have more knowledge of 
the way these diseases progress and more access to those with the diseases at an earlier 
stage.   
 
5.2 SUPPORT: Co-ordinated care 
Co-ordinated care is vitally important for support, especially in the earlier stages of the 
disease when people are likely to be living at home.  Indeed, a lack of co-ordinated support 
is one of the reasons that dying at home is achieved less often than might be desired.  These 




cognition, requiring increasing  support to maintain everyday activities.  The first part of this 
section will show the difficulties that people with the diseases and their carers encountered 
when trying to navigate the health and social care systems.  It explains that people with 
PSP/MSA had a greater difficulty with co-ordination of care because they needed more help 
more quickly and their rarity impacted on the efficiency of the care provided.  The latter half 
of this section compares those dying from PD/PSP/MSA to those dying from cancer as there 
were a few carers who had direct experience of caring for someone with cancer, or having 
cancer themselves, and the differing experiences they encountered were enlightening 
regarding the provision of services. 
 Navigating the system 
This section is divided into healthcare, social care and the co-ordination of services (both 
within and between). Figure 20 below shows some of the services that people with these 
diseases might need and provides a guide to the following subheadings.  Appendix I contains 
a chart that the PSP association produced suggesting the services that people with PSP 
require and the annotations by the carer show the difficulties with achieving their aims in 
the current system. 
 
 
 Navigating the system – Healthcare  
There was a greater degree of frustration from the carers for those with PSP/MSA with 
regard to healthcare because the speed of progression meant that more equipment and 























along with the lack of information they received about future progression there was also a 
lack of guidance about where to turn locally for support from HCPs, which left them feeling 
bewildered  
“I feel it was misinformation, lack of information from the people that you 
thought would point you in the right direction and I just felt all of the time 
that I had to be the driving force and I was often asked ‘what do you want 
us to do, what should we do’ and I thought, I don’t know, I’ve never had PSP, 
we’ve never known anyone with PSP, I don’t know what to do…it’s like being 
in a maze blindfolded, because you don’t know which direction to take, you 
don’t know which direction you’re facing and you don’t know which way to 
turn because you’ve never ever come across anything like it” Margaret (PSP) 
Even when those with PSP/MSA had been told that they would need physiotherapy, 
occupational therapy, speech and language therapy and help from other services there was 
a frustration that the NHS was slow to respond and that joined up care did not automatically 
occur.   
“the most important thing we got out of the specialists was references to 
other appropriate specialists, but that required a lot of work on my part 
because the system was very unresponsive to someone with those needs 
and getting physiotherapy or whatever required me to be quite proactive 
which I found to be quite disconcerting” Charles (MSA) 
Only one woman felt that everything was organised for her husband in a smooth fashion 
and this had occurred because he had been referred to a neurological rehabilitation centre, 
where all services were co-ordinated from one place.  Other carers were grateful for the 
kindness of the staff they did meet but getting access to them had been a struggle and had 
taken up valuable time.  
“when you're at your least fit to do it you have to do all that sort of stuff and 
it's so time consuming and exhausting and although you could take your 
anger out on those sort of systems you really just want to spend time with 
your loved one don’t you rather than having to do all of that and being in a 
battle” Kate (PSP) 
Several relatives took to carrying lists of all of the individuals involved with their loved ones’ 
care, along with a list of their medications, and they handed them out to anyone new who 
was involved.  But it had taken them time to realise it was down to them and that no-one 




“it seemed to me and I didn’t understand this until I went through the 
process that it was like a spider’s web, a web the connection between all the 
people and all the medications and all the processes that we went through 
and we were the spider and we didn’t know that we were the spider and 
that we were controlling the web, no-one else was” Sebastian (MSA) 
Quite often the healthcare system was referred to as inflexible, in stark contrast to the 
transport sector which several carers held in high esteem.  Several examples were given of a 
lack of understanding regarding what it meant to care for a person with PSP/MSA.  As 
PSP/MSA are rare, allied HCPs were often unable to educate carers and those with the 
disease about how it might affect them and they were not always clear exactly what was 
needed. 
“the one thing <the consultant> said to us was ‘you need to get everything 
in place early, these things take time to organise, people can’t just jump 
when you need a piece of equipment or whatever or alterations to the 
house, so you need to get that started’.  So we did go along that route quite 
early on but because they hadn’t come across PSP they were, we didn’t 
really get the right equipment at the right time” Margaret (PSP) 
Those with PD still encountered problems with co-ordination, but this was often at a later 
stage and more often the issues were centred on social care provision; which was a problem 
across all three disease groups.    
 Navigating the system - Social care 
Paid carers made a huge difference to the experience of those with the diseases and their 
relatives.  They were often relied upon to make staying at home possible.  The thing that 
helped most was co-ordination of carers and the continuity of the care team itself but 
getting care providers to recognise this was often a battle. 
“it took a lot of banging on the door to really get what we needed and force 
it home to the care provider why we needed consistency of staff and the 
amount of calls we had and stuff and similarly with the social services team 
to get agreement for that” Simon (PD) 
Social workers helped guide care in some circumstances but in others they told carers they 
were not eligible for funding and would not provide suggestions of care companies. 
“the social worker was pleasant and she was here 90mins doing forms, 30 




said yes she said ‘oh we can’t help you then’ – I said ‘you can’t help 
financially but I need advice.  If we had no money you’d be throwing things 
at me and advice costs nothing’.  It was like having a door slammed in your 
face” Margaret (PSP) 
Hospital stays often led to an increase in care, at least initially after discharge, but the on-
going provision of carers seemed to be strongly influenced by location; because of the way 
carers were paid, they would sometimes only stay 5-10minutes of a 30minute call to allow 
for travel time, a particular problem for those in a rural location. 
“I suppose it wasn’t the carers it was the system; he <the paid carer> would 
come to us in the morning and his next port of call was half an hour away 
but he wasn’t allowed time to travel so of course he came, looked at Donald, 
‘are you ok?’ and then off again and that wasn’t fair because we were 
having to pay for it” Betty (PD) 
Some had services cancelled as they lived too rurally, leading to further isolation. 
“the agency that were providing the care pulled the plug on us and said that 
they didn’t want to come out to this, to our rural village, because she could 
have, deal with more clients in the town without having to allow for travel 
time. So, from then on, I was totally on my own.  Yeh, pretty mean” Angela 
(PD) 
Location, in terms of regional variation was also mentioned regarding continuing healthcare 
(CHC) funding and it certainly seemed that some people received the funding very readily 
whereas others battled multiple times and were still not awarded it. 
“I mean it is really a postcode lottery as to where you live as to how you’re 
going to be treated at the end of life and she <sister in law also caring for 
husband with PD> got continuing care allowance, she got good district 
nurses and I battled for continuing care three times and every time they told 
me that unless he had skin lesions or that he was going completely mental 
and violent they wouldn’t give it me.  But they just took one look at <brother 
in law> and they didn’t even fill the forms out, so she got round the clock 
care and back up nurses and district nurses. I mean here it takes you four 
days to get a district nurse, she got one in 20 minutes, so it really is a 
postcode lottery as to what you are going to get” Pam (PD) 
CHC funding was mentioned a lot as being very difficult to get in most places and for all the 
diseases, with several carers explaining they were only awarded it retrospectively after their 




With mum we did get the continuing healthcare but that was only, we got 
that after she died and we got money back retrospectively and I only knew 
about that because by this stage I think I was googling so much stuff and I 
rang and they said 'oh its highly unlikely you'll get it' so I said 'well I've 
looked at the prescription online for what you are supposed to qualify and I 
think she does' and they said 'well it will be very difficult' and I said 'well 
despite it being very difficult I would like to have a go at it' Kate (PSP) 
The ability to get CHC funding was aided by hospices and hospitals, especially if they co-
ordinated with movement disorder teams or the charities that represented the diseases.  
“the CHC approval had come through, I mean that went through so quickly it 
was unbelievable.  They never questioned it and I think it was beneficial to 
me in that the hospital submitted the application so they knew exactly how 
to do it but they also did it with advice from the PSP association helpline 
nurse because the hospital had not really dealt with anyone with PSP before 
but they were terribly willing to learn” Hope (PSP) 
Given that CHC funding means that all of a person’s care provision is paid for by the NHS, 
getting it awarded had a huge influence on the level of care provided and consequently 
affected POD.  Those awarded CHC funding were able to have a greater number of paid 
carers coming into the home, or even live-in carers.  Despite the problems with co-
ordination this brought, these carers were then available for the end of life period, allowing 
those dying to remain at home. 
“we kept her at home and we managed to get carers, or a series of full-time 
carers using the NHS continuing healthcare system, so that worked very 
well.  They were good kind girls who looked after her very well, looked after 
her physical needs, including in the end feeding her.  It sort of left me free to 
get on with organisational matters of which there were quite a lot at the 
time” Charles (MSA) 
Whereas those without funding had to rationalise additional care  
“I was paying for an overnight sleeper from 10pm to 6am on Monday, 
Wednesday and Friday, that was basically all I could afford because that 
was £100 a night and the carer was 7 days a week” Pam (PD) 
and watch their savings rapidly decrease. 
“in the end the money doesn’t matter it’s just that there’s none left, that’s 




On top of that, those in government systems had such little understanding of the diseases, 
especially for those with PSP/MSA, that benefits were delayed or refused  
“Aileen: it was just horrendous the things that like the benefits agency put 
us through and things it was just absolutely horrendous  
CM: yeh 
Aileen: you know saying that John would be fit to work in a year’s time 
CM: oh my god  
Aileen: you know I had the assembly minister and the local MP involved with 
that one because it was such a scandalous way to behave 
CM: so frustrating 
Aileen: yeh, yep, but I was worried, at that time I was worried that he wasn’t 
going to get his pension coz he had to pay stamp so they were insisting that 
he went into the job centre to sign on <laugh> oh it was just horrendous” 
Aileen (MSA)  
One carer, Julie (MSA), even had to declare bankruptcy because of the money she had spent 
in order to care for her dad at home.  
 Navigating the system – co-ordination across services 
Problems with organising and accessing health and social care were intensified because 
most people, especially those with PSP/MSA, needed access to both.  Generally, carers felt 
that they had encountered a fantastic range of individuals working within the NHS and 
social care, but what they felt was lacking was co-ordination between them all.   
“whatever the NHS is, it’s very good, it’s excellent but it’s very slow… I had 
carers early morning and in the evening to help get her to bed but they only 
sent one carer so I had to do it as well, the adult services provided a gantry 
in the bedroom which was good…there was the bowel nurse, the wheelchair 
service that came out to us a couple of times, the district nurses provided 
the bed.  Why does nobody I ask myself, and one of my big questions is there 
is no co-ordinator in the NHS and that’s really what, I was then a) in a fog 
but b)I co-ordinated it broadly” Colin (PSP) 
It was common that the person who had to co-ordinate everything, bringing health and 
social care together, was the carer, which led to further exhaustion on top of the lack of 
sleep they were often already experiencing.   
In addition, because navigating the system of health/social care was such a struggle, carers 
were concerned about how their loved ones would have coped without them and similarly 




“I must admit I do have sympathy and worry for people with Parkinson’s 
who maybe don’t have people around to shout their corner because whilst 
we did have wonderful care and stuff if we hadn’t fought for it, we wouldn’t 
have got it and that’s a concern I think, because more often than not, people 
develop Parkinson’s in a later stage of life and so say family have moved 
away and they don’t have people around, it’s left to them, and with them 
fighting against an illness like that as well, it’s a lot to ask” Simon (PD) 
One of the problems was a lack of any particular person or team to co-ordinate NHS services 
and Pippa suggested that it would be useful to have a single care co-ordinator to help.   
“My mother had two breakdowns as a consequence of trying to care for my 
father and that was with carers 4 times a day, it is horrific to watch and be 
left helpless. Perhaps having a care coordinator or an advocate to do this 
properly liaising with the different services, social service, OT, mental health, 
Parkinson’s nurse/consultant who meets with the patient at home once a 
month to discuss current condition, monitor status and gain the additional 
help and resources from other services when needed <would help>” Pippa 
(PD) 
GPs did not always know enough about the diseases to co-ordinate well and when they did 
their time was limited.  Movement disorder teams often saw people 6 monthly at most and 
were sometimes geographically remote from services that were local to those with the 
diseases.  Specialist PD nurses were often reported to be without fault and relied upon in 
the latter stages.  They were even more highly prized when they helped to co-ordinate 
services. 
“the Parkinson’s nurse was very helpful to us here at home…she was very 
kind, she organized things from the hospital like equipment etcetera she 
also helped us as far as what was available from the National Health, what 
was available from everybody else, you know she helped fill in forms and she 
was great” Vincent (MSA) 
But quite often those with the diseases and their carers had not had access to a specialist 
nurse, either because they had never been referred (PSP/MSA) or because nurses had left 
and were not replaced.  
“Graham’s Parkinson’s nurse was very good actually but unfortunately she 
left <8 months> before Graham died, so for the crucial last month I didn’t 




 Some people had community matrons to help.  But most often praise was for hospice 
teams and their day centres, whose involvement led to everything running more smoothly.  
“For us the key thing is that hospice referral. That made a huge difference. 
Continuing healthcare we failed. Say we went through that journey and we 
hadn’t had the hospice, I just don’t know what we would have done, I really 
don’t know what we would have done without them” Peter (PSP) 
Unfortunately, even here there was a difficulty in accessing the service; often it was word of 
mouth that led to hospices being contacted by carers. 
“Stephanie: the hospice has been extremely good and very kind but I wish I’d 
known about it before because I just thought, I didn’t really realise that their 
remit also included PSP 
CM: the GP or the neurologist, they hadn’t mentioned the hospice or 
anything? 
Stephanie: no, no-one had, only my sister-in-law, she was the one that went 
on and on at me about it” Stephanie (PSP) 
Most hospices were glad to help once contact was made but there was a lack of 
automaticity regarding SPC/hospice referrals.  
“CM: did you get any help to look after him?  
Susan: no, he wouldn’t have any…one of the things I used to think was if I 
could just get somebody to sit just for half an hour so I could get away  
CM: did he ever get links into the hospice or day centres?  
Susan: no, nobody ever suggested anything like that” Susan (PD) 
This was in stark contrast to experiences some of the carers had had in regard to other 
illnesses. 
<at PSPA group sessions> as soon as you hear someone is getting something 
then you can go off and search for that yourself but it's not an automatic 
thing… it is available for people but it's not like a necessary, oh you've got 
this so go to a, b and c and then you'll get d, e and f.  It doesn’t work like 
that, whereas it certainly does with other illnesses Kate (PSP) 
 Comparison to Cancer 
Several carers mentioned that they noticed a stark difference between the provision of 
support for people with cancer and people with PSP/MSA/PD.  They had either had cancer 
themselves or cared for a family member with cancer, and they saw that support services 




“to be quite honest with you Claire, having faced a stage 3 cancer myself 
and knowing the response of other people and the range of treatments and 
services and everything, I know which I would rather be diagnosed with to 
be quite honest, I would you know.  I think that there is so much more out 
there for people with conditions like cancer than there is for the people with 
the neurological nasties” Hope (PSP) 
Carers who had experienced both diseases compared the battle they had getting help for 
PD/PSP/MSA to care that just ‘flooded in’ for cancer. 
“When my Mum was diagnosed with terminal cancer people came crawling 
out of the woodwork to help. Community Nurses, MacMillan, Admiral, 
Hospice, you name it they all made contact - we were even given free 
parking at the hospitals for appointments! Everything that could be done to 
make things a little easier, was done, the support network was amazing 
right to the end. This was a GOOD DEATH. PSP the basics are; no support 
network, HCP had no idea as they haven't heard of it, constant confusion, 
lack of structure/guidance. No one even knew if it was End of Life, it took 
over 10 days to be referred to Palliative Care Team. This is only the tip of the 
iceberg. This was a BAD DEATH!” Samantha (PSP) 
Whilst this is the perception, this is not confirmed by the VOICES data.  Figure 21 presents 
the data for question 3 of the VOICES survey (see Appendix B).   In regard to people who had 
spent some time at home in the last 3 months there is little difference in services utilised 






Figure 21 Services that had provided help at home in the last three months of life, by COD, England 2012-15 
There were no significant differences between the diseases regarding district nurses.  Those 
with cancer were significantly less likely to have seen ‘other’ nurses than those with PD.  
However, this may be due to their increased use of cancer specialist services: Macmillan 
nurse [Cancer vs PD OR 7.91 (5.81, 10.78) p<0.001; Cancer vs PSP OR 2.73 (1.14, 6.54) 
p=0.24] or Marie Curie [Cancer vs PD OR 3.28 (1.99, 5.42) p<0.001].  Those with cancer were 
statistically less likely than those with PD/PSP/MSA to have had Home Help, a Social Worker, 
or an Occupational Therapist (see Table 9).   
 
Service received  
Cancer compared to: 
PD [OR (CI) p value] PSP MSA 
Home help 0.26 (0.21, 0.32) <0.001 0.17 (0.07, 0.41) <0.001 0.24 (0.08, 0.73) 0.011 
Social worker 0.30 (0.23, 0.37) <0.001 0.13 (0.06, 0.29) <0.001 0.26 (0.08, 0.82) 0.021 
Occupational Therapist 0.36 (0.29, 0.44) <0.001 0.24 (0.11, 0.52) <0.001 0.16 (0.06, 0.45) 0.001 
Table 9 Likelihood of people with cancer receiving services at home in the last 3 months compared to those with PD, PSP or 
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 A larger proportion of the carers of those with cancer answered that no care was needed, 
which may be why this is the case.  Carers who had cared for people with cancer and 
PD/PSP/MSA explained that they felt those with cancer remained able bodied for longer, 
perhaps explaining the reduced provision of Occupational Therapists, Social Workers and 
Home Help.  
“I looked after my mum for 10 months with terminal cancer… looking at 
caring for her and caring for Stephen, I mean she had terminal cancer and 
yet it was much easier caring for my mother, it was nowhere near as bad as 
caring for Stephen coz even though she’d lost so much weight and 
everything she was still going up to bed every night” Elaine (MSA) 
However, when carers were asked in Question 5 of the VOICES survey if they had received 
as much support as they needed when at home in the last three months of life, all groups 
responded similarly, as Figure 22 shows.    
 
Figure 22 When at home, was support adequate in the last three months of life, by COD, England 2012-15 
Here though it is worth remembering that the VOICES survey only looks at the last three 
months of life and the people still living at home with these conditions, by virtue of the fact 
that has remained possible, will likely have a lot of help in place.  
“I had said to Elizabeth when she was first diagnosed with MSA that she 
would not go into a nursing home if we could possibly avoid it. I didn’t know 
then how difficult this would be. To do it you must have plenty of extra 
support. Apart from the Carers you need a GP, District Nurse and OT who 






















Did you get as much help and support from 
health and social services as you needed when at 
home in the last 3 months?
yes as much as needed yes but not as much as needed




It may well be that those who had poor provision of services had already moved to a care 
home, or elsewhere, by this time.  Certainly those with cancer were more likely to have 
spent some of the last three months at home (88%) than those with PD (41%), PSP (57%) or 
MSA (70%).  In addition, the difficulties relayed by the carers of those with PD/PSP/MSA 
were not necessarily that they had not got the help in the end, but more that it had been a 
long time coming.  
“we had the district nurse coming in every 24 hours to do the syringe driver 
so we only had that for I don’t know six or seven weeks, it wasn’t long at all, 
everything was just too late, you know things could have been perhaps more 
comfortable for him uh if they had been done earlier” Margaret (PSP) 
Those who had experienced caring for someone with cancer felt that they could be left 
alone some of the time, whereas caring for someone with PSP/MSA/PD was a 24/7 job, 
often for years, making the physical, mental and monetary costs larger.  
“Parkinson’s is a very long, drawn out grinds you and them down disease 
with masses of different little side effects, whereas the people who had 
nursed people with cancer, it was usually a matter of weeks or months.  The 
person with cancer remained mentally and often physically quite capable of 
managing themselves, they could be left you know, it was a question of pain 
management more than anything. They didn’t have all the horrendous side 
effects and caring duties that the people with Parkinson’s had to face and 
for years you know, so I do think it’s very different” Angela (PD) 
On top of that there was no way of knowing how long the disease would last and the 
uncertainty made caring even more difficult. 
“you know that there’s an end to it almost with cancer, you know that, but 
with Parkinson’s you’re just sort of living through this on a day to day basis 
you don’t really know what’s going to happen, how many years it is going to 
be, what’s coming next.  It is a much harder thing to cope with” Pam (PD) 
 Support summary 
Overall carers felt that although the needs that their relatives had were high, there was a 
lack of co-ordination in place to respond to them in a proactive manner.  There was no 
single person, or service, who co-ordinated care and so the onus was on the carer most of 
the time and that was a struggle which didn’t seem fair when it appeared to occur more 




research was felt to be high, as was the publicity surrounding it, so there was no struggle 
with recognition, whereas some of the difficulties in navigating the system were felt to 
spring from a lack of knowledge about what those with the diseases needed.  This lack of 
knowledge will be presented in the next part of the chapter.  
 
5.3 IDENTITY: Knowledge of disease and community support 
This section presents the frustrations that carers felt about a lack of disease knowledge 
being present in the healthcare system and discusses support from communities.  Chapter 7 
explains in detail how these findings have an impact on identity.  It is presented in this way 
within the thesis as the theme of identity was developed more fully after the initial analysis 
was completed.  Though studies often focus on one aspect of identity, such as the personal 
‘self’ or societal views, Schwartz et al (137), in their textbook on identity, explain that each 
will play a role in the overall identity of a person.  They explain that an individual’s total 
identity is made up of their personal, relational, collective and material identity (see Chapter 
7.2 for definitions).  This section presents data that can affect all these aspects.  It also 
indicates that a disease identity/label can become important in itself, especially when a 
disease is rare.   
 Knowledge of disease amongst HCPs: introduction 
A lack of knowledge was more of an issue for those with PSP/MSA as their rarity meant 
there was little understanding in existence about the diseases; most people had not even 
heard of them.  In contrast most people had heard of PD, even if they were not always 
aware of the challenges that having the disease brought.  Carers felt more knowledge about 
the diseases, would have allowed HCPs to provide better care.  When HCPs had knowledge 
about the diseases, confidence grew, and when HCPs did not know, but tried to find out, 
their effort was appreciated.  Carers also found that empathy grew when knowledge 
increased.  When no effort was made carers were upset by the lack of interest in their loved 




They felt isolated and frustrated due to a lack of knowledge which caused problems both 
during the time they were caring for their loved one and during their bereavement.  
Knowledge about the diseases therefore affected service provision, education, empathy and 
support, as shown in Figure 23. 
 
 
Figure 23 Aspects of care affected by knowledge of the diseases 
 Knowledge of disease amongst HCPs 
One of the reasons that PSP/MSA carers wanted there to be more awareness amongst HCPs 
about the diseases related to a desire to get an earlier diagnosis to enable proactive 
planning. 
“what they <people with PSP> do need is to get in front of a speech therapist 
and to be looking out for falls… so I think there are amelioration aspects of 
those who have it which mean an early diagnosis is important and an early 
diagnosis is only possible if the relevant people know enough” Colin (PSP)  
However, even with proactive planning, the lack of knowledge about PSP/MSA amongst 













“when you have clinicians who don’t have any understanding you really are 
on an up-hill battle with it.  It’s very, very, very hard.  There just isn’t 
enough known about the business and the impact that it has… It was the 
same as when they are talking about care in the home, they think that the 
patient sits in an armchair all day or lays in bed all day. They’ve got no 
concept of how PSP affects you, they have absolutely no idea, the same as 
physiotherapy and so forth” Constance (PSP) 
For those with PD, knowledge was felt to be lacking regarding specific issues such as 
medication, with the importance of timing and the differing preparations frequently 
misunderstood. 
“I said ‘well I brought them in, you can’t get hold of these Parkinson’s drugs 
that easily’, ‘oh well we’ll get some tomorrow’ and I said ‘well that’s not 
good enough he needed them now’; some nurses actually understand about 
Parkinson’s drugs but a lot of them don’t” Pam (PD) 
The other area where lack of understanding was frequently mentioned, across the groups, 
was regarding mobility; several PD carers explained their spouses had lost their mobility in 
hospital.  
“they didn’t keep him on his feet and then he just went off and at the 
hospital it used to take three of them to see to him because he just couldn’t 
stand on his feet properly” Susan (PD)  
[Prior to being admitted to hospital Jacob used to walk with Susan to the 
shops and back] 
Indeed, the only negative comments about hospices were regarding problems with mobility 
during respite stays.  Jade (MSA) had lost her mobility because she had not been helped to 
walk in case she fell and Tony (MSA) had developed a pressure sore through not being 
moved.  Both instances were felt to be due to a lack of knowledge about the disease. 
Happily, for those with PD, knowledge was growing through PD nurses providing education 
within hospitals and that had improved the situation somewhat. 
“having our nurse based at the hospital has made a massive difference 
because all the wards have got information packs about Parkinson’s and if 
anybody has a planned admission she can go up to the wards and prepare 
them in advance as well” Brenda (PD) 





 “I learned about end stage Parkinson's and what to expect through PUK 
factsheets, speaking to a Parkinson's nurse and The GP who cared for Mum 
at the nursing home, and also the Nurse at the nursing home and the carers 
there who were very Parkinson's aware” Jennifer (PD) 
In contrast there was limited information that carers and those with PSP/MSA could learn 
from the HCPs that they encountered. 
“just about everybody we spoke to they were just as much in the dark as I 
was basically and we just didn’t fit into the mould of cancer, Alzheimers, all 
these things that everybody knows about” Margaret (PSP) 
This lack of knowledge meant that the majority of PSP/MSA carers became experts 
themselves, through the internet and the charities, and had to spend their time being 
educators to professionals. 
“I had a book and every time she had to go to <local hospital>, various 
people would come and I’d say ‘have you heard of MSA?’ and they’d say 
‘what’s that?’  
and I’d say ‘multiple system atrophy’  
‘no’  
so I’d give them a book… I was dishing these books out like confetti almost” 
Paul (MSA) 
Some carers found this frustrating and the lack of continuity present in the healthcare 
system, discussed in more detail in Chapter 6.1.2, only made it worse. 
Not all carers found the lack of knowledge frustrating.  Several pointed out that the rareness 
of the diseases did make awareness difficult, it was the apparent reluctance to learn more 
about the diseases that carers sometimes encountered that caused the most anger. 
“what annoyed me Claire is that neither of the doctors were prepared to 
just, I know they were busy, I know they were pulled out and all the rest of it 
but I thought just for the sake of a phonecall <to the neurology team> you 
know you can understand more what my husband’s going through coz 
nobody had a clue” Elaine (MSA) 
An increase in sensitivity was noted when HCPs knew more about what the illness might 
bring. 
“I mean, you would go into your GP and you get your 7 minutes and out. It’s 




they knew that she had what would be considered a terminal diagnosis and 
it was serious, then they actually became kind” Colin (PSP) 
But when HCP’s understanding remained lacking, seemingly affecting the ability to 
empathise with what those with the diseases were going through, carers were reluctant to 
leave their loved ones in healthcare settings as they felt their needs might not be met.  This 
meant that confidence went down as the sense of being alone and unsupported increased. 
“We encountered many GPs who had little or no knowledge of the illness, it 
only added to my sense of isolation” Stephanie (PSP) 
What helped were the places and people who tried to learn more about the diseases.  
Several services, including hospices, care homes, GP practices and care team managers sent 
staff on courses to learn more, which was highly appreciated. 
“the care was absolutely wonderful and they even set up an afternoon for 
their staff in staff training for dealing with PSP” Hope (PSP)  
[regarding a community hospital] 
Places where knowledge of the diseases was high, such as neurological hospitals or research 
centres, were found to be more supportive early on because of the increased empathy they 
showed and the confidence they brought.  Interestingly, however, one carer with 
experience of a specialist neurological care home found it to be impersonal and too 
concerned with health and safety.   
“When its meal time, you will have to hang on and it may be 15 or 20 
minutes before we can take you to the bathroom, but ‘no your wife can’t 
take you because of health and safety issues’… it’s dehumanising for 
anybody” Constance (PSP) 
She felt they knew of the disease but could not see the individual through it enough to 
change their set routines, which was in stark contrast to her husband’s previous hospice 
stay.  Another lady, Gail, had tried respite in a neurological care home but preferred the 
‘normal’ care home she’d been to instead as it was more personal and had a less clinical 
environment.  
“what she didn’t like about it actually was a) it was bleak, that’s to say there 
were no carpets, which is intelligent really for a hospital but nevermind, it 




Colin also felt that empathy wasn’t as forthcoming in the specialist home as at the place his 
wife chose suggesting that inherent knowledge of a disease does not necessarily improve 
empathy, and that when an environment becomes more clinical it may in turn become less 
homely.  Striking the right balance may be difficult.   
It seemed that the type of knowledge needed altered as the diseases progressed, with 
personal identity outweighing disease identity as the end of life drew closer.   
However, even after a person had died knowledge of their disease seemed to be important 
to some carers.   Moira (PD) mentioned that it might have been useful to speak to someone 
with knowledge of PD after her husband died.  Certainly it seemed that a discussion with 
someone who knew about the diseases may have been useful for others carers as well.  For 
example, Vincent (MSA) was shocked when he discovered, in the course of his interview, 
that sudden death was a feature of MSA, but he appeared to be pleased to have found out.  
“I mean the fact that you’ve enlightened me over this sort of dying without 
any notice has helped me a lot it really has, that was like winning the 
football pools if you like because I was sad and annoyed and disappointed 
and all of the negative things that you think about that I wasn’t there and I 
blamed all sorts of people, not face to face, but in my mind I blamed the 
doctors and the nurses, why didn’t they phone me earlier etc etc etc but it’s 
quite possible she put her head down on the pillow and went to sleep… and 
that to me, you know, you have helped me tremendously” Vincent (MSA) 
If someone in the hospital had known about MSA and been able to explain that death could 
occur suddenly, it may have eased aspects of his grief, whereas he was actually faced with a 
doctor who had not heard of MSA and so was not going to write it on the death certificate 
and, in his eyes, didn’t seem to care that it might be important to him.   
“I mean even then, nobody seemed to care… if that makes sense to you, she 
hadn’t done any research, she didn’t know what I was talking about…but it’s 
this lack of um interest you know just another person, just another bed 
number and you’re talking about end of life and that hurt me probably as 
much as the doctor asking me if, or telling me they wouldn’t probably, 
resuscitate her if if she got to that stage” Vincent (MSA) 
Vincent felt MSA should have been on the death certificate to reflect the battle Beatrice had 




view and felt that the diagnosis was only put on the death certificate because they 
requested it.  
“CM: what was your sort of rationale for it needing to be on the death 
certificate? 
Kate: I think I just wanted it to be recognised that mum didn’t die just 
because she was of an elderly age and I think I wanted it to be shown that 
she had an illness… she didn’t just get pneumonia and not get well from 
that, the reason she couldn’t get better and because she was for so long, I 
mean I’d actually forgotten what my mum was like for ages, it’s taken me a 
long time to remember better days because it’s so consuming and so awful 
at the end…I’ll never forget how difficult that was so I think probably it is 
linked to that, you want it acknowledged that the last bit was really 
difficult” Kate (PSP) 
It seemed therefore that having the correct diagnosis on the death certificate mattered to 
some carers because it helped to preserve the identity of their deceased relative.  Alongside 
acknowledgement of what a battle the illness had been Kate, and others, felt getting the 
correct diagnosis on the death certificate was important to further raise awareness of the 
diseases themselves.  
“CM: So they hadn’t put PSP on the first death certificate? 
Constance: No, no and my understanding is that quite often this is the case 
CM: what is your feeling about that? 
Constance:  Well I think it’s wrong because unfortunately if you get a 
diagnosis say of bronchitis or pneumonia or COPD then you are never going 
to get the right statistics, you are never going to know whether its PSP or 
whether its Parkinson’s you know, MS, unless you actually get the first cause 
of death then you will never really get the root cause of the effect that these 
illnesses <have> and the number of deaths that are linked to these illnesses” 
Constance (PSP) 
 
 Knowledge of disease: summary  
There were definite differences related between the diseases when it came to professional 
knowledge.  Those with PD were able to be educated by professionals they met, not just 
movement disorder specialists but care home staff, GPs and paid carers who had previous 
experience of caring for others with PD.  The only area that was mentioned as lacking, 
predominantly amongst hospital staff, was an understanding regarding the importance of 




encounters with health and social care professionals were affected by a lack of 
understanding with regard to the disease, which increased isolation.  So, where PD carers 
might fight for knowledge about aspects of their disease, PSP/MSA carers fight for a 
knowledge of the disease’s existence.   
When HCPs had knowledge of the disease identity it could help maintain an individual’s 
identity in several ways.  Practically it meant that they were often able to remain 
independent for longer if the right help/medication/equipment was in place, maintaining 
their sense of self (or personal identity).  It also meant they were more likely to be able to 
stay at home, maintaining some material identity and relational identity.   Emotional 
support was more likely when HCPs had knowledge of the disease as they showed more 
empathy and a disease label allowed carers to maintain the identity of their relative as a 
strong independent person who was battling an awful disease.   
 Community support: introduction 
The first part of this section explains that because services did not always react proactively, 
or with empathy, carers relied on their community of friends and neighbours for support.  
This helped them to keep their loved ones at home or show them that they still mattered 
once they were in care homes, helping to maintain relational and collective identity.  
However, this section also explains that some carers noted a reduction in visitors as their 
loved one’s deteriorated, which Chapter 7 will show could have impacted on their sense of 
self.  The lack of knowledge encountered, by those with PSP/MSA especially, meant there 
was little public understanding about what they were going through.  The latter part of the 
section therefore explains that the respective charities became lifelines in terms of 
information, guidance and camaraderie and several of the carers continued to attend their 
group meetings after their loved ones had died, as if they had gained a sense of collective 




 Community support 
Due to the difficulties in navigating the health and social care system and a lack of HCP’s 
knowledge, those with the diseases and their carers relied on their community to help them 
manage.   
“we cared for him for so long at home with not much support other than 
friends and family because doctors and specialists didn’t know what the hell 
MSA was” Julie (MSA) 
Local services, such as transport providers, were relied on to get by and quite often they 
responded more quickly, and showed more empathy, than HCPs.  There were many 
examples of friends and neighbours who helped and reduced the isolation that the diseases 
could bring.   
“we were very lucky in so far as we had really really good neighbours who 
had helped me on a number of occasions because he had fallen in the 
garden and they helped to get him up” Stephanie (PSP) 
Some friends made efforts to include those with the diseases in their usual activities, for 
example they moved the locations of coffee mornings into their houses.  Unfortunately, 
however, there were also several carers who explained that there had been a reduction in 
callers because people could not handle facing the disease in front of them. 
“I think along the way, some of the symptoms they can be quite difficult, 
and I know mum and dad lost lots of friends really because they just found it 
too difficult to see mum the way she was and so your world gets very small” 
Kate (PSP) 
This avoidance by some friends and family added to the isolation brought about by the 
diseases themselves, due to immobility and loss of communication, and persisted beyond 
the death for carers because they did not want to reconnect with the people who had let 
them down. 
“So many people just disappeared but funnily enough reappeared at his 
funeral all balling their eyes out and all that and I just couldn’t give them the 
time of day I’m sorry, no way… you weren’t there when he was alive so don’t 
start crying now” Aileen (MSA) 
This was potentially detrimental to their grief as it was predominantly family and friends 




PSP/MSA carers felt that a lack of public awareness about the diseases reduced the support 
and empathy they might have been automatically shown if their loved ones were suffering 
from a better publicised disease.  
“I think it would be nice for people to know what the illness is, just for, you 
know, like everybody knows about motor neurone don’t they, but when you 
say you had PSP it’s nothing really, because it’s just a collection of letters 
isn’t it” Stephanie (PSP) 
PD carers also felt that more empathy might be shown if public information about the 
condition was more representative of the actual problems that occurred.  
“when Parkinson’s is publicised both through charities like Parkinson’s UK 
and through the NHS and other means so much of the emphasis is put on 
sort of the more common symptoms such as stiffness of movement, 
freezing, tremor all those kind of things but so many other symptoms, like 
dementia, like swallowing problems, drooling, constipation all of those kind 
of things which really have a massive effect on quality of life never get really 
discussed in as much detail as potentially I think they should… if people think 
it’s just living with something that causes difficulty getting to the shops, 
maybe they don’t fully understand what an illness it can be” 
Simon (PD) 
The importance of increased publicity about the diseases was mentioned multiple times and 
several of the carers actively campaigned for the charitable trusts and spoke at meetings to 
raise awareness for the public and professionals.  A lot of these meetings were organised by 
the charities and, although it may be a quirk of the recruitment process for the study, it 
appeared that many of the carers relied heavily on the charities for support.   
The charities provided knowledge, advice and empathy through information packs, 
online/telephone support and local face to face support groups.   Interestingly carers 
seemed to be keener on the support groups than their loved ones had been.  People with 
the diseases appeared to have been more ambivalent about the groups.  Some found them 
useful and attended regularly.  Others understood why they helped their carers and went 
for them. 
“he wasn’t keen to go to them initially, which I could understand, but I 
wanted to find out as much as I could, I wanted to know what we were up 




But several did not like seeing what the future might hold and so went to one meeting and 
then declined to go again.   
“he didn’t want to go to anymore because there were people there who 
were further on with PSP than him and he said ‘I don’t want to get like that’ 
because there happened to be a man there who was in an electric 
wheelchair and he was just making these gurgling noises all the time and 
grunting and choking and we hadn’t reached that stage. We did eventually, 
but that horrified Chris to think that that’s what might happen I guess and 
he didn’t want to go anymore” Margaret (PSP) 
Carers found the support meetings were sources of empathy, as other carers could 
understand what you were going through, without the need to have the illness explained to 
them.  
“I know people coming to the group they get a lot of comfort from, well I 
always say to them you never have to explain here, everybody here knows 
what it is all about you never have to explain, because you get tired of 
explaining” Hope (PSP) 
In addition, the advice other carers in the group/forums could give about finances, 
downstairs living, wet rooms, care companies etc was invaluable and facilitated planning 
and managing the home environment. 
 “it’s just as well we started going to these carers meetings because I got 
most of my information from other carers…there was a lot of things that I 
started to claim for that I didn’t realise I could because no one told me I 
could” Paul (MSA) 
The support groups tended to be most useful shortly after diagnosis, when the need for 
information and advice was greater.  They became more difficult to get to as the diseases 
progressed and quite often support then dropped off, which reinforced the isolation for 
some of the carers.   
“my parents had attended Parkinson’s support groups until my dad became 
too unwell to go. But more should be done for the carers during end stage 
Parkinson’s and after that person has died. When my dad deteriorated and 
was unable to go and see the consultant no one came to see him. You get 
the feeling that everyone gives up and you're just helplessly watching this 




Some groups continued to supply support.  Hope explained she sent out a newsletter so 
that information shared in the meetings was available to all.  Other carers used the internet 
forums on the charity websites, or carers groups on social media sites, which lessened the 
isolated feeling. 
 “a few months before he died, there is PSP unlocked… on the website and I 
sort of I looked at that every day and that was quite comforting in a way to 
think that I wasn’t the only person that was having to put up with it” 
Stephanie (PSP) 
Elaine (MSA) made such close friends with people on social media sites that she continued 
to keep in touch with them after Stephen had died, suggesting that the illnesses could in 
fact lead to new community relationships forming.   
A lot of the carers continued to go to the support groups after their loved ones had died or 
set up groups if they were lacking in their locations, in order to protect others from the lack 
of support they had experienced. 
“they didn’t have the support groups and things around when mum was 
alive which is why I’ve done one because I just know I wouldn’t want anyone 
else to be on their own like we were really” Kate (PSP) 
Helping with the charities provided carers with a sense of purpose in the face of life without 
their loved one. 
“I found myself dragged kicking and screaming into becoming a coordinator 
but to be quite honest I wouldn’t change a thing because I have found it very 
very rewarding and in a weird way it’s given me a sort of purpose that at 
age 75 I would never have expected to have at this stage of my life. 
Sometimes I sort of think oh it’s all too much, its taking over, but then 
people say things that make you realise that they get something out of it 
and they appreciate it and you think oh well I’ll plod on a bit longer”  
Hope (PSP) 
As well as helping them to still feel connected to the support network they had valued so 
much 
“I mean everybody from Parkinson’s who’s rung me or written to me has 
done it from, not just from a professional point of view but from a friend’s 
point of view as well, it’s been really nice. It’s been lovely, coz we’re one big 





Some carers continued to attend support groups but felt they should let go. 
“I still carried on <going to the local MSA group> after she died but I’m going 
to have to stop because uh I’m seeing people getting to the stage my wife 
was and I just find it all too distressing so I’m going to stop…I’m just going to 
go to the Christmas do but I’m not going to go back again because I just, I, 
I’ve gotta look forward I’ve got go forward I can’t keep looking back because 
that’s not going to solve anything” Paul (MSA) 
Others met with people from their support groups during their bereavement as they felt it 
was helpful to speak with someone who could understand what they had been through. 
Aileen felt continuing to attend the meetings was of more use to her than any bereavement 
counselling would ever have been, suggesting a potential role for the charities in 
bereavement.  
 “when John was alive I would’ve welcomed more support, I would’ve loved 
to have had the contacts that I have now with MSA and how much we help 
one another through, like the bereavement side was helpful, but we’ve 
chosen who we want to do it with but if they’d offered me bereavement 
counselling or anything else after John died I’d’ve said ‘no’ ”  
Aileen (MSA) 
Aileen was not alone in highlighting how much more support there was available now 
compared to when she was caring for John.  Many carers said they found it gratifying that 
times were changing and support, at least from the charities, was improving. 
 Community support: summary  
The above section incorporates the main points carers made regarding the support they, 
and their loved ones, received outside of the health and social care sector.  Nearly all the 
carers relied heavily on the support of their friends and family, with several stating that if 
they had not been there to help, there was no way they could have kept caring for their 
loved one at home.  The charities for these diseases, especially for those with PSP/MSA 
appeared to be incredibly important in supporting carers and enabling them to care with 
more confidence.  However, some carers still felt that the support dropped off as the 
diseases progressed and finding a way to keep that support flowing was a challenge, 
especially because as the level of care required rose, the time available to search on the 




 Identity summary 
This section has discussed HCPs knowledge of the diseases and community support.  It has 
suggested how these elements can impact on the identity of the person with the disease 
and their carer, though this will be explored in much greater detail in Chapter 7.  
5.4 Overall summary 
Figure 24 shows how the factors influencing end of life care fit into the overall themes of the 
project in regard to preparation, support and identity and shows that there are emotional 
and practical components within the themes.  
 
Figure 24 The principle themes of the project and their representations within this chapter 
From the excerpts presented it is clear that the personal characteristics and preferences of 




carer and wider networks (relational/collective identity) shaped their experiences in terms 
of the preparation they undertook and the support they wanted/received.  Emotional 
preparation is dependent on an individual’s nature, preferences and the way they are 
supported by others.  Knowledge about the biological disease label, is also central to the 
support and preparation that can be undertaken/provided and means that the charities, 
who know more about the diseases, can therefore help.   Desire for people to have 
knowledge about the diseases came across most strongly from the carers of those with 
PSP/MSA because they were faced with such a lack of awareness.  
Though practical elements are often the easiest to target for intervention, without 
awareness of the underlying emotions involved, practical planning may fall flat.  Here no 
advanced planning could take place if those with the diseases did not want to think about 
what the future might bring.  This stood true for those with PSP/MSA and those with PD. 
Practically however, those with PSP/MSA had been told their prognosis and so they 
potentially had more opportunity for planning for the future than those with PD.  Those 
with PSP/MSA were also more likely to have had hospice involvement and hospices were 
excellent at providing support for planning, on a practical and emotional level.  Both of 
these factors, an awareness of prognosis and increased hospice support, may explain why 
more of those with PSP/MSA had made plans and more had indicated a PPOD both in the 
interview and VOICES samples.  
Co-ordinated support was lacking for all of the diseases, with regard to social care 
especially.  CHC funding was difficult to access and, along with provision of funded carers, 
was linked to geographical location.  There was a feeling that CHC funding was easier to 
obtain when services with a greater knowledge of the diseases, such as the charities, 
intervened.  Co-ordinated health care was more of a problem for those with PSP/MSA 
because they needed more concurrent services at an earlier time but unfortunately 
provision often fell short of what was needed.  
The next chapter considers place of death in greater detail and highlights the aspects of care 
that affect experiences across the differing locations.  The elements set out in this chapter 




care at home (from professionals and communities) and practical knowledge about the 





Chapter 6 Experiences of the end of life in different locations  
This chapter concentrates on the last three months of life and explores the different 
components of service provision across the four locations: hospitals, care homes, homes 
and hospices.  Four areas are covered: aspects of staff care that are important to those with 
the diseases; support for symptoms and needs; awareness of dying and PPOD; and finally 
support for the carers themselves. These are summarised in Figure 25.  
 
Figure 25 The elements that affect end of life care 
The conclusion to the chapter relates the aspects of care that were felt to be important back 
to the main themes of the project.  
6.1 Care from staff towards those who were dying 
This section outlines the aspects of staff care that impacted on the overall experience in the 
different locations.  It outlines the importance of the dying person being seen as an 
individual, continuity of care and then comments on paid carers, as they impacted on the 
experience of people in their own homes.  
 Seeing the dying person as an individual: ‘a person not a bed number’ 
The most important aspects of staff care in the last three months were that staff saw the 
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“what do the people who really made a difference to us do, they spend time 
and they talk to us as friends and human beings” Peter (PSP) [Care Home]19 
This is particularly relevant for those dying with PD/PSP/MSA as their ability to 
communicate is affected so much in the latter stages of the diseases; indeed, the majority of 
the carers in the qualitative sample (20/36) stated that problems with communication were 
present at the end of their relatives’ lives.  The ability to communicate was somewhat 
intertwined with being seen as an individual and when the effort to attempt to 
communicate wasn’t made by healthcare staff, greater isolation occurred. 
“I think the biggest thing for John was that he lost the ability to 
communicate and that people didn’t, if he couldn’t, then it was almost like 
he didn’t exist and that was really heart-breaking for him” Aileen (MSA) 
[Hospital] 
Several carers mentioned that their relatives still “had their minds” and could understand 
everything that was happening and so it was crucial that people tried to communicate with 
them. 
“when the nurses came out <to our house> they would ask me, but with 
multiple system atrophy the person’s still there...they’re locked in this body 
that’s let them down” Helen (MSA) [Hospital] 
In all locations there were particular staff that recognised the importance of the ‘patient’ as 
a person, but most carers felt that there was more emphasis placed on communication and 
seeing the individual in hospices, which in turn meant that those dying had built up 
relationships with staff. 
“you have a dedicated nurse there <at the hospice> and that worked 
because she knew Chris, she knew how things were deteriorating, it wasn’t 
seeing someone different every time and that really really helped” Margaret 
(PSP) [Home]   
Although some hospitals also managed this well, there were far more comments regarding 
hospitals that suggested personalised care was lost.  
 




“in the local hospital you’re a bed number.  You come in, it’s a bit of an 
inconvenience, but you’re here for a period so we’ll feed you and water you 
and whatever else” Vincent (MSA) [Hospital] 
Vincent, stated that the difference between the local hospital and the smaller community 
hospital, or the neurological hospital, was like ‘chalk and cheese’; he further explained that 
in the neurological hospital ‘you were a person’ and he felt that should be the case in all 
hospitals, for all diseases.  He was not the only carer to suggest that being an inpatient on a 
neurological ward led to a better experience for those with neurological disease.  However, 
these comparisons were comparing the end of life in a local hospital to an earlier time, 
where the focus on the neurological hospital stay was for research or a change in treatment 
and therefore somewhat more positive.  Only one person, Ronald, died whilst on a 
neurological ward and his daughter related the same troubles that were reported generally 
about hospitals. 
“There was a constant change of staff, always something going on and no 
real calm…It was impersonal” Samantha (PSP) [Hospital] 
Generally acute hospitals were felt to be chaotic and the lack of continuity of staff was 
frequently mentioned.  However, some carers pointed out that staff were overstretched, 
suggesting that at least some of the inadequacies in care may be related to the time that 
staff had available to spend with individuals.  
“I cannot fault the staff they were absolutely marvellous, but it was just 
there was so few of them, there were just so few of them trying to do so 
much” Betty (PD) [Hospital] 
Certainly, in areas of the hospital where there was more of an emphasis on one to one care, 
like in intensive care, recognising the importance of the individual person was not 
overlooked, regardless of their ability to communicate.  
“they were really talking to him…it was lovely, it wasn’t just a case of oh 
well this patient’s totally unconscious so we’ll do this that and the other, 
they were <talking> as if they were expecting him to participate in the 
conversations” Brenda (PD) [Hospital] 
Recognising the importance of meeting an individual’s needs and communicating with them 




questions in the VOICES survey that ask about the degree of respect and dignity shown by 
HCPs across the various locations (see Appendix Di).  
Figure 26 shows that hospice staff were felt to show the highest levels of respect and dignity 
towards those dying of PD/PSP/MSA in the VOICES survey, in the same way that the carers 
in the interview sample had felt hospices showed the greatest care for the individual as a 
person.  
 
Figure 26 A graph demonstrating how often a person dying from PD, PSP or MSA was treated with respect and dignity by 
care providers in the last three months of life 
 
There was a significant difference across the group, with hospital nurses statistically less 
likely to always show respect and dignity in the last 3 months when compared to all other 



































Amount of time people with PD, PSP or MSA were shown 
respect and dignity in the last 3 months of life , by care 
provider, England, 2012-15 




Likelihood of hospital nurses always treating a person with 
respect and dignity in the last 3 months, compared to other 
services 
 OR 95% CI p-value 
Hospital nurses 1.00   
Hospital doctors 0.80 0.62, 1.02   0.069 
Care home 0.69 0.55, 0.87   0.002 
GP 0.27 0.20, 0.37 <0.001 
District Nurses 0.24 0.17, 0.33 <0.001 
Hospice Doctor 0.12 0.04, 0.34 <0.001 
Hospice nurse 0.07 0.02, 0.25 <0.001 
Table 10 Likelihood of hospital nurses always treating the decedent with respect and dignity, compared to other 
services 
There was no difference between those with PD, PSP, or MSA except in the case of 
care homes, where people with PD were significantly more likely to always be 
treated with respect and dignity than those with PSP [PD 59% vs PSP 33% OR 2.906 
(1.225,6.891) p=0.002; see Appendix J ii for other comparisons].  This may relate to 
the fact that people with PSP are more likely to have cognitive impairment than 
people with MSA and are more likely to have speech problems than those with PD.  
When comparing those with PD/PSP/MSA to the other COD (‘Cancer’, ‘CVD’ and 
‘Other’) it appeared that those with PD/PSP/MSA were less likely to always be 
treated with respect and dignity in institutions such as care homes and hospitals and 
more likely to always be treated with respect and dignity by GPs, and hospice nurses 
(see Appendix J iii for graph and statistical comparison).  It is difficult to know why 
this should be the case but again it may be due to the difficulties in communication 
more common to those with PD, PSP and MSA than people without neurological 
conditions.  
Though most of the interviewed carers relayed positive experiences of care homes 




“Derek would be not dressed properly, because he liked to be 
smart…we were asked to fill a form in about what he was like, you 
know he’d been a very clever man with a good job and everything 
but they didn’t know all that; so I think that he was treated with 
dignity but not the same as you would’ve liked” Barbara (PD) [Care 
Home] 
Barbara also related that because Derek had dementia, and mobility problems, he 
was not able to take part in many of the activities that were provided for the 
residents in his care home, meaning quite often he was on his own.  
In hospitals, issues with dignity related to a lack of privacy, lack of effort to maintain 
mobility and cleanliness 
“<the hospital ward> weren’t getting him up, they weren’t moving 
him, he was laying flat in the bed all the time, getting worse and 
worse, because he needed to be got up and moved around.  I went in 
some days, obviously he couldn’t get up and go to the toilet, so I was 
going in some days, soaking wet sheets, he wasn’t on a catheter and 
I said ‘you know this is ridiculous’, ‘oh we were just about to change 
that bed’ and I said ‘oh come on if I didn’t come in he’d have just laid 
here all day’ it was a geriatric ward and it really wasn’t, the lady next 
door to me said ‘this is the last chance saloon this ward’ and it was 
so awful and that’s why I didn’t want him in that place to die. The 
care was awful” Pam (PD) [Hospice] 
Interestingly the proportion of providers felt to always show respect and dignity 
towards those dying increased in the last two days of life, with hospital nurses 
showing the largest increase from 49% to 70% (see Appenidix J iv); so there may well 
be a conscious improvement in care when it is clear that a person is imminently 
going to die.   
“I did find that when the staff appreciated the seriousness of the 
situation, certainly when they realised mum wasn’t going to make it 
at the end, they were very good” Simon (PD) [Hospital] 
However, it is also worth mentioning that some carers had removed their relatives 
from hospitals, before the last two days of their lives, because they were so 
disappointed in the care shown and therefore the apparent improvement in respect 
and dignity seen may not necessarily reflect improvements in care.  For example, 




urine soaked sheets in the hospital was so disappointed in the dignity he was shown 
on the ward that she requested that he was transferred to the local hospice, where 
he later died.   
Nursing needs and privacy were more often achieved in the last 2 days in hospices 
than other locations, significantly more so than in hospitals and care homes (and 
home for nursing needs).  Hospices were more likely to definitely offer enough help 
for personal care needs as well, though this only reached statistical significance 
when compared to care homes.  Overall care homes were proportionally the least 
likely to have enough help to meet an individual’s personal and nursing needs (see 
Appendix J v, vi, and vii for more details). 
 Continuity 
Due to the complexities of medication regimes for PD and the rare nature of 
PSP/MSA there was often a lack of understanding present (as discussed previously in 
Chapter 5.3) and this was perpetuated at the end of life through a lack of continuity 
of care. 
“The biggest problem here was the lack of knowledge or even 
awareness in the GP community with regards to MSA and the use of 
Locums for home visits being the norm, which was not suitable due 
to the need to "educate" different GP's every time they visited” 
James (MSA) [Home] 
This may well explain why out of hours (OOH) teams were considered significantly 
less likely to provide excellent care than all other services (see Figure 27), though 





Figure 27 Overall quality of care in the last 3 months by service provider 
 
Likelihood of OOH team providing excellent care in the 
last 3 months compared to other services 
 OR 95% CI p-value 
OOH 1.00   
Hospital doctors 0.763  0.565, 1.029   0.076 
Hospital nurses 0.715 0.531, 0.963   0.027 
GP 0.592 0.433, 0.811   0.001 
Care Home 0.567 0.426, 0.754 <0.001 
District Nurses 0.535 0.385, 0.744 <0.001 
Hospice  0.117 0.054, 0.254 <0.001 














































Overall quality of care for those dying from PD, PSP 
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OOH teams were rated as excellent 14% of the time for MSA, 17% for PSP and 31% 
for PD and although this difference was not statistically significant (see Appendix J ix) 
there did appear to be a greater degree of frustration with OOH teams from carers 
of people with PSP and MSA because the complexity and rarity of the conditions 
meant a lack of continuity was felt more keenly.   
“you felt as if you were just repeating yourself all the time and you’d 
feel like screaming ‘why doesn’t anybody understand what MSA’s 
about’ you know” Aileen (MSA) 
Compared to other COD regarding the overall rating of care, care homes and 
hospitals were rated as excellent proportionally less for those dying of PD/PSP/MSA.  
GPs were rated excellent significantly more often for those with PD/PSP/MSA than 
those who died from CVD/’other’ causes.  Interestingly this was also true for OOH 
services, though carers of those with PSP and MSA rated OOH care excellent 
proportionally less than all other groups (see Appendix J x).  
In the interview sample it seemed that the provision of care improved when 
continuity of care was provided because this allowed for knowledge about an 
individual as a person and knowledge about their disease to be present.  Continuity 
was a problem in acute hospitals, due to both changes in wards and changes in staff. 
“I’d spent ten minutes explaining to this nurse about the medication, 
when it had to be taken all this that and the other and then she 
turned round and said ‘ok, but I’m off tomorrow for five days’ and I 
thought why’d I bother” William (PD) [Hospital] 
It was less of a problem in community hospitals because stays were longer, which 
perhaps explains why carers were more positive about them than acute hospital 
trusts.  Community hospitals also seemed more willing to find out more about the 
conditions and contact specialists.  
“they were willing to learn from me, they asked me to get 
information for them, they contacted the helpline nurse on one 
occasion” Hope (PSP) [Hospital] 
Whereas in acute hospitals there was a feeling that the underlying diseases were 




“it was like banging my head off a brick wall, I was saying ‘just ring 
neurology’ but they never did, they never did bother because as far 
as they were concerned Stephen was in for a urine infection and that 
was it” Elaine (MSA) [Hospice] 
Continuity was relevant regarding care homes, as when people had lived in the care 
homes a longer time and staff had got to know them care was felt to be better. 
“The Nursing Home staff and her GP knew her well and we knew 
them well too. I believe it made a huge difference to her experience - 
and mine… the care in hospital/respite nursing home who didn't 
know her or about PD was not nearly as good as when she was cared 
for in her nursing home by those who got to know her and were very 
PD aware” Jennifer (PD) [Care Home] 
One carer, Angela felt her husband Graham’s transition to stay in a nursing home 
was made easier by the fact that he had attended the day centre there and had got 
to know the staff.  Several carers mentioned that the strength of hospices was the 
continuity that had been formed through day care and respite stays.  
“Thelma liked going to the day care, she did like the people there, 
she had bonded with them and they’d explained to both of us that 
that’s what it was all about that she should feel at home there, it 
shouldn’t be somewhere she should dread” Philip (MSA) [Hospital] 
Alongside their efforts to maintain continuity, hospices were praised for their 
compassion and time, with most carers stating that they went out of their way to 
help.  
“<the hospice> were very kind, very generous with their time and of 
course very, very caring” Constance (PSP) [Care Home] 
Although no location was devoid of positive comments regarding the caring nature 
of staff, the degree of praise for hospices was great.  There were only four negative 
comments made about hospices, far fewer than the other locations; all relating to 
respite stays earlier in the disease process.  
 Paid carers  
One of the interesting things about the VOICES survey is that paid carers at home are 




provide, yet 30% of people dying from cancer, 45% of people dying from ‘other 
causes’ and 66% of the PD/PSP/MSA sample had ‘home help’ (Appendix B: VOICES 
survey p2 question 3).  
In the interview sample, many people that had spent time at home in the last few 
months had paid carers.  They were mentioned more frequently than GPs or district 
nurses and they were vitally important to the experiences that people had at home; 
both positive 
“we were very lucky with the caring company we had round here all 
the carers you couldn’t fault them they were very very caring and 
very gentle with her and in fact several of them became more friends 
than carers really” Paul (MSA) [Hospice] 
and negative 
“We eventually had carers come to this house and a couple of them 
were good but some of them were awful. I mean they really were 
awful. I mean they would be shouting at Yvonne, ‘you’re not making 
an effort, you’re not making an effort!’ She can’t do it, she can’t roll 
in the bed, you know” Peter (PSP) [Care Home] 
As the quotes above show, when continuity was present, carers often became 
friends, but when continuity was absent, there was little understanding about how 
the diseases affected people; again reflecting the attributes of care most valued 
across the locations. 
 Summary 
This section has explained how attributes of staff across the locations affected the 
end of life experience.  Locations where continuity of care was shown and carers felt 
their relative was seen as an individual person, rather than a patient/statistic, were 





This section outlines the support offered for emotional and spiritual needs, symptom 
relief and eating and drinking.  The figures used in this section relate to the 2014-15 
VOICES surveys only20.  
 Emotional and Spiritual 
Figure 28 shows the degree to which carers in the VOICES sample felt their relative’s 
emotional and spiritual needs were considered.  It appears that emotional and 
spiritual needs are best met in hospices, however this should be interpreted with 
caution as the number of respondents was very small.  Emotional needs were 
significantly more likely to be supported in care homes and at home than in hospitals 
[Hospital vs Care home OR 0.403 (0.241, 0.672) p=0.001; Hospital vs Home OR 0.432 
(0.213, 0.878) p=0.02]; but there was no statistically significant difference regarding 
spiritual needs (see Appendix J xi).  A large proportion of carers in the voices sample 
answered not applicable to the spiritual/religious question (32-43%), perhaps 
suggesting that they took this to be religion rather than a more overarching view of 
spirituality.  
 
20 The question responses changed between 2013 and 2014 and were not 





Figure 28 Support for emotional and spiritual needs for those dying from PD/PSP/MSA by place of death, England 
2014-15 
When comparing the disease groups across the differing locations there was no 
statistically significant difference between support offered for emotional or spiritual 
needs for those dying from PD compared to those dying from PSP, MSA or other 
COD (see Appendix J, xii and xiii).  
In terms of the interview sample emotional support did seem to be achieved more 
often in care homes and hospices than hospitals.  Both locations allowed dogs to be 
brought in and showed high levels of human kindness.  
“I thought the night staff might be less interested but they talked to 
her and I used to try and make her smile when one of them said 
‘come on Grace give us a smile’ and so on so they were quite human, 
they were very human and looked after her” Colin (PSP) [Care Home] 
The main thing that carers mentioned as a positive across all locations was the ability 
to have music playing for their loved one when they died.  Some care homes had 
undertaken ACP for people when they moved there, specifically for the emotional 
elements of their care. 
“they kept her bed turned towards the window, so she could look 

















































His emotional and spiritual/religious needs were 
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to her nursing needs.  She may never have opened her eyes, but if 
she did, she’d be able to see out. The plan also covered things like 
having her favourite music on, and that she would like to be treated 
with dignity and respect, she wanted people to talk to her and touch 
her and she wanted her hand held, and to be given a bath if it was 
possible and she wanted to have her hair combed… from everything I 
saw, they followed it” Jennifer (PD) [Care Home] 
There was no mention of visiting hours in care homes or hospices and friends were 
welcome to visit alongside family.  Visiting for a larger number of people was more 
restrictive in hospitals; even family found it difficult unless their relative was in a side 
room where they could spend time freely together. 
“if he’d been in the side ward earlier on it would’ve been easier for us 
to go and visit, but you had just such a little space and you just felt 
as though you daren’t move, daren’t speak” Betty (PD) [Hospital] 
As with staff attitudes not all hospitals were the same and certainly community 
hospitals seemed much more able to provide for emotional needs.  Again, they let 
dogs in and the continuity of staff meant that rapport had been built.  Alongside the 
lack of space acute hospitals were felt to be busy and chaotic, the food was not 
always good and on shared wards there were problems regarding peace. 
“this is something you can’t help but before he was put in the side 
ward we had a couple of Alzheimer’s patients, well not actually in 
that bay, they were in a different bay, but the noise was terrible, it 
was terrible.  But I mean poor things can’t help it but it doesn’t help 
and they did have, they were ringing the buzzer a lot of the time” 
Stephanie (PSP) [Hospital] 
In contrast the carers noted the environments themselves were supportive in care 
homes and hospices.  A room in a care home allowed ‘home’ to be recreated in a 
different location.  
“in the nursing home he had his own room with his you know 
personal possessions around him, photographs, things like that, it 
was the nearest probably to him being in his own home” Gail (PD) 
[Care Home] 





“it’s set in a beautiful place as they usually are and I couldn’t speak 
highly enough of them…he continued <in the last few days> to eat ok 
because the food at <hospice> was all obviously home cooked 
beautiful food” Elaine (MSA) [Hospice] 
Those dying at home, were able to have a closeness with their relative that they did 
not get elsewhere. 
“at least when she was at home at night, I would be in the bed next 
to her and I could touch her and stuff… in the hospital she’d be in bed 
on her own, sorry I’m saying hospital I mean in the bed in the nursing 
home” Charles (MSA)[Hospital] 
However, the main support, in addition to family, came from paid carers.  GPs and 
district nurses did call daily, but usually to provide symptomatic relief rather than 
emotional support.    
Spirituality/religion was alluded to less frequently.  Personal pastors came to all 
locations for those that had religious beliefs and hospices had chaplains who were 
felt to be very supportive.    
 Pain and other21 symptoms 
Several carers referred to symptoms of pain and other things, such as 
breathlessness, but mostly with a comment that support had been given to control 
them.  
“The lady sorted out some extra pain relief that evening dad went to 
sleep and never woke up. I'm not suggesting the extra meds killed 
him just took the pain away” Pippa (PD) [Hospital] 
 
“So we used Midazolam and they titrated the Midazolam up.  There 
was also something, you know, for the strange breathing towards 
the end of life and they used a drug to try and control that” Peter 
(PSP) [Care Home] 
Only two people were felt to have died with uncontrolled symptoms, John (MSA) 
who died with intractable pain in hospital and Chris (PSP) who died struggling to 
 




breathe at home.  Likewise, Figure 29 indicates that for the majority of those dying 
from PD/PSP/MSA pain and other symptoms were well controlled at the end of life.  
Regardless of POD less than 10% of carers disagreed that sufficient support for 
symptoms occurred.   
 
Figure 29 Support for the relief of symptoms in the last two days of life, by place of death, England 2014-15 
Although support for symptom relief was good across the locations, it was 
significantly better in care homes than in hospitals [Hospital vs Care Home ‘pain’ OR 
0.429 (0.223, 0.825) p=0.011; Hospital vs Care home ‘other’ OR 0.488 (0.281, 0.846) 
p=0.011].  There was no statistically significant difference between hospitals and 
home environments (see Appendix J xiv). 
The interview sample suggests several reasons that might account for this 
difference.  Firstly, although the majority of carers felt symptoms were controlled by 
the very end, they spoke of their frustration at the delay in the treatment of 
symptoms that they witnessed in hospitals, with several of the carers suggesting that 
it was only because they acted as advocates for their relatives that pain relief 





















































Sufficient support was given for pain and other 
symptoms in the last two days of life for those dying from 
PD/PSP/MSA




“I had to make myself unpopular by starting to nag the nurses 30 
minutes before the next shot was due to start getting the morphine 
ready. Otherwise, the shot would have been even further delayed” 
April (PSP) [Hospital] 
There were no reports that a delay of this kind occurred in care homes or hospices, 
or suggestions that carers needed to act as advocates for their loved ones in these 
locations.  However, John’s wife, Aileen, refused to allow him to be transferred from 
the hospital to a care home because she felt that if the hospital SPC team could not 
control his pain then a care home certainly could not.  Therefore, the severity of 
symptoms may keep a person in hospital and the more severe a person’s symptoms, 
the more difficult they are likely to be to control, which may also account for 
hospitals appearing to offer less support to control pain than care homes.  A few 
carers mentioned that the reason that their loved ones left their homes and went to 
hospital was because their symptoms could not be controlled at home, often 
because they related to acute events such as pneumonia. 
“without being in hospital, my mum would have died in a great 
amount of pain” Charlene (MSA) [Hospital] 
This may also account for some of the apparent improvement in symptom control at 
home; when pain was asked about in regard to the last three months it was the 
home environment that seemed least able to manage pain (see Figure 30) yet Figure 




        
Figure 30 Degree of pain control for those dying from PD/PSP/MSA by location, in the last three months of life, 
England 2014-15 
Carers in the interview sample did state that when the end was apparent district 
nurses and GPs called daily at home to manage symptoms, which may also 
contribute to the difference.  
“The GP, who was calling daily, arranged a battery-operated driver 
to inject her with steady amounts of a drug called Hyoscine which 
had the effect of drying up excess mucus. Within an hour or so her 
breathing had become much easier and more regular. The District 
Nurse came in daily to refresh the Hyoscine in the driver” Cecil (MSA) 
[Home] 
As with the levels of respect and dignity shown by staff, this again demonstrates that 
once it is clear a person is close to death, service provision may alter for the better.  
Interestingly, carers of those dying from PD agreed that care homes offered enough 
support for pain significantly more often than those dying from Cancer, CVD or 
‘other’ causes [PD vs cancer OR 1.962 (1.171, 3.287) p=0.01; PD vs CVD OR 2.082 
(1.244, 3.484) p=0.005; PD vs ‘Other’ OR 1.781 (1.075, 2.950) p=0.025].  There was 
no significant difference when comparing COD in other POD.  There was no 














How well was his/her pain relieved in the last 3 
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to have support offered proportionally less often.  There was no significant 
difference regarding ‘other’ symptoms when comparing PD to the different COD (See 
Appendix J xv and xvi). 
 Hydration and nutrition 
In terms of support to eat and drink there was a significant difference across the 
locations.  Care homes and home environments were significantly more likely to be 
supportive than hospitals, where only 67% of carers had agreed that enough support 
was offered (Figure 31) [drinking Hospital vs Care Home OR 0.231 (0.127, 0.419) 
p<0.001; eating Hospital vs Care Home OR 0.285 (0.154, 0.529) p<0.001. Drinking 
Hospital vs Home OR 0.303 (0.130, 0.707) p=0.006; eating Hospital vs Home OR 
0.346 (0.145, 0.824) p=0.017].  There were no significant differences when 
comparing those dying from PD to those dying from other causes across the 
locations (Appendix J xvii and xviii).  
  
Figure 31 Support for hydration and nutrition for those dying from PD/PSP/MSA according to POD, England, 2014-
15 
Many carers in the interview sample stated that they needed to be present to help 





















































In the last two days he/she had support to eat or drink if 
he/she wished




“Because of swallowing difficulties he was becoming dehydrated. I 
was visiting him twice daily and staying as long as I could to help 
with drinks and food. He was in hospital for a month, slowly getting 
worse and unable to eat or drink at the end…The only fluid given was 
by a stick sponge” Moira (PD) [Home]  
Support for eating and drinking is a particularly pertinent issue for those dying of 
PD/PSP/MSA, 22/36 of the qualitative sample mentioned problems with swallowing 
existed by the end of their relative’s lives.   
Home you would think might be less of a problem, but this likely reflects carer 
provision.  One lady was left reeling because she had been told to stop all food and 
drink at the end of her husband’s life and then years later heard the negative press 
about the Liverpool care pathway and felt guilty that he might have suffered.   
“The District Nurse told me and his carers "no fluids, food or 
medication" on day two.  I did not question it at the time, but wish I 
had…I thought it was the right thing to do but after a few days I 
wondered whether it was.  I could see he was desperately thirsty.  
Now with end of life care reaching the headline news I regret that 
fluids were withdrawn and also all of his Parkinson's medication” 
Sandra (PD) [Home] 
Interestingly, the proportion of carers who answered ‘food/drink was not needed 
varied widely across the locations (see Table 12), which was not the case for the 
other needs surveyed.  
Location [number of 
responses] 
Food/nutrition was 
not needed (%) 
Drink/hydration was 
not needed (%) 
Hospital [168] 66 (39) 53 (32) 
Care Home [289] 82 (28) 53 (18) 
Home [81] 25 (31) 20 (25) 
Hospice [15] 10 (67) 9   (60) 
Table 12 The necessity of nutrition/hydration in the last two days of life according to place of death, England 
2014-15 
It is difficult to know why this difference exists but it may come down to 
communication about food and drink and its necessity at the end of life, which did 




The difference between hospitals and hospices may also relate to the focus of care.  
In hospital, where treatment and improvement are often the aim, not giving food 
may be perceived as a failure rather than an active choice due to the distress that 
choking could bring.  Equally, those in a hospice were often there with the purpose 
of dying.  
“he was whisked basically from that ward across the road into the 
hospice and they said he would only live for three days” Pam (PD) 
[Hospice] 
Therefore, they may have been more likely to be unconscious than those dying in 
other locations, making the provision of food and drink seem less 
possible/necessary. 
 Summary 
This section has discussed the support offered for emotional needs, spiritual needs, 
pain relief/other physical symptoms, eating and drinking.  Hospitals were felt to 
meet these needs least often, though were better at supporting physical symptoms 
such as pain than emotional needs or nutrition/hydration.  Even then carers felt they 
had to be present to advocate for their relatives.  Across all needs (apart from 
spiritual) care homes were significantly better than hospitals at offering enough 
support.  Hospices were felt to offer enough support for all needs by all the 
respondents, but the numbers answering were very small.  Looking across the other 
COD, where sample sizes are larger, hospices still appear to meet needs more often 
than the other POD, especially regarding emotional and spiritual needs. 
6.3  Awareness of dying and PPOD 
This section outlines the extent to which people with PD/PSP/MSA were aware that 
they were imminently likely to die.  It then discusses whether a PPOD had been 
chosen and the impact such a choice had on the actual POD.  Lastly it explores 
whether carers felt their relatives had died in the ‘right’ place or not and the ways 




 Awareness of Dying 
There were mixed views regarding how much carers felt their loved ones were 
aware that the end was imminently approaching.  Some people were clearly aware 
and equate to those in the VOICES sample who ‘certainly knew’ that they were dying 
(see Appendix B: VOICES survey question 38). 
“there was no hope and the doctor came in at one point and we told 
Nigel what we were doing and he <doctor> said you know that’s 
what we think is best and Nigel put his thumb up, so he obviously, 
you know in a way at least he knew, because there was no way that 
he was going to come back from it you know” Stephanie (PSP) 
[hospital] 
For others, carers felt sure that they knew but they had not openly discussed it, 
mirroring the probably aware group. 
“I think he knew, he never said anything to us to indicate that he 
knew, but I think he knew definitely” Elaine (MSA) [hospice] 
In the cases where more uncertainty was present, matching the ‘probably not aware’ 
group in the VOICES survey, the reasons for a lack of awareness were often due to 
confusion because of dementia/delirium, more likely in care homes and hospitals, or 
a reduced level of consciousness, common for those transferred to hospices or 
admitted to intensive care. 
“CM: was Andrew aware that he was dying at this point?  
Pam: um he was very very ill at this stage; he wasn’t really talking 
then” Pam (PD) [hospice] 
In other cases, carers were sure their loved one had not been aware, because they 
were not aware either; this was usually because death had been sudden, or 
appeared sudden because HCPs themselves were not aware how ill/close to death a 
person was 
“CM: you were saying he was sick at that point. Did you have 
discussions about whether he was to go into hospital or not? 
Constance: No, the doctor, who was a locum, said ‘well I could send 
him to hospital, but you know antibiotics will do the trick and he will 
be fine again’  




Constance: There was no hint that his passing was imminent” 
Constance (PSP) [care home] 
There are several questions within the VOICES survey that allude to sudden death, or 
a lack of awareness that death was approaching.  Sudden deaths were more likely to 
have occurred in hospitals (25% of hospital deaths vs 7-12% other locations22) and 
carers were also more likely to answer that it was unclear their relative had been 
dying when their death occurred in a hospital (15% vs 5-10%23).  
The acuteness of deterioration in hospitals, the levels of confusion in care homes 
and the reduced levels of consciousness in hospices may explain why those who died 
at home were perceived to be significantly more likely to be aware that they were 
dying, than those dying in other locations [Home vs Hospital OR 3.534 (2.246, 5.562) 
p<0.001; Home vs Care home OR 2.169 (1.476, 3.187) p<0.001; Home vs Hospice OR 
3.689 (1.051, 12.953) p=0.04].  Figure 32 represents the differences graphically.  It is 
also likely that those who were aware they were imminently likely to die chose to 
stay at home or asked to go home; especially if home was their PPOD.  
 
Figure 32 Awareness of dying, by place of death, England 2012-15 
 
22 Derived from VOICES survey question 45 (see Appendix B) 


























Did the person with PD/PSP/MSA know that they 
were dying? 




There was no statistical difference in awareness between those who died from 
PD/PSP/MSA, but those with PD were perceived to be less aware across all locations. 
Those who died from PD were statistically less aware than those who died from 
cancer in all locations, less aware than those dying with CVD/’other’ COD if they died 
in a hospice and more aware than those dying from CVD in home locations, likely 
due to large proportion of sudden death in CVD (see Appendix J xxi for graphs and 
statistical analysis).  Figure 32 shows that a greater proportion of the hospice group 
were unsure whether their relatives knew, which perhaps reflects reduced conscious 
levels, or the difficulties that carers had communicating with their loved ones, and 
this in turn may explain the difference between those dying with PD/PSP/MSA and 
other COD.   
Certainly, in the interview group, carers related that by the time of hospice 
admission communication/consciousness was markedly reduced. 
“I knew in my heart of hearts she wasn’t going to come out.  
Whether she did or did not, coz by then communication with her was 
very very difficult, she wasn’t really talking and it was all these 
squeezes of hands” Paul (MSA) [hospice] 
This may also explain why a large proportion of those dying in hospices had 
apparently not been told that this was the case (78%).  Given the high quality of 
communication that was frequently related with regard to hospices we might have 
expected they would have been more likely than the other locations to have 
informed a person that they were dying, but this was seemingly not the case (see 






Figure 33 Communication regarding approaching death, by POD, England 2012-15 
Figure 33 suggests that a minority of those dying had been told this was the case by 
HCPs.  There were no significant differences between those with PD/PSP/MSA. 
People dying from cancer were significantly more likely to have been told that they 
were dying in all locations compared to those dying from PD.  Those dying from CVD 
were more likely to have been told when at home or in a hospice, when compared to 
those dying from PD and those dying from ‘other’ causes were more likely to have 
been told at home, in hospices and hospitals (see Appendix J xxiii).   
The interviews suggested that the considerations above, such as levels of 
consciousness, confusion and the ability to communicate easily, may have prevented 
staff from telling a person that they were dying. 
“two doctors in particular were just wonderful in so far as they 
would speak to John in the room with me there and talk about end of 
life stuff. We weren’t always 100% sure whether he understood or 
not, whether he was with it or not, but they did it so that he was 
included” Aileen (MSA) [Hospital] 
But there were certainly instances mentioned in the interviews where carers had 















Had healthcare professionals told the person with 





“When the doctors finally withdrew treatment, I told my mother that 
she was dying because I know she would have wanted me to. I do 
acknowledge that this must have frightened and shocked my mum 
but I did not feel that I was entitled to withhold that information 
from her in her final hours of consciousness. I am sure that many 
people would think I did a cruel thing, but nobody knew my mother 
better than me and I know she would not have wanted me to 
withhold the facts. This is one thing I DON'T feel guilty about. But 
because I hadn't anticipated that I would have to tell her, maybe I 
didn't have the words and could have explained it better.” April (PSP) 
[hospital] 
April felt that her mother should have been told that she was dying, suggesting that 
she had thought the HCP might have done this.  Conversely, Philip was angered by 
the appearance of the SPC nurse at his wife’s bedside, perhaps echoing April’s 
suggestion that making someone aware that they are dying may be cruel. 
“Suddenly at the side of the bed, bear in mind that although Thelma 
couldn’t talk very easily, she was cognizant… ‘I’m the palliative care 
nurse’… most people know palliative care as being alarming and of 
course Thelma in the state she was I thought that that was not on, to 
come to her bedside, with her saying that ‘I’m the palliative care 
nurse and I’ve been sent along to chat over a few things with you’. 
And it wasn’t with Thelma and me, it was with me but in front of 
Thelma and I said ‘well excuse me’ and I took her away from the side 
of the bed ‘can we go and talk somewhere’ so I thought that wasn’t 
very good” Philip (MSA) [hospital] 
These extracts allude to a societal view that informing someone they are imminently 
going to die might be cruel, which might further explain why few HCPs appear to 
have done so.  They also show that carers act as advocates for their relatives 
regarding information sharing and may affect the information that their loved ones 
receive; as well as reinforcing that carers feel their loved ones should be the centre 
of the medical encounter, however ill they might be, rather than being ignored. 
 PPOD 
Within the VOICES survey, only 27% of those dying with PD/PSP/MSA had stated a 
PPOD; whereas around half of the carers in the qualitative sample suggested a PPOD 




sample related had come about through informal discussions over the years 
between spouses.  This may explain the difference in proportions as most of the 
interviews were with spouses, whereas a greater proportion of the VOICES 
responses were from children.   
There was no statistically significant difference between those with PD/PSP/MSA in 
the VOICES sample, though the proportions suggest those with PD had discussed a 
PPOD less (36% PSP, 32% MSA and 26% PD).  This likely reflects the differences in 
discussion of prognosis related in chapter 5.1.  The likelihood of those dying from PD 
having a PPOD is equivalent to people with CVD (26%) and ‘other’ causes of death 
(26%) but significantly lower than for people dying from cancer (53%) [PD vs cancer 
OR 0.309 (0.267, 0.357) p<0.001] (see Appendix J xxiv for further graphs/statistical 
comparisons).  
Overall 47% achieved their PPOD and having a PPOD did seem to affect the eventual 
POD.  Those who died at home were significantly more likely to have stated a 
preference than those who died elsewhere (Figure 34) [Home vs Hospital OR 6.42 
(4.205, 9.810) p<0.001; Home vs Care Home OR 8.17 (5.496, 12.158) p<0.001; Home 
vs Hospice OR 5.096 (1.869, 13.897) p=0.001].]  
 














Had he/she ever said where he/she wanted to die, 





It is not that surprising that those dying at home were more likely to have stated a 
preference; home was the most likely choice for PPOD in the VOICES sample for all 
COD (74% for those with PD/PSP, 88% MSA – see Appendix J xxvi for more 
information).  Most of the interview sample who had stated a PPOD had also chosen 
home and certainly for some who had recorded their preference, efforts were made 
to get them there. 
“On the Power of Attorney OH had stated that he wanted to be at 
home and cared for there. P” Martha (PD) [Home] 
However, it was not always possible for people to die in the place that they had 
chosen.  Either acute events had taken people into hospitals, 
“we promised her she wouldn’t ever be alone, or live in a home, or 
die in hospital. I learnt the hard way that you shouldn’t promise 
people things beyond your control…she was rushed into hospital on 
Wednesday morning, and she was told she had pneumonia and that 
she had a couple of hours left” Charlene (MSA) [Hospital] 
or there were logistical reasons cited that prevented those dying from being 
transported home. 
“just before we were about to bring mum home the ambulance staff 
realised that actually her bed was upstairs so how would they get 
her upstairs and the only way really would be to put her on a board 
which they thought would probably be a bit undignified and we 
discussed that and we agreed that given that situation, plus the fact 
that mum really was very ill, the last thing we’d want was perhaps 
for her to pass away when she was being transported in the 
ambulance or something like that”  Simon (PD) [Hospital] 
Or a point had been reached where carers were no longer able to continue to care 
for their loved ones at home and they had moved to a care home, making their 
previously stated preferences impossible to achieve.  
These reasons probably explain why only 44% of the people who had wanted to die 





Figure 35 Actual POD for those whose PPOD was at home, England 2012-15 
 Right place to die? 
Regarding the VOICES sample, irrespective of whether a PPOD had been stated or 
not, PD/PSP/MSA carers were more likely to feel their relatives had died in the right 
place if they died at home [Home vs Hospital OR 17.484 (4.203, 72.727) p<0.001; 
Home vs Care Home OR 5.018 (1.188, 21.205) p=0.028; Home vs Hospice OR 12.474 
(1.959, 79.442) p=0.008].  However, the confidence intervals when comparing 
locations are wide and reflect the fact that most carers were satisfied that the actual 





Where did the people whose PPOD was home die?





Figure 36: Did the person dying from PD/PSP/MSA die in the right place, by POD, England 2012-15 
PD carers were statistically more likely than cancer or CVD carers to feel care homes 
were the right place for their relative to have died, more likely than CVD carers to 
feel home was the right place but less likely than CVD carers to feel hospice was the 
right place (see Appendix J xxviii for other comparisons).  It is interesting that a few 
carers in the VOICES sample felt that the hospice was the wrong place; all had stated 
their relatives wanted to die at home and so perhaps the feeling was that the 
hospice should have facilitated this. 
This finding would appear to be at odds with the interview sample, where carers had 
only positive things to say about hospices and certainly felt they were the right 
place, even when their loved ones had wanted to die at home.  
“he was on the books that they would help him die at home but 
basically, that wasn’t going to happen…our local hospital isn’t the 
greatest and I was very relieved that he wasn’t going to die in there… 
I’m glad really that he was surrounded by nice people and I was 
there, yes that was the right place” Pam (PD) [Hospice] 
These carers felt going home from hospital would not have been possible and, that 
being the case, hospice was preferable to the hospital they were in or to going 
somewhere else. 
I spoke to her in the hospital I said to her you’re going to the 



















moment…coz there’s no way uh I made a promise to her that I’d 
never stick her in a home <broken voice> Paul (MSA) [hospice]  
Despite the negative views that a few carers had about care homes, for those that 
had experienced them and had relatives who had died there, the majority were felt 
to have died in the right place.  Certainly a few of the carers mentioned that they 
had not wanted their relatives to be transferred to hospital; they were grateful that 
palliative care had been provided in the care home and that their loved one was able 
to stay in a familiar environment. 
“I think most people are more nervous or disorientated in a hospital 
situation rather than being in your own bed in what had become his 
own room with things around him, even if he wasn’t fully aware of it 
just the idea of it was nicer...he was with particular people who knew 
him and had cared for him and we were close by and everything ran 
very smoothly” Angela (PD) [care home]  
For several of the carers, their main wish was that their relative did not die in 
hospital, there was not so much a right place of death as a wrong one.  It may 
therefore seem surprising that 82% of those who died in hospital were felt to have 
died in the right place according to the VOICES survey.  Even when focussing on the 
people who had wanted to die at home but died in hospital, 61% of carers still felt 
their relative had died in the right place. 
In the interview sample, a hospital seemed to be the right place when alternative 
options were thought likely to risk the comfort of those dying. 
“This lady came to see my dad the day before he passed away, 
<hospice> had no spaces but I was glad in a way, I don't think he 
would have tolerated being moved” Pippa (PD) [hospital] 
Several carers stated that they would have liked to have taken their loved one’s 
home but that it wasn’t possible and that being the case, they felt it was better to 
keep them where they were comfortable. 
“I wanted him to be at home that’s what I would’ve liked but it just 
wasn’t on and they did offer to transfer him to the hospice at one 
point but they put him in a side room and I just feel that was better 




The reasons given for it not being possible seemed to stem principally from 
exhaustion in carers and increasing care needs that they, or hospital staff, felt they 
would be unable to manage.  There is perhaps here a question about whether more 
support could have been offered to allow people home and certainly there was a 
feeling that people could have stayed at home longer, and been supported there 
better, if continuing care funding had been in place. 
“Had I known then what I now know about um being able to get 
continuing care to have support at home I might have given that a 
try because I did feel, I felt terribly that I had let him down by not 
being able to keep him at home and I never knew, because he never 
accused me, but I always wondered whether he felt that as well” 
Hope (PSP) [hospital] 
Hope’s words also highlight one of the problems with having PPOD, the guilt and 
upset that carers can be left with if it is not achieved.  
“I was very unhappy that she died in hospital because that is 
something we had discussed, that she didn’t want to die in hospital” 
Vincent (MSA) [hospital] 
It is also worth asking who is the place of death right for? In the interview sample, 
home was always reported to be the right place for the person who had died.  
“so it was peaceful really and it was what we had wanted for her, it 
was at home” Sebastian (MSA) [home] 
However, although some people had died at home where they wanted, it did not 
always follow that this was the right place for their carer. 
“he was looking at me so beseechingly because he was at home, he 
wanted to be at home, they had offered him a hospice bed in the last 
week um but he had turned it down he said he wanted, he had 
always said he wanted to be at home and when my daughter asked 
him she said ‘squeeze my hand dad if you would like to go to the 
macmillan hospice’ and she got no response and she said ‘squeeze 
my hand if you want to stay at home’ and that’s what he did and so 
it was horrible right up to the very end” Margaret (PSP) [home] 
Margaret found watching Chris die at home with limited support very difficult and 
another carer, Nicole, had symptoms of PTSD associated with finding her husband 





This section has discussed whether people dying from PD/PSP/MSA were aware that 
was the case and had been told that they were dying, whether a PPOD had been 
discussed and whether carers felt their relatives died in the right place or not.  
A minority were aware that they were dying, less so than people dying from other 
causes, particularly in a hospice environment.  In all locations people with 
PD/PSP/MSA were less aware than those dying of cancer.  Communication 
difficulties at the end of life may set these diseases apart somewhat from other COD 
but carers still felt that an effort should be made to inform their dying relatives and 
expressed satisfaction when open communication was shown.  
A small proportion had discussed a PPOD but it is difficult to know whether this is 
because people with PD/PSP/MSA do not think it is important or whether they had 
just not been asked.  Expressing a preference meant that death at home was more 
likely.  Irrespective of preference most people were felt to die in the right place, 
though this did not mean carers themselves were spared feelings of guilt if 
preferences weren’t met or that caring for a dying person was necessarily easier 
when it was in the ‘right place’. 
6.4 Carers 
This section discusses how carers themselves were treated across the four locations. 
It discusses communication with carers and the support they received at the time of 
their relative’s death.  It then outlines the support carers were shown immediately 
after death and the provision of ongoing bereavement support. 
 Communication 
Regardless of location, the most important thing to carers in the interview sample, 
was that their loved ones were treated well and that their worth was realised.  
“they <hospital staff> realise someone is sick but they don’t realise 
the person who is sick may still have a good quality of life…they don’t 




and I still miss her terribly, they don’t realise they are someone’s 
mum” Philip (MSA) [Hospital] 
Worth, in many instances, equated to HCPs seeing the dying person as an individual, 
as discussed previously, but there were also comments that suggested HCPs were 
perhaps not putting in as much effort as they could. 
 “the feeling which I had at the end of it was oh well we’ve tried this 
but we don’t think it’s worth the effort to do anything else, if you 
know what I mean, and that made me feel a lot more upset” Simon 
(PD) [Hospital] 
One carer, Helen referred to this when she compared her husband’s treatment to 
that of Stephen Hawking. 
I mean to be fair I did get angry because of course you’ve got 
Stephen Hawking who has a chest infection at the same time and he 
comes out and I was saying ‘yeh they wouldn’t pull the bloody plug 
on him would they?’ <laughs> and yet they were just happy to switch 
it off for Tony because they said ‘oh well he’ll probably have brain 
damage give the amount of time without oxygen’ Helen (MSA) 
Some carers felt that there was an automatic assumption that their loved ones must 
have a poor quality of life and therefore it was a life that was not worth saving. 
“he <consultant> said ‘I’m sure you’ll agree Mr Edwards if your wife 
goes into a deep sleep, we’re not going to resuscitate her’  
I said ‘why not?’  
‘well, because of the disease’  
I said ‘well what do you know about the disease?’  
‘well it’s Parkinson’s isn’t it, she’s not going to have a very good 
quality of life’ 
I could’ve hit him across the room, I really could, you know it’s this 
attitude that for some of these people you know they’re so righteous 
they act like bloody gods sort of I’m in control, I can sort of control 
life or death… I mean I just think some of these people have no idea, 
no finesse if you like, no idea how to treat people they’re just 
ignorant, completely ignorant” Vincent (MSA) [Hospital]  
Vincent explained that when the above conversation occurred his wife, Beatrice, had 
just been rushed into hospital and he was stood at her bedside shaking with shock.  
It was not just the judgement regarding Beatrice’s quality of life that upset him, 




there, but also that the consultant had not appreciated how shocked he was feeling 
himself.  Several other carers likewise related instances where they were not 
adequately prepared for the bad news that followed; there had been an assumption 
that they would know what was happening and understand the seriousness of the 
situation because they were caring for someone with a life limiting disease.  They felt 
that more empathy could have been shown  
“maybe they had no idea that I wasn’t expecting something like this, 
I don’t know, but I think that basically I was being told that mum was 
a heck of a lot sicker than what I thought and that mum probably 
wouldn’t pull through so obviously that’s very difficult news to 
communicate and I don’t feel that there was that much empathy if 
I’m honest with you at the time” Simon (PD) [Hospital] 
These problems were usually encountered in hospitals, predominantly in A+E 
departments or medical admissions units; once on the wards more empathy was 
shown, especially when it was apparent that the end was close. 
“I remember watching the doctor reading my mother's notes in 
another ward and preparing himself to come and tell me that she 
was dying and we should withdraw treatment. He clearly had to 
compose himself carefully and he communicated it clearly but 
sensitively. I don't think this could have been better managed in a 
hospice” April (PSP) [Hospital] 
There is no question in the VOICES survey that relates to the empathy shown by staff 
when breaking bad news to carers, but there are questions that relate to 
communication.  Figure 37 shows that staff in hospices were felt to communicate 
with carers best and staff in home environments the worst.  There was no statistical 
difference between the locations when comparing those who strongly 
agreed/agreed to those who did not.  There was no difference when comparing PD 
to PSP or MSA.  When comparing PD to other COD across the locations, PD carers 
were significantly more likely to feel they were informed and had time to discuss 
issues in hospital compared to carers of people who died from other causes.  This 
may be because they were more often present to advocate, or because staff 
communicated with carers more than they did with their patients with PD.  There 




though PD carers were proportionally less likely to feel informed, or that they had 
time to discuss issues, when at home (see Appendix J xxx and xxxi).  
 
Figure 37 Communication between carer and HCPs in the last 2 days of life, by POD, England 2012-15 
Carers in the interview sample felt hospice staff were well informed and had time to 
discuss their relative’s care.  For those that had experienced both hospitals and 
hospices, the continuity of staff, the time available for discussion and the 
communication skills shown in hospices allowed carers to feel better supported. 
“the hospice you know it was the same team, the doctors came 
round regularly, they talked to me, basic communication was so 
much better <than in hospital> and although it’s an awful situation 
when someone’s dying at least you feel much more confident that 
the person is being looked after properly” Pam (PD) [Hospice] 
Nevertheless, many carers related that hospital staff did put time aside to speak with 
them.  Indeed, one of the reasons that breaking bad news was found to be 
problematic more often in hospitals was that carers were told clearly that their loved 
ones were imminently dying more often in hospitals than they were in other 




was approaching prior to transfers occurring.  When at home, carers saw HCPs less 
frequently.  This perhaps explains why 19% of carers in the VOICES sample, when 
POD was home, disagreed they’d had time to discuss their relative’s condition 
(Figure 37).  Even if staff were attending the house regularly, it was rare that the 
nearness of death was discussed.   
“I think the professionals they did know but they didn’t communicate 
that to me, maybe they thought because I was so involved with his 
care that I had picked that up for myself and yes I knew he was going 
to die but I didn’t think he was going to die that soon” Margaret 
(PSP) Home 
Outside of hospitals and hospices the approach of death might have been inferred 
but if it was communicated at all it was done so less clearly, as indicated in the case 
study below (Figure 38).
 
Figure 38 A case study of Angela and Graham (PD) 
The uncertainty of knowing that death was imminent then left carers unprepared for 
the end.  
“I would have liked to have been told in no uncertain terms, if you 
like, exactly what had happened, what was going on or that it was 
the end and to prepare ourselves; because I don’t think we were 
prepared really.  I think I should have been more proactive, but I 
suppose in a way I was too nervous, you know, you almost don’t 
want to hear it I suppose but at the same time you need to hear it” 
Angela (PD) [Care Home] 
As Angela suggested, for some carers it may have been their own wish to deny that 
the end of their loved one’s life was approaching that stopped them from fully 





“I was just trying to sort of pretend you know he was going to get 
better even though the palliative care consultant had come to see us 
on the Friday night and said ‘you know this is probably going to be 
the end, is there anything you want to ask me?’” Elaine (MSA) 
[Hospice] 
The difference though was that when people had been clearly told that the end was 
coming, whether on some level they denied it or not, they were more likely to be 
present and prepared for the end when it came.  Conversely, when communication 
was seemingly less blunt and did not contain the words ‘he/she is dying’ carers 
would not always realise the end had come, were less ready for the death to occur, 
and had more unanswered questions afterwards.  
“the nurses must have seen something and as I say the only thing I 
can rely on is the fact that nurses know about these things and it 
would be nice for me to have known, or would it, did they keep it 
from me, I don’t think they would keep it from me specifically 
because nobody knows when anybody is going to die” Colin (PSP) 
[Care Home] 
As Colin alludes to, prognostication of the exact time of death is very difficult and 
this may account for some of the perceived lack of clarity regarding the approach of 
death.  However, in several interview accounts my interpretation was that the staff 
had probably known but had not communicated to relatives in a way that they 
understood.  As communication at the very end of life principally relates to 
conferring that death is approaching, that it was less likely to be done in care homes 
and at home probably accounts for the carers in the VOICES survey who disagreed 
that they were kept informed (Figure 37).  Though hospitals did inform carers that 
death was approaching, the busyness of staff sometimes meant carers felt they were 
being a nuisance when asking questions, which may explain why hospitals were not 
felt to be better at keeping carers informed.   
“I felt as if they were all terribly busy and having to answer 
questions. I was being a pest and go away and sit quietly and don’t 
bother us <small laugh>” Angela (PD) [Care Home] 
Being made to feel a nuisance, the busy nature of hospitals and the lack of empathy 




support carers sometimes felt hospital staff showed.  Figure 39 illustrates the degree 
of support that carer’s answering the VOICES survey felt they had received in the 
different locations.  There was no significant difference between the locations for 
those that strongly agreed/agreed that they had support (Appendix J xxxii).  There 
was no significant difference between PD, PSP and MSA across the POD either.  
When comparing PD to other COD (cancer, CVD and Other), PD carers were 
statistically more likely to agree that they had been supported in hospitals; there 
was no difference in the other POD (see Appendix J xxxiii)   
 
Figure 39 Support from HCPs in the last 2 days of life towards carers of people who died from PD/PSP/MSA, by 
POD, England 2014-15 
Though there was no significant difference across the groups, a slightly greater 
proportion of carers felt unsupported by staff when their relative died at home.  This 
was mirrored in the interview sample, with carers spending much of their time alone 
with their dying relative. 
“a Marie Curie Nurse came for 3 nights out of the ten that he was so 
ill, but sadly not on the night he died” Sandra (PD) [Home] 
Although some carers welcomed the chance to be alone with their relative at the 
end of life in hospitals, care homes or hospices, support was there if they needed it, 




In locations other than home, aside from good communication, support for carers 
was provided through food, tea and space, with care homes and hospices both 
praised for the way they looked after the needs of carers.  
“The aged care facility provided us with a quiet room where we could 
also sleep and offered us meals and endless cups of tea and coffee, 
biscuits and bowls of fresh fruit. Those small gestures did not go 
unnoticed and were deeply appreciated by us” Abigail (MSA) [Care 
Home] 
Though food and drink were provided less in hospitals, aside from on intensive care 
units, most carers stated that hospitals were happy to allow them to stay by their 
loved one’s bedside, making it more likely that they would be present when the end 
came.  Being present was one of the most important things to carers in the interview 
sample, almost all stated that they had been glad that they had been there  
“you know if there is one thing I will always be grateful for it was 
that I was there <slightly teary>, I was there holding his hand…and 
I’m always glad of that, coz not everybody gets that comfort” 
Hope (PSP) [Hospital] 
or sad that they had not. 
“I was very unhappy about the fact that I didn’t say goodbye to her” 
Vincent (MSA) [Hospital]  
Many carers in both the interview sample and the VOICES survey were able to be 
with their relative when they died.  Figure 40 shows that this was more likely to be 
the case if death occurred at home or in a hospice, principally because carers were 
already there; with carers significantly less likely to have been present when death 
occurred in hospitals compared to all other locations [Hospital vs Care Home OR 0.66 
(0.499, 0.877) p=0.004; Hospital vs Home OR 0.218 (0.132, 0.359) p<0.001; Hospital 
vs Hospice OR 0.249 (0.071, 0.870) p=0.029].  When comparing COD, PD carers were 
more likely to be present than CVD carers when death occurred at home or in a care 
home, more likely to be present than ‘Other’ carers at home but less likely in 
hospital, and less likely to be present than Cancer carers at home or in hospital (see 





Figure 40 Were carers present when their relative died? By POD, England 2012-15  
Although the uncertainty of the exact timing can make it difficult to be there, when 
carers were aware that the end was close, they were more likely to stay with their 
loved ones.  Hope (PSP) was wavering between staying in the community hospital or 
going home, the staff said they would make her up a bed on the floor of the physio 
gym and so she decided to stay; twenty minutes later Dennis died.  This reinforces 
why supporting carers and explaining that death is approaching is important.  
In the interview sample, when carers were unable to be there it was principally 
because death had been sudden in hospitals or because it had not been made clear 
that their relatives were dying in care homes.  In the VOICES sample, carers were 
more likely to be present at the end in care homes than hospitals however, perhaps 
because geographically they were nearer to the homes of carers and sudden death 
was less likely.  
 Support at time of death 
In terms of the support that the differing locations offered at the time of death, 
hospices appeared to be most supportive, followed by care homes (Figure 41). 
Carers of people with PD/PSP/MSA who died in hospital were statistically less likely 


























Were carers contacted to give them enough time to be 
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Hospices or Care Homes [Hospital vs Hospice OR 0.264 (0.087, 0.799) p=0.018;  
Hospital vs Care Homes OR 0.635 (0.477, 0.844) p=0.002].    
 
Figure 41 Support for carers at the time of death, by POD, England 2012-15 
Carers whose relatives had died at home seemed more likely to have felt they were 
definitely supported than those in hospital, but this was not statistically significant 
[Hospital vs Home OR 0.739 (0.498, 1.096) p=0.133].  There were no significant 
differences between the responses of PD carers compared to carers whose relatives 
died from other causes across all POD (Appendix J xxxvii).  
As Figure 41 shows, carers whose relatives died at home were more likely to have 
answered that they were not given enough help than those in other locations.  In 
another question regarding the sensitivity of staff after death24 16% of carers whose 
relatives died at home answered that they had no contact with staff after their 
relatives’ deaths, suggesting that they were alone, as carers in the interview sample 
had related was often the case.  In other locations, help and support again equated 
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to touches of humanity, such as cups of tea being offered, and to being able to 
spend time with their loved one after they had died.  
A point that carers in the interview sample mentioned, which may well differ from 
those dying of other causes, was the importance of ensuring that brain donation was 
accomplished at the time of death, if those dying had previously indicated it was 
their wish.  When the process was dealt with well, carers related how gratifying they 
had found the experience.  But sometimes staff were not aware about the details of 
brain donation. 
“this is another thing that we were quite upset about, it was about 
half an hour after the machines had been turned off and we said 
‘right he was a brain donor’,  
‘oh, it’s too late now you should’ve told us’,  
‘beg your pardon’,  
‘yeh, you need to be kept alive’  
we were like, right” Julie (MSA) [Hospital] 
When Julie later found out that what she had been told was not true, it would not 
have been too late, she was even more frustrated and felt that more awareness 
about brain donation should be present.  Even if staff were aware of the process, in 
the acuteness of the situation carers sometimes forgot to mention it, prompting 
Charles (MSA) to suggest that hospitals should actively record donor status on 
admission. 
“I regret to say that when she went into hospital dying that was the 
last thing on my mind…I made a suggestion to the MSA trust that 
they should use their influence with the NHS that if someone goes 
into hospital you can complete a long form of all your history and 
details and so on but a question they ought to add to that is do you 
belong to any donor bank” Charles (MSA) Hospital 
 After death  
After their relatives had died, most carers in the VOICES survey felt that staff dealt 




Place of death 
[total answering] 
Staff dealt with carer in a 
sensitive manner (%) 
Hospital [314] 291 (93) 
Care Home [531] 514 (95) 
Home [128] 122 (97) 
Hospice [23] 23 (100) 
 
This was significantly less likely to be the case in hospitals when compared to care 
homes [OR 0.418 (0.220, 0.796) p = 0.008], and less likely to be the case in hospitals 
than at home, though this did not reach statistical significance [OR 0.622 (0.247 to 
1.566) p=0.314].  In hospices all carers in the VOICES survey felt that they had been 
dealt with sensitively.  
Much of the interview sample felt that they were somewhat supported across all 
locations, with carers explaining that they had been seen by SPC teams in hospitals 
and care homes who were very helpful.  
“the palliative care team at the <hospital> were great as well, they 
came and spoke to me before mum died, but after they were really 
empathetic, very supportive” Simon (PD)  
Some GPs were great, seeing carers weekly after their relatives had died and one 
care home had set up a celebration of life service.  Elaine (MSA) mentioned that the 
hospice had provided her with pre and post bereavement counselling, which helped 
her immensely.  
April (PSP) mentioned that one of the most helpful things that occurred after her 
mum died was that she was able to speak with the doctor who completed her 
mum’s death certificate.  
She <doctor> explained that she had considered carefully how to 
record the cause of the death and had decided to put PSP as the 
primary cause and pneumonia as the second cause. This was 
because if my mum had not had PSP, she should have been able to 
overcome a small patch of pneumonia. But because her breathing 
was so weak, she couldn't fight it. This explanation helped me 




enormously, because I had felt - and still feel - that I should have 
noticed her chest infection earlier. I am really grateful for those five 
minutes with the doctor; if I hadn't turned up slightly early, I would 
have just been handed the death certificate without explanation 
April (PSP) [Hospital] 
There were a few carers who mentioned the guilt they felt due to their relative’s 
acute deterioration and several others who suggested that some kind of discussion, 
or debrief, would have helped them to process the events of the final few days 
because they were left with a lot of unanswered questions.  Brenda (PD) explained 
that she was due to return to the ICU to speak through Eddie’s admission, so it 
appears that in some hospitals at least, a sort of debrief sometimes occurs.    
“apparently in a couple of weeks’ time we get invited in to talk to the 
sister if anything, if they could’ve done anything different, or was 
there anything we didn’t like them doing or was there anything we 
thought was really good” Brenda (PD) [Hospital] 
The only comments that carers suggested were insensitive occurred when HCPs 
seemingly found it hard to understand why a carer would be shocked that their 
loved one had died. 
“Tony’s doctor came out and I said ‘I thought I’d have him for a little 
bit longer’ and he just said something like ‘well it happens to us all 
you know’ and I went ‘yeh, but I just wasn’t expecting it at that time’ 
and he said ‘but you knew the illness what did you think was going to 
happen’ ” Helen (MSA) [Hospital] 
Helen explained that she knew the end would come one day but that she had been 
expecting drifting away, not the sudden choking that occurred.  She had practically 
prepared for life after Tony, for example he had taught her how to use the 
lawnmower and she already did the finances, but the emotional preparation was 
something different and several other carers echoed this sentiment.   
“Even though we knew that eventually this would come to an end 
you really are not prepared for it and I really don’t think that anyone 
who has not been through something like this can honestly help you 
because I feel very differently now that he’s gone than I did before, 
even though I knew it would eventually happen, and I wasn’t ready 




In several cases carers had willed their loved one to die to relieve their suffering, but 
this was different to being emotionally prepared to live without them.  A few carers 
were ready in both senses, those whose loved ones had agreed to withdrawal of 
further treatment and the spouses who had been aware the end was coming from 
day one and witnessed a steady decline. 
 Bereavement support 
Unsurprisingly a carer’s awareness and acceptance regarding the end of their loved 
one’s life was related to their bereavement.  Death that was unexpected, for 
emotional or practical reasons, was harder for relatives to come to terms with and 
these carers appeared to have more unanswered questions and more expressed 
regret after their loved ones had died.  
“I now have physical disabilities due to caring for him as well as 
flashbacks of the morning I found him dead… I don’t think any 
amount of counselling will ever get me over this, people and family 
think I have come to terms with it but I haven’t” Tina (MSA) [Home] 
Sudden death did not always lead to increased grief, Susan, for example, took 
comfort from the fact that Paul had died suddenly. 
“it sounds horrible but I was pleased the way he died because that’s 
the way he would’ve wanted to go” Susan (PD) [Hospital] 
Paul had not wanted to linger in bed and despite Susan promising that she would 
never let him go into a care home, the hospital had made the decision that he was 
going; sudden death was therefore acceptable.     
Because most of the carers had been providing care intensely for a long period of 
time, not only did they have to be prepared for the loss of their partner/parent but 
also for a loss of their own role.  
“for people whose whole life revolves around the person you’re 
caring for and then suddenly you’ve lost your raison d’etre if you like, 
much as it’s an awful grind” Angela (PD) Care Home 
One might think this would mean that they were more likely to have been offered 




Most carers in the VOICES survey had not talked to any HCPs after their relative’s 
deaths (Figure 43).  Carers whose relatives had died in hospices were significantly 
more likely to have talked to an HCP about their bereavement compared to all other 
locations [Hospice vs Hospital OR 7.385 (3.002 – 18.166) p<0.001; Hospice vs Care 
Home OR 13.486 (5.483 – 33.171) p<0.001; Hospice vs Home OR 4.926 (1.939 – 
12.516) p=0.001].  There was no significant difference between PD, PSP and MSA.  
There was little difference when comparing POD by COD, though PD carers were 
statistically less likely than cancer carers to have received bereavement support if 
their relative died in hospital (see Appendix J xxxix).   
 
Figure 43 Bereavement support, by POD, England 2012-15 
It appeared that many carers in the VOICES survey had not spoken to anyone 
because they hadn’t wanted to; this was true of all carers except those whose 
relatives died in hospices (Figure 43).   
There were several carers who felt the same way in the interview sample, stating 
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“CM: If it <bereavement support> had been offered do you think that 
it is something you would have been interested in?  
Charles: most certainly not, that’s not my character” Charles (MSA) 
[Hospital] 
There was some suggestion that people shouldn’t need professional help; that they 
should be getting on with things themselves. 
“I think unfortunately whatever somebody’s condition is, whether it’s 
PSP related or any other condition, to a very large degree you have 
got to pick yourself up and dust yourself down and get on with it” 
Constance (PSP) Care Home 
And one gentleman, Colin, could not see what good it would bring to have 
bereavement support, suggesting perhaps what it could offer should be clarified. 
“well what do you think bereavement support is? What does it 
mean? I mean people talk to me or whatever, or people do practical 
things? I mean I actually, I have to say, I mean bereavement 
counselling after a death I find it a difficult notion. I mean the 
person’s gone, I spent my life with them and all that; what are they 
going to do to help me except to tell me to do other things and done 
the best you can and all these other sorts of things. I’m not a believer 
in bereavement counselling that sort of way, that’s me I’m afraid” 
Colin (PSP) Care Home 
There was a suggestion then by several carers that needing bereavement support 
was almost a negative character trait, with people talking about being ‘sufficiently 
strong’ to manage on their own.  This likely reflects a societal viewpoint regarding 
coping with adversity which may well differ if this study was conducted in another 
country where counselling may be less of a taboo. 
Other carers were not against the idea of professional bereavement support as such 
but felt that they had adequate support from other people in their lives. 
CM: And do you think it would have been useful at any point since 
he’s died to have talked to somebody about it? 
Susan:“no coz I’ve talked to my family instead of just keeping 
everything all bottled in, I talked to them and they were just sitting 
and listening to us and that’s all I needed” Susan (PD) Hospital 
 




“yes, I did, but I didn’t really feel I needed it. I had terrific 
bereavement support, if that’s what it is, from having a personal 
pastor, someone who actually does come and see me and talk to me 
and pray with me” Sebastian (MSA) Home 
In the VOICES survey, carers whose relatives died in care homes were less likely to 
have spoken to HCPs in their bereavement, but they were also less likely to have 
wanted to talk to anyone.  It is not entirely clear why this is the case, but it may be 
because carers had already grieved to some extent and detached themselves a little, 
especially in cases of disease related dementia, which was more common in care 
homes. 
“his personality did change, he wasn’t the same person, I feel 
personally that, I know I’m saying that Derek died <9 months prior> 
but for me personally I lost him a long time before that, it was 
gradual and I think <12 months ago> when he went into hospital 
with the chest infection I think it would’ve been a shock if he’d gone 
then but it would’ve been kinder, because the deterioration after 
that was so awful that I think if he’d gone then it would’ve been 
better for everybody” Gail (PD) Care Home 
Importantly, a few of the carers who’d had counselling had needed it much later, 
certainly more than a year after their relatives had died.  If the VOICES survey had 
been sent to them 4-11 months after their relatives had died, they would likely have 
answered no to wanting help, it was only later that the need arose.  Julie (MSA) 
mentioned that she had initially not wanted bereavement counselling when her dad 
died, but she needed it two years later when everything caught up with her.  Hope 
(PSP) also recalled that she’d had her counselling too early; now that she runs a 
support group she advises people to wait, if they have the option, because they will 
know when they need it.  
“I was offered bereavement counselling by the hospice and I took it, I 
didn’t feel I needed it but I thought it was polite <laughs>…what I 
realised was that I took it too soon, I really needed it when all the 
business that follows a death, the probate and everything, all that 
had finished and that’s when the foreverness kicks in and you realise 




Hope took up bereavement support because it was offered to her, even though she 
had not felt she needed it.  If an offer had been made to carers in the interview 
sample it usually came from hospices and this probably accounts for the significantly 
higher proportion of surveyed carers who answered that they had spoken to 
someone after their relative died in a hospice, as opposed to the other locations.  
Some carers mentioned they knew there was support available from somewhere if 
they needed it and others had contacted charities, such as Cruse, and gone on their 
courses, or attended bereavement retreats.  Only a few carers had been in contact 
with their movement disorder teams, but when they had they found it beneficial.  A 
lot of carers mentioned letters they had received from HCPs, which were 
appreciated.  
“Six weeks later I received a call from his neurologist (and promptly 
burst into tears) but he was a very kind man, and I also received a 
really lovely letter from his dentist.  At my next visit to my GP I told 
her that my husband had died, but there was no support offered” 
Sandra (PD) Home 
Unfortunately, often letters were the only communication that carers received in 
their bereavement.  There were several carers in the interview sample who had 
wanted more help but didn’t get it. 
“I do wish that 'end of life' support for the remaining spouse/family 
members were in place. If one has a faith then the hospital chaplain 
attends but for just one session. There are so many questions one 
wants to ask. Not just the nursing team but to ask the consultants 
too. I know that would be near impossible due to time and cost to 
NHS. Perhaps if someone (a PD nurse?) could visit a short while after 
a death in order to answer questions; that could be a possibility” 
Barbara (PD) Hospital 
Others had contacted Cruse or similar charities to find that they did not cover their 
area or had not known who to ask; these people equate to the carers in the VOICES 
sample who would’ve liked to talk to someone but had not.   
Interestingly, despite hospices being most likely to have offered bereavement help, 
Figure 43 shows that they are no less likely to leave people wanting additional help.  




but when she later told them that she had considered suicide they informed her they 
were not a bereavement service and that they would need to report her suicidal 
intent.  She answered ‘no’ when asked if she had received bereavement help, as did 
Angela below, so it may be the quality of the interaction which reflects whether 
people feel they have talked with someone about their bereavement or not.   
“no I haven’t had any bereavement support at all...my doctor did 
suggest seeing the counsellor that comes occasionally to the surgery 
and I did see her eventually, this was more than a year after 
Graham’s death, but she just talked about anxiety and how to cope 
with anxiety and she didn’t talk at all about the bereavement and so 
it wasn’t any use really” Angela (PD) Care Home 
Angela explained that she had not talked the whole experience of her husband’s 
death through with anyone outside of her family until her interview, which indicates 
that bereavement support means different things to different people and might 
explain the proportion of surveyed carers who were ‘not sure’ whether they had 
talked to anyone or not.   
Most of the interview sample were unsure if bereavement help would be useful; 
because it had not been offered, they couldn’t say whether they would have wanted 
it or not.  
“I didn’t have any offer of any sort of support whatsoever from 
anybody, whether it would’ve been well received I don’t know 
because I never got it so I can’t give you an answer” Vincent (MSA) 
Hospital  
As there was no option in the VOICES survey for people who were unsure whether 
contact with professionals would’ve helped them after their loved one died, these 
people are not represented in the VOICES survey.  It is these carers, along with those 
who would have liked additional help, who may benefit most from bereavement 
support. 
 Summary 
This section has discussed the interactions between the carers themselves and HCPs 




carers and whether bereavement support was wanted/needed.  Once again one of 
the most important points for carers was that their loved one was valued by the 
healthcare system and that their loss was therefore realised.  Because carers had 
been caring intensely for a long time, they were often exhausted and felt bewildered 
when the end came and several of them were then left with unanswered questions. 
Despite an apparent need for bereavement support few people had been offered it 
and though many people felt they did not need it at first, some had found the 
counselling they had received useful. 
Hospices seemed best at supporting carers.  There was little difference found 
between the other locations though care homes were felt to show more sensitivity 
and support at the time of death than hospitals.  Although home might be the PPOD 
ideologically, there are gaps in support systems that make a home death difficult for 
carers and a greater proportion of carers disagreed or strongly disagreed they had 
been supported when their relative died at home.    
6.5 Overall Summary 
In conclusion, most people who died from PD/PSP/MSA had not expressed a 
preference for POD; when they had expressed a preference, home was the most 
likely choice.  Experiences at home were very dependent on the level of support 
available.  Care at home was largely provided by the carer themselves, with 
additional support from paid carers or family.  When the level of support was not 
great enough, and carers had become exhausted, it was unlikely that a person would 
die at home.  Similarly, unless it was clear that a person was dying and they had 
expressed a wish to remain at home, often admission to hospital occurred and for a 
variety of reasons it was then difficult to get people home again.  Interestingly, 
private homes were not significantly better than hospitals, the place that carers felt 
their loved ones would least like to die, across most domains.  Care homes however 
did provide a greater support for the emotional needs and physical symptoms of 
those dying, and for the carers themselves, than hospitals did.  There were several 




home, referencing negative media reports.  Given that care homes provide a level of 
support at the end of life, which is second only to hospices across most domains, 
there is perhaps a suggestion that the rhetoric surrounding care homes should 
change.  That being said, respect and dignity appeared to be shown less often in care 
homes than home environments and both hospitals and care homes appeared to 
treat people with PD/PSP/MSA with less respect and dignity than people dying from 
other causes.  Chapter 5.1.3 (Table 8) showed that people with PD, MSA and 
especially PSP were felt to be less able to make their own decisions at the end of life 
than people dying from other causes and this may well be linked to the respect and 
dignity they were perceived to have been shown.  Indeed, the other area of 
difference when comparing COD was regarding awareness of dying; with people 
dying from PD being less aware than people dying from other causes.  Certainly they 
were less likely to have been informed that they were dying and again cognition, and 
the ability to communicate, may well play a role.  Hospices appeared to be rated 
most highly across the VOICES survey and so access to hospice provision is an 
important point of discussion.  However, the qualitative data showed that there are 
positive and negative points across all locations and though some aspects of care 
provision are difficult to change, such as the business of hospitals, there are simple 
changes that could be made to at least improve experience.   
This chapter shows that maintaining identity by seeing a person as an individual and 
supporting their choices is the key to providing good care regardless of location. This 
improves not only the experience of the person dying but also improves the 
experience of their carer as they are more likely to have faith in a location that 
obviously recognises their relative’s worth.   Figure 44 outlines the themes of the 
chapter, it shows identity as the central focus with emotional and practical elements 
of support and preparation impacting on experience.  Identity, in this chapter, 
encompasses personal identity regarding being seen as an individual, relational 
identity in regard to having family present and material identity being represented 






Figure 44 The principle themes of the project as they are represented in this chapter 
Emotional support at the end of life comes from recognising a person’s individual 
characteristics and sense of self and trying to maintain the things that give them joy, 
while practical support centres more on symptom control.  This chapter shows that 
all locations are good at symptom control but that emotional support can sometimes 
be lacking.   It also shows how important preparation is if dying in a particular place 
is of importance and that making carers aware that the end is imminently 
approaching is of benefit.  Emotionally, people who are dying must be able to 
think/talk about it to prepare but, practically, they also have to be told.  The same is 
true of carers.  It may seem obvious to HCPs that the end is approaching but without 
clear unambiguous communication relatives can be left with unanswered questions 




In conclusion, it is hard to predict when the end of life is close for people with 
PD/PSP/MSA but it certainly appeared that prior planning, and being cared for by 
staff that knew the individual person and about their disease, improved the 
experience; not only for those dying, but their carers as well.  Much of the support 
had to be set up far in advance of the last three months of life and has been 




Chapter 7 Identity, preparation and support 
This chapter will outline a model that explains the main themes of the thesis.  It will then 
explore the themes in greater depth and situate them within sociological and health policy 
literature.  
7.1 A model  
The two results chapters show that there are many emotional and practical elements that 
affect a person’s end of life experience, but that they are principally related to preparation, 
support and identity.  There are emotional and practical elements to preparation for the 
end of life, including awareness & acceptance of dying and ACP, which in turn require 
emotional and practical support, with co-ordinated care being delivered empathetically.  
The level of support a person needs and the level of preparation for the end that they 
undergo is shaped by their identity, encompassing personal, relational, collective and 
material elements. In addition, disease identity (here represented by HCP’s knowledge of 
the disease) appears to be important as it also affects the way that an individual, and their 
family, interact with the healthcare system.  
In the last few days of life identity, preparation and support continue to shape experience. 
Here preparation relates to the awareness of dying and the knowledge that death is 
approaching imminently; not only for the person who is dying but also for their 
carer/relatives.  Support here relates to the relief of symptoms such as pain, support with 
eating and the ability to have family present.  Support also relates to attempting to get 
someone to their PPOD, and to be able to do this awareness that death is imminent is 
needed.  An understanding of an individual’s identity is required to allow emotional support 
to be delivered and to ascertain the degree to which awareness of dying is desired, so the 
three themes remain closely related when death is imminent.   
Figure 45 outlines the components that affect the end of life care experience for people 





Figure 45 A model of the components affecting palliative and end of life care for people with PD, PSP and MSA 
The model shows that there are factors which have more of an impact before death is 
imminent, those that are more in line with chapter 5 and those that have more of an effect 
when death is imminent, more closely aligned to chapter 6.  However, at any point in time, 
from the diagnosis of a life limiting condition to the time that a person dies (and after the 
death for carers) there is preparation that can be undertaken for the death and support that 
can be offered.  These factors may not necessarily be different than those dying from other 
conditions but there are some potential inequities in care born out from the rarity of 
PSP/MSA and the fact that PD is not always considered to be life limiting.  In addition, these 
identifying labels, and HCPs understanding of them, shape the experience that people with 
these conditions have regarding the other factors.  The individual nature of each person 
with the disease, the biological make up of symptoms, their psychological adjustment to the 
disease and what that means for their social situation will shape the preparation that they 
do and the support that they need; for this reason identity is central to the other factors.  
Identity is not split into differing time periods because the importance of self, worth (the 
way that a person was perceived by others), the relationships they had with 





The following sections will talk through the three themes of identity, support and 
preparation, comparing them to the existing sociological literature and UK health policy.  As 
this study was situated in the UK, most references are made to western societal values and 
the way they are represented in health policy.  As the main differences compared to other 
COD appeared to be regarding identity and awareness of dying, these areas are focussed on 
more strongly within the discussion.  
7.2 Identity 
Identity in this project was comprised of the nature of the individual who died, the 
relationships they had with their families and friends, the way that their disease affected 
their sense of self and the way their family believed HCPs perceived them as an individual.  
Disease identity also played a role.   
There are a multitude of ways to consider identity and it has been studied through many 
disciplines.  Schwartz et al (137) in their handbook of identity theory summarised the 
different ways identity can be considered as: 
• Personal identity: how an individual views them self as a person e.g. kind, brave 
• Relational identity: their interpersonal role regarding others e.g. dad, husband  
• Collective identity: their identification with groups or social categories e.g. British 
• Material identity: what their clothes, house, car, finances say about them as a person 
 
Schwartz et al (137) called for an integrated definition of identity suggesting that studies 
usually focus on one of the components rather than recognising that all will actually play a 




neurodegenerative disease has the potential to affect all these aspects (see Figure 46). 
 
Figure 46 Aspects of Identity in this project 
In the interviews it was clear that the personal identity of people with PD/PSP/MSA is 
threatened not only through the symptoms that occur due to the diseases but also through 
the way people with the diseases were treated by family, friends and HCPs.  In the UK and 
other western cultures individualism is the dominant authority of society (138) and as such, 
personal identity and autonomy are felt to be of paramount importance.  Anything which 
threatens individualism/independence is therefore problematic.   
In 1982 Bury (139) described the ‘biographical disruption’ that can occur for people with 
chronic diseases, where a presumed future life is altered drastically by the problems the 
chronic disease brings.  Charmaz (140) later outlined the loss of self that could occur 
through chronic disease.  Although not previously discussed in regard to PD/PSP/MSA, 
biographical disruption and loss of self has been described in MND (141) and loss of 
self/personhood has been described multiple times in dementia (142-144); though there is 
some debate about the extent to which personhood persists in dementia (145), likely 
dependent on the definition of personhood adopted (146).  The effect of relational identity 
is referenced in the literature that explores changing roles and carer burden.  While some 




















strained (147, 148); both were related by carers in this study.  Collective identity was 
decreased by the fact people could no longer get to groups or activities, especially if friends 
did not call.  However, it was also increased in relation to being a person (and carer of 
someone) with these disease labels, as support groups and forums provided the 
camaraderie of people going through the same thing.  Lastly the burden of the diseases 
affected finances, either through loss of jobs or cost of care, and several carers related that 
they had to move to a new house or change cars to adapt to the diseases; reflecting changes 
to material identity.  Preservation of material identity at the end of life occurred by ensuring 
environments were filled with photos and by ensuring a person was dressed in their correct 
clothes, to maintain their dignity.  
Although all forms of identity play a role, the focus of this chapter will largely be on personal 
identity because of the level of importance it plays in UK society and health policy, in 
relation to autonomy and ACP.   
 Personal identity and loss of self 
Charmaz described the ways that chronic illness could lead to a loss of self by discussing four 
points: individuals living restricted lives, social isolation, discrediting definitions of self and 
becoming a burden (140).  In this study carers explained that as PD/PSP/MSA progressed 
their relatives were more restricted and required increasing amounts of care.  Several carers 
were upset by the social isolation that they encountered as friends and family dropped 
away.  Charmaz (140) suggested that sometimes restrictions and social isolation can be 
voluntarily, but prematurely, caused by individuals due to the stigma they feel.  This has 
certainly been described in PD previously, with reduced mobility (9, 10), tremor (10) and 
speech difficulties (7) all cited as reasons for social withdrawal.  Some of these points were 
echoed by carers in the interviews, but for the most part it appeared that they fought to 
keep their loved ones from social isolation and found it disappointing when relatives or 
friends stated it was too emotionally difficult for them to visit.  Adequate access to support 
and timely rehabilitation interventions may reduce the degree of restriction.  
In terms of interactions with HCPs, carers related multiple instances where discrediting 




a person was not trying when it was their physical illness that precluded them from doing 
what had been asked.  Predominantly however, discrediting occurred through tacit means 
by not acknowledging the person with PD/PSP/MSA as a ‘bona fide participant’ (140, p184) 
because communication was difficult, or treating them as a problem rather than a  person; a 
frequently shared experience in regard to medical admission units.  Carers were aware of 
this and felt that they could not leave their relatives alone, at home or in hospitals, because 
no-one would make the effort to talk to them.     
The idea of tacit discrediting mirrors that of social death somewhat, where it appears, at 
least to some parties, that a person is gone and they are just looking after a body (149, 150).  
Bramley and Eatough (151) in their IPA study regarding an individual with PD reported that 
their subject experienced an inner self (mind) and outer self (body) at odds with one 
another.  Her body was deteriorating, yet her mind remained intact; she felt ok around her 
family, as they knew the inner self, but was not ok around others as they only saw her body 
(151).  Similarly, most carers in this study did not perceive a loss of personhood, whereas 
when they encountered HCPs they found that some of them perhaps had; there were 
multiple examples of communication where the individual with the disease was ignored and 
carers were spoken to instead.  Timmermans(152) explored the idea of social death in 
regard to resuscitation and found that the way staff perceived the social worth of a person 
directly influenced the resuscitation attempts that were made (despite previous authors 
stating that the protocolised nature of CPR would prevent this from occurring).  A similar 
phenomenon appeared in this study regarding discussions about admittance to ICU and 
whether a person should be for resuscitation; quality of life appeared to be frequently cited 
as a reason to avoid aggressive treatment, without first ascertaining the subjective quality of 
life that individual was experiencing.  The anger relatives who experienced this felt was not 
just due to the judgement they had witnessed regarding their relative’s worth, but also the 
fact that these pronouncements were often made in front of their loved ones, as if they 
were not there; further discrediting sense of self.  One could argue that a more subtle form 
of discreditation occurred when health and safety concerns, even in hospices, overruled 




dehumanising by Constance (PSP), who was prevented from helping her husband to the 
toilet, meaning he had to wait, anxious that he might be incontinent.   
Charmaz points out that ‘supportive intimates usually bolster the ill person’s self’(140 p183) 
and the sense of identity that the carers of those with PSP/MSA related was strong.  This 
may be related to their knowledge of the disease and how it could affect their relative.   
They were so expert in the disease process they were able to separate its burden from their 
loved one’s self and understand that it did not define them; though this of course could be 
due to post processing and the methods of recruitment used for this study.  Those who are 
alone, without people who have prior knowledge of their identity are at greater risk of 
discrediting by medical personal because they do not have others to reaffirm their 
importance; something which echoes the fears that carers mentioned in their interviews in 
regard to people who did not have relatives to speak out on their behalf.  
The last point in Charmaz’s article regarding loss of self is in regard to becoming a burden, 
where physical dependency results in reduced independence and a person can feel useless, 
especially when they see the strain that care takes on their caregiver (140).  Carers in this 
study frequently mentioned their exhaustion and certainly the length of time that care is 
provided, and the intensity of that care, is likely higher than for other diseases.  An 
interesting point Charmaz makes is that part of becoming a burden is the ill person 
recognising that their illness has become their major source of social identity (140); it would 
therefore be interesting to know whether people with PSP/MSA desire an increase in 
knowledge regarding their diseases as much as their caregivers do.  
Loss of personal identity/self is particularly pertinent in western societies, because much of 
our values are based on independence, autonomy and the role we have in society (153).  
Interestingly loss of the ability to communicate is rarely discussed in regard to personhood 
or the self and yet it is what sets these diseases apart from many other chronic illnesses and 
makes the threat for loss of personhood even greater (154).  It is perhaps therefore not 
surprising that a proportion of the group had expressed that they did not want their life 
prolonged and in some cases that they wanted to hasten death.  Monforte-Royo et al (155) 
in their systematic review regarding ‘what lies behind a wish to hasten death’ found that 




becoming a burden, feeling physicians have given up and a fear of losing autonomy are the 
principle reasons that people with parkinsonism requested assisted suicide at DIGNITAS 
(156)     
 Will to die (WTD)/wish to hasten death (WTHD) 
Studies have shown that 20-30% of people with PD express death intent/WTD and around 
11% express suicidal intent/WTHD; with depression being a consistent predictor of both 
(157-160).  There are no published studies that discuss WTD/WTHD for people with 
PSP/MSA despite the fact that health related quality of life is shown to be worse, and 
depression greater, than for people with PD (161).  The MND population have a higher 
request rate for assisted dying than any other disease group (162) and as the progression of 
symptoms for those with PSP/MSA is closer to MND than PD it is not necessarily surprising 
that some people with PSP/MSA expressed a WTHD to their carers.  The reasons given for 
why people with MND have a WTHD are varied; some studies have shown a link with 
depression (163), others have not (164-167); being a burden (163, 166), feeling hopeless 
(164, 167) and maintaining control (164, 165) are all related, reflecting the loss of ‘self’ 
mentioned above (and the desire to maintain it).   
Other studies concerned with the broader WTD, rather than a WTHD, have shown multiple 
related factors including increased disability (168, 169), speech impairment (169), 
incontinence (170) and depression (171).  This study found that a WTD had been expressed 
by people with PD/PSP/MSA to their relatives and this may not be surprising given that 
Saleem et al (172) showed that 51% of people with PD/PSP/MSA had severe mobility 
problems, 28% had severe communication problems, 13% had severe trouble controlling 
urine and 16% felt depressed most of the time.   Ohnsorge et al (173) have criticised the 
literature surrounding the WTD because when WTD is studied in surveys there is little effort 
made to distinguish between the differing intentions behind the WTD.  Following multiple 
repeated interviews with 30 people diagnosed with terminal cancer and their caregivers 
(both relatives and HCPs n=116), they compiled a typology of intentions (173) that could 
account for a person expressing a WTD; many of these intentions appear to have been 





Onsorge et al’s 
intentions 
Examples for this study 
Wish to live “CM: she’d never expressed that she wanted things to end? Charles: 
quite the opposite, it was the attitude was well we’ll keep this ship 
going as long as we possibly can” Charles (MSA)  
Acceptance “My mother was calm, comfortable and at peace. She said things like ‘I 
just want to sleep... forever’, ‘Is this what dying is like?’ in the weeks 
before she died” Jennifer (PD) 




Looking forward to 
dying 
“he did say on several occasions, not just to me, but he said that you 
know, he would be happy to go, because it wasn’t living” Constance 
(PSP) 
Hoping that dying 
happens more quickly 
“she would ask our pastor occasionally and perhaps the week before ‘is 
it alright to ask Jesus to take me now?” Sebastian (MSA) 
Desiring to die (but 
hastening death is not 
considered) 
“He had previously told his carer he did not want to live anymore and 






death (in future, if 
certain things happen) 
“we had discussed it and he said that there’s no way he said that he 
would stockpile pills or something he would do something you know 
before things got too bad” Aileen (MSA) 
Actually considering 
hastening death, but at 
the moment (for moral 
or other reasons) it is 
not an option 
“and he said ‘oh, just let me take a tablet’, I said ‘do you know 
something dad, if I had one, I would’ and he said ‘I know you would, I 
know’ ” Julie (MSA) 
Actually considering 
hastening death, 
hastening death is a 
(moral) option 
“she said ‘I wouldn’t want to go abroad to that clinic’ and by then she 
wouldn’t have been mobile enough it would’ve been a major task 
anyway, she said ‘if my doctor offered me an injection tomorrow I’d 
take it, but I don’t want to go to a Swiss clinic’ “Philip (MSA) 
Will to die  
Explicit request “I went in one day and they said to me ‘we have to tell you this, 
because last night when the night team were going round he asked 
them to give him something’ and I knew what they meant, he didn’t 
want to wake up” Hope (PSP) 
Refusing life-sustaining 
support (such as food 
or treatments) with the 
intention of hastening 
death 
“My daughter tried to give Elizabeth a dose of antibiotics and although 
she couldn’t speak Elizabeth clamped her mouth shut, her intentions 
were clear” Cecil (MSA) 
Acting towards dying 
(such as suicide or 
assisted dying)  
No examples of this in the study  




In a different paper, reporting results from the same cohort, Ohnsorge et al presented the 
reasons, meanings and functions of WTD requests (174).  The reasons related to the full 
range of bio-psycho-social and spiritual causes, including pain, anxiety, loneliness and being 
locked in a disabled body (174).  The meanings related more closely to relationships with 
others and their culture, such as a desire to let nature take its course and avoid being a 
burden.  The functions related to more practical concerns, such as an appeal for help with 
symptoms, a gateway into discussing dying or a way to preserve agency (174).  Ohnsorge et 
al cautioned caregivers not to assume that expressions of a WTD equated to depression 
(174) and although people with MND who have depression are more likely to express a WTD 
than those who are not depressed, many people expressing a will to die do not have 
depression (175).  Most carers in this study did not feel that depression was the cause of 
their loved one’s WTD.  They equated it far more often with the existential suffering that 
loss of independence, speech and swallowing could bring and a readiness to die to escape 
from that suffering.  Often, they saw the WTD as a marker of acceptance and saw that their 
loved ones continued to live, enjoying time with grandchildren for example, at the same 
time as expressing a WTD.  Ohnsorge et al described that the wish to die coexisted with the 
will to live and both fluctuated over the course of a person’s deterioration in a non-linear 
fashion (173, 174).  Within their study 8 people had a fixed WTD, 5 only ever had a will to 
live and the remaining 17 fluctuated, illustrating the dynamic characteristic of a WTD (174).  
Within the narratives related by carers in this study some were fixed in their desire for 
death to come, because their lives had become unbearable.  Others only ever wanted to live 
and continue as long as possible.  Others who had mentioned that they would end their lives 
when things got worse, didn’t seem to reach the point at which life became unbearable and 
some seemed more at peace as the disease progressed.  
The fluctuation of a will to die likely reflects the response to loss of self that is described in 
the literature.  Charmaz pointed out in later work that loss of self is not fixed in most cases, 
but fluctuates, and people find varying ways of dealing with their illnesses from fighting the 
diagnosis, to surrendering to the diagnosis (contentedly) or to resigning oneself to the 
diagnosis in depression (176).  As people are faced with the threat to identity that chronic 




that disruption in differing ways.  The different ways of coping, especially those that allow 
people to construct new meaning in their lives, has been termed biographical repair.   
 Biographical repair 
Biographical disruption was first described by Bury, who postulated that being diagnosed 
with a chronic illness forced a person to review their previous life goals and led to a 
requirement for social change, due to the stigma associated with chronic illness (139). 
Locock et al revisited this work when they explored biographical disruption in MND, showing 
that the idea of biographical disruption and subsequent repair was possible even within a 
terminal disease, where improvement from a symptom point of view was not possible (141). 
They explained an abruption, a feeling that life was already over when people were first 
given the diagnosis of MND, disruption much like Charmaz’s loss of self, and varying 
examples of repair, including (141 p1047) 
• balancing avoidance and acceptance of the future  
• keeping hold of normality, which sometimes meant employing paid carers to 
allow informal carers to return to a role of relative instead 
• creating new normality by starting new hobbies or socialising online 
• living life to the full 
• and finding new meaning; becoming closer in personal relationships 
All these factors were mentioned by carers in this study (see Table 14).  Locock et al 
explained that each time a new hurdle occurs, life can become disrupted again and so, as 
with the WTD, the process of disruption and repair is in flux (141).  As repair happens, 
people can deal with more than they thought possible and this has important implications 
for the timing of discussions regarding future wishes.  Repair also means that people may 
value life and that no-one should make a judgement about its quality and importance 





Indicators of biographical repair  Examples from forums and interviews 
balancing avoidance and acceptance 
of the future  
“Talking about it when it is less critical early on in 
diagnosis was what my Mum had wanted to do - then it 
was put aside. She - when very unwell - would say ‘I 
think it is time for my Advance now.’ So I think it gave 
her reassurance” Jennifer (PD) 
keeping hold of normality, which 
sometimes meant employing paid 
carers to allow informal carers to 
return to a role of relative instead 
“I think the reason we did it was I didn’t want to be her 
carer anymore I wanted to be her daughter and just go 
and chat to her because she couldn’t talk, move or do 
anything by that stage  and it was just nice going in, 
taking the kids in to see her and taking the dog in and all 
those sorts of things rather than worrying about whether 
she had food or medication, all that sort of thing” Kate 
(PSP) 
creating new normality by starting 
new hobbies or socialising online 
“he was a voluntary educator for Parkinson’s, which 
mean you, they give you, they they train you and you 
have um disks and you know DVDs to show and you go 
to care homes and speak to the staff… so he enjoyed 
doing that” Brenda (PD) 
living life to the full “one of her preoccupations was spending time with the 
grandchildren and doing all the usual granny things with 
them… she was very determined to keep going and as 
she declined we became more and more expert at 
keeping her mobile to the extent that in the month 
before she died, and she was getting pretty bad at that 
point, uh we managed to fit in a trip to Ireland, fit in a 
trip to Lourdes and fit in a trip up the shard in London” 
Charles (MSA) 
finding new meaning; becoming 
closer in personal relationships 
“you do start to appreciate each other, all over again  
you know because life kind of takes you on a whirl you 
know you’re both working, and that forced us to be 
together so although it was a horrible time I actually look 
back and think well weren’t we lucky” Helen (MSA) 
Table 14 Quotations from the qualitative sample that indicated biographical repair, as defined by Locock et al (141, p1047) 
Some of these instances of repair relate closely to personal identity, whereas many of them 
are more to do with relational, collective and material identity.  As the attributes that 
people value in themselves are affected and bodily function decreases, it is likely that 
people will look more strongly towards other aspects of their identity to help them to 
continue to live with the presence of the disease.  Fegg et al showed this in their study 
regarding meaning of life for people with PSP (177); those affected with PSP attributed less 




animals and spirituality retained their importance.  Fegg et al had previously shown similar 
results with an MND population (178).     
Western literature, regarding identity, is predominantly related to personal self and almost 
all UK policy, with regard to patient care, references person-centred care equating to 
personal self and autonomy.  Roger et al in Canada are critical of the importance placed on 
autonomy and noted that the people they interviewed with PD, and their relatives, very 
much lived an intertwining identity as a cooperative unit (25).  The same appeared to be 
apparent in this study, relational identity and the collective identity of the immediate family 
seemed at least as important as autonomy.  This may be because carers were interviewed 
rather than individuals actually living with/dying from the diseases, but it mirrors what I see 
in practice.    
Boersma et al found that as people with PD felt threatened by a loss of personal identity, 
identifying with the larger PD community gave meaningful friendship and support (10). 
Hudson et al noted that PD groups provided psychosocial support, practical support and 
continued connection, especially for carers, whereas some people with PD (and occasionally 
carers) found the groups depressing (7).  As with Hudson et al’s findings, carers in this study 
appeared to gain benefit from the charity support groups, but there appeared to have been 
more ambivalence reported from those with the diseases; especially MSA/PSP.  Locock and 
Brown (179) explored the attitudes of people with MND and their carers towards peer 
support groups and showed a similar level of ambivalence.  Some people with MND found 
the social comparison useful to give them hope or make them feel better about their 
current situation, perhaps aiding repair, whereas others were shocked by what lay ahead 
(179).  Some people rejected being seen as a person with MND and labelled because of their 
diagnosis (179).  Whereas others liked being a part of a group that was in the situation 
together and revelled in the collective identity; these people also felt they could be more 
like themselves and talk about things other than MND because the group already 
understood MND, so it restored their ‘normalised identity’(179, p1502).  
This last point may explain to some extent why knowledge of disease is such an important 
issue, especially for people with rare diseases such as PSP/MSA/MND; when other 




individual person from their diagnosis.  This point, along with other factors that make 
knowledge of disease important, will be explored in the following section.    
 Knowledge of disease 
The desire for HCPs to know more about particular diseases and the way they can affect a 
person is common in the palliative care literature: the CQC have identified a lack of 
understanding and training as an issue in caring for people with dementia (180, 181) and 
authors in the UK have cited a lack of knowledge as an issue for people with MND, especially 
with regard to paid home care workers (107, 182).  Hudson et al identified the same 
concerns in Australia regarding PD; carers were particularly anxious that HCPs knew enough 
about PD to meet the needs of their relative and anxiety over hospital admissions was 
reduced when carers perceived that expertise was available (7).  In this study one carer 
mentioned that if people thought more about the non-motor side of PD they may be more 
forthcoming with empathy, but the desire for increased knowledge was predominantly 
related to practical concerns, such as medication, mobilisation and support for eating and 
drinking.  
The emphasis on knowledge of disease from the carers of people with PSP/MSA was 
greater.  The practical concerns were still there, but there appeared to be a stronger 
emotional element attached to the disease label that was related to identity.  In terms of 
self-identity, having to explain a diagnosis repeatedly to HCPs means the focus of care, at 
least initially, is on the diagnosis and learning about it, so a proportion of time is spent 
explaining the disease rather than addressing the concerns of the actual person; the focus 
automatically becomes biological to some extent.  If continuity of care is not present, and 
the diagnosis needs to be explained repeatedly, this could lead to a person feeling defined 
by the disease, rather than feeling they are an individual who happens to have the disease 
(reflecting the burden of chronic disease suggested by Charmaz (140)).  In addition, having 
to repeatedly explain the disease and how it affects you, sets a person apart from others 
and increases isolation, a phenomenon reported in the report from Rare Disease UK 
regarding mental health (183).  Relational identity might be affected through increasing 




in the position of a carer may also start to incorporate the disease into the way they view 
their loved one, especially if they must repeatedly explain the diagnosis to other people.  
However, if repetition and explanation was the principle problem, then it should not matter 
if HCPs were not interested in knowing about the disease, provided they were able to 
deliver adequate care.  Although one carer, Charles (MSA), did express this view, most were 
adamant that a lack of knowledge affected care.  Other carers said that it was not the lack of 
knowledge that bothered them per se, they recognised that the rarity of the disease 
precluded widespread knowledge; it was when HCPs did not want to learn more about it 
that they were most frustrated.  This was related to empathy.  If HCPs knew more about the 
disease they could understand better what a person was going through.  Perhaps HCPs need 
to think more about the concepts of biographical disruption (and repair) so that they 
understand that dismissing the importance of knowing more about a disease is belittling the 
huge hurdle that the individual, and their family, have surmounted.  Getting the diagnosis 
on the death certificate is an extension of this and appeared to help carers maintain the 
identity of their loved one as a person who fought bravely until the end, rather than 
someone who weakly succumbed to a ‘simple’ chest infection.  
There is very little literature regarding the way rare diseases impact on identity, possibly 
because 80% are genetic and affect children, whose personal identity was not necessarily 
established before the disease took hold; so degenerative diseases like PSP/MSA are rarer in 
their experiences still.  Interestingly MND is a rare disease in terms of numbers25 and yet 
due to increased publicity it was not perceived to be as rare by carers in this study; they felt 
more HCPs and members of the general public knew what it was.  A literature search 
suggests the same is true within medical circles as there are 20179 studies for MND on 
‘Medline’ but only 2239 for PSP and 2575 for MSA; even less when it comes to end of life 
care.  Joachim and Acorn (184) in their Canadian study regarding life with a rare chronic 
disease found that the ignorance people encountered affected their sense of self; they 
suggested that HCPs need to consider the rarity of a disease as well as the symptoms it 
 





causes to provide useful care. The EURORDIS survey, a cross Europe survey of people with 
rare diseases suggested the same was true of relationships with friends and family, with 
around 50% of respondents feeling that the rarity of their disease caused, or amplified, their 
isolation due to a lack of understanding, (185), though interestingly 45% felt it had 
strengthened their immediate family unit.  
The rare disease surveys show that there is a lack of information and understanding about 
rare diseases and highlights that patients themselves have to become the experts.  This in 
itself can change the dynamic between people with the diseases and HCPs (186) and 
certainly affected the degree that carers in this study felt they could trust the professionals 
they met.  There were increased concerns regarding the practical delivery of care such as 
getting the right equipment at the right time, as that relied on understanding the disease 
and its progression, and several carers noted a delay in adequate services because they 
were not yet experts themselves.  Carers also explained the difficulties they had 
encountered with gaining CHC funding and benefits, partly because the diseases were 
unheard of and partly because unless they went to the support groups no-one had informed 
them about their rights. This again reflects the EURORDIS survey, where 70% of people 
surveyed with rare diseases felt ill informed about their social rights (185).  
Better knowledge about diseases certainly improves care on a practical level.  Though 
papers written about rare diseases state that medical education should provide increased 
knowledge of that disease, across healthcare disciplines, this is not a particularly practical 
suggestion.  Far better is the provision of continuity of care, so that constant focus on the 
disease itself and re-explanation about what it means is unnecessary.  Arguably patients 
should be looked after in specialist centres with expertise and MDT working, and yet many 
people with rare diseases do not know if there is a specialist centre for their disease (187).  
Most of the carers for people with PSP/MSA in this study stated that they went to specialist 
hospitals for their care, with some of them travelling for hours to attend, yet the services 
suggested did not then automatically follow.  Carers were forced to organise them 
themselves, spending hours trying to co-ordinate care; issues that were common in the rare 




 Summary: Identity 
This section has explained the theme of identity, something that has not been discussed in 
detail regarding PD/PSP/MSA before.  Although Charmaz’s theory of loss of self and the idea 
of biographical disruption was described for chronic diseases in general, the fact that PD, 
PSP and MSA often cause a loss of speech, mobility and cognition makes the threat to 
personal identity even higher than for many non-neurological chronic diseases.  For 
PSP/MSA, the rarity of the diseases further affects identity and adds an additional 
component to the complexities of managing care.  When it comes to planning, decisions will 
undoubtedly be affected by an individual’s identity, not just the way they have always felt 
about planning, but also how much loss of self they have undergone and similarly where 
they are in terms of any biographical repair.  Towards the end of life, carers related that 
support hinged on human factors and allowing things that matter to an individual to be 
provided, again showing the importance of identity and how it increases right at the end of 
life.  
7.3 Support 
Support in this project comprised of the help provided by HCPs, family, friends and external 
agencies, such as transport providers.  ‘Support’ was also split into time frames: before 
death was imminent, at time of death and after death (for carers).  It overlapped with the 
other two themes as good support improved preparation (and vice versa) and excellent 
support was felt to be akin to care which bolstered identity.       
Both results chapters discussed the importance of co-ordinated care and indicated the high 
care needs that people with PD/PSP/MSA have as the conditions progress.  Within the 
interviews carers clearly voiced the difficulties they had with providing 24-hour care, seven 
days a week, for months/years prior to death being imminent.  One of the main issues 
described was a lack of timely access to services, including the automaticity of referrals to 
SPC.  A lack of support can lead to an individual feeling more like a burden and, as discussed 




 Access to medical and social services 
A lack of co-ordinated care has been described multiple times for those with PD (5, 9, 148); 
it is also the focus of the majority of reports aiming to improve palliative care provision (82, 
180, 188, 189).  The lack of knowledge about rare diseases makes co-ordinated care even 
more pertinent and the rare disease strategy set out guidance for improving the provision of 
services for rare diseases by 2020 with one of its main aims being an improvement in co-
ordination of care (190).  Unfortunately, a recent report showed that people with rare 
diseases still felt co-ordination was a problem, with 35% feeling care was less coordinated in 
2015 than in 2010 (187).   In addition, although centralised specialist clinics were meant to 
liaise and educate local services to improve knowledge, and continuity, this only happened 
in 30% of cases (187).  This reflected the findings from the interviews in this project; co-
ordinated care was a rarity and when specialist nurses were able to help co-ordinate they 
were lauded.  People with rare diseases are meant to have a co-ordinator to drive care and 
yet only 12% of people surveyed in the rare disease report did; most often this was a 
specialist nurse (191).  Parkinson’s UK’s most recent audit, in 2017, showed that 96% have 
access to a PD nurse (improved from previous audits) and that most services were 
improving access to people specifically trained in PD (192).  Ideally Parkinson’s UK would 
prefer clinics run on an MDT basis, so that physiotherapy, occupational therapy, doctors, 
nurses and other allied health professionals were all available in a one stop shop and 
availability of this type of clinic had increased in the latest audit, but not everywhere.  In this 
project, some carers lived in an area where a neurological navigator was present and they 
reported a better access to services; Calvert (193) showed the same was true for people 
with PSP/MSA in their research.  Care coordinators/navigators have been put forward as a 
way to improve coordination across services in the government’s commitment to end of life 
care (189), with the national council of palliative care set to look into implementation.   
In terms of social services support and help finding paid carers, CHC funding was reported to 
be a big problem in this project (see Chapter 5.2.3).  This has been reported across other 
disease groups and widespread geographical variation has been shown (194).  As of October 
2018 new rules came into force regarding CHC provision that aimed to lessen the postcode 




assessment(195, 196).  The new assessment is based on need, rather than diagnosis, to 
provide a more equitable service and part of the assessment is to take place with the main 
HCP, which may lessen the effect that a lack of knowledge can bring (195).  
 Access to SPC and the hospice 
During the interviews, carers pointed out that they had noticed that access to SPC services 
and support did not occur with the automaticity they perceived for people with cancer.  
Similarly, Hasson et al commented on the lack of automatic referrals to hospices and a 
difficulty in accessing them for those with PD (5).  This is a common finding in the literature 
for non-cancer conditions (180, 197-200).  Indeed, the NCPC report in 2015-16 pointed out 
that whilst only 31% of people who died had cancer, they made up 60% of hospice care, 
with older people being represented less often; people with neurological disease (not 
including MND or dementia) made up 10% and accounted for 4% of deaths (199).  Non-
cancer provision has risen but inequity is still there(199).  A 2018 retrospective cohort study 
across UK hospices also showed that older people, and those with non-cancer conditions, 
were likely to be referred later to palliative care(200), reflecting the feeling carers had in 
regard to services coming too late (see Chapter 5.2.5).  However, part of the question 
should be what are hospices and SPC providing people.  Although the symptom burden of 
many diseases, in terms of number of symptoms, equals that of cancer, many of the 
symptoms in movement disorders relate to issues that SPC cannot necessarily help with, 
such as reduced mobility and fatigue.  There is no denying that people with severe pain that 
has not been eased by their usual doctors should be seen by SPC but a lot of the things that 
carers loved about the hospice, such as the way that they helped co-ordinate care and 
provided respite periods could be provided by existing medical/social services.  Field and 
Addington hall (201) discussed whether it was right to roll out SPC to all and argued that 
although people needed better holistic care this should not have to be provided by SPC. 
They also argued that most SPC physicians were skilled in cancer, but not other diseases 
(201), although the balance of this has probably been redressed now as more SPC physicians 




Arguably this study indicates the hospice is not necessarily needed for practical support, 
aside from the coordinating role it performs, but may be needed to a greater extent for 
emotional support.  Given the existential crisis that people with these diseases undergo in 
terms of identity, especially PSP/MSA due to the speed of decline and rarity compared to 
PD, they may need earlier access to the hospice for help managing this.  Studies have 
suggested short term SPC access for people with neurological conditions (74), which 
certainly may work for PD, whereas this thesis indicates the rarer diseases may need 
sustained access, partly because the diseases progress faster, but also because the hospice 
can already provide a continuity that other services lack.   
 Support at the end of life  
At the very end of life, when death was imminent, support related to the control of physical 
symptoms and practical concerns, such as eating and drinking, as well as human factors that 
were more closely related to an individual’s identity.   
Several surveys, reviews and qualitative studies have been conducted worldwide to 
ascertain issues that are felt to be important at the end of life for people with terminal 
diseases (life expectancy though to be less than 6 months).  For those dying, and their 
relatives, control of physical symptoms ranks highly (202-204) as does the need to have 
confidence in physicians (202, 204).  Care that is respectful/compassionate (204) is felt to be 
important, as is honest/effective communication from doctors (202, 203).  A recent review 
regarding hospital deaths highlighted that those that are dying also feel the environment 
they are in is important, in terms of larger de-medicalised rooms (205), yet interestingly in 
almost all of the surveys actual place of death is ranked as one of the least important 
concerns.   
 Physical symptoms/support 
Dying in pain is one of the things that people with palliative conditions fear most (77) and it 
is one of the aspects that people dying from chronic diseases and current/bereaved family 
members feel is most important to control (202-205).  Most people did not have pain or 




(Chapter 6.2.2); this meant they were not raised as an issue of predominant focus in the 
interviews.  However, when pain was present and intractable, as in the narrative from 
Aileen regarding her husband John, it became the focus of care and was hugely important. 
Fortunately, most people with PD/PSP/MSA do not suffer from uncontrollable pain; in the 
VOICES survey (2014/15) only 2.8% of carers disagreed that their relative had sufficient pain 
relief in the last 2 days, with 20% stating pain relief was not needed at all.  This contrasts 
with Goy et al’s (12) study where 27% of carers felt those with PDRD received no pain relief, 
despite moderate/severe pain being present.  It is not clear why there is such a difference 
except that their study asked about the last month of life and the VOICES data implies that 
pain relief improves across all locations in the final 2 days.  
The importance of eating and drinking seemed to be related to the amount of 
communication from HCPs.  Where communication was good and reasons for preventing 
eating/drinking were explained, as in hospices, carers did not feel it was an important issue 
(see Chapter 6.2.3).  Many carers felt they had to be present to advocate in hospital 
situations for pain relief, and food/drink, and this was also reported by Teno et al (206) in 
their study with bereaved relatives.  In their study carers only felt relief from the burden of 
advocacy once hospice/SPC was involved(206).  
 Emotional/spiritual support 
Although a review by Virdun et al (205) mentioned that it was important HCPs took a 
personal interest in a dying person and treated them with dignity, several of the studies 
informing the review had ‘being seen as an individual’ ranked lower than many other 
attributes (202, 204).  This finding contrasts with this thesis as HCPs recognising the person 
as an individual was hugely important.  This difference may be because people with reduced 
communication were excluded from the surveys that informed the review and these are the 
people most at risk from being ignored, and whose relatives are most concerned about 
efforts being made to see them as a person.  Dignity in this study related to maintenance of 
identity and having worth recognised by HCPs and this is in keeping with the Royal College 
of Nursing’s definition of dignity (207).  In the VOICES surveys, although there was no 




PD/PSP/MSA to those dying from cancer, this was not the true for dignity and respect.  
Although the ranking of services was the same, the percentages of people always treated 
with respect were higher for people with cancer across all services, apart from GPs.  The 
difference may well reflect the fact that a higher proportion of people with cancer will 
retain communication and cognition; only 7% of people dying from cancer were felt unable 
to make decisions in the last 3 months compared with 23% MSA, 52% PSP and 30% PD.  The 
fact that respect and dignity is significantly lower in care homes highlights an area to focus 
improvements.  The VOICES survey does not show the length of time a person was in a care 
home before they died, and this would be an interesting area of exploration as carers in the 
interviews suggested care was better when staff knew the person and their family well.  
There is some work suggesting that transfer to a care home, especially if from a hospice 
setting is met with dissatisfaction (208).  A couple of carers had experienced this transition, 
one found it fine, the other felt care decreased mainly because it was a specialist 
neurological home and she felt there was not enough focus on the individual, something 
which had not occurred in the hospice. 
That trust/confidence in physicians ranks highly, is important regarding the rarer conditions 
as it was clear less trust/confidence was present if staff did not know about PSP/MSA and 
more confidence was present if they did.  Compassion was also related to knowledge of the 
diseases.   
 Summary: support 
Regardless of place, the main determinants of positive care in this study were time, 
continuity and communication.  The environments that provided these factors were felt to 
be more supportive.   
7.4 Preparation 
Preparation in this study related to knowledge about prognosis, ACP and awareness that 
death was approaching for those dying and their carers.  The preparation that could be 
undertaken was related to whether a person had the information to prepare practically and 




Preparation, both practical and emotional is linked to the awareness and acceptance of 
dying.  There is debate in the sociological literature about the extent to which a denial of 
dying is present in society (91) but many policy documents in the UK decree that denial of 
dying is a national issue which is affecting planning for good end of life care provision (77, 
82, 83).  Part of this denial, it is postulated, comes from the removal of dying from 
communities into institutions, meaning that most people have not readily experienced 
dying.   
Historically, along with medicalisation removing people from communities and into 
hospitals, there was also a switch in power with regard to who controlled an individual’s 
death(91).  Research in the USA, in the 60s, illustrated that patients had little say in what 
was happening to them, especially with regard to awareness of dying (95, 209).  Glaser and 
Strauss’ study in 1966 led to the development of awareness contexts, with the states of 
awareness being 
• Closed awareness: doctors (and often relatives) know an individual is dying but the 
dying individual is not told and remains unaware 
• Suspicion aware: the dying individual suspects something is wrong and tries to get 
the healthcare staff to tell them  
• Mutual pretense: the dying individual is pretty sure they are dying, the 
doctors/relatives feel the same, but no-one openly talks about it and the dying 
individual is not told that they are dying 
• Open awareness: the dying individual is told that they are dying  
 
Glaser and Strauss suggested that HCPs were deliberately preventing awareness in dying 
individuals because acknowledgement of dying opened up additional emotions and made 
providing care more difficult (95).  Their study, alongside other pieces of work such as 
Elizabeth Kubler Ross’s ‘on death and dying’ (94), led to calls for more open awareness and 
there followed an assumption that open awareness was preferable for patients, as well as 
HCPs, at least in the UK/USA (110).  There has been criticism of Glaser and Strauss’ model 
because it paid little attention to the part that the emotions of a dying person play in their 
awareness (210, 211) and arguably, as open awareness increased, the way that an individual 
dealt with the knowledge that they were dying required more exploration.  Timmermans 
added to Glaser and Strauss’ construct by pointing out that once a person had been told 




awareness constructs to focus on the dying individual themselves, so that open awareness 
split into three parts: suspended, uncertain, and active.  Suspended open awareness 
referred to those who block out the bad news they have received, uncertain open 
awareness referred to a maintenance of hope (that relied on the uncertainty of prognosis) 
and active open awareness referred to people fully accepting and able to discuss aspects of 
future care.  Most of the people with PSP/MSA were in some form of open awareness in this 
study, but it was clear their ability to think about it in depth affected how open.  
Timmermans (211) pointed out the role that HCPs have to play in awareness but arguably, 
with the advent of support groups and online information, the ability to be better informed 
exists and so closed awareness should be more unlikely still.   
The next section outlines issues akin to awareness of dying: the sharing of prognosis and 
information regarding dying once the conditions worsened.  
 Prognosis/planning/awareness of dying 
The ‘information tension’(212) that has been noted previously for people with PD was 
evident in the stories carers recounted in this project.  There are several reasons that have 
been recounted in the literature that could account for this; a lack of acknowledgement that 
people die from PD (7, 9), a reluctance to discuss dying on the side of patients and their 
families (4, 9, 10) and the difficulty doctors have emotionally discussing the life limiting 
nature of disease(213).  The latter two reasons are likely to be the same for those with 
PSP/MSA, though prior to this study there was little/no literature regarding the sharing of 
prognosis/ACP in these diseases to support this assertion.   
 Is PD terminal? 
In 2006 Hudson et al discussed that one of the major barriers to people with PD receiving 
palliative care was that it was not considered to be a terminal disease (7).  Most of the 
carers in this study had been told that ‘you do not die from Parkinson’s disease’ and in a 
recent Irish study most people were told that PD was not terminal (9).  One might argue that 
this is akin to closed awareness, but Glaser and Strauss (95) suggested that doctors willingly 




difficult; it may well be that HCPs had not discussed the end of life because they had not 
believed it would be caused by PD.  Awareness is not as reliant on doctors now as it was in 
the 60s, especially with the widespread use of the internet; multiple studies have shown 
that life expectancy is reduced by PD (57, 214, 215) yet the idea that you can die from PD, or 
rather the complications directly related to it, is not readily acknowledged on PD websites 
(216, 217) and this should perhaps be rectified.  This study adds to the evidence that PD can 
lead to death, with data from the VOICES survey suggesting that up to 50% of deaths are 
thought to be directly attributable to PD (chapter 4.1.1).  These figures may well be an 
overestimate regarding the total number of people with PD, as the VOICES data can only 
investigate those people that had PD recorded on their death certificate.  Hobson and 
Meara (57) found 34% of their cohort had PD recorded as an underlying COD and these 
figures are likely lower than the VOICES survey because they include data from an entire PD 
service, including those who did not have PD recorded anywhere on their death certificates 
(47% of their cohort).     
However, does knowing a disease might be life-limiting change anything in terms of quality 
of life?  The CQC in their report addressing inequalities in healthcare felt that people with 
dementia were not having conversations about their future wishes early enough because 
many doctors had not considered their disease to be terminal (180) and they felt this 
negatively impacted on experience.  Hasson et al, in Northern Ireland, found that many of 
the carers they spoke to were unprepared for the end, in some cases because they were 
unaware PD was incurable (5).  There were certainly carers in this study who felt they, and 
their loved ones, would have acted differently in life if they had been aware of the incurable 
nature of the disease.  However, even if prognosis was certain, it does not necessarily mean 
that those with PD/PSP/MSA want to talk about it and for many people the way they can 
cope with a disease is to maintain some degree of hope through denial (111), reflecting the 
uncertain awareness that Timmermans discussed (211).  
 Do people want to confront the future? 
There is a huge variability in the amount of information that people want, especially at 




diagnosed with PD wanted differing amounts of information about the future; some wanted 
to know everything, others wanted to live day to day.  Giles and Mijasaki (4) in Canada 
discussed the idea of ‘wanting but not wanting’ information.  This matches the findings of 
this study and was described by the PSP/MSA carers as well.  This concept is not unique to 
these diseases.  Pollock et al showed the same was true across a range of chronic illness in 
the UK (105) and multiple studies regarding heart failure have shown the same (218-220); 
the desire for knowledge about the future is very individual.    
However, there should be a willingness amongst doctors to discuss the future with 
individuals if they would like that to happen, which does not appear to necessarily be 
present, even when people have entered the advanced stages of the diseases.  
 Are doctors able to tell people about the future? 
As with other studies in PD (5, 221) carers related that clinics predominantly focused on 
medication, even though, in some cases, the medication had failed to work for some time.  
In those with cancer, studies have shown that the very fact that it is possible to try more 
medication allows the possibility of delaying a difficult discussion, even in those who are 
rapidly deteriorating (213, 222).  To some extent the same is true in PD, drugs can always be 
altered to try and improve symptoms and so the availability of trying one more thing may 
delay, or prevent, doctors having confronting conversations.  Some carers in this study 
noted that doctors in movement disorder clinics were reluctant to talk about the end of life 
and the 2017 Parkinson’s UK audit showed that although 21% of those with PD had signs of 
advanced disease only 37% of them had end of life discussions recorded (192).   
However, even though prognosis was disclosed to those with PSP/MSA and medication is far 
less effective, there still appeared to be a reluctance on behalf of HCPs, certainly in 
movement disorder clinics, to give further information about how the disease might 
progress.  This is again not unique to PD/PSP/MSA; it seems doctors are often reluctant to 




 Future care discussions 
In order to plan for the future, there has to be some degree of open awareness and 
Timmerman’s additional contexts reflect the ways that people manage their diagnosis and 
prognosis (211).  People in active open awareness are more likely to make plans, as they are 
actively thinking about what dying means.  It may be incumbent on doctors to help those in 
other awareness contexts by drawing attention to signs of deterioration and allowing a 
person to plan for themselves.  Or to find a way to allow plans to be made despite a lack of 
active open awareness.  Although people who are dying often use denial as a way of 
managing to cope, they also fluctuate between denial and a desire to know more (111).  So 
there may be opportunities for discussion that are missed if not actively sought.  
There is some argument, both in the UK and abroad, that we should all be more open about 
the future and the inevitability of death, as it is denial about death that prevents us, in part, 
from having the end we desire.  UK policy now reflects this, with suggestion that we should 
all talk about death more with our families, and HCPs, and have the chance to record our 
wishes in writing.  Theoretically this is a sound idea, especially if done in the way it was 
intended, so that people can truly have their voices heard and their considerations for total 
care (biological, psychological, social and spiritual) followed.  However, the danger is that if 
ACP is done en masse, without properly trained staff, it will become a repeat of the 
Liverpool Care Pathway; when done well it will be good for patients, families and the 
patient-HCP relationship, when done badly it could break down relationships, encourage 
nihilism and lead to more harm than good.  Chapter 6.1.1 suggested some negative 
experiences had occurred, especially when DNAR was considered prior to the time death 
was imminent and was discussed quickly by staff that did not know the individual.  
In addition, there is a policy/research disconnect to some extent.  Policy suggests ACP 
should be done, research explains the barriers against undertaking planning for all (105).  
The main issues in the literature, and this study, relate to the timing of ACP, the content of 




 Timing  
Pollock and Wilson (105) in their study regarding communication between HCPs and 
patients showed that current policy regarding ACP had not translated into practice due to a 
multitude of barriers.  In addition to difficulty in prognosticating, and the variability of 
patients’ desire for open awareness, another barrier related to the fact that individuals were 
unsure if their views, or indeed their future options, would change if they planned too early 
(105).  Other studies have shown a reluctance to plan too early because views may change 
(223), and some have shown that views can fluctuate over time (173, 224).  So, for many 
people, waiting until the end of life is closer may make sense; especially considering the 
adaptation to having a chronic/terminal illness that might occur (see section 7.2.3).  
However, delaying may just reflect Timmerman’s suspended open awareness context and 
this thesis shows that when decisions are delayed, they often become reactive rather than 
proactive, or may not happen at all; something which echoes Pollock and Wilson’s findings 
(105).   
Pollock and Wilson (105) also pointed out that guidelines for ACP (which suggest discussion 
should occur when a person is likely to die in the next twelve months) incorrectly assume 
prognostication is accurate, most likely because they are based on cancer care.  This finding 
was echoed in the 2016 CQC report on inequalities in healthcare, which showed that the 
difficulties in identifying the last 12 months mean conversations don’t always happen early 
enough, especially for those with dementia (180)26.  The CQC suggested a shift from the last 
year of life to talking about preferences at an earlier stage, though prognosis may not be 
clear.  In 2018 NHS England, in collaboration with the Alzheimer’s society, suggested that all 
patients with dementia should be able to discuss ACP early in their disease process (225); as 
ACP is fundamental for those with dementia in order that they keep their autonomy. 
Interestingly however, when de Boer et al (226) in the Netherlands asked people with early 
dementia what they thought about planning for the future most preferred to live day to day 
 
26 This report is of relevance to people with movement disorders as 40% of people with PD 
will develop dementia. Cognitive impairment is a recognised feature of PSP and is 




and didn’t want to discuss it.  This is not an uncommon finding within research about ACP 
initiation, in dementia (227) and other diseases (105, 128, 219).  Yet in de Boer et al’s study 
despite initial reticence to discuss the future, individuals with dementia became more 
interested in the idea of ACP as interviews progressed (226).  The authors concluded that 
dynamic discussions with relatives over time may be better than fixed plans, such as ADRTs, 
which would be defunct if views changed (226).  
The findings in chapter 5.1 show that this dichotomy is just as present for those with 
PD/PSP/MSA; there is a balance between not wanting to plan too early and risking the 
ability to make their wishes known if they wait.  There are limited studies regarding ACP in 
PD/PSP/MSA.  Tuck et al (8) in Oregon showed people with PD preferred to discuss plans 
regarding the end of life only when they worsened and Fox et al (9)  in Ireland found that as 
medication worked less well people were more receptive to the idea of ACP, suggesting that 
waiting until the complex stage may be preferable.  If this were taken as a suggestion, then 
the implication would be to discuss the future for those with PSP/MSA from the start but 
this did not appear to have happened with the people in this study.  The only study 
regarding ACP in MSA, a retrospective notes review of an American neurological clinic, 
concluded that planning was done too late; most of the people with MSA were too unwell 
to discuss goals of care, or already on ICU when discussions happened (13).   
 The content of ACP 
ACP covers a large range of future decisions.  If we take ACP to relate to recorded plans, as 
policy seems to suggest, then the range of options in the UK are to do with those that refuse 
certain medical interventions, such as ADRTS and those that allow decisions to be made by 
family members should a person lose the capacity to make them themselves (LPAs).  These 
are the decisions that have an element of legal weight to them in England and Wales 
(Scottish law differs).  Other forms of ACP such as advanced statements have been used in 
SPC for a long time to allow a person, who is usually in the last months of life, to express 
their preferences for care that they would/would not like.  Advanced statements are an 
indication of preferences rather than a legally binding document.  This study showed that 




were related more closely to practical life planning, for example wills, rather than decisions 
that were healthcare related.  Churm showed the same in her work on ACP in PD in the 
north east of England (228).  Churm suggested we should focus less on the healthcare 
element because of this; however, it may well be that the reason the plans were not 
healthcare related was that no-one from a healthcare setting had raised ACP, as suggested 
by carers in this study.   
In this study, those with PSP/MSA were more likely to have discussed plans that related to 
their healthcare needs, such as PEG insertion, but few of them had recorded their wishes, 
with the exception of DNAR orders.  In the Canadian notes review in MSA, 8/22 had a DNAR 
(four put in place by a proxy), 6/22 had a discussion about PEG and 5 had refused to have 
one inserted (13).  There was no mention that a preferred place of care had been discussed, 
though it was suggested in the framework the authors developed for palliative care 
discussions in MSA (13).  
It is worth noting that although policy in the UK suggests that everyone should plan, to 
maintain their autonomy, UK law limits the plans that can be made.  For example, in current 
UK law doctors have the final say regarding the futility of resuscitation, the provision of 
intensive care beds and assisted dying is illegal.  Therefore, the most fundamental decisions 
that a person could make in terms of life prolongation, or shortening life, are not available.  
Preferred place of death (PPOD) 
As discussed in the introduction PPOD is frequently cited as being an important component 
of ACP (82, 96, 189).  In this study only 30% of the VOICES sample had mentioned a PPOD.  A 
larger proportion of the qualitative sample had discussed PPOD but it did not appear to be 
the issue of most importance.  This is not necessarily a surprising finding, when Steinhauser 
surveyed patients with chronic illness, bereaved carers and HCPs about what they 
considered were important issues at the end of life, only 35% of patients felt dying at home 
was important, in fact it scored lower than any other component in the survey (204).  In the 
UK Pollock et al (105) found that 9 of the 21 people they interviewed had recorded home as 
their PPOD but it was not a fixed view and patients were more concerned about reducing 




interesting because not achieving a PPOD was one of the things that carers felt the most 
guilt about; even when it had not been discussed carers felt terrible that they had not 
enabled their relative to die at home.  Perhaps we should be mindful that carers can feel 
this way and bring place of death into a pragmatic discussion so that people with life limiting 
illness can say whether it matters to them or not.  If it doesn’t matter carers can be 
reassured; if it does matter then we can plan how to help people achieve their aim to die at 
home, with adequate support in place.  In addition, policy makers should be mindful of this 
potential guilt before they decree that home is best; home is best for some people, but not 
all (22, 90).  One of the main studies used to suggest home is best was based on a survey of 
the general population who, for the most part, did not have health problems (100).  This 
survey (100) also suggested that as people age they are less likely to desire a home death 
and Gott et al showed the same, especially if a chronic disease was present (229); people 
felt safer knowing help was close.  The idea that home is best has been described as a 
somewhat false sociological ideology, because actually many of the people who previously 
died at home, before medicalization occurred, may well have been in severe pain or distress 
(92).  PPOD is still pushed forward in UK policy.  This may be because there is a cost saving 
to be had by preventing hospital admissions (22, 230-232) and also because POD is perhaps 
an easier target to measure and improve on than other aspects of end of life care.    
Do Not Attempt Cardiopulmonary Resuscitation (DNACPR or DNAR)  
Some of the carers in this study related that they had not made formal plans or agreed to 
DNARs in the community, because they felt it might be detrimental to future care provision. 
This is not a concern unique to these conditions, 29% of adults who had been asked about 
ACP in Norfolk felt that if they wrote their plans down doctors would stop treatment too 
soon (233).  These concerns are not unfounded.  Fritz et al when discussing alternatives to 
DNACPR cite several studies that have shown care can be compromised, in terms of the 
efforts shown to sustain life, when DNARs are in place (234).  Due to the assumptions that 
carers encountered within hospitals with regard to quality of life, where they perceived that 
HCPs were blind to their loved one’s personhood, it is even more understandable that they 
would not suggest a decision that might lead to potential withholding of care.  DNARs are 




Cambridgeshire’ (235) and ‘Winspear versus CHS Sunderland’ (236) that if a DNAR is put in 
place the person it relates to is informed (or their family in cases of absent capacity).  
Currently a doctor has the right to refuse to resuscitate if they feel it would be 
physiologically futile but if there is disagreement between an HCP and a patient (or their 
family) then decisions are often revoked to prevent breakdown of doctor-patient or doctor-
carer relationships. 
 Models of ACP 
Due to concerns that levels of care may reduce where a DNAR is in place and because plans 
for the future change over time, there has been some movement away from fixed refusals 
of treatment to more of an over-riding view of preferences (78, 237).  This would work well 
for diseases like PD/PSP/MSA where the trajectories are variable and the diseases are 
heterogeneous.  Churm found that most people with PD in the service she worked in had no 
idea what ACP was about, or what options were available(228).  This is clearly of practical 
importance; if people do not know what choices they have, they won’t know where to start 
even if they have a desire to plan.  There is a such a variety of tools available that even HCPs 
are uncertain what can be offered.  There are many models across the country, such as the 
ReSPECT document advocated by Fritz and ‘Deciding Right’ in the North East.  The 
department for health and social care in their document ‘our commitment to you for the 
end of life’ are piloting “serious illness conversations”27 with a view to rolling it out across 
the UK if it proves successful (189).  It may make more sense for there to be a countywide 
consensus, at least so that charities could signpost better and less confusion over acronyms 
existed.  Whichever document is used, the principle is to gain a better understanding of a 
person’s goals, with some discussion regarding quantity versus quality of life, whilst 
maintaining the understanding that goals can change.  What is not always made clear is that 
these documents should be reviewed regularly to be useful. 
 
27 a system for discussing future wishes with patients that was developed by Atul Gawande 




However, one of the dangers with placing emphasis on discussion and recording of 
preferences rather than legal refusal is what doctors may feel they are legally required to 
do.  Kate (PSP) explained that even though both she and her father were practically begging 
the doctors not to place a PEG tube, the doctors overruled them because no documentation 
was present (see quote in Chapter 5.1.6).  Policy is now suggesting relatives have a greater 
say in healthcare decisions where a person cannot speak for themselves, yet the over-riding 
control is with the doctors in the UK; which is not the case in the USA.  One wonders that 
with negligence now being a prosecutable offence that the very thing that ACP was set up to 
avoid, prolonging life without gaining quality, might become more of an issue.  Even when 
legally binding ADRTs exist, there have been reports that treatment was instigated anyway 
(107) and this may become more of an issue in an increasingly litigious society, where the 
balance of law stands in providing life sustaining treatment if a lack of clarity exists.   
One way to ensure that carers have more say and cannot be overruled by doctors is to have 
a LPA set up.  Against this there has been much criticism that views are not always shared 
and that carers decisions do not align well with those of the dying person (81, 238-240).  The 
crucial point of a LPA is that it only really works, and helps carers, if previous conversations 
have been had in regard to what it is that a person might want  The carers in this study who 
had had open conversations felt better knowing what their loved one wanted, whereas the 
carers who had been unable to discuss plans (for whatever reason) often felt guilty with 
hindsight that care went on too long and was perhaps more invasive than they, and 
certainly their loved one, would have wished.  Studies have shown one element of a dying 
person feeling like a burden is that they worry about their loved one having to be 
responsible for future decisions (241) and so encouraging dialogue between those dying and 
their relatives may reduce their sense of burden and in some way increase their sense of 
self.  In addition, a review of power of attorney decisions found that being responsible for 
formally making decisions for a relative caused significant distress and guilt for about a third 
of carers, yet a clear knowledge of preferences, through discussions or recorded wishes, 




 Who should take part in ACP with a dying person? 
In response to the societal denial of dying there have been an increasing number of 
publications that explain the differing options that people have regarding planning for the 
future.  One of the problems however is whether people are signposted towards these or 
not.  The MND association have an award-winning booklet that explains the differing 
options and outlines future considerations for people with MND (243); there is nothing 
similar available for PD/PSP/MSA. 
Although policy states everyone should be involved in ACP it is likely to be more beneficial 
when it is undertaken in collaboration with an HCP who knows about the disease, as they 
can suggest potential healthcare issues that might need to be planned for.  A potential 
problem with policy suggesting everyone undertakes ACP is that it will become rushed and 
won’t actually allow a person to consider what they would want.  One of the selling points 
of the serious illness conversations, suggested in the department of health and social care 
policy (189), is that the conversation can be done and recorded in 22 minutes.  Pushing 
everyone to undertake planning does not take into account the views of the person the 
planning is for.  As discussed above some people do not actually want to plan, and Pollock et 
al suggest that ACP would work better as structured interventions to specific groups, by 
specific people, rather than something for everyone.  In addition, policy predominantly 
refers to planning for healthcare events and PPOD, whereas some of the best plans that 
carers in the study related were from care homes.  In part the purpose of the planning 
should indicate the best team to carry it out.  Useful ACP takes time and decisions should be 
considered as dynamic, which is why they are done so well in hospice day care settings, 
because continuity is assured and time can be taken.  From the interviews in this study it did 
not appear that movement disorder services were undertaking ACP and the Parkinson’s UK 
audit seemed to support this; although it showed that an increasing number of people with 
palliative stage PD had appointed an LPA, the end of life discussions did not appear to have 




 Awareness of imminent death  
For patients 
At the very end of life preparation equates to awareness that death is imminent.  As Chapter 
6.3.1 showed most people did not know they were dying with any certainty.  Only 20% were 
felt to be certain and an even smaller proportion had been told that they were dying.  This is 
a smaller proportion than Goy et al (12) felt were aware in their USA study (36%) but 
comparable with a UK study in the 90s in which 20.8% of those dying from non-cancer 
causes were felt to be certainly aware (110).  In that study Seale et al (110) showed that 
those dying from cancer were more likely to be aware (50.8% vs 20.8%) which was a finding 
that was replicated in this thesis.  Seale also showed that mental confusion made awareness 
less likely (110); though there was no comment in regard to whether the ability to 
communicate affected awareness.   
Over time there has been a move away from the suggestion that every dying person should 
be made aware that their death is imminent.  Field and Copp (244) suggested that HCPs 
should develop a conditional disclosure, in the first instance ascertaining what the person 
actually wants to know, and this view is incorporated into the most commonly used tools for 
‘breaking bad news’.  However, as with Seale’s study (110), those with PD/PSP/MSA who 
died at home were more likely to be aware than those dying in other locations and so if 
dying at home is important to a person then open disclosure about dying should occur.  That 
being said, Seale, when discussing awareness contexts, explains that there will be some 
people for whom awareness is not possible, as neither HCPs nor the dying person are aware 
that death is imminent (110).   
Sullivan et al (245) conducted interviews with physicians who had looked after patients that 
had recently died in two USA hospitals and found that 11% of them anticipated the patient 
would die weeks before death occurred, 57% days before and 18% hours before.  Most 
(76.8%) had not discussed the imminence of death with the patient.  Part of the reason that 
the disclosure of death to patients themselves was low was that by the time dying was 
diagnosed the patient was unconscious or delirious in two thirds of the cases (245). 




older patients less likely to have been told that they were dying(245). This has implications 
for people with PD/PSP/MSA as they are conditions that are associated with ageing.  
For carers 
Although patients had rarely been told that they were likely to die in Sullivan et al’s study,  
88.6% of families had been informed (245).  Whilst it may not always be possible to explain 
to a person that they are dying, explaining to their family, so that they can prepare has been 
shown to be beneficial, especially in regard to bereavement outcomes (246, 247).  Although 
carer awareness of death being imminent is not measured in the VOICES survey, the 
qualitative forums/interviews suggested a greater proportion of carers had been told than 
those dying.  Unfortunately, several carers explained that the way the news was 
communicated did not help them to prepare themselves because it was too ambiguous and 
several studies have related the need for clear, but sensitive, communication (248, 249).  
Cherlin et al discuss that the amount of information carers desire and can process regarding 
end of life issues varies (250).  Certainly in this study some carers related that they had to 
account for their own emotional denial to understand that the end was near and others 
stated that they were so exhausted from caring they were not fully aware of what was 
happening.  Breen et al (248) discussed that it was often exhaustion from caring that 
hampered emotional preparedness in carers and they explained that forewarning carers 
that death was close did not mean they were prepared.  Carers in the interview sample 
suggested that the emotional side of preparation was more difficult to predict and control 
than the practical side.  Hebert et al (249) specifically explored preparation for death in 
carers and found that previous life experiences, uncertainty and communication all 
impacted on preparedness.  They discussed that preparedness was made up of cognitive 
(information need), affective (emotional readiness) and behavioural (tasks such as funeral 
planning) elements and found that clear communication from healthcare teams was the 
best predictor of preparation (249).  As described in chapter 6.4 of this thesis, Hebert et al 
found that there was a tendency for HCPs to assume preparedness in long term carers 




There are several reasons for ensuring carers are prepared for their relative’s deaths: they 
can advocate for their loved one’s wishes to be met, including PPOD if important and they 
are more likely to be present at time of death.  In addition, being prepared has been shown 
to reduce anxiety after death and lessens the need for bereavement support (246, 249). 
7.5 Summary: Preparation 
This section has related the theme of preparation to the literature.  Although ACP is 
advocated for all by policy makers there are many practical and emotional reasons that 
prevent an uptake in planning.  In addition, even if plans have been made, without 
awareness that death is imminent they will not necessarily be able to be enacted.  
Awareness of dying close to the end of life is difficult for the dying person, as often the 
diagnosis of dying becomes apparent when conscious levels reduce.  The additional 
reduction in communication and cognition that many people with PD/PSP/MSA experience 
further complicates planning and awareness.  Empathetic communication helps carers 
prepare.  Helping informal carers to prepare for the end enables any plans that are in 
existence to be considered, and achieved, as well as improving outcomes for bereaved 
carers.   
7.6 Overall Summary 
This chapter has related the central themes of this thesis to the sociological literature and 
situated the results within current UK health policy.  It highlights the factors that are 
important for quality care to be delivered, regardless of location, explaining that 
preparation, support and maintenance of identity all play a role (see Figure 45 at the start of 
this chapter).  The emotional and practical issues are intertwined and without both being 
accounted for, care for a person at the end of their life falls flat.  The practical side is 
perhaps achieved more often (and is easier to measure) but it is the emotional side, which 
hinges on understanding who the dying person is as an individual, that needs to be achieved 
to ensure excellent care.  This is true of all end of life care, regardless of the disease process, 
but because these diseases cause slowing down, quiet/absent speech and mobility/visual 




be needed to ensure the individual person and their wishes are truly considered.  In an NHS 
under time pressure and in locations where little continuity can be offered, such as with 





Chapter 8 Discussion 
This first part of this chapter will briefly compare the findings of this thesis to the existing 
literature concerned with palliative care and the end of life in PD, PSP and MSA.  The next 
section will discuss recommendations for clinical practice in line with current UK policy 
guidance.  The final section will discuss the strengths and limitations of the project and 
suggestions for future research.  
8.1 Comparison to existing literature regarding the palliative and end of life experience of 
people with PD, PSP, MSA and their carers 
 Information and ACP 
In PD 
The existing literature showed a lack of clear information being presented through 
Parkinson’s services.  Saleem et al’s (11) study showed that 62% of people with PD/PSP/MSA 
felt they had full access to information, with 38% feeling they would have liked more.  The 
2017 Parkinson’s UK audit (192) showed that only 61% of people with PD felt they had 
enough information presented at the point of diagnosis.  Neither of them explored the 
content of the desired information but other studies in Canada (10), Australia (7), Ireland (9) 
and Northern Ireland (5) have suggested that, in the main, the missing information pertains 
to a discussion regarding prognosis.  This study indicates that the same is true in the NHS in 
England.  This study mirrored others in regard to variability in the amount of information 
people with PD, and their carers, actually want to know about the future (4, 9, 10) and the 
varying degrees that people want to engage with ACP (8).  Tuck et al, in the USA, and Fox et 
al, in Ireland, suggested that a greater proportion of people with PD preferred to delay 
future planning until their disease worsened (8, 9).  Likewise, carers in this study had not felt 
discussing the end of life was necessarily needed in the earlier stages.  Parkinson’s UK 
showed that an increasing number of people in the palliative stage of PD had discussed/set 
up an LPA, but they also showed that only 37% of people in the advanced stages of PD had 
an end of life discussion recorded.  Other studies have shown that movement disorder 




(5, 10).  Carers in this study noted the focus on medication and suggested a perceived 
reluctance for doctors to discuss the future or explain that the disease had reached a 
palliative stage; something that Higginson et al had discussed in regard to their London 
cohort (6).   
In PSP/MSA 
Calvert et al (193) showed that 47% of those with MSA and 65.4% of those with PSP were 
offered information about their condition on diagnosis.  Dayal et al found ACP was often 
undertaken too late for people with MSA (13).   
What this study adds 
There are no qualitative studies in PSP/MSA that discuss the issues above.  This is the first to 
have done so; most carers in this study related that they had to search online or get in 
contact with the disease charities to get the information they desired.  The same issues of 
variability regarding the amount of desired information were present as with the PD 
literature.  It appeared that those with PSP/MSA and their carers did more planning for the 
future than those with PD and that their plans were more closely related to healthcare 
needs, such as PEG and DNAR.  It seemed that hospice staff, local GPs (for DNAR) and 
speech and language teams (for PEG) did more planning than the movement disorder 
services.  Exploring the types of future plans that people with these diseases have in the UK 
in a quantitative manner and exploring their acceptance of ACP is an area of potential future 
study.   
 Access to health and social care 
In PD 
The difficulties with accessing co-ordinated health and social care that were raised in this 
study have been shown previously in qualitative studies in other healthcare settings (4, 5, 7, 
10).  Saleem et al (11) showed that 42% of the people they surveyed with late stage 
PD/PSP/MSA had practical needs that were unmet by services.  The need for a 




audit (192) indicates that there has only been a slight improvement in the number of clinics 
that contained a multidisciplinary team.  In the audit, most clinics reported that the people 
they saw had access to a PD nurse (96%), but interestingly in the patient reported 
experience measure only 87.6% felt they had access (192).  This may be related to response 
bias (192) but it could also reflect the regional variation that was mentioned in this study, 
where people travelled across clinical boundaries to get to specialist clinics and nurses that 
were assigned to people left the service.  This study indicated that a few people had noted a 
decrease in input from the PD team when their relative was unable to get to appointments 
readily, something that has also been suggested previously (9).  Studies, including this one, 
have suggested that support needs are most extensive when a person is living at home (7) 
and that people who live on their own have a greater need because relatives provide a lot of 
care and organisation of services (9).   
In PSP/MSA 
Calvert et al (193) in their UK study regarding the quality of life and support needs of people 
with rare neurological diseases found that patients with rare conditions used less health and 
social care services than their needs required, agreeing with Saleem et al’s conclusions (11). 
Interestingly, in Calvert’s study, 52.9% (n=9) of those with MSA and 42.3% (n=11) of those 
with PSP had a co-ordinating health or social care worker and it seemed that they had 
higher access to services than the diseases without a co-ordinator (193).  In this study carers 
indicated the need for someone who could officially co-ordinate care and it did not seem as 
if usefully co-ordinated care was as prevalent as Calvert et al’s (193) study suggests; not 
until people received support from hospice services anyway.  This may be because of recall 
bias in this study, or because the people involved in the projects were based in different 
locations around the UK; some areas have more access than others.  
What this study adds 
This study, due to its qualitative nature, adds an understanding of the way that health and 
social care providers’ knowledge of a rare disease impacts on the quality of the support 





 QOL, symptoms and SPC 
In PD 
Fox et al suggested a need for greater psychological support for people with PD (9).  The 
increased prevalence of depression and anxiety in people with PD, compared to the general 
population, is well known and thought to be directly related to changes in brain chemistry 
(251, 252).  Alongside the increased likelihood of depression through biochemical changes, 
other studies have noted the psychosocial burden in PD that aligns with a loss of identity 
due to changing roles (10), social withdrawal due to symptoms (7, 9, 10) and isolation as 
friends/family visit less frequently (5, 7) which contribute to/are a part of depression and 
anxiety.  Depression in PD has been shown to cause a decrease in cognition, worse motor 
symptoms and an increase in caregiver burden; it is also the main determinant of reduced 
QOL scores (253) and expressions of suicidal intent (157-159).   Given the multifactorial 
nature of depression/anxiety it has been suggested that a combination of antidepressants 
and psychotherapy might be most beneficial in helping to alleviate depression in PD (254) 
and both types of treatment have shown some reduction in levels of depression (255, 256).   
This huge psychosocial burden of PD, along with symptoms of pain (15), fatigue (6, 9)  and 
immobility (6, 15), which are comparable to the symptom burden of cancer (7, 11) and MND 
(12), has led to the suggestion of increased SPC input.  The carers in this study did not 
mention pain as often as the psychosocial aspects, but physical mobility and change in 
cognition were mentioned a lot.  Most PD carers indicated that they had not accessed SPC 
services or had hospice suggested as an option; a few people attended the day centre 
services at local care homes and this provided some respite.  The day to day care needs and 
the level of support available from paid carers was a bigger concern, especially regarding the 
regional variation encountered.  This was perhaps more evident in this study than it may be 
in others because the recruitment was UK wide and even the carers recruited locally came 
from a wide geographical area which included rural locations.  
In PSP/MSA 
There have been several studies that have aimed to measure health related QOL in PSP (17) 




(161, 258).  Overall these studies show that disease severity and depression are inversely 
related to QOL and the discussions explain that QOL is lower in these diseases than for 
people with PD at the same disease duration.  This is predictable given the fact that 
PSP/MSA progress more quickly than PD and so people are likely to be in a more severe 
disease category at a given duration length.  Higginson et al (6) showed the difference in 
QOL scores remained true in late stage disease, though those included with PSP/MSA still 
had higher Hoehn and Yahr scores than the majority of those with PD.  The lower QOL 
scores and the higher levels of depression suggest that people with PSP/MSA may have an 
even greater need for psychological support than people with PD and may also explain why 
the carers of people with PSP/MSA in this study related a greater degree of suicidal/death 
ideation in their loved ones.  
What this study adds 
This study adds to the PD literature on identity and links the experience of people with 
these diseases to the sociological literature regarding biographical disruption and the loss of 
self, demonstrating why they are particularly at risk in regard to threats to their identity.  
This study also suggests that people with rare diseases might experience the rarity of their 
disease as an even greater threat to identity, something which is alluded to the Rare Disease 
UK report relating rarity to mental health (183).  In addition, this study highlights the greater 
need that people with PSP/MSA have for SPC services and the positive difference that being 
involved with SPC and hospice services has for people with these diseases and their carers.  
8.2 The very end of life (the last three months/2 Days), after death and bereavement 
Very few studies have explored the last few months of life in PD with the exception of Goy 
et al’s USA study (12) and Hasson et al’s Northern Ireland study (5); both used the views of 
bereaved carers.  Other than the three people included in Goy and Carter’s study (2 with 
PSP, 1 with MSA), no study has explored the last few months/days of life for those with 




 The last few days of life and POD 
Goy et al showed that at the end of life 42% of people dying from Parkinson’s Disease 
Related Disorders (PDRD) had moderate or severe pain and that 27% of them had no relief 
from their pain (12).  This study also indicated that pain remained a feature for people with 
PD; with 81% having pain in the last 2 days in the VOICES survey.  Though the VOICES survey 
did not indicate severity of pain, it gives an assessment of how well pain was relieved and 
only 4% of carers disagreed/strongly disagreed that their relative had enough pain relief.  
Goy et al also assessed awareness of dying in their survey and showed that 36% of those 
with PDRD were very aware death was imminent and 35% were somewhat aware (12); this 
study asked whether people with PD/PSP/MSA knew they were likely to die and 21% were 
certainly aware and 35% were probably aware, so awareness about the imminence of death 
appears to be slightly less common in the UK, though the surveys are not directly 
comparable.  Goy et al (12) showed that 19% of those with PDRD were not mentally alert at 
any point in their last week of life and a lack of alertness was a commonly reported finding 
in this study.  In terms of POD, in the USA study 40% died in care homes, 13% in hospital and 
25% in their own home (12), so more people died in their own home than in hospital, which 
contrasts with this study.  This may be explained by the people in Goy et al’s study, as 88% 
had an LPA and 90% had an ADRT (12).  It could also be explained by the comprehensive 
hospice at home services available in the USA and the cost of hospital admissions, to an 
individual themselves, in the USA compared to the UK.  Interestingly, despite the prevalence 
of ACP documents, Goy et al’s study indicated that only 42% of those who died from PDRD 
died where they desired (12).  In this study, although only a small proportion of people had 
indicated a PPOD (29%), for those that had, 47% died in the place they desired.  
What this study adds 
This study is the first to consider whether POD and PPOD align for people with PD in the UK. 
No other study has explored the PPOD for people with PD and this study indicated that POD 
does not appear to be high on the priority list for people with PD.  Only 28% of people who 
died from/with PD in the VOICES surveys 2012-15 had indicated a preference (23% home, 




where they died).  Dying at home was pushed in government policy in part because it 
reflected general population surveys but also because Gomes and Higginson indicated that 
by 2030 institutions (i.e hospitals and hospices) would be unable to cope with the growing 
numbers of people predicted to die in them (230).   Nevertheless, there appears to have 
been a shift away from stating that home is best in current UK policy, which is welcome 
given the guilt that carers can feel when they are unable to continue to provide care at 
home (22, 90), something alluded to in this study and mentioned by Fox et al in theirs (9).   
Most studies that look at POD for PD have shown that the majority die in hospital, followed 
by care homes, home and then hospices.  Across the VOICES surveys, when looking at every 
person with PD, whether it was a contributing or underlying COD, 42.7% died in hospital 
(n=1704), 42.7% died in a care home (n=1704), 12.8% died at home (n=509) and 1.8% died 
in a hospice (n=73).  Those dying with PD as a contributing cause were more likely to die in 
hospital and those dying with PD as an underlying cause were more likely to die in a care 
home.   
43% of the people who died with/of PSP (n=49) had indicated a PPOD (31% home, 6% care 
home, 4% hospice, 2% somewhere else).  In terms of POD of the 106 people with PSP as an 
underlying or contributory cause on their death certificate 34% died in hospital (n=36), 38% 
died in a care home (n=40), 24% died at home (n=25) and 5% died in a hospice (n=5). 
38% of the people who died with/of MSA (n=26) had indicated a PPOD (35% home, 4% 
hospice).  In terms of POD 45% (n=28) died hospital, 26% (n=16) died in a care home, 21% 
(n=13) died at home and 8% (n=5) died in a hospice.  
In addition to indicating where people with PD/PSP/MSA might prefer to die and providing 
population wide data on where they died, this study is the first to explore the end of life 
experience according to the place that they actually died.  One of NHS England’s current end 
of life care workstreams is to improve the experience of end of life care across the locations 
of hospital, care homes, home and hospice (23).  This thesis sheds light on matters of 
importance across differing healthcare locations.  The recommendations for practice set out 
in this chapter indicate the ways that all locations could improve the end of life experience 




 Carers after death and bereavement 
Hasson et al’s study showed that many carers of people who died from PD were themselves 
unaware that death was imminent and felt underprepared (5).  They also showed that 
carers struggled to cope after death because, along with missing their loved one, they had 
become isolated themselves through the caring process (5).  In addition, because caring had 
become their new role, they lost some sense of purpose when the caring stopped and the 
support they had been getting through the PD services also disappeared, compounding their 
loneliness (5).   Their findings were echoed in this study; many carers were aware that their 
loved one was deteriorating but felt completely unprepared for the end and for the way 
that they would adapt emotionally after the death.  This study, along with Hasson et al’s (5) 
showed how much people rely on their family and friends to help with their bereavement 
and both indicated a lack of available services.  Hudson et al mentioned one of the carers 
they interviewed stated they continued to go to the support group after their husband died 
because ‘it’s like going home’ (7) and certainly many carers in this study continued to 
frequent support groups once their relative had died, some through routine and friendships, 
and some to retain the sense of purpose they had when caring, by helping others through 
similar situations.  
What this study adds 
Although previous studies have indicated a need for bereavement support, this is the first to 
explore whether bereavement support would be welcomed by the carers of those with 
PD/PSP/MSA (see Chapter 6.4.4) and the first to suggest ways that bereavement support 
might best be offered.  
 In summary 
This study reflects the existing PD literature regarding SPC need and adds strength to the 
call for better information regarding prognosis and future care needs, alongside better 
signposting towards future care planning.  It adds new insight into considerations of PPOD, 




Other than the symptom comparison from Saleem et al (11) and Higginson et al (6) there 
are no published studies that explore the SPC, or end of life needs of people with PSP or 
MSA.  This study has addressed that gap.  Part of the reason that studies for these people 
are sparse may be their disease rarity and in addition to explaining the experience for 
people with PSP/MSA this thesis also sheds light on the experience of navigating the 




8.3 Recommendations for clinical practice 
As the purpose of this mixed methods study was one of pragmatism this part of the 
discussion will outline the varying ways that service delivery could be improved.  In current 
UK policy, guidance for palliative and end of life care is based on the ambitions for palliative 
and end of life care document (77) and so the recommendations for practice will be set out 
according to these ambitions.  There are six ambitions laid out in the document, which are 
shown in Figure 47.  
 




 Ambition 1: Each person is seen as an individual  
To achieve this ambition the document suggests that every person (the dying individual and 
those close to them) is offered the chance to talk about death, dying and bereavement at an 
early enough opportunity to allow them to make plans.  It suggests the barriers affecting the 
discussion of death and dying are broken down and that local teams make people aware of 
what can be reasonably delivered by the service.  It also suggests that every dying person 
has access to needs-based integrated health and social care, with a structured care plan and 
personal budget that is individual to them.  Lastly it points out that good end of life care 
includes bereavement (77).  
Honest conversations: about prognosis  
This study demonstrates that people with PD/PSP/MSA had a variable degree of desire for 
information about prognosis and that there was a gap between their need for information 
and what was provided.  Because of the complexity of the diseases regular care is largely 
removed from primary care services and into specialist movement disorder services; it is 
here that information about prognosis and help with ACP should improve.  There has been 
an improvement in the number of people that are given details of charity support in PD 
(192) and most of the carers of people with PSP/MSA indicated they had been given the 
details of the relevant disease charities, which enabled them to access more information. 
Nevertheless, information regarding future choices can be more personalised if related by 
an HCP who knows about the disease and the way it is affecting the individual in front of 
them (7).  The palliative care section of the 2017 NICE guidance for PD (259) makes it clearer 
that movement disorder teams are expected to proactively offer information about 
progression, as well as support with ACP.  
As the ambitions document suggests discussions about death and dying should be the norm 
it would be sensible for movement disorder clinics to have leaflets available about planning 
ahead.  The Compassion in Dying charity have produced a resource called ‘starting the 
conversation’ (260) which explains the types of conversations people should be having with 
their family, and doctors, about the future and this could be placed in the waiting rooms of 




diseases, it might encourage people to raise questions about the future with movement 
disorder teams.  Parkinson’s UK do have a booklet about the end of life and decisions such 
as wills, LPAs and advanced statements but it is not very disease specific in regard to what 
could happen in term of speech, cognition or swallowing (261).  The charities could develop 
something similar to the MND association’s (243) award winning end of life booklet, which 
details the sorts of problems that may need to be planned for, such as PEG tubes.  This 
would also be a useful resource for movement disorder teams to give to patients and their 
families to aid in any discussion.  As a minimum movement disorder services should have a 
list of resources: written information, charity helplines, internet sites, social media groups, 
local support groups etc that could be given to people in clinic so they have a range of 
options to choose from when seeking more information.  
Within the actual clinic appointment doctors and specialist nurses should ask people 
whether they want to talk about future deterioration or not, rather than assuming they 
would find it harmful to do so.  NICE guidance suggests that there should be a balance of 
honest information and promoting a feeling of optimism when communicating with people 
with PD and their carers (259) and this may make doctors reluctant to discuss future 
deterioration and dying.  However, maintaining optimism whilst planning for a future death 
are not mutually exclusive.  Several carers in this study related that they found it easier to 
discuss the end of life when it was more hypothetical.  Some felt that planning for the future 
strengthened their relationships.  There are tools becoming available for professionals to 
help to guide conversations, such as the serious illness conversations (189), that suggest 
phrases that could be used to start a conversation.  In addition, there are a multitude of 
training courses available regarding palliative care and ACP.  These could be incorporated 
into training and continued professional development, something jointly suggested by the 
European association of palliative care and the European academy of neurology (262).     
As discussed in the previous chapter the variable prognosis of PD, and PSP/MSA to some 
extent, may make it hard to know when to discuss the future.  One option, for PD especially, 
could be to wait until the indicators that identity the end of life phase in neurological 




Indicators of end of life care phase 
in neurological disease 
Swallowing problems 
Recurring infections 
Marked decline in physical status 




Significant complex symptoms 
Table 15 Indicators that a person with a neurological disease may be approaching the end of their life (263, 264) 
Doctors and specialist nurses working in movement disorder services should proactively ask 
people about these symptoms so that they can identity people who may be approaching the 
end of life or use their findings as a trigger for discussion, e.g. swallowing problems and PEG.  
The caveat to this is that waiting until this point in neurological conditions can mean 
communication and cognition are affected, making planning for the person concerned 
difficult.  However, even if the indicators of the end of life phase are not useful for planning, 
identifying this palliative stage will allow better communication with carers that time may 
be limited.  This may help prepare them better and allow them to help facilitate a PPOD, if a 
location was of importance to the dying individual or themselves.  Continuity of care, from 
one movement disorder physician, once a person is in a complex phase would help, in part 
to identify deterioration and so that trust has been built and discussion about the future 
with a person and their family seems less abrupt.  
In terms of the completion of ACP this does not necessarily need to be done in movement 
disorder clinics or by one person, in fact it may work better across services because 
neurology/movement disorder centres may not be located in the same geographical area as 
many of the people with these diseases; especially true of those with PSP/MSA.  Ideally, as 
suggested in the ambitions document, services should be linked electronically so that if 
someone has already discussed their wishes that information is available for all and they do 
not need to continually revisit the end of life.  Electronic records also allow for the updating 




This may be tricky across movement disorder services for PSP/MSA, given the differing CCGs 
that people will be referred from, but at the very least specialists could inform their patients 
about what might happen, and relate that discussion to GPs.  This, in turn, would educate 
GPs regarding points they should be mindful of regarding progression and the UK rare 
disease strategy states that centres should have protocols in place to share their expertise 
with local teams.  As related by carers in this study, hospices are excellent at ACP, because it 
is done in a holistic manner rather than as a tick box exercise.  It may be that hospices are 
best placed to undertake ACP with people with these diseases but referral into SPC still 
requires honesty from movement disorder teams about what the future may hold.  In 
addition, for some people, especially those who actively want information and to plan, 
hospice might not be necessary at the point these discussions should be taking place.   





Figure 48 Summary of recommendations regarding ACP 
Honest conversations: about the imminence of death  
As discussed in the previous chapters, awareness regarding the imminence of death allows 
people to prepare for the end. 
Improving communication about the imminence of dying can come from many sectors.  In 
part it comes from education, on the part of movement disorder teams and the charities, 
for carers and other HCPs regarding what the end of life looks like.  HCPs in general should 
be more open about the possibility of death.  Rather than an active cure versus a palliative 
approach there should be more crossover so that people are actively treated for infection 
with a clear plan of what to do if that fails.  Shared decision making should occur so that 
people with the diseases and their carers can discuss the aggressiveness of treatment. 
• Movement disorder services 
o Place generic leaflets about thinking ahead in waiting rooms e.g. 
starting conversations 
o Actively ask people about thinking ahead using model such as 
serious illness conversations. Discuss what could happen. Have 
leaflets available regarding options people could choose. Suggest 
open to re-discussion anytime 
o Signpost regarding choices that may need to be made, even if link 
to local service such as GP to ensure they could be made, e.g. 
services in place 
o Ensure staff have been on ACP training so they become 
comfortable with raising discussions before it is too late  
o Once people reach complex stage try and ensure they are seen by 
the same doctor so that 
▪ Trust is built and initiation of end of life planning is more 
natural 
▪ Deterioration between appointments is more evident  
o Use local electronic systems so that any discussions amongst the 
team e.g. with Speech and Language services can be shared. If 
possible link to GPs/hospices as well 
 
• Charities 
o Develop disease specific guidance about the sorts of plans people 
may need to make/consider e.g. PEG, NIV, PPOD  





Importantly any discussion about quality of life should come from the person with the 
disease or their carers; rather than a judgement from HCPs.  There are various documents 
becoming available, such as ReSPECT (265), that will enable hospital staff to be clearer 
about where a person’s priorities lie and they should lead to more proactive planning in the 
acute stage.  HCPs should ask about the existence of prior plans and discuss them openly, 
including how prior plans could be achieved or explaining clearly if there are 
insurmountable reasons why they cannot; this may lessen the guilt of carers if prior wishes 
cannot be achieved.  
Although there is much uncertainty about how imminent death might be, this uncertainty 
can be communicated to relatives so that they feel less in the dark and less isolated.  HCPs, 
in all locations, should be mindful of the fact that people with life-limiting diseases and their 
carers can be unaware that the end has come.  HCPs should be mindful that a person who 
has lost verbal communication can still be part of the decision-making process and they 
should remain the centre of discussions unless they indicate they would prefer not to be.  
Some degree of protective denial may well be in place and sensitive conversations rely on 
people being mindful of this fact; even if people who are dying seem reluctant to discuss it, 
this does not mean permission to speak with their relatives about their care cannot be 
sought.  It may be that GPs/care homes feel they know less about the diseases than carers 
but they are likely to have more objectivity and should check whether a relative is aware 
that the end is imminent, or not, rather than assuming awareness.  When discussing how 
close death is, language should be unambiguous and explicitly mention dying so that 
confusion is lessened and carers are aware that they should stay if it is important to them 
that they are there for the end.   





Figure 49 Summary of recommendations regarding communication in the last 2 days of life 
Bereavement support:  
Not every person wants bereavement support from HCPs and only a small percentage of 
people (around 10%) are left with prolonged/complicated grief that requires counselling 
(266). However, carers of people with PD/PSP/MSA are at particular risk of situational 
factors that might lead to complicated grief as increased burden pre-loss, changes in role 
and lack of preparedness all increase the risk (267, 268), as does sudden death (269).  For 
some of these risks pre-bereavement counselling may be useful as it may help prepare for 
the end; the national bereavement alliance, in their bereavement toolkit for commissioners, 
suggested that pre-bereavement counselling should be widely available (266).  Aoun et al 
(270) showed that a barrier to finding counselling after death useful was that bereaved 
people felt a stranger was involved who did not know them, or the person who had died; 
pre-bereavement counselling would address these concerns.  However, one of the problems 
with arranging pre-bereavement counselling for this group of carers is how to manage the 
time when they are providing care 24/7.  Several of the interviewed carers had pointed out 
they were unable to make their charity support groups because they had no free time.  
• Place of Death 
o Staff in all sectors should be clear about the goals of care of the 
people they are looking after 
o HCP should not assume that people with PD/PSP/MSA and their 
carers are aware that death is imminent and should check 
understanding; this is particularly pertinent in home/care home 
environments 
o If it is clear someone is approaching death then prior plans should 
be discussed with the dying person unless they indicate they would 
prefer not to; a lack of verbal communication does not preclude 
decision making, carers can often interpret better than staff 
o If a dying person is too unwell to discuss that death is approaching 
imminently, their relatives should still be informed to enable them 
to plan and be present if they choose   
o When discussing death clear unambiguous language should be used, 




Logistically the best/only time would be to offer sessions alongside day care sessions either 
in hospices or care homes, but it would need to be piloted with regard to uptake as this is 
often the only ‘free’ time that carers have available to be themselves and not ‘a carer’.   
Formal bereavement support works best when people opt in to taking part (268), but in 
order for people to do that they need to be aware of their options.  Hospitals have 
bereavement support teams, who could suggest options, and hospices have their own 
bereavement teams, but for people who die at home, or in care homes, carers do not 
necessarily know where to look, unless GPs are proactive in offering information about 
services.  Carers in this study said they felt better just knowing that options for ongoing 
support were there.   
Several carers implied a debrief would have been useful and this may be something that 
movement disorder teams could think about offering.  Letters of condolences were 
appreciated by relatives; it made carers feel less abandoned by the services they had been 
involved with for years and made it clear that their relative had mattered.  Phone calls were 
also appreciated and in some cases PD nurse specialists had offered to call in to visit 
bereaved carers they had built a relationship with over time.  If a phone call or offer of a 
visit could be arranged as standard this might help reduce some of the ‘cut off’ feeling 
carers had.  It might also help answer some of the questions people were left with and help 
signpost them to further support, or to hospital teams who could better answer questions 
regarding acute admissions.  In addition, such a visit or phone call could also be used to 
screen for people who are more at risk of complicated grief and a GP could be informed, or 
a referral could be made to bereavement services if the carer was willing.  
Lastly, it may be beneficial for the charity groups to consider setting up bereavement 
support buddies, either face to face, by telephone or online.  A lot of bereavement services 
are run with volunteers who act as a befriending service but given the rarity/complexity of 
these diseases it may help people to be able to speak with someone who had been through 
a similar situation.  Parkinson’s UK offers peer to peer support through their website (271) 
and this could be extended to include bereavement.  Some carers stated they preferred to 
speak with other people who had been long-term carers of people with PD/PSP/MSA 




bereaved people in support groups meeting each other and other carers formed lasting 
friendships with bereaved carers they met on Facebook groups.  
Many bereaved carers want to feel useful and continue to take on volunteering roles, 
including helping at support groups, but Locock and Brown’s study (179) regarding support 
groups in MND perhaps cautions against too many bereaved carers being present in groups; 
some people with the disease felt it changed the focus of the meetings.  Another option for 
those who want to help may be taking on a bereavement support role or chairing groups for 
newly bereaved people.  There are limited studies regarding disease specific/situation 
specific bereavement groups.  Cruse in Wales are in the process of developing a dementia 
specific support, including dementia specific bereavement training (272), and something like 
this could potentially be adapted to suit carers of those who died from other 
neurodegenerative conditions.  In addition, the MND association is currently running focus 
groups with bereaved carers to review the bereavement support they offer (273); the 
findings could be used as a model for the other charities or they could perhaps join together 
to forms groups for bereavement in neurodegenerative diseases.  A joint group would help 
reduce the issue of travelling for bereaved carers as MND, PSP and MSA are all rare and so 
the likely number of bereaved relatives for each individual disease in a given location will be 
small.   





Figure 50 Summary of the recommendations for bereavement support 
In summary, ambition one is about treating people as individuals and as such many of the 
points interlink with ambition 3, maximising wellbeing.  It is the very fact that people are all 
individual and approach life, death and their bereavement in different ways that means that 
• Pre-bereavement counselling 
o If a person with the disease is already attending day hospice/day care in a 
care home, suggesting that considerable carer burden may already be 
present, this could be offered  
 
• Place of death  
o Once death has occurred the bereaved carer should be given information 
on the range of services available locally, on the telephone and online. 
Hospitals, care homes, GPs and hospices should all have a range of 
support available;, in fact the list could be provided through the CCGs 
 
• Movement disorder teams/GPs/hospice 
o A letter of condolence at the very least should be sent once the team 
learns about the death 
o Ideally a phone call should be made +/- a follow up visit for those who 
want it to allow a carer to discuss any concerns or questions  
o This phone call or visit could signpost the bereaved carer to other services 
and allow a check for risk factors for complicated grief 
 
• Charities 
o Consider extending existing peer to peer support to include bereavement 
(Parkinson’s UK) and consider setting up peer to peer bereavement 
support for PSP/MSA 
o Consider training existing volunteers who are themselves bereaved in 
bereavement support and trial local bereavement support groups for 
bereaved PD carers 
o Parkinson’s UK, the PSPA, MSA trust and MND association, or 
combinations, could consider working together to set up a joint group for 
bereavement for carers who have been bereaved through 
neurodegenerative disease, perhaps modelled on the dementia training 
from Cruse in Wales 
 
• Wherever the offers of bereavement support come from it should be made clear 
that people can self- refer at a later date as bereavement often lasts more than a 
year and prolonged/complicated grief is only diagnosed if persistent for more 




services need to offer a range of options to people across the healthcare, social care and 
voluntary sectors rather than a prescriptive one size fits all model in one modality.  
 Ambition 2 and 4: Fair access to care & care is co-ordinated 
The steps suggested to achieve ambition 2 are predominantly related to audit and data 
analysis, suggesting that local services check they are providing equitable provision of care. 
The steps to achieve ambition 4 suggest finding a way to share records across IT systems to 
help co-ordinate care.  Instigating a system wide response to co-ordinate care is suggested, 
with clear indications of the roles of people involved in care.  Ambition 4 also states that 
‘everyone matters’ and that services should find a way to encompass the needs of every 
person, including those living with loss, rather than focussing on those living with more 
‘predictable illness’ (77, p28).  
Each person gets fair access to care/everyone matters  
In terms of fair access to care one of the problems highlighted in this study was the problem 
with continuing care assessments and how they varied across regions; this has been noted 
several times and highlighted in the national audit office report in 2017 (194).   Following 
this report a new national framework for CHC assessments was implemented in October 
2018 to reduce some of the inequity and improve provision of CHC funding (195).  The 
framework suggests that “It is important that those contributing to this process have the 
relevant skills and knowledge”(195, p39) and so it is important that people with 
PD/PSP/MSA are assessed by someone with expertise in movement disorders.   
Equitable access to SPC was also raised as an issue in the interviews; in part this seemed to 
stem from a lack of referral from movement disorder teams/GPs, but in a few cases it 
appeared people were told they were not eligible until the last year of life.  In terms of PD 
not everyone will need SPC but trying to assess who might is important.  Richfield adapted 
the Palliative care needs assessment tool (PC-NAT) to be used in PD to indicate palliative 
care need and triggers for referral to SPC (274); the POS-PD and EQ-5D used frequently in 
QOL research could also be used.  Ultimately an agreement between services about what 




short term SPC interventions for people with neurodegenerative diseases to see if they 
would be beneficial and they have indicated an improvement in QOL, in terms of physical 
symptom burden, for those involved in the intervention arm (74, 275).  A multicentre RCT, 
‘OPTCARE neuro’, evaluating the effectiveness of short term SPC intervention for 
progressive long term neurological diseases is ongoing in the UK (75).  Professionals involved 
in ‘OPTCARE neuro’ were surveyed regarding their views on integrating SPC into neurology 
services and some of the barriers that might occur (75).  SPC doctors felt that discharging 
people following short term intervention would be difficult, or inappropriate, and 
neurologists and palliative care physicians both felt that an increase in referrals might 
become a problem in regard to an unmet need for increased resources (75).  It is important 
to ascertain what SPC will deliver above that which could be arranged through the 
movement disorder services.  Short term intervention may well work for PD, the condition 
progresses more slowly so there is possibly more time after end of life triggers become 
evident to refer; it would also work for physical symptom need.  This study suggests that at 
present it would not be enough for people with PSP/MSA because the rarity of the diseases 
means the continuity found in SPC is highly valued.  Their rarity also adds to the degree of 
existential/identity burden on top of their ongoing needs and continual losses.  In addition, 
the rarity of the diseases should allow continued hospice care as the numbers of people 
engaging with services is unlikely to overburden them.  
Importantly movement disorder teams need to ensure that care is provided right up until 
the end of life, rather than waning when it becomes difficult for people to reach clinics. 
Some may feel that GPs could take over once a person was in a nursing home/homebound 
and unable to come to clinic but this is the very time that more expert input is likely to be 
needed.  In addition, because these people are told that their condition should be managed 
by movement disorder teams, GPs are disenfranchised and are unlikely to be equipped to 
deal with these disorders in the complex/palliative phases.  Movement disorder teams that 




that they have, to ensure that the people with these conditions who most likely have the 
highest degree of need are not abandoned.  
Care is co-ordinated  
One of the reasons hospices were lauded in this study was that they had a single point of 
continuous contact and helped with co-ordination of care.  This should not have to be the 
remit of SPC and could be organised outside of the care SPC services provide.  The need for 
co-ordinated care is not unique to these diseases, but the uniqueness of the diseases makes 
efficient co-coordination of care, for those without disease specific knowledge, difficult.  
Healthcare navigators have been suggested as a way to improve co-ordination of care (189) 
and, where they are in place, better co-ordination and satisfaction with services has been 
shown (180, 193).  Health Education England have produced a competency framework 
about care navigation and a figure illustrating the current roles of navigators (see Figure 51); 





Figure 51 Elements of care navigation according to job descriptions in the UK (276)p17 
The rare diseases strategy suggests people with rare diseases should have a co-ordinator for 
their care but a survey of people with rare diseases in the UK shows that only 19% do (191); 
which appeared to be reflected by the carers’ views in this study.  NHS England is developing 
a set of criteria that will hold providers of care for people with rare disease to account, to 
ensure that “there is a person responsible for coordinating the care of every person with a 
rare disease”(187)p39.  In light of this Clinical Commissioning Groups (CCGs) should ensure a 
set person is available to coordinate care.  
Many CCGs already have existing navigators, all with differing roles, and perhaps there could 
be some provision made for neurological training so that the needs of people with these 
diseases are better able to be met.  Ideally a navigator who was specifically trained to 




may be something that could be added as a role into movement disorder teams.  Even if 
navigators were available the ability to share records across services would aid in co-
ordination and continuity of care.  The care of people with PSP/MSA often crosses CCGs as 
neurology services are mainly found in larger teaching hospitals; something the neurologists 
in the OPTCARE neuro raised as a potential barrier to the short term SPC initiative (75). 
These recommendations are summarised in Figure 52. 
 
Figure 52 Summary of recommendations for co-ordinated and fair care provision 
 Ambition 3: Maximising comfort and wellbeing  
The steps to achieve this ambition are for staff in every setting to recognise and address all 
forms of distress whether caused by physical, emotional, social or spiritual suffering.  A part 
of this aim is to ensure excellent assessment and management of physical symptoms, such 
as pain, and agree with the person dying the extent to which they are managed, for instance 
balancing pain against conscious level (77).  
Wish to die statements 
Maximising wellbeing is important all the way through a disease process and is one of the 
reasons that SPC intervention is advocated before the last year of life.  What is interesting is 
that a large proportion of people with chronic diseases, and certainly those with 
• CCG/movement disorder service 
o Ensure share records within service and ideally across different services to 
allow continuity of care 
o Consider training of a neurological navigator to act as point of access and 
co-ordinator of services 
 
• Movement disorder services 
o Consider palliative needs of the person in the service using an assessment 
tool such as NAT-PD. Use the tool to help decide whether people would 
benefit from SPC or not and refer appropriately 
 
• Hospice/SPC 
o Receive people based on need rather than diagnosis or prognosis  
o Work with local care homes to replicate day centre set up for those with 




neurological disease, express death and suicidal ideation, which the ambitions document 
does not mention.  HCPs are often uncertain of what they should say to people who express 
a wish to die and rather than explore it they tend to avoid the subject (174, 277).  However, 
those that have studied expressions of a wish to die have shown that exploring it can help 
people address physical symptoms, social and psychological concerns (173, 174, 277). 
Hudson et al suggested a two phased approach in response to desire to die statements; first 
asses the nature of the statement and then asses factors that might be contributing, 
discussing ways these could be addressed (277).  It has been suggested, given the 
prevalence of death and suicidal ideation, physicians should actively be asking about it in 
their reviews to enable them to provide better care (174).  Even if reversible issues were not 
found patients could be guided to ACP documents that would at least allow them a choice 
regarding the aggressiveness of future care and may help them feel more in control.  
At the very end of life 
It was clear from the interviews that if physical symptoms, such as pain, were present in the 
last few days the control of these symptoms took over all other concerns.  It can be difficult 
to ascertain pain when people have cognitive or communication difficulties but there are 
pain scales available that have been designed for use in elderly people with limited 
communication which may be helpful (278). 
Control of physical symptoms is important but once this is addressed it is the emotional 
factors that relate to identity that matter the most at the end of life.  When people with 
advanced chronic illness were asked the most important factors at the end of life freedom 
from pain, being at peace with god and the presence of family all ranked highest (204).  In 
addition, 95% or more felt that being kept clean, having a nurse they felt comfortable with, 
being listened to and maintaining dignity were very important (204).  In this study human 
factors were important, including recognition of the dying person as an individual and the 
presence of family, as were environmental factors such as good food, music, pets and space. 
Places that provided food, drink and space clearly provided a better end of life experience 
for all, especially the carers; as did places with continuity of care.  This is one of the points 




are simple things hospitals could do to improve matters such as minimising changes in staff 
(by assigning someone who is going to be present for the week), providing free parking to 
the carers of people who are dying, food/drink vouchers for cafes or at least 
tea/coffee/sandwiches on the ward and potentially allowing pets to come in, especially if 
the dying person is in a side room.  Another factor is ascertaining whether POD is a matter 
of importance and, if it is, all effort should be made to ensure it is achievable, with 
unnecessary delays minimised.  Ultimately having a discussion with people about what they 
want is important and certainly ACP in some nursing homes seem to allow these important 
aspects to be planned for in advance.  
These recommendations are summarised in Figure 53. 
 
Figure 53 Summary of recommendations for maximising wellbeing 
 
• Movement disorder team/hospice/GP 
o Explore physical, psychological, social and spiritual health when reviewing 
o Specifically explore what people are finding hard and if appropriate ask 
whether people have ever thought that life is not worth living?  
o Given that in PD there is an association between death ideation and 
depression a formal depression assessment should be done for people 
who share they have death ideation with an explanation that brain 
chemistry in this disease makes depression more likely 
o If people outwardly say they wish it was over then explore why they feel 
that way to ascertain if increased social help, symptom control or future 
planning may help alleviate the feeling  
 
• Place of dying 
o Ensure physical symptoms such as pain, breathlessness and nausea are 
asked about and treated according to the desires of patients  
▪ If problems with cognition/communication are present then 
discuss with carers and use appropriate pain scales  
o Ask if any ACP has been completed to ascertain issues of importance for 
the end of life, including whether a PPOD exists 
o Try to minimise changes in staff so that the dying person and their carers 
have some degree of continuity 
o Allocate a space for relatives if possible, aim for care in a side room, 




 Ambition 5: All staff are prepared to care 
The steps to achieve this aim are that everyone in the health and social care sectors should 
be trained in end of life care to ensure they understand the holistic nature of caring for a 
dying person and staff should be supported with comprehensive supervision.  HCPs can only 
provide good care when trained and so education and improving knowledge, including 
awareness of legislation, is key; palliative and end of life care should be supported at board 
level as an issue of governance in all organisations.  Lastly HCPs should become used to 
working with technology that might improve their own knowledge and access to those they 
care for (77).  
Knowledge based judgement  
Although movement disorder teams can, and do, provide education within hospitals and 
local care homes regarding PD, the bulk of education comes from the disease charities.  In 
this study some care homes, GP practices and care agencies invited expert speakers to teach 
them about MSA/PSP when they were caring for someone with the diseases and this should 
be encouraged as a point of good practice.  Parkinson’s UK have a comprehensive booklet 
for care home staff and have recently made a 20minute video for care homes to inform 
them about PD.  They have a podcast on keeping people safe in hospital and are launching 
an interactive course for ward staff, which hospitals could add to available training; they 
also have an online ‘palliative care in PD’ module with the open university.  The MSA trust 
and PSPA are much smaller charities, both have booklets about caring for people with the 
conditions; which carers in this study frequently handed out.  However, one of the limiting 
factors for staff, especially in acute hospitals, is time and a quick video made by the charities 
may provide information in a more easily accessible format.  All three charities run study 
days which increase the profile of the diseases and provide education.  Part of NHS 
England’s rare disease insert includes a clause suggesting that each provider should give 
their patients an ‘alert card’ containing information about the condition, treatments and 
contact details for individual experts (187).  Given that these alert cards are set to become a 




some charities such as the MND association and Muscular dystrophy UK make alert cards 
already and this may be something else the MSA trust/PSPA could consider. 
One of the problems that Rare Disease UK identified in their report on the way that having a 
rare disease impacted on mental health was that HCPs do not understand the additional 
emotional burden that a rare disease brings (183).  Individual rare diseases are often not 
included on medical school curriculums, because they are rare, but curriculums could be 
adapted to teach about the experience of living with a rare disease.  In addition, staff could 
be taught techniques to help them when encountering a person with a rare disease; even 
looking it up beforehand would help show interest and allow the focus of discussion to then 
be on the individual rather than the disease.  
Using new technology 
The suggestions above have indicated the ways that technology could be used to facilitate 
care and especially education.  In addition, technology could be used to better facilitate 
episodes of care in movement disorder services.  A lack of information is something that 
people with the diseases and their carers are concerned about and there are a lot of online 
sites which contain information and peer to peer support that movement disorder teams 
could signpost people towards.  This was a recommendation in the rare disease report into 
mental health and along with a mention of charity support groups it referenced ‘Facebook’ 
groups and ‘Rareconnect’ as online sites for people to gain peer support.  An additional use 
of technology in clinics would be to use telemedicine to maintain a connection with people 
who were unable to come to clinics, something that has been shown to be effective in frail 
elderly populations in Scotland and Wales (279) and is mentioned in the rare disease 
strategy (280).  Charity support groups could also look at using technology such as 
teleconferencing to enable people with the diseases and carers to remotely access their 
meetings once travelling became too difficult.  Parkinson’s UK is developing an app and 
device library and this might be useful for people with PSP/MSA as a resource as well.    





Figure 54 Summary of recommendations regarding staff preparation to care 
 Ambition 6: Each community is prepared to help 
The steps to achieving this ambition relate to public health initiatives and a call for all 
organisations to raise public awareness regarding the difficulties people face, alongside help 
they can receive.  It suggests local health and voluntary organisations should work with each 
other to provide support and information/training and highlights the fact that more 
volunteers should be recruited to help deliver support in differing ways (77).  
Public Awareness 
Increasing awareness about PSP/MSA and the non-motor side of PD, and how that can 
affect people, were all suggested as areas that need improvement by carers in this study. 
Public awareness about SPC would help as one of the reasons people with 
• Movement disorder teams 
o Continue to provide training to hospital staff, medical schools and care 
homes about movement disorders 
o Consider using telemedicine via apps such as skype to allow continuity of 
care with people unable to attend clinic appointments 
o Explore and signpost people to the range of support services available, 
including online sources 
 
• Care providers 




o Consider training medical students, nursing students and allied health 
professionals about the experience of people with rare diseases and how 
to make that experience better 
 
• Charities – MSA trust/PSPA 
o Develop short videos that could impart key information about the 
disease to healthcare and social care providers  
o Consider designing ‘alert cards’ that people could carry with them to 
share information and contact details of experts 





neurodegenerative disease may not want to engage with SPC is because of its link with 
death (75); movement disorder services can help to dispel this myth.  The charity websites 
already point out SPC is not just for the dying and carers in this study pointed out that local 
support groups help raise awareness about this as well.    
Another important point of public opinion to work on is the negative attitude towards care 
homes.  This study should help to reassure people that care homes can, and do, deliver 
good care, especially at the end of life.  People should be encouraged to think of care homes 
as positive choices rather than second best.  Day care with possible hospice involvement in 
care homes would allow people to access care homes at an earlier stage and build up a 
relationship with staff so that the idea of living in a home was not so negative.  Respite stays 
in care homes rather than hospices could also be considered, if training for staff had taken 
place.  Although having additional carers coming into a person’s private home or moving 
into a care home are huge changes, it is not uncommon that people find they regain their 
roles as husbands, wives, sons and daughters when caring duties are relieved, and this 
should be relayed as a positive more often.    
Practical support 
Several suggestions for increased practical support have already been outlined above, such 
as using teleconferencing for support groups or providing disease specific ACP guidance. 
Other options that the PSPA/MSA trust could consider would be peer to peer support.  Data 
privacy laws may make this difficult, but if carers gave permission the charities would be 
able to link local carers together for mutual support.  
Volunteers 
All three charities have volunteers and there are various ways that former carers can help. 
Increasing their involvement in bereavement support may be helpful.  Another suggestion 
would be for hospices/care homes to actively recruit former carers of people with 
movement disorders to help raise awareness among staff.  Teaching hospitals could build 
links with the charities to increase undergraduate experiences and people with the diseases 




experiences within the hospital; not only would this raise awareness of the diseases, but it 
may also change practices for the better.  
These recommendations are summarised in Figure 55. 
 
Figure 55 Summary of recommendations regarding the community 
 Summary 
This section has outlined recommendations for clinical practice based on the findings of this 
thesis and linked to current UK policy.   
8.4 Strengths and Limitations  
 Bereaved carers as proxy 
As discussed in the methods chapter there has been debate in the past over whether 
bereaved carers’ views represent a reasonable proxy view of patient experiences (79, 80).  
Reliability studies showed that views match well for service provision and less well for 
symptoms and psychological matters (80).  Taking this into account the aspects of this study 
that reflect on service provision, such as co-ordinated care, communication and planning 
are likely to be closer to the views of the people that had died than views on pain, mood 
and identity.  Given the variability, lack of communication and cognition that can occur in 
the latter stages of these diseases however, it is arguable that carers have to be used to 
represent the experiences of people dying in the palliative phases.  In addition, as some 
people don’t want to think about the end of life, and often within clinics they have not been 
told they are approaching the end of life, recruiting people within the palliative phase in an 
• Movement disorder teams/specialist nurses 
o Explain that hospices/SPC teams provide care to many people who are 
years from dying 
o Talk of the positive aspects of care homes 
 
• Charities 
o Make peer to peer support available locally 
o Encourage volunteers to help in hospices and care homes to increase 
knowledge of the diseases and to support others 




ethical manner could be very difficult. If recruitment did occur it would also be more likely 
to represent those who were in full open awareness and willing to talk about death, which 
may over predict the willingness for ACP.  Often studies that did interview people in the 
latter stages of these conditions excluded people who were unable to speak or had 
significant cognitive impairment (11, 74) whereas this study was able to capture their 
experiences to some extent by interviewing bereaved carers.  In addition, as the aim of 
palliative care is to treat the person who is dying and their family as a unit of care, the fact 
that views may not align entirely is perhaps less important when evaluating palliative/end of 
life care delivery.  A leading matter of importance to those dying is that their family is cared 
for around, and after, the time of their death and in terms of health policy, most of the 
changes that have occurred in the last five years have done so because of the voices of the 
bereaved (83).  That being said there are some limitations in this study in regard to the 
selection of bereaved carers, with the main issue of potential validity related to the time of 
bereavement.   
Time since bereavement  
Some carers responded quickly and may have been subject to more negative views due to 
grief; though that did not appear to be the case.  Other carers were interviewed a long time 
after their relative’s deaths and so their recollections may have been more at risk of recall 
bias (80) and not accurately reflect what was said at the time.  However, as processing likely 
occurred, recollections/feelings that were still vividly present after time were likely to be 
important.   
In addition, because improvements have been made in certain areas and the charities have 
grown some of the issues that were shared in the interviews of carers bereaved years ago 
were less relevant to current healthcare policy; although this was taken into account when 
the analysis took place.  A strength of interviewing people who had undergone a longer 
period of bereavement was that it demonstrated the ways that people managed their 





One of the challenges of this project was that the local information governance team did not 
allow next of kin details to be used to contact bereaved relatives.  This resulted in a project 
redesign that affected the timescales of the project.  However, the fact that the recruitment 
methods had to change became one of the strengths of the project.  In most projects that 
look at the palliative needs of people with PD/PSP/MSA participants are recruited through 
movement disorder services and an element of gatekeeping can take place; this was 
lessened by the opt-in nature of the project.  In addition, most studies are centred on one 
region or service and, as these services are often leading the field regarding the disease 
groups they are studying, they may not represent the experiences of the rest of the 
population.  In contrast this study recruited people from across England and Wales and so 
shows the range of experiences that people can have in different locations, rather than 
reflecting one service.  
Whilst the opt in nature limits the bias of healthcare teams, it can lead to bias in another 
way as it is possible that it is mainly the people with the strongest views, both negative and 
positive that respond.  There is no way to avoid this, but it led to a greater need for 
consideration when undertaking analysis to ensure that all views are represented.  I was 
mindful of this fact during the analysis phase and as such ensured that the voice of every 
participant is represented in this thesis, even if their view on a subject was not as 
vehemently expressed as another’s might have been.   
Sampling  
Another limitation of this project was that aside from the carers of people with PD who 
were interviewed locally there was no way of checking the diagnosis of the people who had 
died. In addition, because the numbers recruited were small and people who contacted me 
through the charities were keen to participate the sample was recruited as a convenience 
sample rather than purposefully; despite this all places of death were represented across 
the three diseases.  Where purposeful sampling was able to be used, in the local PD carers, 
people who died with PD and dementia were actively recruited, because they are 





The forums did not work as well as was hoped. The levels of recruitment were dependent 
on where/how they were advertised and resulted in limited recruitment.  In addition, they 
did not act as a forum; there was little interaction between participants and people tended 
to join, post a comment and then leave, which made it difficult to ask follow up questions.  
The forums did not feel as comfortable as the interviews because it was more difficult to 
check emotional responses to questions than in an interview.  It was also difficult to check 
the demographics of the people taking part because they only interacted with the forum 
once.  
However, a strength of using the forums was that information posted came in a pre-
considered response and so every part was relevant to the initial questions about place of 
death and the matters of greatest importance were clearly presented.  The forums also 
allowed people to post responses when they felt they were ready because of their opt-in 
nature and showed that some people are willing to share their experiences long before the 
usual bereavement period of 3-4 months that many studies fix upon.  
 Reflexivity 
One of the strengths of this study was that, as a trainee in Geriatric medicine, I was involved 
in working in a movement disorder team at the start of the project and had a reasonable 
knowledge of PD, PSP and MSA before the project began.  This helped me to build rapport, 
especially in the interviews with the PSP/MSA carers, where it seemed they appreciated that 
I knew about the diseases because it meant that they did not have to explain them.  In 
addition, because I had recent experience of working in acute hospitals, with previous 
experience working in hospices and into care homes, I was also aware of the treatments and 
interventions that people with the diseases may have encountered, meaning that the flow 
of the interviews did not need to be halted because of a lack of understanding.  Conversely, 
however, it is possible that because of this understanding of hospitals I may have made 
assumptions about certain scenarios that were presented without exploring them in depth 
from the point of view of the participants.  For example, when people related to me the 




situation I encountered regularly.  Being a doctor may have affected the degree to which 
people felt they were able to share their feelings about negative aspects of the healthcare 
service and there did appear to be more reticence to discuss negative views in the locally 
recruited carers.   
Another difficulty was the adjustment to becoming an interviewer rather than an educator, 
which became easier with time.  Once or twice the roles coincided and that may have 
influenced the nature of the interviews.  For example, in an early interview after Vincent 
had explained how hard he found it to process the fact that his wife died without warning I 
said ‘well you probably know that sudden death is fairly common for people with MSA’ only 
to be told he was unaware.  This then led to a discussion about sudden death which, 
although he said it helped him, undoubtedly changed the remainder of the interview.  
Several qualitative researchers speak of the need to protect themselves when undertaking 
bereavement research because of its emotional nature and I was concerned part way 
through the process that I was not emotionally affected as much as I felt I should have been. 
This is likely due to my usual role as a geriatrician; I see people die and speak to their 
families about death regularly and so death has become less of a taboo.  This did not mean 
that I was unable to show empathy, but my objectivity is likely to have affected the analysis 
of the interviews and forum samples.  In addition, because the aim of this project was to try 
and improve services it is possible that the analysis is swayed towards matters that could be 
improved and are negative, rather than reflecting many of the positive aspects of care that 
were relayed, as I was looking for things to fix.   
 VOICES 
Strengths 
The strengths of using the VOICES survey is that it includes opinions from across England 
and Wales, rather than a single geographical area and allows the viewpoints of multiple 
carers to be considered and compared.  As it was collected by the ONS it is not subject to 
the bias it might be if it was sent by local teams.  Because the sample was large (n=1074) 




showed in their VOICES redesign for the national survey that a NET sample size of 651 was 
enough to make statistical comparisons with a margin of error of 0.025 (125).   
Limitations  
The main limitation of the VOICES survey when used to compare POD is that the recorded 
POD on a death certificate and the perceived POD from a carers point of view can differ. 
Table 16 shows the degree of disagreement.  
POD according to Death 
Certificate [total number 
of dc]  







Hospice [27] Elsewhere [8] 
Hospital [331]  320  2  1  4  4  
Care Home [538]  4  524  4  3  3  
Home [162]  0 5  157  0 0 
Hospice [21]  0 0 0 20  1  
Table 16 A comparison of POD according to the death certificate and bereaved carers, England 2012-15 
In addition, in the 2012-13 surveys carers were asked ‘where their relative had spent their 
last 2 days’ and again there was an indication that the views carers shared about the last 
two days may not match the recorded POD (see Table 17). 
 
POD according to 
Death Certificate 
[total number of dc] 
Where did he/she spend the last two days of their life according to carer [total 
number of responses] 
Hospital all 
time [138]  
Care Home all 
time [246]  
Home all 
time [76] 
Hospice all time 
[8]  
Other [13] 
Hospital [153] 137  7  2  0 7  
Care Home [242] 1  235  0 1  5  
Home [79] 0 4  74  0 1  
Hospice [7] 0 0 0 7  0 





Most of the viewpoints did match, but it does mean that questions regarding the last 2 days 
of life may not be entirely representative of the place recorded on the death certificate in all 
cases.   
The final limitation of using the ONS data is that the surveys were not completed with any 
researcher guidance, which may make it difficult to compare issues such as respect and 
dignity because it is possible they will mean different things to different people and 
different things according to location.  For example dignity may mean being kept clean in a 
hospital or care home but might mean respectful communication from a GP. 
 Overall 
The main strength of this study is that it is mixed methods, and this helps to overcome some 
of the limitations in terms of adequately representing place in the qualitative component 
and in terms of interpreting survey responses in the quantitative sample. 
8.5 Suggestions for future research 
This study has answered some questions regarding POD for people dying due to the 
diseases and it might be interesting to compare those dying from PD as an underlying or 
contributory cause to see if there are differences. 
In addition, carers of people with these diseases felt that care was not as good as it might be 
for cancer.  It would also be interesting to compare these diseases to cancer over time to 
see if any differences in service provision are lessening; we might expect this to be the case 
as SPC for neurological conditions is likely to have increased over time. The ONS plan on 
making the free text responses to the VOICES survey available for analysis and comparing 
them to the views of this study would be of interest.  
Lastly, although this study has described the experiences of people with PSP/MSA according 
to their carers there is still a huge gap in the qualitative literature in terms of understanding 
the way that people with these diseases experience care.  Certainly, some of the issues 
suggested by this study in regard to potential loss of self and adjustment to disease, as well 




support.  Given that there is little in the qualitative literature about the experiences of rare 
diseases, findings from such studies would add to the rare disease literature as well. 
8.6 Thesis Conclusion  
This study aimed to explore two areas of research with little available literature:  
1. The palliative and end of life care needs of people with PD, PSP and MSA 
2. Whether the quality of the end of life care experience varies by location for people 
with PD, PSP and MSA 
These areas were explored through qualitative interviews, internet forums and analysis of 
the National bereavement surveys.  
The main findings were that the rapidity of decline, combined with the rareness of PSP and 
MSA, shaped experience, meaning it differed to some extent from people with PD.  
All locations had positive aspects of care reported but those that provided good 
communication, time, an effort to understand the dying person, and continuity, provided 
the best care.  It is the reduction in verbal communication (and to some extent cognition) 
which makes these factors even more important to people with PD, PSP and MSA but at the 




 Information Sheets and Consent Forms 




The MSA Trust has kindly agreed to send this letter to you as they know that you cared for 
someone who has died from MSA.  I know that this may still be a very difficult time for you 
but I would like to invite you to take part in a piece of research aiming to improve the 
services and care provided at the end of life for people with Multiple System Atrophy.  
 
Taking part in the study would involve being interviewed over the telephone about the time 
surrounding the end of your loved one’s life.  This interview would be carried out by Claire 
Morris, a research doctor currently working with the Northumbria Parkinson’s disease team.  
The interview would last around 60 minutes and is very valuable as it would allow us to hear 
from you what you felt were the most important factors for you and your loved one nearing 
the end of their life. Ideally we want to try and determine what, in your opinion, influences 
good and bad experiences when a person with Multiple System Atrophy is approaching the 
end of their life.  We would not want this to be overly upsetting for you and so if any 
questions were too distressing or difficult to answer Claire would move past them.  Also the 
interview could be stopped at any time.  We would want you to be as honest with your 
feelings as you were able to be when answering, as we want to get an accurate opinion so 
that we can try and improve services for the better.  The interview would be audio-recorded 
and once it was completed it would be kept in a secure location and transcribed; at this 
point it would be made anonymous.  Once the whole project is completed, which is likely to 
take around eighteen months, Claire would send you a summary of the results. 
 
If you do decide you might like to take part please contact Claire on the details provided at 




information.  Whether you take part or not after reading the pack, your personal details will 
not be released to anyone else and it will not affect your future care in any way.  
 
Thank you very much for your time, 
 
Professor Richard Walker 
Consultant Physician Northumbria Healthcare NHS Foundation Trust 
 
Details for Claire Morris: 









ii. Project information for participants 
 
Factors that influence the quality of the end of life 
experience for people with Parkinson’s disease (PD), 
Progressive Supranuclear Palsy (PSP) and Multi-system 
Atrophy (MSA) 
Introduction 
Thank you for agreeing to receive more information about this project. Please take time to 
read the following information carefully.  You can ask the researcher questions and please 
talk the study over with others if you wish. 
What is the study about? 
This study is about understanding what factors affect the experience of a person with PD, 
PSP or MSA in the last months of their life.  We specifically want to focus on people with PD, 
PSP and MSA as the nature of the diseases means their experiences at the end of life may be 
very different from the general population.  The aim is to use this information to try and 
improve care and services for people with these diseases coming to the end of their lives 
To enable us to do this we are interviewing the carers of the people who have died and also 
setting up internet forums. 
The interview is to understand what you, as a carer, feel are actually the most important 
issues for us to focus on when looking after a person with Parkinson’s disease coming 
towards the end of their life.  
What difference will the research make? 
We hope that this research will lead to improvements in the way that we provide services 
and care for people coming to the end of their lives with PD, PSP and MSA. It will help 
develop guidance for HCPs, care homes and hospitals about what matters most in the last 




It will also help us to see which symptoms we should focus on controlling better and 
whether Parkinson’s medication is beneficial for people with PD right up to the end of their 
life. 
Why have I been invited? 
We are interested in what contributes to good and bad experiences at the end of a person’s 
life. You have been sent this leaflet because we know that you cared for someone with 
Parkinson’s disease and you previously indicated you would be willing to be contacted with 
regards to research. 
Do I have to take part? 
It is up to you to decide whether you wish to participate in the study.  Your decision will not 
affect the care you receive. Even if you agree to have an interview, you can change your 
mind at any time and do not have to give a reason.  Deciding you do not want to be 
interviewed, even at the last minute, will not affect the standard of care you receive in 
anyway. 
If you are willing to take part in this research study please read and complete the consent 
form in this pack and return it to us. If you do not want to take part please just let us know 
and we will not contact you again.  
What will happen if I decide to take part? 
If you decide to take part, Claire, the main researcher will explain the interview over the 
phone, check that you are still happy to take part and that you understand the research.  
Please feel free to ask her any questions.  She will then agree a time and a place which is 
most convenient for you for the interview to take place.  We would anticipate this to be 
within three weeks from the phone call, providing that this would fit into your plans  
What will the interview entail? 
During the interview she will ask you to talk her through, in your own words, the last few 
months and days of your loved one’s life.  She will ask you your thoughts and feelings about: 
• Whether where the environment your loved one died made a difference, e.g. at 




• Whether you think the place they died was the right place or not 
• She will also ask whether you received enough information and, if not, what you feel 
would have helped more 
She may also explore with you: 
• What you think constitutes ‘a good death’ for people with Parkinson’s disease? 
• What you feel were the positive and negative experiences at the end of your loved 
one’s life? 
• What you think could have improved this time for your loved one and yourself/your 
family?  
This allows you to tell us what you think made a difference in your own words, rather than 
us interpreting what represents quality from questionnaires/guidelines. 
The interview will last about 1 hour, but it can be stopped at any time if you wish.  The 
interview will be audio-recorded.  You do not need to answer any question you do not feel 
comfortable with.  Except in extreme circumstances, i.e. you disclose something illegal that 
she has to report, everything you say will be confidential, even from the Parkinson’s disease 
team. The interviews will then be transcribed and made anonymous.  Once they have been 
transcribed, the original audio recording will be destroyed.  
What are the possible benefits of taking part? 
Some people find it helpful to talk through their experiences and feelings after caring for a 
loved one who has died. In some cases it can also help with the bereavement process.     
What happens to the information I give? 
At the end of the study, the findings will be reported to GPs, consultants and other 
professionals who care for people with PD, PSP and MSA. They will also form part of an 
educational project for Claire and they may be published in medical journals.  We will also 
send a written copy of the key results to you.  Your name will not appear in any reports or 
publications arising from the study.  No comment or reflection you make about your loved 
one’s care/experience will affect the standard of care you receive in the future.  All 




computer network; the original recordings will be destroyed once they have been 
transcribed. 
The study has been reviewed and approved by the Research Ethics Committee (REC 
Reference number: 15/NE/0066).  
Who is organising and paying for the study? 
The study is funded by the Northumbria Healthcare NHS Foundation Trust and is part of a 
MD undertaken at Newcastle University by Dr Claire Morris. The research team is based at 
North Tyneside General Hospital and is led by Professor Richard Walker.  
For further information about the study please contact: 
 
Dr Claire Morris c.e.morris3@newcastle.ac.uk 07745302325  
What if I have a problem or wish to make a complaint? 
If you have any concerns or complaints about the research, we will do our best to resolve 
them.  Please contact: 
 
Ms Caroline Potts 
North Tyneside General Hospital 
Rake Lane 
North Shields 
Newcastle upon Tyne 
NE29 8NH 
Telephone: 0344 811 8111 
Email:  caroline.potts@nhct.nhs.uk 
 




For further information about the study or for extra support please contact your Parkinson’s 
Disease Nurse Specialist or Dr Claire Morris.  
 
You may find it helpful to speak to your family, a friend or your GP about bereavement. You 







0808 800 0303 
 Cruse bereavement www.cruse.org.uk 
Telephone: 0844 477 9400 
e-mail: helpline@cruse.org.uk 
  





iii. Consent form for the interviews 
Factors that influence the quality of the end of life experience for people 
with PD, PSP or MSA 
Name of participant: Please 
initial 
• I confirm that I have read and understand the information sheet for 
the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered 
satisfactorily 
 
• I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
medical care or legal rights being affected 
 
• I understand that the information collected during the study may 
be looked at by individuals at Northumbria NHS Trust, Newcastle 
University or regulatory authorities where it is relevant to my 
taking part in this research   
 
• I understand that my interview will be audio-recorded  
• I understand that all information I give will be stored in a locked, 
secure storage system and/or on a password protected computer 
network only accessible by the research team 
 
• I understand that any publications involving information collected 
will be made completely anonymous prior to publication  
 
• Should I for any reason lose capacity I consent to any information 
previously gained to be used in data analysis 
 
• I agree to take part in the above study  
 
.………………….…………     …….………….   ……… .………………….. 
  Name of Research participant    Date            Signature 
.………………….…………     …….………….   ……… .………………….. 









v. Terms and Conditions on the forum 
 
• I confirm that I have read and understand the information 
for the above study.  I have had the opportunity to 
consider the information,  e-mail questions and have had 
these answered satisfactorily 
 
• I understand that my participation is voluntary and that I 
am free to withdraw at any time without giving any reason 
 
• I understand that the information collected during the 
study may be looked at by individuals at Northumbria 
NHS Trust, Newcastle University or regulatory authorities 
where it is relevant to my taking part in this research   
 
• I understand that the e-mail I use to sign up with will be 
seen by the main researcher but will not be shared with 
other third parties by the research team 
 
• I understand that all comments I make will be visible to 
other people on the forum 
 
• I understand that any comment I type will be read by the 
research team and analysed alongside other comments and 
interviews 
 
• I understand that as the forum is hosted on the internet it is 
impossible to ensure complete security 
 
• I understand that any publications involving information 
collected will be made anonymous prior to publication and 
my pseudonym will be changed 
 
• Should I for any reason lose capacity I consent to any 
comments previously made to be used in data analysis 
 


























































 Death certificates and Contributory/Underlying Causes of death 
i. Death certificates with Parkinson’s disease as an underlying COD  
 



















 How responses were collapsed 
i. Care from staff towards those who were dying 
 




In the last three months, how 
often was he treated with 
respect and dignity by 
a) District nurses (Q13) 
b) GPs (Q16)  
c) Care Home staff (Q21) 
d) hospital doctors (Q25) 
e) hospital nurses (Q25) 
f) hospice doctors (Q30) 
g) hospice nurses (Q30) 
Always Always Always being treated 
with respect should 
be the norm Mostly Not Always 
Sometimes 
Never 
Don’t know  
 




Overall how would you rate 
the care given to him in the 
last three months by: 
a) Out of Hours (Q11) 
b) District nurses (Q14) 
c) GP (Q19) 
d) Care Homes (Q23) 
e) Hospital Doctors (Q28) 
f) Hospital nurses (Q28) 
g) Hospice staff (Q32) 
Excellent Excellent Aim should be for 
excellent care 









Question 35 Responses Way collapsed for 
statistical inferences 
Rationale 
In the last two days of 
life he had sufficient 
support for  
a) pain,  
b) eating  
c) drinking 
d) other symptoms 
e) emotional needs 
f) spiritual needs 
Strongly Agree Agree  
Agree 
Neither agree nor 
disagree 
Do not agree 
Disagree 
Strongly disagree 
Not sure  
Not applicable  
(pain relief/ 
food/drink not needed 




Question 35 Responses Way collapsed for 
statistical inferences 
Rationale 
In the last two days of 
life he had sufficient 




d) other symptoms 
e) emotional needs 
f) spiritual needs 
 
Strongly Agree Food and drink were 
needed/pain relief 
was not applicable 
Appeared to be a large 
variation across the 
locations with regard 
to those who felt relief 
from symptoms/eating 
and drinking was/was 
not required 
Agree 





Not applicable  
(pain relief/ 
food/drink not 
needed or does not 
apply) 
Food and drink were 





iii. Awareness of Dying and PPOD 
 
Question 38 Responses Way collapsed for 
statistical inferences 
Rationale 
Did he know he was 
likely to die? 
Yes, certainly Certainly Previous analysis on 
awareness of dying 
compares those who 
certainly knew 
Yes, probably Not certainly 
No, probably not 
No, definitely not 
Not sure 
 
Question 39 Responses Way collapsed for 
statistical inferences 
Rationale 
Did the person who 
told him he was dying 
do so in a sensitive 
manner 
Yes, definitely Told dying  
 
So few people had 
been told they were 
dying that this 
question could not be 
used to compare 
places with regard to 
the empathy shown. It 
was useful to compare 
how likely people 
were to have been 
told however 
Yes, somewhat 
No, not at all 
Not sure  
N/A they didn’t know 
he was dying 
 
N/A they didn’t tell 
him he was dying 
Not told dying 
 
Question 42 Responses Way collapsed for 
statistical inferences 
Rationale 
Had he ever said 
where he wanted to 
die? 
Yes Yes  
No No/not sure 
Not sure 
 






Do you think he died 
in the right place 
Yes Yes  






iv. Staff communication with carers 




a) were kept informed 
on his condition and 
care 
b) had enough time with 
staff to ask questions 
c) had a supportive 
relationship with staff 
Strongly Agree Agree  
Agree 
Neither agree or 
disagree 
Do not agree 
Disagree 
Strongly disagree 
Does not apply  
Not sure  
 
Question 40 Responses Way collapsed for 
statistical inferences 
Rationale 
Were you contacted to 
give you enough time to 
be there before he died? 
Yes Able to be there 
 
Comparing those who 
had been told in 
enough time wouldn’t 
have worked because 
some groups had a 
large proportion of 
carers who were 
‘already there’ 
I was already there 
No Not able to be there 
It wasn’t clear he 
was dying 
I couldn’t have got 
there anyway 
 
Question 47 Responses Way collapsed for 
statistical inferences 
Rationale 
Were you given enough 
support at the actual 
time of his death? 
Yes, definitely Yes, definitely Either a person has 
enough support or 
their support is 
inadequate 
Yes, somewhat Somewhat, no, not 
sure 














Question 53 Responses Way collapsed for 
statistical inferences 
Rationale 
Since he had died, 
have you spoken to 
anyone in health or 
social services about 
your bereavement? 
Yes Yes  
No, but would’ve liked 
to 
No/not sure 
No, but didn’t want to 
Not sure 
Question 48 Responses Way collapsed for 
statistical inferences 
Rationale 
After he died, did staff 
deal with you in a 
sensitive manner? 
Yes Yes  
No No/not sure 
Not Sure 
N/A no contact with 
staff 
 
Question 53 Responses Way collapsed for 
statistical inferences 
Rationale 
Since he had died, 
have you spoken to 
anyone in health or 
social services about 
your bereavement? 
Yes Wanted bereavement 
support 
 
No, but would’ve liked 
to 
No, but didn’t want to Didn’t want support 




 Demographics of the VOICES sample 
ONS demographic data before response was considered. For each demographic the below 
tables show firstly the data for every person with PD/PSP/MSA somewhere on their death 
certificate and then split the data according to whether PD/PSP/MSA were recorded as a 
contributory or underlying COD.  
i.  Age 
Mentioned on death 
certificate 
50-74 75-84 85+ 
PD [3990] 477 (11) 1932 (48) 1581 (40) 
PSP [107] 41 (39) 51 (47) 15 (14) 
MSA [63] 31 (50) 24 (38) 8 (13) 
 
Contributory COD 50-74 75-84 85+ 
PD [1960] 251 (13) 944 (48) 765 (39) 
PSP [14] 7 (50) 7 (50) 0 
MSA [12] 4 (33) 7 (58) 1 (8) 
 
As underlying cause on 
death certificate 
50-74 75-84 85+ 
PD [2029] 225 (11) 988 (49) 816 (40) 
PSP [93] 34 (37) 44 (47) 15 (16) 






Mentioned on death certificate Male Female 
PD [3990] 2458 (62) 1532 (38) 
PSP [107] 53 (49) 54 (51) 
MSA [63] 35 (56) 28 (44) 
 
As contributory cause on death 
certificate 
Male Female 
PD [1960] 1240 (63) 720 (37) 
PSP [14] 7 (50) 7 (50) 
MSA [12] 4 (33) 8 (67) 
 
As underlying cause on death 
certificate 
Male Female 
PD [2029] 1218 (60) 812 (40) 
PSP [93] 46 (49) 47 (51) 
MSA [51] 30 (59) 21 (41) 
 












PD [3990] 558 (14) 711 (18) 857 (22) 944 (24) 920 (23) 
      
MSA [63] 8 (13) 8 (13) 20 (32) 12 (19) 15 (24) 
 
As underlying cause 





Middle  2nd least 
deprived 
Least deprived 
PD [2029] 254 (13) 368 (18) 440 (22) 486 (24) 482 (24)622 
PSP [93] 13 (14) 16 (17) 28 (30) 21 (23) 15 (16) 
MSA[51] 6 (12) 5 (10) 16 (31) 11 (22) 13 (25) 
 
As contributory 






Middle  2nd least 
deprived 
Least deprived 
PD [1960] 304 (16) 343 (18) 417 (21) 458 (23) 438 (22) 
PSP [14]      





iv. Dementia mentioned on death certificate 
Mentioned on death certificate Dementia mentioned on death 
certificate 
Dementia not mentioned on 
death certificate 
PD [3990] 1084 (27) 2906 (73) 
PSP [107] 10 (9) 97 (91) 
MSA [63] 4 (6) 59 (94) 
 
As underlying cause on death 
certificate 
Dementia mentioned on death 
certificate 
Dementia not mentioned on 
death certificate 
PD [2029] 750 (37) 1280 (63) 
PSP [93] 10 (11) 83 (89) 
MSA [51] 3 (6) 48 (94) 
 
As contributory cause on death 
certificate 
Dementia mentioned on death 
certificate 
Dementia not mentioned on 
death certificate 
PD [1960] 334 (17) 1626 (83) 
PSP [14] 0 14 (100) 
MSA [12] 1 (8) 11 (92) 
 
 
v. The underlying causes of death for the diseases  
The underlying causes of death for those who had PD/PSP/MSA but were not thought to 





Cancer CVD Pneumonia Other 
PD [1960] 254 (13) 539 (28) 374 (19) 793 (40) 
PSP [14] 2 (14) 1 (7) 7 (50) 4 (29) 
MSA [12] 0 (0) 1 (8) 6 (50) 5 (42) 
 
Commonest causes of death listed in part 1a for those with PD 
Most common COD recorded in 
part 1a for those where PD was 
the underlying factor [2029] 
 Most common COD recorded in 
part 1a for those where PD was the 
contributory factor [1960] 
 Cause Frequency (%) Cause Frequency 
PD   526 (26) Pneumonia 652 (33) 
Pneumonia 431 (21) CVD 539 (28) 
Aspiration 
pneumonia 
267 (13) Cancer 254 (13) 





198 (10) Sepsis 78 (4) 
vi. Place of death     
Disease mentioned 
on death certificate 
Hospital Care Home Home Hospice 
PD [3990] 1704 (43) 1704 (43) 509 (13) 73 (2) 
PSP [107] 36 (34) 41 (38) 25 (24) 5 (5) 





Underlying cause on 
death certificate  
Hospital Care Home Home Hospice 
PD [2029] 687 (34) 1044 (52) 263 (13) 35 (2) 
PSP [93] 26 (28) 38 (41) 24 (26) 5 (5) 
MSA [51] 21 (41) 15 (29) 10 (20) 5 (10) 
 
Contributory cause 
on death certificate  
Hospital Care Home Home Hospice 
PD [1960] 1017 (52) 659 (34) 246 (13) 38 (2) 
PSP [14] 10 (71) 3 (21) 1 (7) 0 
MSA [12] 8 (67) 2 (17) 2 (17) 0 
 
vii. Response rates 
Disease mentioned on death 
certificate 
Response No response 
PD [3990] 1933 (48) 2056 (52) 
PSP [107] 49 (46) 58 (54) 
MSA [63] 27 (43) 36 (57) 
 
Underlying cause on death 
certificate 
Response No response 
PD [2029] 1007 (50) 1022 (50) 
PSP [93] 44 (47) 49 (53) 
MSA [51] 23 (45) 28 (55) 
 
Contributory cause on death 
certificate 
Response No response 
PD [1960] 926 (47) 1034 (53) 
PSP [14] 5 (36) 9 (64) 







 Differences in overall positive ratings between those with PD, PSP 
and MSA 
Percentage of carers for each underlying COD who rated the overall care given as 





















































Male [576] Female [396] Male [18] Female [26] Male [13] Female [9]
PD PSP MSA


































































































































































































































































































no [606] yes [366] no [41] yes [3] no [21] yes [1]
PD PSP MSA
Positive care rating according to whether 




























child [19] other [4] spouse
[14]
child [7] other [1]
PD PSP MSA

























Male [327] Female [606] Male [23] Female [20] Male [8] Female [14]
PD PSP MSA











































































































































































































































































 Overall ratings: positive care vs negative care 
i. COD 
Underlying COD Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
PD [973] 870 (89) 103 (11) 1 
PSP [44] 34 (77) 10 (23) OR 0.40 (CI 0.19 to 
0.84); p=0.015 




Age of decedent Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
50-74 [112] 83 (74) 29 (26) 1 
75-84 [510] 410 (80) 100 (20) OR 1.43 (CI 0.89 to 
2.31); p=0.14 




Gender of decedent Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Male [607] 481 (79) 126 (21) 1 





mentioned on the 
death certificate? 
Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
No [668] 547 (82) 121 (18) 1 






v. Deprivation index 
Deprivation index of 
decedent 
Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Most deprived 20% 
[110] 
84 (76) 26 (24) 1 
2nd most deprived 
20% [172] 
137 (80) 35 (20) OR 1.21 (CI 0.68 to 
2.15); p0.51 
Middle 20% [253] 198 (78) 55 (22) OR 1.11 (0.66 to 1.90); 
p=0.69 
2nd least deprived 20% 
[251] 
206 (82) 45 (18) OR 1.42 (CI 0.82 to 
2.45); p=0.21 
Least deprived 20% 
[252] 
210 (83) 41 (17) OR 1.59 (CI 0.91 to 
2.76); p=0.10 
 
vi. Religious belief 
Religion of decedent Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Christian [869] 704 (81) 165 (19) 1 
None/other [153] 117 (76) 36 (24) OR 0.76 (CI 0.51 to 
1.15); p=0.19 
 
vii. Carer decedent relationship 
Carer’s relationship to 
decedent 
Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Spouse/partner [358] 303 (85)  55 (15) 1 
Son/daughter [553] 428 (77) 125 (23) OR 0.62 (CI 0.44 to 
0.88); p=0.008 






viii. Carer’s Age 
Carer’s Age Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
18-49 [105] 75 (71) 30 (29) 1 
50-59 [309] 232 (75) 77 (25) OR 1.21 (CI 0.73 to 
1.98) p=0.46 
60-69 [286] 237 (83) 49 (17) OR 1.94 (CI 1.15 to 
3.27); p=0.013 
70-79 [207] 176 (85) 31 (15) OR 2.27 (CI 1.28 to 
4.02); p0.005 
80+ [122] 108 (89) 14 (11) OR 3.09 (CI 1.53 to 
6.21); p0.002 
 
ix. Carer’s Gender 
Carer’s Gender Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Male [358] 299 (84) 59 (16) 1 
Female [640] 506 (79) 134 (21) OR 0.75 (CI 0.53 to 
1.05); p=0.088 
 
x. Time at home 
Did he/she spend any 
time at home in the 
last 3 months 
Overall how would you rate the quality of care in the last three months? 
Outstanding/Excellent/Good Fair/Poor Significance 
Yes [408] 321 (79) 87 (21) 1 
No, Care Home whole 
time [513] 
431 (84) 82 (16) OR 1.43 (CI 1.02 to 
1.99) p=0.038 
No, Hospital whole 
time [62] 
43 (69) 19 (31) OR 0.61 (CI 0.34 to 
1.11) p=0.10 
 
xi. Place of Death 
Place of death  Outstanding/excellent/good Fair/poor significance 
Hospital [320] 240 (75) 80 (25) 1 
Care Home [544] 453 (83) 91 (17) OR 1.66 (CI 1.18 to 
2.33) p=0.0030 
Home [155] 127 (82) 28 (18) OR 1.51 (CI 0.94 to 
2.45) p=0.092 





 Qualitative case summaries 
i. Summaries of people who died from PD 
 
Jennifer and Doris 
Doris, died in a care home 2 years before her daughter Jennifer posted on the forum. 
Jennifer and her mum found having an advanced directive drawn up hugely helpful and she 
felt that their acceptance of the end of her mum’s life may have helped. She also felt a lot of 
the important things for her mum were human touches, which had been included in her end 
of life care plan, which the care home had suggested she write. She felt that education of 
staff to make them more ‘PD aware’ would be helpful re: time needed for people with PD, 
medication etc. 
 
Sandra and Edmond 
Edmond died at home six and a half years before his wife Sandra posted on the forum. He 
had been declining in health with several infections; he then contracted pneumonia. Sandra 
had promised she would not make him go back into hospital (after a previously harrowing 
experience where they felt vulnerable). He therefore died at home. There was very little 
information imparted to the family. The community nurse told them to stop all of his 
fluid/food/medication, they were not involved in this decision. Sandra was uncertain about 
denying fluids at the time and now feels wracked with guilt she did not questions the 
decision, due to the more recent media coverage around the withdrawal of fluid at the end 
of life.  
 
Moira and Samuel 
Samuel, a gentleman in his 80s, died in hospital one month before his wife Moira posted. He 
had multiple comorbidities and deteriorated whilst an inpatient. Moira felt they had given 




as she had a lot of unanswered questions.  She felt a debrief following the admission, even if 
PDNS or similar could visit at home, would have been beneficial.  
 
Pippa and Cedric 
Cedric died in hospital 15 months before his daughter Pippa posted. He’d had multiple 
admissions in the past where the family had been told he was dying and, on most, his 
medication had been stopped due to fears of aspiration. Pippa felt PD is a killer and we 
should be more open about the fact it can cause people to die. She also felt we should warn 
people about future symptoms such as hallucinations, which she and her mum found very 
difficult to manage. She felt that there is not enough support given to families when people 
are in the more complex stages of PD and suggested a co-ordinator of care would help.     
 
Martha and Fred 
Fred died at home 5 months before his wife Martha posted. He had been admitted to 
hospital with pneumonia and staff spoke to Martha and told her they thought he was dying. 
The couple had previously discussed the end of life and put POA in place and she was able 
to tell the staff that his wish was to die at home. The hospital facilitated a transfer back 
home and her GP then came and explained what the end might be like. She felt the staff 
she’d encountered were caring and communication was excellent throughout. 
 
Brenda and Eddie 
Eddie was diagnosed with Parkinson’s at a fairly young age. Because there were no support 
services where he lived he was instrumental in setting up a support group. His wife, Brenda, 
helped develop the service as well and they successfully managed to get a post for a PD 
nurse, who improved local services dramatically. Eddie had complex PD but things had 
improved somewhat with a recent change to his treatment. He was admitted to hospital 
with what was thought to be a urine infection but he deteriorated quickly and was 
transferred to ICU. Unfortunately things did not improve and eventually he was diagnosed 




consultant, the staff on ICU looked after him well, communication was great and they 
listened to his wife Brenda when it came to aspects of his PD management, liaising with the 
PD nurse as well. Support around the time of his death was good and Brenda was going to 
return to the ICU for a follow up with the staff. Our interview took place three weeks after 
Eddie’s death.  
 
William and Pearl 
Pearl was getting on ok with her Parkinson’s though her mobility was affected quite badly. 
Her husband, William, was her main carer and had to help her with most things. Years 
before they had discussed resuscitation and put in place POAs. One day Pearl got up from 
the chair and fell causing herself significant chest trauma. She was admitted to hospital 
where she was treated; the staff were kind and caring but did not get the medication 
timings right. Sometimes the family felt they were not listened to and things happened 
without them being involved in the decisions, but William was fairly stoical about this.  
Pearl seemed to be improving but then died suddenly and unexpectedly. William has had no 
formal bereavement support; he was fairly distressed during the interview but he doesn’t 
feel bereavement support would help him a lot and he gets by with the support of his 
family.   
 
Barbara and Derek 
Derek had developed PD dementia and Barbara cared for him at home. This was becoming 
increasingly difficult and she was exhausted. He was admitted to hospital with an infection 
and was there for weeks, a planning meeting was held and the mutual decisions between 
staff and family was that Derek moved to a care home. He deteriorated there over the 
following weeks and was treated with antibiotics for a presumed chest infection. He did not 
improve and died in the care home. Barbara was glad he was able to have palliative care 
input in the care home, she had not wanted him to be transferred back to hospital and they 
chose the care home because it could deliver end of life care on site. She actually felt she 





Angela and Graham 
Graham had symptoms of PD for several years before he was diagnosed, his PD then 
progressed rapidly. Because Graham and his wife Angela lived in a semi-rural location 
getting carers was difficult, so Angela was solely responsible for caring for Graham; night-
time hallucinations and incontinence meant very little sleep. Graham had an acute episode 
of abdominal pain and was admitted to hospital, they couldn’t find the cause but did 
diagnose him with pneumonia. He was in hospital for weeks and became much weaker, the 
staff suggested Graham needed nursing care and so he was discharged to a nursing home, 
where thankfully he knew the staff as he had gone once a week to the day centre. About 
two weeks after he moved there he vomited blood and the decision was made for him to 
stay in the home. There were semi-cryptic suggestions that he might be dying, but Angela 
was not told this was the case outright and so she felt she was somewhat unprepared for his 
death. She felt that bereavement support would have been useful as she was not formally 
offered any and some of the services, like cruse, were an hour’s drive away.   
 
Pam and Andrew 
Andrew had been living with Parkinson’s for more than 15 years and had reached the end 
stages of the disease. Pam, his wife, had tried to get continuing healthcare assistance to 
help her to provide care at home but had been unsuccessful, she felt this was due to her 
geographical location/her health board. Andrew had several hospitalisations with infections 
in the last year of life and was treated at home with multiple courses of antibiotics. When 
he failed to respond to one course his GP discussed hospital admission with him and he 
agreed. He deteriorated in the hospital and, because Pam had concerns about his care 
there, she was sure that was not where she wanted him to die. He had wanted to die at 
home but without additional care Pam knew she could not manage so, as Andrew had been 
attending the hospice, it was arranged that he go there for end of life care. His death was 
somewhat of a relief as Pam had found it very hard watching Andrew’s deterioration and 
was exhausted through being a carer.  She felt this exhaustion in some way prevented her 
grieving properly but she contacted cruse for bereavement support and attended a nun’s 





Susan and Paul 
Paul had developed dementia a few years after being diagnosed with PD. His condition 
worsened fairly quickly and his wife Susan needed to help him with everything. Occasionally 
he was aggressive which was very unlike his previous personality. Susan found the PD team 
were very supportive but she felt she would really have benefitted from some additional 
help in the house, even for half an hour; Paul refused carers and nothing else was 
suggested. One day Paul had a fall and broke his arm. His mobility deteriorated hugely in 
hospital and the team there felt he needed a care home placement. Susan felt terrible about 
this and did not agree with the decision at the time as she had promised she would not let 
him go into a home. He died suddenly in hospital before his discharge. She felt this was the 
right thing for him and the end he would have wanted. She did not get any formal 
bereavement support but felt that her family were all she needed. 
 
Simon and Gladys 
Gladys had developed Parkinson’s dementia about 7 years after diagnosis, her son Simon 
moved home to help care for her. She had a lot of problems with hallucinations but these 
improved when her medication was decreased. She became immobile, was unable to 
communicate verbally and had swallowing problems but Simon felt she was at peace and 
happy. Gladys had continuing healthcare and a great care package, although it had taken 
some fighting to get it. Gladys became unwell over a couple of days and was admitted to 
hospital; Simon was shocked to be told she had a severe pneumonia, as he had not spotted 
any signs.  Although things initially seemed to improve, Gladys went downhill and Simon 
was informed she was likely to die. Simon felt the news of her pneumonia and the likely 
poor outcome were explained a little bluntly but the nursing staff were caring and he found 
the palliative care input on the ward supportive. They had discussed getting Gladys home to 
die, but this was not logistically possible. He has not had any formal bereavement support 
but he has information to contact people should he need it and feels this is helpful and all 





Betty and Donald 
Donald had quite a lot of medical problems and then developed PD. He steadily 
deteriorated and due to their remote location getting decent care provision was tricky. 
Luckily Betty knew of a local carer who they hired privately and she was a ‘godsend’. Donald 
was admitted to hospital several times, though it was not clear what was wrong. Donald did 
not eat well and eventually Betty and the carer were unable to get him out of his chair at all 
and so he went into a care home. He collapsed when he moved there and they could not 
rouse him and so he was admitted to hospital.  They felt he had seizures but Betty was 
never clear exactly what was going on as no-one really had time to explain. He got worse 
and she was told things were not going to improve and palliative care was suggested with a 
transfer back to the care home. He died before that happened. She was pleased about this 
as she felt moving Donald would have been too much. Betty had good friends and her 
daughter to support her after Donald died but she did not have any formal bereavement 





ii. Summaries of people who died from PSP 
April and Janice 
April and her mum Janice had discussed her Janice’s wishes at an earlier stage but the end 
came quicker than expected. Janice contracted pneumonia and was admitted to hospital. 
She needed oxygen and morphine to help her symptoms and April felt, because her mum 
declined quickly, she could not have provided this at home. She felt her mum would have 
preferred to die elsewhere, as hospitals are busy and stressful, but she did not feel that 
communication or the kindness shown to her mum could have been better elsewhere. 
April’s main concern in hospital was that she needed to ‘nag’ to ensure her mum had 
morphine in a timely fashion to help her pain, so she worried about others who did not have 
family members to act as advocates.  She told her mum that the team were withdrawing 
care and chose not to alert the nurses when she felt her mum was imminently dying as she 
wanted them to be alone as they had wished. Fortuitously a doctor was present when she 
picked up the death certificate and that helped because she felt guilty she hadn’t noticed 
symptoms of pneumonia but the doctor explained she felt that without PSP the pneumonia 
would not have ended her mum’s life.  
 
Samantha and Ronald 
Samantha had experienced her mum dying from cancer not long before her dad died from 
PSP. She felt the support available for cancer, where people were ‘crawling out of the 
woodwork’ far outweighed that of PSP, principally because HCPs did not understand or 
know what PSP was.  Her dad died in hospital and she felt she had to be there to be his 
advocate due to the staff’s difficulty in communicating with him. She felt staff were mostly 
great but that a lack of knowledge affected their ability to make timely decisions about his 
care.  
 
Peter and Yvonne 
Yvonne was diagnosed with PSP in her 50s with double vision and mobility being her main 




speak remained until the last few days. When at home her husband Peter felt he had to do a 
lot of organising and chasing to get her what she needed. He felt sometimes HCPs did not 
understand how Yvonne was limited by PSP and so labelled her as lazy and chastised her for 
not trying, whereas in reality she was unable to move. A GP dropped off some DNAR forms 
without any discussion and this upset Yvonne who hadn’t wanted to discuss the future. 
After raising this with the GP surgery the couple were then referred to the hospice. There a 
nurse discussed the future over four sessions and this allowed Yvonne the time to think 
about what she wanted. The hospice offered Yvonne a day care place and was also able to 
get CHC funding and helped co-ordinate services. On her third neurology review the 
consultant told her she was advanced and she rapidly decline the following week refusing to 
eat or take her meds, the hospice brought her in for an emergency stay and she then went 
to a nursing home. They provided Yvonne with excellent care and she improved. She 
reached a family milestone and then died with her family present. Initially Peter felt guilty 
that she wasn’t at home as she had wanted but others told him she was, because the care 
home had become her home and he agreed because they had essentially moved operations 
to be based there. He had bereavement support through the hospice and found it helpful. 
He does volunteer work for the hospice and the nursing homes now and that helps too. 
Overall the thing he felt made the most difference was people giving them time and getting 
to know them and treating them like friends, he wasn’t overly enamoured with the medical 
professionals because they never had enough time 
 
Constance and Thomas 
Thomas started to notice he felt off balance and had trouble with double vision, after some 
difficulty with getting a diagnosis he was diagnosed with PSP. His wife Constance did a lot of 
research and contacted the PSP association and they went to local support groups. They 
found hydrotherapy session and the hospice day care to be very supportive and they also 
took part in research trials, which felt like a pleasant break from it all.  Unfortunately, 
Thomas had a few falls and this seemed to increase his speed of decline and he was 
admitted to their local hospice. He was there for several months and eventually had a PEG 
fitted and stabilised and so left the hospice to go into a specialist neurological nursing home. 




be a little too regimented in its ways and the lack of flexibility and attention to health and 
safety sometimes meant Thomas was made to wait to go to the toilet as they wouldn’t let 
her take him, which she felt was dehumanising.  She noticed he was behaving strangely one 
day, as he sometimes did with a UTI and she told the care home staff. They called a doctor 
but there was some delay and he deteriorated a lot whilst waiting. The doctor and staff 
were sure he would improve with antibiotics but later that night he died. This was a shock to 
the care home, so much so Constance felt, that they started CPR on him, despite a DNAR 
order. He was a brain donor but this did not happen, as death certificates etc were not 
sorted in a timely manner. As it happened a post mortem was carried out and COD recorded 
as PSP and COPD.  Constance has not had any offers of formal bereavement support and 
although she might have welcomed it she feels there is a large element of dust yourself off 
and get on. 
 
Stephanie and Nigel 
Nigel started to have falls, most of them backwards, and was quickly referred to a 
neurologist and diagnosed with PSP. Nigel’s main problems were falls, impulsivity and visual 
sensitivity to light. Stephanie cared for him at home, he had several admissions to hospital 
due to falls and she found that these were helpful in providing future support for her at 
home as a review of their home circumstances was carried out. Nigel took part in a few 
pieces of research and this helped him feel ‘useful’. They had to move house, due to Nigel’s 
PSP and buy a new car, both things they lost money doing.  Latterly Stephanie’s sister 
pushed her towards asking for help from the hospice, something Stephanie had not thought 
would be available for people without cancer; she found the hospice day care was excellent. 
As they were getting a wet room fitted Nigel went into a care home for respite but he was 
admitted to hospital two days later with pneumonia.  He initially improved with antibiotics 
and NG feeding but when he tried to eat again he got another pneumonia. He did not want 
PEG feeding and his chest was not improving with antibiotics and so in discussion with the 
hospital team they stopped treatment and withdrew food and fluids. He died a couple of 
days later with Stephanie and their son by his side. She initially felt some relief that her 
husband was free from the disease and that she could get back to herself again somewhat. 




depression.  Now she helps with a local PSPA support group, something that was absent in 
her area when Nigel was alive, and she finds this rewarding. She feels the profile of PSP 
should be raised as if more people knew about it, aside from the increased likelihood of a 
cure, there would be more empathy for those suffering with it and their carers.    
 
Kate and Marion 
Marion had a lot of falls and after a couple of years was eventually diagnosed with PSP by 
which time her eyes were badly affected. Her daughter, Kate, helped her father to care for 
Marion, who lost her ability to speak soon after diagnosis. Kate felt that a lot of the help 
they got had required them to fight, whereas when her dad was later diagnosed with cancer 
support flooded in. Her mother in law was also later diagnosed with PD and again there was 
a need to ask for help rather than the automatic response of support a cancer diagnosis had 
brought her father. After one hospital admission with pneumonia, where Marion had a PEG 
inserted against the wishes of her husband and daughter, they made the decision for her to 
live in a care home. Kate says part of the reason for this was that she wanted to be a 
daughter again rather than a carer. The care home staff were kind and also looked after her 
father, who stayed there all day and had his meals there. Marion went back into the hospital 
a few times when she was living in the home but was often discharged in less than 24 hours. 
After a few months of living in the care home she was admitted with another chest 
infection, which turned out to be more serious, and she died. Kate asked that the diagnosis 
of PSP would be put on the death certificate, she felt this was important because of the 
struggle her mum had had with the disease. During the time Kate looked after her mum she 
had found information from the PSP association helpful, especially their care advisors, and 
because there were no support groups in the area when her mum had PSP she has since set 
one up so that others do not feel the isolation her family did.  
 
Margaret and Chris 
Chris initially started having trouble with slurred speech but was reluctant to see anyone 
about it, when he did the pathway to diagnosis took 3.5 years. After diagnosis his wife, 




need. Unfortunately it was a struggle to get the integration of services to provide the level 
of help they needed and when people did come they didn’t know much about PSP so they 
didn’t always get the right equipment at the right time. A lot of things came through chance 
mentions with Margaret chasing them up, and she felt people were asking her what was 
needed but she didn’t know; she felt it was like being in a maze with a blindfold on and that 
everything came too late. Due to a meeting with another carer she found out about hospice 
and contacted them and they accepted Chris for respite, he had three stays in total. He had 
already completed an ADRT, the hospice consultant counselled against it saying things like 
pneumonia could be easily treated, but Chris felt there was no point as his existence wasn’t 
living. One of Chris’ main problems was thick saliva and they had hoped he would get Botox 
to help, however after waiting and hoping for months when he got his appointment they 
told him he was not eligible because his swallow was not safe. Margaret felt this 
disappointment combined with another episode of ‘bungled’ care after a fall led him to 
somewhat give up and he rapidly deteriorated over a 10 day period. Initially, because Chris 
had deteriorated in steps, Margaret felt it was just another step down which would plateaux 
and none of the visiting HCPs alerted her otherwise. After about a week she told them she 
thought he was dying, even though deep down she still wasn’t prepared for it; he struggled 
and was present till the end and she found this very hard. After he died she wanted to end 
things but is gradually trying to get back to some of the things she enjoyed before Chris got 
ill. She would like to start a support group or volunteer in the hospice but they have advised 
her to wait a while; she has not had formal bereavement support and is unsure whether it 
would help her as she finds reliving the experience difficult.  
 
Hope and Dennis 
Dennis was diagnosed at a late stage of PSP. His mobility and speech had decreased but he 
had put it down to ageing. When he sought an opinion and saw a neurologist privately the 
diagnosis came quickly.  He was relieved he did not have PD and didn’t want to know too 
much about the new diagnosis. His wife, Hope, who had been caring for him sought out 
information and was appalled at what she found.  Eventually, Hope became exhausted and 
when A GP was called to review Dennis’s cough he admitted him to a community hospital in 




and Dennis declined. They felt he could not return home and so a CHC application was 
completed and a care home place found. Whilst in hospital Hope felt Dennis gave up and at 
one point he asked the nurses to give him something to end his life. He deteriorated further 
and she was called in to see him, he was unconscious. She sat with him and was trying to 
decide whether to stay or go home, the nurses said they would make a bed up for her and 
she felt Dennis had heard the exchange because he died minutes later. She was very glad 
she had stayed and was with him. He was due to start attending the day unit of a local 
hospice, but was admitted before this occurred, the hospice did offer Hope bereavement 
counselling however which she complete. She felt that actually she would have been better 
to wait a little longer, as it was later that year she found she really needed help, after all the 
sorting and probate etc was done.  She is now a co-ordinator for a local PSPA group and this 
has given her a new sense of purpose and she finds supporting other carers and people with 
PSP very rewarding.  
 
Colin and Grace 
Grace had noticed she had problems lifting her feet when walking, she saw a neurologist 
and they diagnosed her. Over the years her swallow worsened but she refused to have a 
PEG. Colin found he had to organise everything; although he felt NHS individuals were very 
good the system itself was slow and unresponsive and not well co-ordinated. After a while 
Grace decided she would move into a care home as she was concerned about how 
exhausted Colin was getting. Most people suggested she try the neurological care home but 
she had found it a bit clinical environment wise and preferred to go to a local care home 
which was more homely and where staff had a more personal touch. She had previously 
discussed that she did not want to be treated if she acutely worsened and had recorded a 
DNAR with her GP. One day staff noticed she was worse and called a GP but no-on really 
communicated to Colin what they had noticed. As Grace did not seem that altered to Colin it 
was a great surprise to him when he was called at 5am the next day and told to hurry in as 
she was dying. She died before he got there and although he finds this sad for himself as he 
would have like to be with her, he felt it would have been a relief to Grace who had long 
since had enough. He got a lot of support from his family and does not feel talking to a 




PSP/CBD is important so that people are diagnosed earlier and can get co-ordinated care at 





iii. Summaries of people who died from MSA 
 
Charlene and Evelyn 
Evelyn remained independent even with the need for four times a day care. Her family had 
promised her she could stay at home, whatever happened, but she was rushed into hospital 
with pneumonia and told she was imminently likely to die. Charlene, her daughter, managed 
to get the family to her side and they were present when she died. She felt that her mum 
would have been in distress and pain if she had not been in hospital and praised the 
empathy shown by hospital staff. Evelyn died less than a month before Charlene posted.   
 
James and Rachel  
Rachel maintained a sense of macabre humour throughout her journey with MSA, she 
wanted to plan for the future, and did, without knowing exactly what the disease would 
bring. The biggest problems James and Rachel encountered was a lack of knowledge of 
MSA, meaning the system did not cater for her needs. The thing that hurt Rachel most was 
that some of her friends and family disappeared as her condition worsened. To counter the 
hopelessness she felt she had decided to donate her brain to research. Rachel had discussed 
euthanasia several times and asked James to help her at the end, this affected decisions in 
regard to further antibiotics for future infections. In the last month Rachel deteriorated and 
said she was ready to die, palliative care helped support her, and her family, at home. She 
died 3 years before James posted.  
 
Nicole and Jake 
Nicole cared for Jake single-handedly for years, leaving her with physical disabilities.  Jake 
had made it clear for about six months that he wanted to die. He was given antibiotics for a 
chest infection one day and the next morning Nicole found that he had died suddenly 
overnight. He was a spinal cord donor and the post mortem report mentioned infection 
around removed toenails, as Nicole had signed the consent for the procedure she was left 




to die at home however and that fact that he did gave her comfort; she felt he would not 
have forgiven her if she had transferred him to hospital. Though her family think she has 
come to terms with his death, Nicole does not think any amount of counselling will help and 
she still suffers with flashbacks of finding him dead and worries if other people stay in his 
room that they won’t wake up. Jake died 9 years before Nicole posted. 
 
Abigail and Stella 
A year before Stella died she had a fall and moved into a care home. Staff were great but 
not always aware of Stella’s needs due to the rarity of MSA; luckily the specialist team 
visited the care home and gave information sessions to staff on several occasions. Stella was 
clear about her wishes and her daughter helped her to document them, in collaboration 
with the community palliative care team. Being a brain donor was very important to her.  At 
the end of Stella’s life Abigail was able to stay with her in her room, the palliative care team 
helped with pain relief and Stella died peacefully with her family present.  Abigail felt that 
although discussing the future could be challenging it was hugely important to understand 
what was best for her mum. Being open also meant her mum told her she was ready to die 
and she felt that was important for both of them. The fact that the family did so much to 
honour Stella’s wishes, with the care home and church doing the same, gives Abigail some 
peace in her bereavement. Stella died 5 months before Abigail posted.   
 
Julie and David 
David and his wife worked fulltime to pay off the mortgage and had two children, a son 
Mark and a daughter Julie. David was diagnosed with MSA aged 47, he felt as though he was 
drunk when he walked; they were not told that the condition was palliative. He maintained 
his sense of humour whilst he lost his mobility and his speech, and maintained his cognitive 
function throughout.  He brought up the subject of euthanasia once or twice but had not 
written down any concrete plans. The family were preparing to get a DNAR order sorted 
when he became suddenly unwell and suffered a cardiac arrest. He was admitted to ICU. 
There were conflicting feelings between son and daughter about how aggressive to be with 




who came to the ICU and suggested end of life care would be more appropriate, given 
David’s disease and prior wishes. He died on ICU aged 53 and his daughter feels this gave 
them a chance to be with him and say goodbye. She felt the staff on the ICU were caring and 
supportive. He had a huge funeral, as he was a popular guy, and they raised a lot of money 
for the MSA trust. He died in 2007, eight years before this interview took place. Caring for 
her father left Julie with a lot of financial problems. His death resulted in a depression and 
she even attempted suicide; this was a couple of years after he died and she received 
counselling at that point.  She now lives life with a positive outlook but maintains that she 
strongly believes in the right to die. She is a member of ‘Dignitas’ and if she were diagnosed 
with MSA she would want an assisted death.  
 
Helen and Tony 
Tony worked in farming and loved being outdoors; Helen worked full time as well. Tony 
started to notice he was unsteady at work and after several medical reviews he was 
diagnosed with MSA. They were told he’d be in a wheelchair in 5-10 years and were both 
devastated by the news. Tony did not want to know about what the future held and so they 
did not discuss future plans. As Tony deteriorated Helen gave up work to care for him full 
time, they both wanted him to stay at home and she thought he was worth more than the 
amount of care social services could provide. Overtime they used a lot of equipment and 
inventive ways to enable Tony to live life as much as possible. Helen found it frustrating that 
people did not try to communicate with Tony once his speech went as his mind was still 
there and he was still the same person. People who recognised this and did communicate 
with him were held in high esteem. He was undergoing treatment for a chest infection when 
he suddenly stopped breathing one night, she started CPR and he was transferred to the 
hospital. Once there the decision was made to withdraw medical treatment and he died, 
though Helen feels really he had died at home. He died in 2008 seven years before this 
interview took place. Helen found his death incredibly hard to deal with as he had been her 
world and reason for living, she became depressed and found the healthcare services to be 





Vincent and Beatrice 
Beatrice was a highly intelligent businesswoman who delivered training all over the world. 
When she started having mobility problems she began researching potential diagnoses on 
the internet and felt that MSA was the most likely diagnosis. She had difficulty in persuading 
local services that this was the case and it was by chance, when abroad at their holiday 
home she spoke with someone who saw a neurologist for PD. They got in touch with this 
neurologist who confirmed MSA was likely and recommended a neurologist in the UK. The 
UK neurologist was based at a research hub and Vincent felt that going there and seeing 
that neurologist helped Beatrice, as being involved with research gave her purpose. He felt 
all staff at the research hospital cared about an individual as a person and built confidence, 
which was a complete contrast to the local district hospital where he felt a lot of staff 
treated patients as bed numbers and had a poor vocational work ethic. Over the years 
Beatrice and Vincent discussed death and dying but had not made any concrete plans 
because they were managing well. One day Beatrice became unwell and collapsed, requiring 
CPR, she was admitted to hospital and diagnosed with pneumonia. Vincent felt the way that 
DNAR was discussed with him on admission was presumptive and uncaring. Beatrice 
improved and was due to go home but then one night she suddenly died. He was most 
upset that the doctor who was completing the death certificate was not going to record 
MSA as COD because he felt saying she had died of pneumonia was incorrect. He did not get 
bereavement support so although he felt it might have helped he can’t be sure.       
 
Paul and Emmy 
Emmy was a healthcare professional and was close to retirement, she started having 
difficulty with her bladder and mobility. When she was diagnosed Paul asked the MSA nurse 
to inform him of the prognosis, she told him and said most people steadily decline and die 
peacefully. He felt he watched his wife deteriorate every day and he could see through her 
deterioration that she was dying. Although Emmy did make plans she preferred to discuss 
them with her pastor and friends, rather than with Paul; he felt she was in some way trying 
to protect him. Towards the latter stage of the illness she had told friends she was waiting 
to die. She was admitted to hospital with a suspected urine infection but the medical team 




sister suggested the hospice might be appropriate and Paul and the sister asked Emmy if she 
would want that and she agreed. She was in the hospice for three weeks and then died.  
Paul continued to go to support groups after she died but now feels he has to move on. He 
would have liked more information about what the end of life in MSA could look like.    
  
Elaine and Stephen 
Elaine and Stephen had always been open about discussing death, for a long time before 
Stephen was diagnosed with MSA. He was eventually diagnosed due to increasing problems 
with mobility, but years after he had a long term catheter placed for continence issues. He 
had recurrent urine infections and was admitted to hospital when the latest course of oral 
antibiotics failed to help his confusion. Once in hospital he was boarded to an orthopaedic 
ward and despite Elaine’s concerns his antibiotics were kept the same as at home and no-
one seemed to understand he was not getting better. Elaine found it very frustrating that 
no-one understood what MSA was and despite her suggestion that they contacted 
Stephen’s consultant no-one seemed to care about the fact he had MSA. Because Stephen 
had attended the local hospice as a day patient for some time Elaine, in her despair, 
contacted the consultant there and after a couple of days he was transferred. The 
improvement in communication, care and environment was huge but unfortunately 
Stephen was diagnosed with pneumonia. The consultant explained he was likely to die and 
his family were all with him when he died the next day. Whilst at the hospice Elaine had pre-
bereavement counselling and she continued to see the counsellor for a year after Stephen’s 
death, she feel this helped her immeasurably. Throughout Stephen’s illness Elaine had 
gained a huge amount for MSA support groups and she continues to interact with online 
support groups, including an MSA widow’s site.   
 
Aileen and John 
When John was diagnosed with MSA he and Aileen made the decision to move across the 
UK to be closer to family. This meant leaving a lot of their support network behind and their 
jobs. Benefit agencies with little knowledge of MSA made matters worse. John was clear 




the MSA took over.  One day he fell down the stairs, sustaining a head injury that took him 
into hospital. He was in hospital for months and kept deteriorating. He already had a lot of 
communication difficulties and Aileen did not feel able to leave him because no-one 
understood what he needed and he also suffered with intractable pain. Eventually the 
palliative care team got involved and pain relief provided a little help, but never completely 
alleviated his pain. He was transferred to a community hospital and although staff did not 
know about MSA they were willing to learn more and because he was there for months 
Aileen and the staff built up an understanding and respect, even if they did not always 
agree. Eventually it was clear John was not going to get better and Aileen bluntly raised this 
in a best interest meeting; she refused to have him transferred to a care home as even in 
hospital his pain was not controlled. After he died she did not want bereavement support as 
she feel able to manage on her own, however, she feels it might be beneficial for her 
daughter who still struggles with the memories of her dad’s last weeks. She now runs a 
support group and is gratified that more have started, as she would have gained a lot if one 
had been available when they first moved.  
 
Charles and Anna 
Anna had never wanted to think about or discuss what the future might bring and so never 
discussed the future with Charles. She was devoted to her grandchildren and loved to spend 
time with them. They remained determined to live life to the full and continued to travel 
and go out to restaurants, with help from carers. One of the most difficult things was that 
she lost the strength in her voice and yet was unable to manage communication devices due 
to her co-ordination. Charles found that there was a lack of co-ordination within the health 
and social care service that he found disconcerting, he also found it contrasted with his 
experience of the travel industry. Anna had considered the possibility of a care home if she 
deteriorated and she tried one out but it was not a success and neither was a respite stay in 
the hospice, home was best for her. They managed to keep her at home through continuing 
healthcare funding (which it was a challenge to get) and had a series of live in carers who 
looked after her well.  At the end Anna developed pneumonia, the doctor reviewed her at 
home and admitted her to hospital.  The family were told she was dying and were able to be 




a brain donor but because of the sudden nature of her deterioration with pneumonia, 
Charles forgot to mention this on admission. He feel staff should actively seek this 
information out. He was not offered bereavement support but would have refused it 
anyway as he managed with his family and accepting external help was not in his character.   
 
Philip and Thelma 
Thelma started having trouble with her legs and after a while she saw a private neurologist 
who diagnosed her with PD. As the medication he prescribed did not help she was referred 
on and the MSA diagnosis was made. The neurologist made it clear she was never to stop 
her tablets and her condition could worsen a great deal, and this information stuck with 
Philip. As the MSA progressed many different health and social care workers were 
encountered and Philip labelled them the goodies and the baddies. The district nurses were 
helpful and taught his a lot and the hospice day care were always amazing. The social care 
assessors were less well received. Thelma loved her GP who offered excellent continuity of 
care and always tried to keep her at home as much as possible, but he then retired. Wen 
Thelma became unwell one day the new GP refused to visit and she was admitted into the 
hospital. Because she was unwell she was made nil by mouth and this led Philip to panic 
because she was not getting her medication. Communication was not good. He felt the 
hospital never understood how important she was as a person, whereas the hospice did. 
She was diagnosed with pancreatitis and her MSA was overlooked, no-one seemed to 
understand why Philip felt it was important. Philip was told Thelma was likely to die and he 
asked that she be transferred to the hospice, as they had previously agreed that Thelma 
would want to die in the hospice, or at home if the hospice were unavailable.  However, the 
transfer did not happen because a different doctor told him Thelma had improved. When it 
became clear she hadn’t and the palliative care team in the hospital reviewed her it was too 
late to transfer her.  They gave her increasing pain relief and Philip feels this killed her. He 







Sebastian and Jade 
Jade had symptoms for six years before she was diagnosed with MSA. They ended up with 
live in carers, who were variable and the co-ordination between different care agencies and 
the district nurses left a lot to be desired. Due to a lack of knowledge about MSA Sebastian 
carried information with him to give to anyone new involved in Jade’s care. He also found 
that a lack of knowledge in the hospice and concern for health and safety meant Jade lost 
her mobility on a respite stay. They had discussed PPOD and Jade wanted to be at home, so 
when she developed a chest infection the GP gave her antibiotics and discussed equipment 
that could be brought in if needed. Their GP was good, was honest about her lack of 
knowledge regarding MSA but keen to look it up, something Sebastian appreciated. Jade 
was a Christian and had never had any trouble discussing the future. She had asked their 
pastor if it was alright to ask God to take her for a few months before she died.   Sebastian 
had a leaflet about bereavement support from the hospice but felt adequately supported by 









 VOICES graphs and stats 
i. Respect and Dignity by service provider for those with PD,PSP,MSA, England 2012-15 
 
Likelihood of always being treated with respect and dignity by hospital nurses in the last 
3months of life compared to other service providers  
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Hospital Nurses     148.328 6 0.000       
Hospital Doctor -0.229 0.126 3.305 1 0.069 0.795 0.621 1.018 
Care Home -0.369 0.118 9.837 1 0.002 0.692 0.549 0.871 
GP -1.293 0.151 73.272 1 0.000 0.274 0.204 0.369 
District Nurse -1.433 0.169 71.667 1 0.000 0.239 0.171 0.332 
Hospice Doctor -2.140 0.537 15.916 1 0.000 0.118 0.041 0.337 
Hospice Nurse -2.569 0.606 17.976 1 0.000 0.077 0.023 0.251 



















































































PD District Nurse [267]
PSP District Nurse [20]
MSA District Nurse [12]
PD Hospice Dr [31]
PSP Hospice Dr [4]
MSA Hospice Dr [2]
PD Hospice Nurse [35]
PSP Hospice Nurse [4]
MSA Hospice Nurse [2]
PD Hospital Dr [455]
PSP Hospital Dr [16]
MSA Hospital Dr [13]
PD Hospital Nurse [499]
PSP Hospital Nurse [17]
MSA Hospital Nurse [14]
PD Care Home [623]
PSP Care Home [24]
MSA Care Home [9]
Respect and dignity by service provider according to PD, PSP 
or MSA diagnosis
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Other Hospital Nurse [21373]
CVD Hospital nurse [12457]
Cancer Hospital nurses [17020]
PDRD Hospital nurses [530]
Other Hospital Doctor [19614]
CVD Hospital Doctor [11547]
Cancer hospital doctors [15970]
PDRD hospital doctors [484]
Other Care Home [16774]
CVD Care Home [6606]
Cancer Care Home [4513]





Other District nurse [9767]
CVD District Nurse [6014]
Cancer DN [14732]
PDRD DN [299]
Other Hospice Nurse [954]
CVD Hospice Nurse [510]
Cancer Hospice nurse [5887]
PDRD Hospice nurse [41]
Other Hospice doctor [884]
CVD Hospice doctor [462]
Cancer hospice doctor [5683]
PDRD Hospice doctor [37]
How often was he/she treated with respect and dignity in the 
last 3 months by service provider and COD, England '12-15




Likelihood of always being treated with respect and dignity according to service 
provider and COD 
PD/PSP/MSA Vs Cancer Vs CVD Vs Other 
Care Home OR 0.715 (0.61 to 
0.85) p<0.001 
OR 0.90 (0.77 to 
1.06) p=0.21 
OR 0.83 (0.70 to 
0.97) p=0.02 
Hospital Dr OR 0.86 (0.72 to 
1.04) p=0.114 
OR 0.79 (0.66 to 
0.95) p=0.012 
OR 0.86 (0.72 to 
1.03) p=0.106 
Hospital Nurse OR 0.91 (0.77 to 
1.09) p=0.307 
OR 0.84 (0.71 to 
0.99) p=0.048 
OR 0.88 (0.74 to 
1.05) p=0.151 
Hospice Dr OR 0.68 (0.24 to 
1.92) p=0.463 
OR 1.83 (0.63 to 
5.31) p=0.264 
OR 2.17 (0.76 to 
6.20) p=0.149 
Hospice nurse OR 1.30 (0.40 to 
4.20) p=0.667 
OR 2.9 (0.88 to 9.59) 
p= 0.081 
OR 3.86 (1.18 to 
12.64) p=0.025 
District Nurse OR 0.91 (0.68 to 
1.21) p=0.528 
OR 1.27 (0.95 to 
1.70) p=0.105 
OR 1.24 (0.93 to 
1.65) p= 0.146 
GP OR 1.26 (0.99 to 
1.61) p=0.062 
OR 1.49 (1.17 to 
1.91) p=0.001 
OR 1.50 (1.18 to 
1.92) p=0.001 
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Dignity and respect by care provider to people with PD, PSP or 
MSA in the last 2 days of life,  England, 2012-15




















There was enough help to meet his personal care 
needs, by POD, England '14-15




















There was enough help with nursing care in the 
last 2 days, by POD, England '14-15





















There was enough privacy in bed area and 
surrounding environment, by POD, England '12-15










ix. Overall ratings of care by service provider in the last 3 months of life according to PD, 
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MSA Hospital Dr [14]
PD Hospital Nurse [516]
PSP Hospital Nurse [20]
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PSP Care Home [24]
MSA Care Home [10]
PD District Nurse [276]
PSP District Nurse [21]




Overall level of care in the last three months by 
service provider according to PD, PSP or MSA 
diagnosis, England 2012-15

































































































































Other Hospital nurse [21749]
CVD Hospital nurse [12615]
Cancer Hospital Nurse [17156]
PDRD Hospital Nurse [539]
Other Hospital Dr [20431]
CVD Hospital Dr [11950]
Cancer hospital Dr [16314]





Other Care Home [16934]
CVD Care Home [6674]
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PDRD Care Home [665]
Other District Nurse [9780]
CVD District nurse [6026]
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Overall how would you rate the level of care 
provided by services in the last 3 months, by 
COD, England '12-15




Likelihood of care being rated as excellent according to service provider and cod 
PD from… Vs Cancer Vs CVD Vs Other 
Hospice OR 0.73 (0.33 to 
1.58) p=0.423 
OR 1.68 (0.76 to 
3.74) p=0.202 
OR 1.88 (0.86 to 
4.13) p=0.115 
District Nurse OR 0.79 (0.63 to 
0.99) p=0.049 
OR 1.2 (0.95 to 1.52) 
p=0.120 
OR 1.15 (0.91 to 
1.45) p=0.24 
Care Home OR 0.77 (0.65 to 
0.90) p=0.001 
OR 0.95 (p.81 to 
1.11) p=0.52 
OR 0.88 (0.76 to 
1.03) p=0.12 
GP OR 1.04 (0.85 to 
1.28) p=0.69 
OR 1.49 (1.22 to 
1.83) p<0.001 
OR 1.55 (1.26 to 
1.90) p<0.001 
Hospital Nurses OR 0.92 (0.77 to 1.1) 
p=0.38 
OR 0.89 (0.74 to 
1.06) p=0.19 
OR 0.996 (0.34 to 
1.19) p=0.96 
Hospital Doctor OR 0.92 (0.77 to 
1.10) p=0.37  
OR 0.87 (0.72 to 
1.04) p=0.12 
OR 0.95 (0.79 to 
1.14) p=0.55 
OOH OR 1.07 (0.83 to 
1.36) p=-0.616 
OR 1.31 (1.02 to 
1.67) p=0.035 
































































































































Emotional needs were supported in the last 2 days, by 
location and COD, England 2014-15





























































































































Enough support was given for spiritual needs in the last 2 
days, by location and COD, England 2014-15































































































































Enough support was given in the last 2 days for pain, by 
location and COD, England 2014-15






























































































































Enough support was given for spiritual needs in the last 
2 days, by location and COD, England 2014-15




































































































































Enough support was given in the last 2 days to assist with 
drinking, by location and COD, England 2014-15 





























































































































Enough Support was given in the last 2 days to assist with 
eating, by location and COD, England 2014-15
















































































































































































Awareness of Dying, by COD and location, England 2012-
15 















































































































Dying person was informed that they were dying, 









xxiv. PPOD by COD 
 
 




























Preferred place of death by COD, England 2012-15




xxvi. Where did he/she want to die, by COD, England 2012-15 
 

































Where did he/she say they wanted to die? By COD, England 
2012-15






















































































































Died in the right place by COD


































































































































The extent to which carers felt they were kept informed about 
their relative's care and condition by COD and location, 
england 2014-15



























































































































The extent that carers felt they had enough time to discuss 
concerns with staff by location and COD, England 2014-15


































































































































Extent to which carers felt they had a supportive relationship 
with staff in the last two days of their relative's life, by COD 
and location, Enaglnd 2014-15









xxxiv. Carer present at time of death  
 































































































Was carer present at the time of their relative's death, by 
COD and POD, England 2012-15








xxxvi. Support at actual time of death for PD/PSP/MSA carers by POD England 2012-15 
 































































































Did carer feel supported at the actual time of their relative's 
death, by COD and POD, England 2012-15









xxxviii. Bereavement support for PD/PSP/MSA carers by POD, England 2012-15 
 











































































































































Did carers receive bereavement support from a healthcare 
professional after their relative died, by COD and POD, 
England 2012-15








 Background summary of each ambition 
i. Ambition 1 
Ambition 1 explains that people who are dying fear having their wishes ignored and 
overridden. It explains that people want to be involved in their care, and decisions made 
about them, and should be helped with this, in terms of information and support. Though 
talking about the future might be difficult, it explains that people want to repeated 
opportunities to decide on whether they are ready to discuss the future or not. When death 
seems imminent it explains that this should be identified and communicated, alongside any 
uncertainty that exists.   
ii. Ambition 2/4 
Ambition 2 explains that that care is harder to access for people in rural areas and that there 
are unacceptable inequalities regarding palliative/end of life care for those with dementia 
and non-malignant conditions. It also points out there are unacceptable variation in access 
to pain control across different care settings.   
Ambition 4 explains that fragmented care and a lack of co-ordinated care cause distress and 
points out that poor communication between services is not good enough. It suggests social 
care should be provided regardless of financial circumstances and that palliative services 
should be available 24/7. Lastly it points out that access to, and trust in, community services 
is paramount to providing care outside of hospitals, where most people prefer to be 
iii. Ambition 3 
This ambition explains that many people approaching the end of life are fearful of being in 
pain and that dying is a source of emotional distress and social isolation. It explains that pain 
is something that can be relived through expert palliative care and that palliative care from 
an early stage improves quality of life. It also indicates that witnessing a peaceful death can 
help adjustment in bereavement. 
iv. Ambition 5 
The background to this ambition is that looking after the dying is difficult and often staff are 




unsupported then providing compassionate care becomes harder.  In order to make dying at 
home more achievable paid carers need to be provided with enough support as well; 
something which is currently lacking. 
v. Ambition 6 
The background to this ambition is related to the denial of dying thesis. It states that death 
and dying are not health or social care events but effect every person and community, 
despite this people feel disconnected when going through the experience. There should be 
more public openness about dying and communities should be able to provide support, with 
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